Strain Name:

B6.Cg-Lepob Ldlrtm1Her/J

Stock Number:


Order this mouse


Cryopreserved - Ready for recovery

The mice may be useful in studies of diabetes, metabolism, hyperglycemia, atherosclerosis, and hypercholesterolemia.


The genotypes of the animals provided may not reflect those discussed in the strain description or the mating scheme utilized by The Jackson Laboratory prior to cryopreservation. Please inquire for possible genotypes for this specific strain.

Strain Information

Type Congenic; Spontaneous Mutation; Targeted Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Additional information on Congenic nomenclature.
Specieslaboratory mouse
Generation Definitions
Donating InvestigatorDr. Jan L. Breslow,   Rockefeller University

Independently, the C57BL/6-Lepob homozygotes (Stock No. 000632) model the increasingly prevalent metabolic disorder seen in humans (hyperglycemia, hyperinsulinemia, and hyperlipidemia), while LDLR-deficient mice (Stock No. 002207) are predisposed to atherosclerosis. When mutant mice are homozygous for both mutant alleles, they exhibit exacerbated hyperlipidemia and extensive atherosclerotic lesions in the aorta. The mice may be useful in studies of diabetes, metabolism, hyperglycemia, atherosclerosis, and hypercholesterolemia.

The Ldlrtm1Her mutation was made by Dr. Robert Hammer and Joachim Herz (HHMI, University of Texas Southwestern Medical Center). Briefly, a targeting vector was used to insert a neo cassette into exon 4. The vector was electroporated into 129S7/SvEvBrd-derived AB1 embryonic stem (ES) cells. Chimeric mice were bred to C57BL/6J, and the strain was made congenic on a C57BL/6J genetic background at The Jackson Laboratory (Stock No. 002207). The ob spontaneous mutation in the leptin gene is maintained on a congenic C57BL/6J genetic background at The Jackson Laboratory (Stock No. 000632). To generate the double mutant strain, Stock No. 002207 mice were bred with Stock No. 000632 mice in the laboratory of Dr. Jan Breslow at The Rockefeller University. Double mutant mice were bred as heterozygous for the ob mutation and homozygous for the LDLR mutation for many generations prior to arrival at The Jackson Laboratory.

Control Information

   Wild-type for Lepob, Homozygous for Ldlrtm1Her
   000664 C57BL/6J
  Considerations for Choosing Controls

Related Strains

View Strains carrying   Ldlrtm1Her     (15 strains)

Strains carrying   Lepob allele
000632   B6.Cg-Lepob/J
000696   BKS.Cg-Lepob/J
004824   BTBR.Cg-Lepob/WiscJ
View Strains carrying   Lepob     (3 strains)

View Strains carrying other alleles of Ldlr     (4 strains)


Phenotype Information

View Related Disease (OMIM) Terms

Related Disease (OMIM) Terms provided by MGI
- Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
Hypercholesterolemia, Familial
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested.
Leptin Deficiency or Dysfunction; LEPD   (LEP)
View Mammalian Phenotype Terms

Mammalian Phenotype Terms provided by MGI
      assigned by genotype

Ldlrtm1Her/Ldlr+ Lepob/Lepob

        B6.Cg-Lepob Ldlrtm1Her
  • homeostasis/metabolism phenotype
  • increased circulating cholesterol level
    • age dependent increase in cholesterol levels between 1 and 4 months of age, with maximal values at 3-4 months of age (282 mg/dl vs 81 md/dl in wild-type) that are maintained thereafter   (MGI Ref ID J:72027)
    • increased circulating HDL cholesterol level
      • slightly elevated at 3 and 8 months of age   (MGI Ref ID J:72027)
  • increased liver cholesterol level
    • livers exhibit slightly, but significantly, higher levels of cholesterol   (MGI Ref ID J:72027)
  • increased liver triglyceride level
    • livers exhibit about 10x higher levels of triglyceride, however no increase in plasma triglyceride levels   (MGI Ref ID J:72027)
  • liver/biliary system phenotype
  • increased liver cholesterol level
    • livers exhibit slightly, but significantly, higher levels of cholesterol   (MGI Ref ID J:72027)
  • increased liver triglyceride level
    • livers exhibit about 10x higher levels of triglyceride, however no increase in plasma triglyceride levels   (MGI Ref ID J:72027)

Ldlrtm1Her/Ldlrtm1Her Lepob/Lepob

        B6.Cg-Lepob Ldlrtm1Her
  • cardiovascular system phenotype
  • atherosclerotic lesions
    • extensive atherosclerotic lesions throughout the aorta by 6 months of age   (MGI Ref ID J:72027)
  • homeostasis/metabolism phenotype
  • abnormal circulating cholesterol level
    • plasma contains severely elevated and broadened lipoprotein peak, ranging from VLDL/LDL-sized particles to LDL-sized particles   (MGI Ref ID J:72027)
    • increased circulating cholesterol level
      • age dependent increase in cholesterol levels between 1 and 4 months of age, with maximal values at 3-4 months of age (1715 mg/dl vs. 81 mg/dl in wild-type), followed by a gradual decrease by 8 months   (MGI Ref ID J:72027)
      • fasting, diet restriction, and low-level leptin treatment only slightly lowers plasma cholesterol levels   (MGI Ref ID J:72027)
      • increased circulating HDL cholesterol level
        • elevated at 3 and 8 months of age   (MGI Ref ID J:72027)
  • hyperlipidemia   (MGI Ref ID J:72027)
  • increased circulating triglyceride level
    • age dependent increase in triglyceride levels between 1 and 4 months of age, with maximal values at 3-4 months of age, followed by a gradual decrease by 8 months   (MGI Ref ID J:72027)
    • fasting, diet restriction, and low-level leptin treatment significantly lowers plasma triglyceride levels   (MGI Ref ID J:72027)
  • increased liver cholesterol level
    • livers exhibit slightly, but significantly, higher levels of cholesterol   (MGI Ref ID J:72027)
  • increased liver triglyceride level
    • livers exhibit about 10x higher levels of triglyceride   (MGI Ref ID J:72027)
  • liver/biliary system phenotype
  • increased liver cholesterol level
    • livers exhibit slightly, but significantly, higher levels of cholesterol   (MGI Ref ID J:72027)
  • increased liver triglyceride level
    • livers exhibit about 10x higher levels of triglyceride   (MGI Ref ID J:72027)
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Cardiovascular Research
      altered fat metabolism

Diabetes and Obesity Research

Metabolism Research
Lipid Metabolism

Research Tools
Cardiovascular Research
Diabetes and Obesity Research
Metabolism Research

Ldlrtm1Her related

Cardiovascular Research

Metabolism Research
Lipid Metabolism

Lepob related

Diabetes and Obesity Research
Impaired Wound Healing
Insulin Resistance
Obesity With Diabetes

Endocrine Deficiency Research
Adipose Defects
Hypothalamus/Pituitary Defects
Pancreas Defects

Immunology, Inflammation and Autoimmunity Research
Immunodeficiency Associated with Other Defects

Internal/Organ Research
Adipose Defects

Metabolism Research

Reproductive Biology Research
Fertility Defects

Genes & Alleles

Gene & Allele Information provided by MGI

Allele Symbol Ldlrtm1Her
Allele Name targeted mutation 1, Joachim Herz
Allele Type Targeted (Null/Knockout)
Common Name(s) LDLR KO; LDLR-; LDLr-KO; LDLr0; LDLrKO; Ldlrtm1Her;
Mutation Made ByDr. Joachim Herz,   Univ of Texas Southwest Med Ctr Dallas
Strain of Origin129S7/SvEvBrd-Hprt<+>
ES Cell Line NameAB1
ES Cell Line Strain129S7/SvEvBrd-Hprt<+>
Site of ExpressionImmunoblot analysis of liver membranes detected a truncated protein in homozygous mutant animals.
Gene Symbol and Name Ldlr, low density lipoprotein receptor
Chromosome 9
Gene Common Name(s) FH; FHC; LDLCQ2; LDLRA;
General Note When used in bone marrow transplant into Ldlrtm1Her homozygous mice, Abca1tm1Jdm Abcg1tm1Dgen homozygous cells accelerate the development of atherosclerosis. (J:130777)
Phenotypic Similarity to Human Syndrome: Type 1 Diabetic Macrovascular Disease (J:174983)
Molecular Note Insertion of a neomycin resistance cassette into exon 4. The authors predict that the targeted allele would encode a truncated non-functional protein that will not bind LDL, and that lacks a membrane spanning segment. Immunoblot analysis of liver membranes detected a truncated protein in homozygous mutant animals. [MGI Ref ID J:37394]
Allele Symbol Lepob
Allele Name obese
Allele Type Spontaneous (Null/Knockout)
Common Name(s) ob; ob/ob;
Strain of OriginSTOCK Mlph a Tgfa Cdh23 Ednrb
Gene Symbol and Name Lep, leptin
Chromosome 6
Gene Common Name(s) LEPD; OB; OBS; ob; obese;
General Note

Phenotypic Similarity to Human Syndrome: Metabolic Syndrome J:219470.

Molecular Note Sequencing of RT-PCR products revealed a nonsense mutation in codon 105 resulting from a C to T point mutation. The 16 kDa leptin protein, expressed predominantly in adipose tissue of normal mice, is missing from homozygous mutant mice (J:29081). [MGI Ref ID J:20512] [MGI Ref ID J:29081] [MGI Ref ID J:45748]


Genotyping Information

Genotyping Protocols

Ldlrtm1Her-alternate 1, High Resolution Melting
Lep ob, End Point Analysis
Lepob, Pyrosequencing
Lepob, Restriction Enzyme Digest

Helpful Links

Genotyping resources and troubleshooting


References provided by MGI

Additional References

Ishibashi S; Brown MS; Goldstein JL; Gerard RD; Hammer RE; Herz J. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments] J Clin Invest 92(2):883-93. [PubMed: 8349823]  [MGI Ref ID J:37394]

Zhang Y; Proenca R; Maffei M; Barone M; Leopold L; Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479] [see comments] Nature 372(6505):425-32. [PubMed: 7984236]  [MGI Ref ID J:20512]

Ldlrtm1Her related

Accad M; Smith SJ; Newland DL; Sanan DA; King LE Jr; Linton MF; Fazio S; Farese RV Jr. 2000. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1 [see comments] J Clin Invest 105(6):711-9. [PubMed: 10727439]  [MGI Ref ID J:61147]

Adachi H; Kondo T; Koh GY; Nagy A; Oike Y; Araki E. 2011. Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice. Biochem Biophys Res Commun 409(2):177-80. [PubMed: 21549101]  [MGI Ref ID J:172599]

Afek A; Keren G; Harats D; George J. 2001. Whole body hyperthermia accelerates atherogenesis in low-density lipoprotein receptor deficient mice. Exp Mol Pathol 71(1):63-72. [PubMed: 11502098]  [MGI Ref ID J:106255]

Ahmad PJ; Trcka D; Xue S; Franco C; Speer MY; Giachelli CM; Bendeck MP. 2009. Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. Am J Pathol 175(6):2686-96. [PubMed: 19893047]  [MGI Ref ID J:155320]

Ait-Oufella H; Herbin O; Lahoute C; Coatrieux C; Loyer X; Joffre J; Laurans L; Ramkhelawon B; Blanc-Brude O; Karabina S; Girard CA; Payre C; Yamamoto K; Binder CJ; Murakami M; Tedgui A; Lambeau G; Mallat Z. 2013. Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 33(3):466-73. [PubMed: 23349189]  [MGI Ref ID J:216884]

Ait-Oufella H; Kinugawa K; Zoll J; Simon T; Boddaert J; Heeneman S; Blanc-Brude O; Barateau V; Potteaux S; Merval R; Esposito B; Teissier E; Daemen MJ; Leseche G; Boulanger C; Tedgui A; Mallat Z. 2007. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115(16):2168-77. [PubMed: 17420351]  [MGI Ref ID J:135906]

Ait-Oufella H; Pouresmail V; Simon T; Blanc-Brude O; Kinugawa K; Merval R; Offenstadt G; Leseche G; Cohen PL; Tedgui A; Mallat Z. 2008. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol 28(8):1429-31. [PubMed: 18467644]  [MGI Ref ID J:159811]

Ait-Oufella H; Salomon BL; Potteaux S; Robertson AK; Gourdy P; Zoll J; Merval R; Esposito B; Cohen JL; Fisson S; Flavell RA; Hansson GK; Klatzmann D; Tedgui A; Mallat Z. 2006. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12(2):178-80. [PubMed: 16462800]  [MGI Ref ID J:105800]

Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F. 2010. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Cardiovasc Res 86(2):321-9. [PubMed: 20110335]  [MGI Ref ID J:175882]

Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL. 2010. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. J Biol Chem 285(19):14267-74. [PubMed: 20231283]  [MGI Ref ID J:162960]

Allred KF; Smart EJ; Wilson ME. 2006. Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. J Biol Chem 281(3):1419-25. [PubMed: 16299001]  [MGI Ref ID J:107322]

Altenburg M; Arbones-Mainar J; Johnson L; Wilder J; Maeda N. 2008. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arterioscler Thromb Vasc Biol 28(6):1104-10. [PubMed: 18369154]  [MGI Ref ID J:149026]

Angeli V; Llodra J; Rong JX; Satoh K; Ishii S; Shimizu T; Fisher EA; Randolph GJ. 2004. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21(4):561-74. [PubMed: 15485633]  [MGI Ref ID J:93917]

Anggraeni VY; Emoto N; Yagi K; Mayasari DS; Nakayama K; Izumikawa T; Kitagawa H; Hirata K. 2011. Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosis. Biochem Biophys Res Commun 406(1):36-41. [PubMed: 21284936]  [MGI Ref ID J:170936]

Arai S; Shelton JM; Chen M; Bradley MN; Castrillo A; Bookout AL; Mak PA; Edwards PA; Mangelsdorf DJ; Tontonoz P; Miyazaki T. 2005. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 1(3):201-13. [PubMed: 16054063]  [MGI Ref ID J:129845]

Aslanian AM; Chapman HA; Charo IF. 2005. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 25(3):628-32. [PubMed: 15591216]  [MGI Ref ID J:110061]

Aslanian AM; Charo IF. 2006. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114(6):583-90. [PubMed: 16880330]  [MGI Ref ID J:123851]

Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S. 2014. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE. J Lipid Res 55(11):2370-9. [PubMed: 25258384]  [MGI Ref ID J:216603]

Asterholm IW; Rutkowski JM; Fujikawa T; Cho YR; Fukuda M; Tao C; Wang ZV; Gupta RK; Elmquist JK; Scherer PE. 2014. Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. Diabetologia 57(6):1209-18. [PubMed: 24623101]  [MGI Ref ID J:210884]

Avraham-Davidi I; Ely Y; Pham VN; Castranova D; Grunspan M; Malkinson G; Gibbs-Bar L; Mayseless O; Allmog G; Lo B; Warren CM; Chen TT; Ungos J; Kidd K; Shaw K; Rogachev I; Wan W; Murphy PM; Farber SA; Carmel L; Shelness GS; Iruela-Arispe ML; Weinstein BM; Yaniv K. 2012. ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1. Nat Med 18(6):967-73. [PubMed: 22581286]  [MGI Ref ID J:187459]

Azhar S; Luo Y; Medicherla S; Reaven E. 1999. Upregulation of selective cholesteryl ester uptake pathway in mice with deletion of low-density lipoprotein receptor function. J Cell Physiol 180(2):190-202. [PubMed: 10395289]  [MGI Ref ID J:56099]

Babaev VR; Chew JD; Ding L; Davis S; Breyer MD; Breyer RM; Oates JA; Fazio S; Linton MF. 2008. Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 8(6):492-501. [PubMed: 19041765]  [MGI Ref ID J:144376]

Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF. 2006. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice. Circulation 113(1):108-17. [PubMed: 16380543]  [MGI Ref ID J:121507]

Babaev VR; Hebron KE; Wiese CB; Toth CL; Ding L; Zhang Y; May JM; Fazio S; Vickers KC; Linton MF. 2014. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice. J Lipid Res 55(11):2296-308. [PubMed: 25240046]  [MGI Ref ID J:216614]

Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF. 2007. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 116(12):1404-12. [PubMed: 17724261]  [MGI Ref ID J:139843]

Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF. 2005. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25(8):1647-53. [PubMed: 15947238]  [MGI Ref ID J:114332]

Baeyens N; Mulligan-Kehoe MJ; Corti F; Simon DD; Ross TD; Rhodes JM; Wang TZ; Mejean CO; Simons M; Humphrey J; Schwartz MA. 2014. Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling. Proc Natl Acad Sci U S A 111(48):17308-13. [PubMed: 25404299]  [MGI Ref ID J:216650]

Baldan A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA. 2006. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Arterioscler Thromb Vasc Biol 26(10):2301-7. [PubMed: 16888235]  [MGI Ref ID J:128048]

Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH. 2014. Glycogen synthase kinase 3alpha deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice. Am J Pathol 184(12):3394-404. [PubMed: 25451156]  [MGI Ref ID J:218258]

Barish GD; Yu RT; Karunasiri MS; Becerra D; Kim J; Tseng TW; Tai LJ; Leblanc M; Diehl C; Cerchietti L; Miller YI; Witztum JL; Melnick AM; Dent AL; Tangirala RK; Evans RM. 2012. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab 15(4):554-62. [PubMed: 22465074]  [MGI Ref ID J:184208]

Barlic J; Murphy PM. 2007. Chemokine regulation of atherosclerosis. J Leukoc Biol 82(2):226-36. [PubMed: 17329566]  [MGI Ref ID J:123530]

Bartelt A; Bruns OT; Reimer R; Hohenberg H; Ittrich H; Peldschus K; Kaul MG; Tromsdorf UI; Weller H; Waurisch C; Eychmuller A; Gordts PL; Rinninger F; Bruegelmann K; Freund B; Nielsen P; Merkel M; Heeren J. 2011. Brown adipose tissue activity controls triglyceride clearance. Nat Med 17(2):200-5. [PubMed: 21258337]  [MGI Ref ID J:168555]

Barthwal MK; Anzinger JJ; Xu Q; Bohnacker T; Wymann MP; Kruth HS. 2013. Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formation. PLoS One 8(3):e58054. [PubMed: 23536783]  [MGI Ref ID J:199527]

Bassett CM; Edel AL; Patenaude AF; McCullough RS; Blackwood DP; Chouinard PY; Paquin P; Lamarche B; Pierce GN. 2010. Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J Nutr 140(1):18-24. [PubMed: 19923390]  [MGI Ref ID J:155556]

Basso F; Amar MJ; Wagner EM; Vaisman B; Paigen B; Santamarina-Fojo S; Remaley AT. 2006. Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet. Biochem Biophys Res Commun 351(2):398-404. [PubMed: 17070501]  [MGI Ref ID J:116554]

Basso F; Freeman LA; Ko C; Joyce C; Amar MJ; Shamburek RD; Tansey T; Thomas F; Wu J; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB Jr. 2007. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. J Lipid Res 48(1):114-26. [PubMed: 17060690]  [MGI Ref ID J:117682]

Bavendiek U; Zirlik A; LaClair S; MacFarlane L; Libby P; Schonbeck U. 2005. Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells. Arterioscler Thromb Vasc Biol 25(6):1244-9. [PubMed: 15746436]  [MGI Ref ID J:114293]

Becker L; Liu NC; Averill MM; Yuan W; Pamir N; Peng Y; Irwin AD; Fu X; Bornfeldt KE; Heinecke JW. 2012. Unique proteomic signatures distinguish macrophages and dendritic cells. PLoS One 7(3):e33297. [PubMed: 22428014]  [MGI Ref ID J:186914]

Becker M; Rabe K; Lebherz C; Zugwurst J; Goke B; Parhofer KG; Lehrke M; Broedl UC. 2010. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 59(11):2898-903. [PubMed: 20724582]  [MGI Ref ID J:169337]

Bell TA 3rd; Kelley K; Wilson MD; Sawyer JK; Rudel LL. 2007. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Arterioscler Thromb Vasc Biol 27(6):1396-402. [PubMed: 17431188]  [MGI Ref ID J:134910]

Bernal-Mizrachi C; Weng S; Feng C; Finck BN; Knutsen RH; Leone TC; Coleman T; Mecham RP; Kelly DP; Semenkovich CF. 2003. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9(8):1069-75. [PubMed: 12847522]  [MGI Ref ID J:84844]

Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587-596. [PubMed: 17435771]  [MGI Ref ID J:121807]

Bhasin KK; van Nas A; Martin LJ; Davis RC; Devaskar SU; Lusis AJ. 2009. Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction. Diabetes 58(3):559-66. [PubMed: 19073773]  [MGI Ref ID J:146932]

Bhatia VK; Yun S; Leung V; Grimsditch DC; Benson GM; Botto MB; Boyle JJ; Haskard DO. 2007. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 170(1):416-26. [PubMed: 17200212]  [MGI Ref ID J:117210]

Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS. 2013. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis. Arterioscler Thromb Vasc Biol 33(10):2288-96. [PubMed: 23814116]  [MGI Ref ID J:222231]

Bie J; Wang J; Marqueen KE; Osborne R; Kakiyama G; Korzun W; Ghosh SS; Ghosh S. 2013. Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice. Arterioscler Thromb Vasc Biol 33(8):1795-802. [PubMed: 23744992]  [MGI Ref ID J:221021]

Bie J; Wang J; Yuan Q; Kakiyama G; Ghosh SS; Ghosh S. 2014. Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice. J Lipid Res 55(4):729-38. [PubMed: 24563511]  [MGI Ref ID J:208896]

Bie J; Zhao B; Ghosh S. 2011. Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice. Am J Physiol Regul Integr Comp Physiol 301(4):R967-74. [PubMed: 21795638]  [MGI Ref ID J:178811]

Bie J; Zhao B; Song J; Ghosh S. 2010. Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue. J Biol Chem 285(18):13630-7. [PubMed: 20189995]  [MGI Ref ID J:163056]

Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lutjohann D; Staels B; Hofker MH; Shiri-Sverdlov R. 2012. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS One 7(1):e30668. [PubMed: 22295101]  [MGI Ref ID J:184219]

Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK. 2010. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 30(5):931-7. [PubMed: 20167657]  [MGI Ref ID J:175820]

Billon-Gales A; Fontaine C; Douin-Echinard V; Delpy L; Berges H; Calippe B; Lenfant F; Laurell H; Guery JC; Gourdy P; Arnal JF. 2009. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 120(25):2567-76. [PubMed: 19996016]  [MGI Ref ID J:168125]

Billon-Gales A; Fontaine C; Filipe C; Douin-Echinard V; Fouque MJ; Flouriot G; Gourdy P; Lenfant F; Laurell H; Krust A; Chambon P; Arnal JF. 2009. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci U S A 106(6):2053-8. [PubMed: 19188600]  [MGI Ref ID J:144952]

Billon-Gales A; Krust A; Fontaine C; Abot A; Flouriot G; Toutain C; Berges H; Gadeau AP; Lenfant F; Gourdy P; Chambon P; Arnal JF. 2011. Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc Natl Acad Sci U S A 108(32):13311-6. [PubMed: 21788522]  [MGI Ref ID J:175619]

Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114(3):427-37. [PubMed: 15286809]  [MGI Ref ID J:118092]

Binder CJ; Horkko S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9(6):736-43. [PubMed: 12740573]  [MGI Ref ID J:83726]

Bischoff ED; Daige CL; Petrowski M; Dedman H; Pattison J; Juliano J; Li AC; Schulman IG. 2010. Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. J Lipid Res 51(5):900-6. [PubMed: 20388921]  [MGI Ref ID J:160160]

Bjorkegren JL; Hagg S; Talukdar HA; Foroughi Asl H; Jain RK; Cedergren C; Shang MM; Rossignoli A; Takolander R; Melander O; Hamsten A; Michoel T; Skogsberg J. 2014. Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis. PLoS Genet 10(2):e1004201. [PubMed: 24586211]  [MGI Ref ID J:211003]

Blasiole DA; Oler AT; Attie AD. 2008. Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB. J Biol Chem 283(17):11374-81. [PubMed: 18272520]  [MGI Ref ID J:136523]

Boisvert WA; Rose DM; Johnson KA; Fuentes ME; Lira SA; Curtiss LK; Terkeltaub RA. 2006. Up-regulated expression of the CXCR2 Ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 168(4):1385-95. [PubMed: 16565511]  [MGI Ref ID J:107325]

Boisvert WA; Santiago R; Curtiss LK; Terkeltaub RA. 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101(2):353-63. [PubMed: 9435307]  [MGI Ref ID J:45392]

Bojic LA; Telford DE; Fullerton MD; Ford RJ; Sutherland BG; Edwards JY; Sawyez CG; Gros R; Kemp BE; Steinberg GR; Huff MW. 2014. PPARdelta activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity. J Lipid Res 55(7):1254-1266. [PubMed: 24864274]  [MGI Ref ID J:214996]

Bol V; Desjardins F; Reusens B; Balligand JL; Remacle C. 2010. Does early mismatched nutrition predispose to hypertension and atherosclerosis, in male mice? PLoS One 5(9):. [PubMed: 20844591]  [MGI Ref ID J:165129]

Bolduc V; Baraghis E; Duquette N; Thorin-Trescases N; Lambert J; Lesage F; Thorin E. 2012. Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow. Am J Physiol Heart Circ Physiol 302(6):H1330-9. [PubMed: 22268108]  [MGI Ref ID J:186586]

Bolduc V; Drouin A; Gillis MA; Duquette N; Thorin-Trescases N; Frayne-Robillard I; Des Rosiers C; Tardif JC; Thorin E. 2011. Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice. Am J Physiol Heart Circ Physiol 301(5):H2081-92. [PubMed: 21926346]  [MGI Ref ID J:178785]

Bolick DT; Skaflen MD; Johnson LE; Kwon SC; Howatt D; Daugherty A; Ravichandran KS; Hedrick CC. 2009. G2A deficiency in mice promotes macrophage activation and atherosclerosis. Circ Res 104(3):318-27. [PubMed: 19106413]  [MGI Ref ID J:163438]

Bonfleur ML; Vanzela EC; Ribeiro RA; de Gabriel Dorighello G; de Franca Carvalho CP; Collares-Buzato CB; Carneiro EM; Boschero AC; de Oliveira HC. 2010. Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity. Biochim Biophys Acta 1801(2):183-90. [PubMed: 19913637]  [MGI Ref ID J:164825]

Bostrom MA; Boyanovsky BB; Jordan CT; Wadsworth MP; Taatjes DJ; de Beer FC; Webb NR. 2007. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol 27(3):600-6. [PubMed: 17204667]  [MGI Ref ID J:149057]

Bot M; Bot I; Lopez-Vales R; van de Lest CH; Saulnier-Blache JS; Helms JB; David S; van Berkel TJ; Biessen EA. 2010. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 176(6):3073-84. [PubMed: 20431029]  [MGI Ref ID J:161328]

Bot M; Van Veldhoven PP; de Jager SC; Johnson J; Nijstad N; Van Santbrink PJ; Westra MM; Van Der Hoeven G; Gijbels MJ; Muller-Tidow C; Varga G; Tietge UJ; Kuiper J; Van Berkel TJ; Nofer JR; Bot I; Biessen EA. 2013. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. PLoS One 8(5):e63360. [PubMed: 23700419]  [MGI Ref ID J:200844]

Bot M; de Jager SC; MacAleese L; Lagraauw HM; van Berkel TJ; Quax PH; Kuiper J; Heeren RM; Biessen EA; Bot I. 2013. Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. J Lipid Res 54(5):1265-74. [PubMed: 23396975]  [MGI Ref ID J:196303]

Boucher P; Gotthardt M; Li WP; Anderson RG; Herz J. 2003. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300(5617):329-32. [PubMed: 12690199]  [MGI Ref ID J:82871]

Boucher P; Li WP; Matz RL; Takayama Y; Auwerx J; Anderson RG; Herz J. 2007. LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS ONE 2(5):e448. [PubMed: 17505534]  [MGI Ref ID J:129347]

Bovenschen N; Mertens K; Hu L; Havekes LM; van Vlijmen BJ. 2005. LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo. Blood 106(3):906-12. [PubMed: 15840700]  [MGI Ref ID J:117317]

Boyanovsky B; Zack M; Forrest K; Webb NR. 2009. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo. Arterioscler Thromb Vasc Biol 29(4):532-8. [PubMed: 19164803]  [MGI Ref ID J:159779]

Boyanovsky BB; van der Westhuyzen DR; Webb NR. 2005. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans. J Biol Chem 280(38):32746-52. [PubMed: 16040605]  [MGI Ref ID J:102157]

Bretillon L; Acar N; Seeliger MW; Santos M; Maire MA; Juaneda P; Martine L; Gregoire S; Joffre C; Bron AM; Creuzot-Garcher C. 2008. ApoB100,LDLR-/- mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Invest Ophthalmol Vis Sci 49(4):1307-14. [PubMed: 18385042]  [MGI Ref ID J:136142]

Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ. 2004. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins. Circ Res 94(12):1554-61. [PubMed: 15117821]  [MGI Ref ID J:100064]

Brown JM; Bell TA 3rd; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL. 2008. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J Biol Chem 283(16):10522-34. [PubMed: 18281279]  [MGI Ref ID J:136556]

Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen T; Zhu X; Duong MN; Wibley AL; Shah R; Davis MA; Kelley K; Wilson MD; Kent C; Parks JS; Rudel LL. 2008. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 118(14):1467-75. [PubMed: 18794388]  [MGI Ref ID J:158044]

Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen TM; Zhu X; Duong MN; Brown AL; Lord C; Shah R; Davis MA; Kelley K; Wilson MD; Madenspacher J; Fessler MB; Parks JS; Rudel LL. 2010. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 30(1):24-30. [PubMed: 19834103]  [MGI Ref ID J:171803]

Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR. 2009. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis. Arterioscler Thromb Vasc Biol 29(4):548-54. [PubMed: 19201688]  [MGI Ref ID J:159775]

Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH. 2011. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol 31(5):1100-7. [PubMed: 21393583]  [MGI Ref ID J:191478]

Buga GM; Frank JS; Mottino GA; Hakhamian A; Narasimha A; Watson AD; Yekta B; Navab M; Reddy ST; Anantharamaiah GM; Fogelman AM. 2008. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res 49(1):192-205. [PubMed: 17925450]  [MGI Ref ID J:130095]

Buga GM; Frank JS; Mottino GA; Hendizadeh M; Hakhamian A; Tillisch JH; Reddy ST; Navab M; Anantharamaiah GM; Ignarro LJ; Fogelman AM. 2006. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res 47(10):2148-60. [PubMed: 16835442]  [MGI Ref ID J:116493]

Buono C; Binder CJ; Stavrakis G; Witztum JL; Glimcher LH; Lichtman AH. 2005. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A 102(5):1596-601. [PubMed: 15665085]  [MGI Ref ID J:96110]

Buono C; Come CE; Stavrakis G; Maguire GF; Connelly PW; Lichtman AH. 2003. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 23(3):454-60. [PubMed: 12615659]  [MGI Ref ID J:103072]

Buono C; Come CE; Witztum JL; Maguire GF; Connelly PW; Carroll M; Lichtman AH. 2002. Influence of C3 deficiency on atherosclerosis. Circulation 105(25):3025-31. [PubMed: 12081998]  [MGI Ref ID J:103349]

Burkhardt R; Sundermann S; Ludwig D; Ceglarek U; Holdt LM; Thiery J; Teupser D. 2011. Cosegregation of aortic root atherosclerosis and intermediate lipid phenotypes on chromosomes 2 and 8 in an intercross of C57BL/6 and BALBc/ByJ low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 31(4):775-84. [PubMed: 21252064]  [MGI Ref ID J:184168]

Burkhardt R; Toh SA; Lagor WR; Birkeland A; Levin M; Li X; Robblee M; Fedorov VD; Yamamoto M; Satoh T; Akira S; Kathiresan S; Breslow JL; Rader DJ. 2010. Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J Clin Invest 120(12):4410-4. [PubMed: 21084752]  [MGI Ref ID J:171867]

Burleigh ME; Babaev VR; Oates JA; Harris RC; Gautam S; Riendeau D; Marnett LJ; Morrow JD; Fazio S; Linton MF. 2002. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105(15):1816-23. [PubMed: 11956125]  [MGI Ref ID J:103220]

Busch M; Westhofen TC; Koch M; Lutz MB; Zernecke A. 2014. Dendritic cell subset distributions in the aorta in healthy and atherosclerotic mice. PLoS One 9(2):e88452. [PubMed: 24551105]  [MGI Ref ID J:213070]

Cain WJ; Millar JS; Himebauch AS; Tietge UJ; Maugeais C; Usher D; Rader DJ. 2005. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. J Lipid Res 46(12):2681-91. [PubMed: 16150825]  [MGI Ref ID J:106146]

Calara F; Silvestre M; Casanada F; Yuan N; Napoli C; Palinski W. 2001. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 195(2):257-63. [PubMed: 11592107]  [MGI Ref ID J:71794]

Caligiuri G; Levy B; Pernow J; Thoren P; Hansson GK. 1999. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 96(12):6920-4. [PubMed: 10359814]  [MGI Ref ID J:55973]

Campbell IC; Weiss D; Suever JD; Virmani R; Veneziani A; Vito RP; Oshinski JN; Taylor WR. 2013. Biomechanical modeling and morphology analysis indicates plaque rupture due to mechanical failure unlikely in atherosclerosis-prone mice. Am J Physiol Heart Circ Physiol 304(3):H473-86. [PubMed: 23203971]  [MGI Ref ID J:194633]

Cao D; Fukuchi K; Wan H; Kim H; Li L. 2006. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging 27(11):1632-43. [PubMed: 16236385]  [MGI Ref ID J:114480]

Cao Q; Wang X; Jia L; Mondal AK; Diallo A; Hawkins GA; Das SK; Parks JS; Yu L; Shi H; Shi H; Xue B. 2014. Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology 155(12):4925-38. [PubMed: 25251587]  [MGI Ref ID J:219682]

Carpenter B; Lin Y; Stoll S; Raffai RL; McCuskey R; Wang R. 2005. VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132(14):3293-303. [PubMed: 15944181]  [MGI Ref ID J:100427]

Casagrande V; Menghini R; Menini S; Marino A; Marchetti V; Cavalera M; Fabrizi M; Hribal ML; Pugliese G; Gentileschi P; Schillaci O; Porzio O; Lauro D; Sbraccia P; Lauro R; Federici M. 2012. Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 32(1):74-81. [PubMed: 22015660]  [MGI Ref ID J:195978]

Casquero AC; Berti JA; Salerno AG; Bighetti EJ; Cazita PM; Ketelhuth DF; Gidlund M; Oliveira HC. 2006. Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice. J Lipid Res 47(7):1526-34. [PubMed: 16603720]  [MGI Ref ID J:112057]

Cassis LA; Gupte M; Thayer S; Zhang X; Charnigo R; Howatt DA; Rateri DL; Daugherty A. 2009. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 296(5):H1660-5. [PubMed: 19252100]  [MGI Ref ID J:150893]

Cassis LA; Rateri DL; Lu H; Daugherty A. 2007. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 27(2):380-6. [PubMed: 17158350]  [MGI Ref ID J:130546]

Castellani LW; Chang JJ; Wang X; Lusis AJ; Reynolds WF. 2006. Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males. J Lipid Res 47(7):1366-77. [PubMed: 16639078]  [MGI Ref ID J:112085]

Catanozi S; Rocha JC; Passarelli M; Guzzo ML; Alves C; Furukawa LN; Nunes VS; Nakandakare ER; Heimann JC; Quintao EC. 2003. Dietary sodium chloride restriction enhances aortic wall lipid storage and raises plasma lipid concentration in LDL receptor knockout mice. J Lipid Res 44(4):727-32. [PubMed: 12562870]  [MGI Ref ID J:120709]

Cazita PM; Berti JA; Aoki C; Gidlund M; Harada LM; Nunes VS; Quintao EC; Oliveira HC. 2003. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice. J Lipid Res 44(1):33-40. [PubMed: 12518020]  [MGI Ref ID J:120685]

Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Luscher TF; Chanson M; Kwak BR. 2006. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113(24):2835-43. [PubMed: 16769907]  [MGI Ref ID J:122443]

Chakraborty M; Lou C; Huan C; Kuo MS; Park TS; Cao G; Jiang XC. 2013. Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis. J Clin Invest 123(4):1784-97. [PubMed: 23549085]  [MGI Ref ID J:197606]

Chan JC; Piper DE; Cao Q; Liu D; King C; Wang W; Tang J; Liu Q; Higbee J; Xia Z; Di Y; Shetterly S; Arimura Z; Salomonis H; Romanow WG; Thibault ST; Zhang R; Cao P; Yang XP; Yu T; Lu M; Retter MW; Kwon G; Henne K; Pan O; Tsai MM; Fuchslocher B; Yang E; Zhou L; Lee KJ; Daris M; Sheng J; Wang Y; Shen WD; Yeh WC; Emery M; Walker NP; Shan B; Schwarz M; Jackson SM. 2009. A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci U S A 106(24):9820-5. [PubMed: 19443683]  [MGI Ref ID J:150005]

Chehaibi K; Cedo L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vazquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escola-Gil JC. 2015. PPAR-beta/delta activation promotes phospholipid transfer protein expression. Biochem Pharmacol 94(2):101-8. [PubMed: 25662586]  [MGI Ref ID J:219883]

Chellan B; Koroleva EP; Sontag TJ; Tumanov AV; Fu YX; Getz GS; Reardon CA. 2013. LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. PLoS One 8(1):e54719. [PubMed: 23355893]  [MGI Ref ID J:195803]

Chen CT; Ma DW; Kim JH; Mount HT; Bazinet RP. 2008. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J Lipid Res 49(1):147-52. [PubMed: 17932396]  [MGI Ref ID J:130078]

Chen X; Rateri DL; Howatt DA; Balakrishnan A; Moorleghen JJ; Morris AJ; Charnigo R; Cassis LA; Daugherty A. 2013. Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. PLoS One 8(11):e81743. [PubMed: 24244746]  [MGI Ref ID J:209689]

Chen Z; Fitzgerald RL; Li G; Davidson NO; Schonfeld G. 2004. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele. J Lipid Res 45(1):155-63. [PubMed: 13130124]  [MGI Ref ID J:87974]

Cheng SL; Shao JS; Halstead LR; Distelhorst K; Sierra O; Towler DA. 2010. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 107(2):271-82. [PubMed: 20489161]  [MGI Ref ID J:175050]

Choi JH; Cheong C; Dandamudi DB; Park CG; Rodriguez A; Mehandru S; Velinzon K; Jung IH; Yoo JY; Oh GT; Steinman RM. 2011. Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis. Immunity 35(5):819-31. [PubMed: 22078798]  [MGI Ref ID J:178831]

Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT. 2005. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 25(11):2404-9. [PubMed: 16141407]  [MGI Ref ID J:116800]

Christoffersen C; Benn M; Christensen PM; Gordts PL; Roebroek AJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlback B; Nielsen LB. 2012. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles. J Lipid Res 53(10):2198-204. [PubMed: 22826357]  [MGI Ref ID J:188041]

Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlback B; Nielsen LB. 2008. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J Biol Chem 283(4):1839-47. [PubMed: 18006500]  [MGI Ref ID J:130647]

Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlback B; Nielsen LB. 2010. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis. Circ Res 106(10):1624-34. [PubMed: 20360257]  [MGI Ref ID J:172136]

Cochain C; Chaudhari SM; Koch M; Wiendl H; Eckstein HH; Zernecke A. 2014. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS One 9(4):e93280. [PubMed: 24691202]  [MGI Ref ID J:215043]

Coenen KR; Gruen ML; Chait A; Hasty AH. 2007. Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 56(3):564-73. [PubMed: 17327423]  [MGI Ref ID J:122029]

Coenen KR; Gruen ML; Lee-Young RS; Puglisi MJ; Wasserman DH; Hasty AH. 2009. Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia 52(2):318-28. [PubMed: 19052722]  [MGI Ref ID J:144370]

Coenen KR; Hasty AH. 2007. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Am J Physiol Endocrinol Metab 293(2):E492-9. [PubMed: 17566116]  [MGI Ref ID J:123342]

Collins AR; Gupte AA; Ji R; Ramirez MR; Minze LJ; Liu JZ; Arredondo M; Ren Y; Deng T; Wang J; Lyon CJ; Hsueh WA. 2012. Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury. Arterioscler Thromb Vasc Biol 32(12):2839-46. [PubMed: 23023374]  [MGI Ref ID J:208317]

Constantinou C; Mpatsoulis D; Natsos A; Petropoulou PI; Zvintzou E; Traish AM; Voshol PJ; Karagiannides I; Kypreos KE. 2014. The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations. J Lipid Res 55(7):1434-1447. [PubMed: 24837748]  [MGI Ref ID J:215003]

Curtiss LK; Black AS; Bonnet DJ; Tobias PS. 2012. Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists. J Lipid Res 53(10):2126-32. [PubMed: 22822027]  [MGI Ref ID J:188042]

Cybulsky MI; Iiyama K; Li H; Zhu S; Chen M; Iiyama M; Davis V; Gutierrez-Ramos JC; Connelly PW; Milstone DS. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10):1255-62. [PubMed: 11375415]  [MGI Ref ID J:69597]

Cyrus T; Tang LX; Rokach J; FitzGerald GA; Pratico D. 2001. Lipid peroxidation and platelet activation in murine atherosclerosis. Circulation 104(16):1940-5. [PubMed: 11602498]  [MGI Ref ID J:103216]

Daissormont IT; Christ A; Temmerman L; Sampedro Millares S; Seijkens T; Manca M; Rousch M; Poggi M; Boon L; van der Loos C; Daemen M; Lutgens E; Halvorsen B; Aukrust P; Janssen E; Biessen EA. 2011. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ Res 109(12):1387-95. [PubMed: 22021930]  [MGI Ref ID J:192720]

Dandapat A; Hu CP; Chen J; Liu Y; Khan JA; Remeo F; Carey RM; Hermonat PL; Mehta JL. 2008. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochem Biophys Res Commun 366(4):871-7. [PubMed: 18037370]  [MGI Ref ID J:130186]

Daugherty A; Rateri DL; Howatt DA; Charnigo R; Cassis LA. 2013. PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism. PLoS One 8(4):e61849. [PubMed: 23593499]  [MGI Ref ID J:200118]

Davies MR; Lund RJ; Mathew S; Hruska KA. 2005. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16(4):917-28. [PubMed: 15743994]  [MGI Ref ID J:110048]

Day SM; Reeve JL; Pedersen B; Farris DM; Myers DD; Im M; Wakefield TW; Mackman N; Fay WP. 2005. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105(1):192-8. [PubMed: 15339841]  [MGI Ref ID J:96377]

Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV. 2008. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118(12):4002-13. [PubMed: 19033669]  [MGI Ref ID J:144730]

Deevska GM; Rozenova KA; Giltiay NV; Chambers MA; White J; Boyanovsky BB; Wei J; Daugherty A; Smart EJ; Reid MB; Merrill AH Jr; Nikolova-Karakashian M. 2009. Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice. J Biol Chem 284(13):8359-68. [PubMed: 19074137]  [MGI Ref ID J:148558]

Degrace P; Moindrot B; Mohamed I; Gresti J; Du ZY; Chardigny JM; Sebedio JL; Clouet P. 2006. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. J Lipid Res 47(12):2647-55. [PubMed: 16957181]  [MGI Ref ID J:117203]

Denis M; Marcinkiewicz J; Zaid A; Gauthier D; Poirier S; Lazure C; Seidah NG; Prat A. 2012. Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice. Circulation 125(7):894-901. [PubMed: 22261195]  [MGI Ref ID J:196628]

Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB. 2012. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese ldlr-/- mice. J Nutr 142(8):1495-503. [PubMed: 22739374]  [MGI Ref ID J:186393]

Derwall M; Malhotra R; Lai CS; Beppu Y; Aikawa E; Seehra JS; Zapol WM; Bloch KD; Yu PB. 2012. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 32(3):613-22. [PubMed: 22223731]  [MGI Ref ID J:195959]

Devlin CM; Kuriakose G; Hirsch E; Tabas I. 2002. Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size. Proc Natl Acad Sci U S A 99(9):6280-5. [PubMed: 11983917]  [MGI Ref ID J:76336]

Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I. 2008. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 28(10):1723-30. [PubMed: 18669882]  [MGI Ref ID J:148825]

Dichek HL; Agrawal N; El Andaloussi N; Qian K. 2006. Attenuated corticosterone response to chronic ACTH stimulation in hepatic lipase-deficient mice: evidence for a role for hepatic lipase in adrenal physiology. Am J Physiol Endocrinol Metab 290(5):E908-15. [PubMed: 16368783]  [MGI Ref ID J:108412]

Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW. 2001. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice. J Lipid Res 42(2):201-10. [PubMed: 11181749]  [MGI Ref ID J:68351]

Dichek HL; Qian K; Agrawal N. 2004. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis. Arterioscler Thromb Vasc Biol 24(9):1696-702. [PubMed: 15205216]  [MGI Ref ID J:134693]

Dichek HL; Qian K; Agrawal N. 2004. The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient 'apoB-48-only' and 'apoB-100-only' mice. J Lipid Res 45(3):551-60. [PubMed: 14679168]  [MGI Ref ID J:88634]

Ding Z; Mizeracki AM; Hu C; Mehta JL. 2013. LOX-1 deletion and macrophage trafficking in atherosclerosis. Biochem Biophys Res Commun 440(2):210-4. [PubMed: 24036126]  [MGI Ref ID J:211431]

Dong Y; Zhang M; Liang B; Xie Z; Zhao Z; Asfa S; Choi HC; Zou MH. 2010. Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 121(6):792-803. [PubMed: 20124121]  [MGI Ref ID J:170442]

Doring Y; Manthey HD; Drechsler M; Lievens D; Megens RT; Soehnlein O; Busch M; Manca M; Koenen RR; Pelisek J; Daemen MJ; Lutgens E; Zenke M; Binder CJ; Weber C; Zernecke A. 2012. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 125(13):1673-83. [PubMed: 22388324]  [MGI Ref ID J:198616]

Drechsler M; Megens RT; van Zandvoort M; Weber C; Soehnlein O. 2010. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122(18):1837-45. [PubMed: 20956207]  [MGI Ref ID J:179481]

Drouin A; Bolduc V; Thorin-Trescases N; Belanger E; Fernandes P; Baraghis E; Lesage F; Gillis MA; Villeneuve L; Hamel E; Ferland G; Thorin E. 2010. Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice. Am J Physiol Heart Circ Physiol :. [PubMed: 21186270]  [MGI Ref ID J:167205]

Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nunez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357-61. [PubMed: 20428172]  [MGI Ref ID J:159453]

Dullens SP; Mensink RP; Bragt MC; Kies AK; Plat J. 2008. Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice. J Lipid Res 49(4):790-6. [PubMed: 18162663]  [MGI Ref ID J:133589]

Dupasquier CM; Dibrov E; Kneesh AL; Cheung PK; Lee KG; Alexander HK; Yeganeh BK; Moghadasian MH; Pierce GN. 2007. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 293(4):H2394-402. [PubMed: 17616740]  [MGI Ref ID J:126120]

Eberle C; Merki E; Yamashita T; Johnson S; Armando AM; Quehenberger O; Napoli C; Palinski W. 2012. Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes. PLoS One 7(9):e45361. [PubMed: 23028961]  [MGI Ref ID J:192004]

Egan KM; Lawson JA; Fries S; Koller B; Rader DJ; Smyth EM; Fitzgerald GA. 2004. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306(5703):1954-7. [PubMed: 15550624]  [MGI Ref ID J:105640]

Elder GA; Cho JY; English DF; Franciosi S; Schmeidler J; Sosa MA; Gasperi RD; Fisher EA; Mathews PM; Haroutunian V; Buxbaum JD. 2007. Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor. J Neurochem 102(4):1220-31. [PubMed: 17472705]  [MGI Ref ID J:124132]

Elder GA; Ragnauth A; Dorr N; Franciosi S; Schmeidler J; Haroutunian V; Buxbaum JD. 2008. Increased locomotor activity in mice lacking the low-density lipoprotein receptor. Behav Brain Res 191(2):256-265. [PubMed: 18466986]  [MGI Ref ID J:135078]

Erickson RP; Bhattacharyya A; Hunter RJ; Heidenreich RA; Cherrington NJ. 2005. Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet. Am J Physiol Gastrointest Liver Physiol 289(2):G300-7. [PubMed: 15790756]  [MGI Ref ID J:100351]

Erickson RP; Kiela M; Garver WS; Krishnan K; Heidenreich RA. 2001. Cholesterol signaling at the endoplasmic reticulum occurs in npc1(-/-) but not in npc1(-/-), LDLR(-/-) mice. Biochem Biophys Res Commun 284(2):326-30. [PubMed: 11394880]  [MGI Ref ID J:69915]

Eriksson EE; Xie X; Werr J; Thoren P; Lindbom L. 2001. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J 15(7):1149-57. [PubMed: 11344083]  [MGI Ref ID J:120455]

Eriksson EE; Xie X; Werr J; Thoren P; Lindbom L. 2001. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med 194(2):205-18. [PubMed: 11457895]  [MGI Ref ID J:118726]

Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ. 2004. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol. Blood 103(10):3777-82. [PubMed: 14739216]  [MGI Ref ID J:90547]

Estrada-Smith D; Collins AR; Wang X; Crockett C; Castellani L; Lusis AJ; Davis RC. 2006. Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice. Diabetes 55(8):2265-71. [PubMed: 16873689]  [MGI Ref ID J:116503]

Fan J; Stukas S; Wong C; Chan J; May S; Devalle N; Hirsch-Reinshagen V; Wilkinson A; Oda MN; Wellington CL. 2011. An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia. J Lipid Res 52(9):1605-16. [PubMed: 21705806]  [MGI Ref ID J:175557]

Farris SD; Hu JH; Krishnan R; Emery I; Chu T; Du L; Kremen M; Dichek HL; Gold E; Ramsey SA; Dichek DA. 2011. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins. J Biol Chem 286(25):22665-77. [PubMed: 21536666]  [MGI Ref ID J:174810]

Fazio S; Babaev VR; Burleigh ME; Major AS; Hasty AH; Linton MF. 2002. Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice. J Lipid Res 43(10):1602-9. [PubMed: 12364544]  [MGI Ref ID J:79439]

Fazio S; Hasty AH; Carter KJ; Murray AB; Price JO; Linton MF. 1997. Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse. J Lipid Res 38(2):391-400. [PubMed: 9162757]  [MGI Ref ID J:38840]

Feig JE; Parathath S; Rong JX; Mick SL; Vengrenyuk Y; Grauer L; Young SG; Fisher EA. 2011. Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123(9):989-98. [PubMed: 21339485]  [MGI Ref ID J:183750]

Feig JE; Pineda-Torra I; Sanson M; Bradley MN; Vengrenyuk Y; Bogunovic D; Gautier EL; Rubinstein D; Hong C; Liu J; Wu C; van Rooijen N; Bhardwaj N; Garabedian M; Tontonoz P; Fisher EA. 2010. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 120(12):4415-24. [PubMed: 21041949]  [MGI Ref ID J:171875]

Feng Y; Schouteden S; Geenens R; Van Duppen V; Herijgers P; Holvoet P; Van Veldhoven PP; Verfaillie CM. 2012. Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. PLoS One 7(11):e47286. [PubMed: 23144813]  [MGI Ref ID J:194860]

Findeisen HM; Gizard F; Zhao Y; Cohn D; Heywood EB; Jones KL; Lovett DH; Howatt DA; Daugherty A; Bruemmer D. 2011. Telomerase deficiency in bone marrow-derived cells attenuates angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 31(2):253-60. [PubMed: 21088250]  [MGI Ref ID J:184181]

Foks AC; Ran IA; Frodermann V; Bot I; van Santbrink PJ; Kuiper J; van Puijvelde GH. 2013. Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development. PLoS One 8(12):e83134. [PubMed: 24376654]  [MGI Ref ID J:211124]

Foks AC; Ran IA; Wasserman L; Frodermann V; Ter Borg MN; de Jager SC; van Santbrink PJ; Yagita H; Akiba H; Bot I; Kuiper J; van Puijvelde GH. 2013. T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis. Arterioscler Thromb Vasc Biol 33(11):2558-65. [PubMed: 23990206]  [MGI Ref ID J:222219]

Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J. 2013. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis. J Immunol 191(9):4573-80. [PubMed: 24068673]  [MGI Ref ID J:206243]

Fontana K; Campos GE; Staron RS; da Cruz-Hofling MA. 2013. Effects of anabolic steroids and high-intensity aerobic exercise on skeletal muscle of transgenic mice. PLoS One 8(11):e80909. [PubMed: 24260508]  [MGI Ref ID J:209673]

Forte TM; Subbanagounder G; Berliner JA; Blanche PJ; Clermont AO; Jia Z; Oda MN; Krauss RM; Bielicki JK. 2002. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J Lipid Res 43(3):477-85. [PubMed: 11893784]  [MGI Ref ID J:75568]

Fougerat A; Gayral S; Gourdy P; Schambourg A; Ruckle T; Schwarz MK; Rommel C; Hirsch E; Arnal JF; Salles JP; Perret B; Breton-Douillon M; Wymann MP; Laffargue M. 2008. Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 117(10):1310-7. [PubMed: 18268153]  [MGI Ref ID J:148451]

Franco C; Ahmad PJ; Hou G; Wong E; Bendeck MP. 2010. Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ Res 106(11):1775-83. [PubMed: 20448217]  [MGI Ref ID J:172702]

Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP. 2009. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circ Res 105(11):1141-8. [PubMed: 19834008]  [MGI Ref ID J:170145]

Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP. 2008. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circ Res 102(10):1202-11. [PubMed: 18451340]  [MGI Ref ID J:149015]

Francone OL; Royer L; Boucher G; Haghpassand M; Freeman A; Brees D; Aiello RJ. 2005. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 25(6):1198-205. [PubMed: 15831807]  [MGI Ref ID J:114227]

Freeman L; Amar MJ; Shamburek R; Paigen B; Brewer HB Jr; Santamarina-Fojo S; Gonzalez-Navarro H. 2007. Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice. J Lipid Res 48(1):104-13. [PubMed: 17071916]  [MGI Ref ID J:117481]

Freigang S; Ampenberger F; Weiss A; Kanneganti TD; Iwakura Y; Hersberger M; Kopf M. 2013. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis. Nat Immunol 14(10):1045-53. [PubMed: 23995233]  [MGI Ref ID J:208219]

Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L. 2012. Scavenger receptors target glycolipids for natural killer T cell activation. J Clin Invest 122(11):3943-54. [PubMed: 23064364]  [MGI Ref ID J:193547]

Freigang S; Zadorozhny V; McKinney MK; Krebs P; Herro R; Pawlak J; Kain L; Schrantz N; Masuda K; Liu Y; Savage PB; Bendelac A; Cravatt BF; Teyton L. 2010. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice. J Clin Invest 120(6):1873-84. [PubMed: 20484813]  [MGI Ref ID J:161640]

Fryer JD; Demattos RB; McCormick LM; O'Dell MA; Spinner ML; Bales KR; Paul SM; Sullivan PM; Parsadanian M; Bu G; Holtzman DM. 2005. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J Biol Chem 280(27):25754-9. [PubMed: 15888448]  [MGI Ref ID J:100836]

Fukuda D; Aikawa E; Swirski FK; Novobrantseva TI; Kotelianski V; Gorgun CZ; Chudnovskiy A; Yamazaki H; Croce K; Weissleder R; Aster JC; Hotamisligil GS; Yagita H; Aikawa M. 2012. Notch ligand Delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A 109(27):E1868-77. [PubMed: 22699504]  [MGI Ref ID J:186429]

Furbee JW Jr; Francone O; Parks JS. 2001. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT. J Lipid Res 42(10):1626-35. [PubMed: 11590219]  [MGI Ref ID J:124250]

Furbee JW Jr; Francone O; Parks JS. 2002. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice. J Lipid Res 43(3):428-37. [PubMed: 11893779]  [MGI Ref ID J:75567]

Furbee JW Jr; Sawyer JK; Parks JS. 2002. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. J Biol Chem 277(5):3511-9. [PubMed: 11719520]  [MGI Ref ID J:74315]

Gaudreault N; Kumar N; Posada JM; Stephens KB; Reyes de Mochel NS; Eberle D; Olivas VR; Kim RY; Harms MJ; Johnson S; Messina LM; Rapp JH; Raffai RL. 2012. ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium. Arterioscler Thromb Vasc Biol 32(2):264-72. [PubMed: 22053073]  [MGI Ref ID J:195610]

Ge S; Hertel B; Koltsova EK; Sorensen-Zender I; Kielstein JT; Ley K; Haller H; von Vietinghoff S. 2013. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. Circ Res 113(8):965-74. [PubMed: 23908345]  [MGI Ref ID J:213467]

Gendron ME; Theoret JF; Mamarbachi AM; Drouin A; Nguyen A; Bolduc V; Thorin-Trescases N; Merhi Y; Thorin E. 2010. Late chronic catechin antioxidant treatment is deleterious to the endothelial function in aging mice with established atherosclerosis. Am J Physiol Heart Circ Physiol 298(6):H2062-70. [PubMed: 20382853]  [MGI Ref ID J:160434]

George J; Afek A; Shaish A; Levkovitz H; Bloom N; Cyrus T; Zhao L; Funk CD; Sigal E; Harats D. 2001. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 104(14):1646-50. [PubMed: 11581143]  [MGI Ref ID J:86385]

George J; Shoenfeld Y; Harats D. 1999. The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J Autoimmun 13(1):57-60. [PubMed: 10441168]  [MGI Ref ID J:56653]

German DC; Quintero EM; Liang C; Xie C; Dietschy JM. 2001. Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 105(4):999-1005. [PubMed: 11530237]  [MGI Ref ID J:126474]

Gessner DK; Ringseis R; Moller C; Eder K. 2012. Increased plasma thyroid hormone concentrations in LDL receptor deficient mice may be explained by inhibition of aryl hydrocarbon receptor-dependent expression of hepatic UDP-glucuronosyltransferases. Biochim Biophys Acta 1820(4):495-502. [PubMed: 22185956]  [MGI Ref ID J:182449]

Ghazalpour A; Wang X; Lusis AJ; Mehrabian M. 2006. Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice. Genetics 173(2):943-51. [PubMed: 16624897]  [MGI Ref ID J:109792]

Ghesquiere SA; Gijbels MJ; Anthonsen M; van Gorp PJ; van der Made I; Johansen B; Hofker MH; de Winther MP. 2005. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition. J Lipid Res 46(2):201-10. [PubMed: 15576846]  [MGI Ref ID J:136941]

Girod WG; Jones SP; Sieber N; Aw TY; Lefer DJ. 1999. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 19(11):2776-81. [PubMed: 10559025]  [MGI Ref ID J:129258]

Gistera A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK. 2013. Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 5(196):196ra100. [PubMed: 23903754]  [MGI Ref ID J:213468]

Gitlin JM; Homeister JW; Bulgrien J; Counselman J; Curtiss LK; Lowe JB; Boisvert WA. 2009. Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice. Am J Pathol 174(1):343-50. [PubMed: 19056851]  [MGI Ref ID J:144237]

Goel R; Schrank BR; Arora S; Boylan B; Fleming B; Miura H; Newman PJ; Molthen RC; Newman DK. 2008. Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28(11):1996-2002. [PubMed: 18669884]  [MGI Ref ID J:159801]

Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS. 2008. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes 57(6):1674-82. [PubMed: 18346984]  [MGI Ref ID J:136922]

Goldberg IJ; Huang LS; Huggins LA; Yu S; Nagareddy PR; Scanlan TS; Ehrenkranz JR. 2012. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway. Endocrinology 153(11):5143-9. [PubMed: 22948212]  [MGI Ref ID J:192913]

Gonon AT; Bulhak A; Broijersen A; Pernow J. 2005. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart. Br J Pharmacol 144(6):860-6. [PubMed: 15685207]  [MGI Ref ID J:110052]

Gonzales JC; Gordts PL; Foley EM; Esko JD. 2013. Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. J Clin Invest 123(6):2742-51. [PubMed: 23676495]  [MGI Ref ID J:201440]

Goossens P; Gijbels MJ; Zernecke A; Eijgelaar W; Vergouwe MN; van der Made I; Vanderlocht J; Beckers L; Buurman WA; Daemen MJ; Kalinke U; Weber C; Lutgens E; de Winther MP. 2010. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 12(2):142-53. [PubMed: 20674859]  [MGI Ref ID J:163078]

Goossens P; Vergouwe MN; Gijbels MJ; Curfs DM; van Woezik JH; Hoeksema MA; Xanthoulea S; Leenen PJ; Rupec RA; Hofker MH; de Winther MP. 2011. Myeloid IkappaBalpha Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques. PLoS One 6(7):e22327. [PubMed: 21814576]  [MGI Ref ID J:174920]

Gordts PL; Reekmans S; Lauwers A; Van Dongen A; Verbeek L; Roebroek AJ. 2009. Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 29(9):1258-64. [PubMed: 19667105]  [MGI Ref ID J:167801]

Gordts SC; Van Craeyveld E; Muthuramu I; Singh N; Jacobs F; De Geest B. 2012. Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function. PLoS One 7(10):e46849. [PubMed: 23056485]  [MGI Ref ID J:191934]

Graham MJ; Lee RG; Bell TA 3rd; Fu W; Mullick AE; Alexander VJ; Singleton W; Viney N; Geary R; Su J; Baker BF; Burkey J; Crooke ST; Crooke RM. 2013. Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res 112(11):1479-90. [PubMed: 23542898]  [MGI Ref ID J:213303]

Grainger DJ; Reckless J; McKilligin E. 2004. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173(10):6366-75. [PubMed: 15528376]  [MGI Ref ID J:94282]

Gu L; Okada Y; Clinton SK; Gerard C; Sukhova GK; Libby P; Rollins BJ. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2(2):275-81. [PubMed: 9734366]  [MGI Ref ID J:75837]

Guo W; Wong S; Bhasin S. 2013. AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosis. PLoS One 8(8):e71017. [PubMed: 23936482]  [MGI Ref ID J:205772]

Gupte AA; Minze LJ; Reyes M; Ren Y; Wang X; Brunner G; Ghosn M; Cordero-Reyes AM; Ding K; Pratico D; Morrisett J; Shi ZZ; Hamilton DJ; Lyon CJ; Hsueh WA. 2013. High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance. Endocrinology 154(8):2650-62. [PubMed: 23709089]  [MGI Ref ID J:201180]

Haeusler RA; Pratt-Hyatt M; Welch CL; Klaassen CD; Accili D. 2012. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab 15(1):65-74. [PubMed: 22197325]  [MGI Ref ID J:182348]

Hager L; Li L; Pun H; Liu L; Hossain MA; Maguire GF; Naples M; Baker C; Magomedova L; Tam J; Adeli K; Cummins CL; Connelly PW; Ng DS. 2012. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice. J Biol Chem 287(24):20755-68. [PubMed: 22500017]  [MGI Ref ID J:186520]

Hamers AA; Vos M; Rassam F; Marinkovic G; Kurakula K; van Gorp PJ; de Winther MP; Gijbels MJ; de Waard V; de Vries CJ. 2012. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ Res 110(3):428-38. [PubMed: 22194623]  [MGI Ref ID J:192703]

Han CY; Subramanian S; Chan CK; Omer M; Chiba T; Wight TN; Chait A. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56(9):2260-73. [PubMed: 17563062]  [MGI Ref ID J:126587]

Han L; Tang MX; Ti Y; Wang ZH; Wang J; Ding WY; Wang H; Zhang Y; Zhang W; Zhong M. 2013. Overexpressing STAMP2 improves insulin resistance in diabetic ApoE(-)/(-)/LDLR(-)/(-) mice via macrophage polarization shift in adipose tissues. PLoS One 8(11):e78903. [PubMed: 24236066]  [MGI Ref ID J:209316]

Han S; Liang CP; DeVries-Seimon T; Ranalletta M; Welch CL; Collins-Fletcher K; Accili D; Tabas I; Tall AR. 2006. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab 3(4):257-66. [PubMed: 16581003]  [MGI Ref ID J:129653]

Han S; Liang CP; Westerterp M; Senokuchi T; Welch CL; Wang Q; Matsumoto M; Accili D; Tall AR. 2009. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest 119(4):1029-41. [PubMed: 19273907]  [MGI Ref ID J:149755]

Hanna RN; Shaked I; Hubbeling HG; Punt JA; Wu R; Herrley E; Zaugg C; Pei H; Geissmann F; Ley K; Hedrick CC. 2012. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res 110(3):416-27. [PubMed: 22194622]  [MGI Ref ID J:192704]

Harada-Shiba M; Takagi A; Marutsuka K; Moriguchi S; Yagyu H; Ishibashi S; Asada Y; Yokoyama S. 2004. Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo. Circ Res 95(9):945-52. [PubMed: 15472122]  [MGI Ref ID J:102291]

Harats D; Shaish A; George J; Mulkins M; Kurihara H; Levkovitz H; Sigal E. 2000. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 20(9):2100-5. [PubMed: 10978255]  [MGI Ref ID J:127953]

Hartman HB; Lai K; Evans MJ. 2009. Loss of small heterodimer partner expression in the liver protects against dyslipidemia. J Lipid Res 50(2):193-203. [PubMed: 18820241]  [MGI Ref ID J:149005]

Hartvigsen K; Binder CJ; Hansen LF; Rafia A; Juliano J; Horkko S; Steinberg D; Palinski W; Witztum JL; Li AC. 2007. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol 27(4):878-85. [PubMed: 17255537]  [MGI Ref ID J:148155]

Hasty AH; Shimano H; Osuga Ji; Namatame I; Takahashi A; Yahagi N; Perrey S; Iizuka Y; Tamura Y; Amemiya-Kudo M; Yoshikawa T; Okazaki H; Ohashi K; Harada K; Matsuzaka T; Sone H; Gotoda T; Nagai R; Ishibashi S; Yamada N. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276(40):37402-8. [PubMed: 11445560]  [MGI Ref ID J:72027]

Hauer AD; Uyttenhove C; de Vos P; Stroobant V; Renauld JC; van Berkel TJ; van Snick J; Kuiper J. 2005. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 112(7):1054-62. [PubMed: 16103256]  [MGI Ref ID J:117550]

Heikkila HM; Trosien J; Metso J; Jauhiainen M; Pentikainen MO; Kovanen PT; Lindstedt KA. 2010. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation. J Cell Biochem 109(3):615-23. [PubMed: 20024959]  [MGI Ref ID J:161254]

Heinonen SE; Leppanen P; Kholova I; Lumivuori H; Hakkinen SK; Bosch F; Laakso M; Yla-Herttuala S. 2007. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Circ Res 101(10):1058-67. [PubMed: 17872464]  [MGI Ref ID J:141333]

Hemdahl AL; Falk E; Thoren P; Hansson GK. 2004. Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice. Am J Physiol Heart Circ Physiol 287(2):H872-7. [PubMed: 15031124]  [MGI Ref ID J:95598]

Hendrikx T; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Jeurissen ML; Steinbusch MM; Vaes N; Binder CJ; Koek GH; Stienstra R; Netea MG; Hofker MH; Shiri-Sverdlov R. 2013. Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice. PLoS One 8(12):e78792. [PubMed: 24312444]  [MGI Ref ID J:209749]

Henninger DD; Gerritsen ME; Granger DN. 1997. Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ Res 81(2):274-81. [PubMed: 9242189]  [MGI Ref ID J:42527]

Herijgers N; Van Eck M; Korporaal SJ; Hoogerbrugge PM; Van Berkel TJ. 2000. Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages J Lipid Res 41(7):1163-71. [PubMed: 10884299]  [MGI Ref ID J:63449]

Herijgers N; de Winther MP; Van Eck M; Havekes LM; Hofker MH; Hoogerbrugge PM; Van Berkel TJ. 2000. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice J Lipid Res 41(9):1402-9. [PubMed: 10974047]  [MGI Ref ID J:64891]

Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc Natl Acad Sci U S A 92(10):4611-5. [PubMed: 7753850]  [MGI Ref ID J:25195]

Hilgendorf I; Theurl I; Gerhardt LM; Robbins CS; Weber GF; Gonen A; Iwamoto Y; Degousee N; Holderried TA; Winter C; Zirlik A; Lin HY; Sukhova GK; Butany J; Rubin BB; Witztum JL; Libby P; Nahrendorf M; Weissleder R; Swirski FK. 2014. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation 129(16):1677-87. [PubMed: 24488984]  [MGI Ref ID J:221696]

Hime NJ; Black AS; Bulgrien JJ; Curtiss LK. 2008. Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP. J Lipid Res 49(10):2113-23. [PubMed: 18599739]  [MGI Ref ID J:140426]

Hockings PD; Roberts T; Galloway GJ; Reid DG; Harris DA; Vidgeon-Hart M; Groot PH; Suckling KE; Benson GM. 2002. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation 106(13):1716-21. [PubMed: 12270868]  [MGI Ref ID J:103222]

Hoekstra M; Stitzinger M; van Wanrooij EJ; Michon IN; Kruijt JK; Kamphorst J; Van Eck M; Vreugdenhil E; Van Berkel TJ; Kuiper J. 2006. Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. J Lipid Res 47(10):2198-207. [PubMed: 16885566]  [MGI Ref ID J:116502]

Holdt LM; Thiery J; Breslow JL; Teupser D. 2008. Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice. Arterioscler Thromb Vasc Biol 28(6):1097-103. [PubMed: 18356551]  [MGI Ref ID J:149028]

Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL. 2008. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 79(2):287-93. [PubMed: 18453637]  [MGI Ref ID J:161897]

Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbee JF; Havekes LM; van Vlijmen BJ; Tamsma JT. 2006. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler Thromb Vasc Biol 26(12):2710-5. [PubMed: 17038633]  [MGI Ref ID J:129557]

Hu L; van der Hoogt CC; Espirito Santo SM; Out R; Kypreos KE; van Vlijmen BJ; Van Berkel TJ; Romijn JA; Havekes LM; van Dijk KW; Rensen PC. 2008. The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI. J Lipid Res 49(7):1553-61. [PubMed: 18367731]  [MGI Ref ID J:138462]

Huang F; Thompson JC; Wilson PG; Aung HH; Rutledge JC; Tannock LR. 2008. Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. J Lipid Res 49(3):521-30. [PubMed: 18033753]  [MGI Ref ID J:133289]

Huang Y; Liu XQ; Rall SC Jr; Taylor JM; von Eckardstein A; Assmann G; Mahley RW. 1998. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 273(41):26388-93. [PubMed: 9756870]  [MGI Ref ID J:115206]

Huang Y; Rall SC Jr; Mahley RW. 1997. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler Thromb Vasc Biol 17(11):2817-24. [PubMed: 9409260]  [MGI Ref ID J:45728]

Hui Y; Ricciotti E; Crichton I; Yu Z; Wang D; Stubbe J; Wang M; Pure E; FitzGerald GA. 2010. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation 121(24):2654-60. [PubMed: 20530000]  [MGI Ref ID J:178670]

Huszar D; Varban ML; Rinninger F; Feeley R; Arai T; Fairchild-Huntress V; Donovan MJ; Tall AR. 2000. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20(4):1068-73. [PubMed: 10764675]  [MGI Ref ID J:62371]

Igbavboa U; Avdulov NA; Chochina SV; Wood WG. 1997. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J Neurochem 69(4):1661-7. [PubMed: 9326295]  [MGI Ref ID J:43043]

Iqbal J; Rudel LL; Hussain MM. 2008. Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition. J Biol Chem 283(29):19967-80. [PubMed: 18502767]  [MGI Ref ID J:138737]

Ishibashi S; Brown MS; Goldstein JL; Gerard RD; Hammer RE; Herz J. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments] J Clin Invest 92(2):883-93. [PubMed: 8349823]  [MGI Ref ID J:37394]

Ishibashi S; Goldstein JL; Brown MS; Herz J; Burns DK. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93(5):1885-93. [PubMed: 8182121]  [MGI Ref ID J:77012]

Ishibashi S; Hammer RE; Herz J. 1994. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J Biol Chem 269(45):27803-6. [PubMed: 7961705]  [MGI Ref ID J:21380]

Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in knockout mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A 91(10):4431-5. [PubMed: 8183926]  [MGI Ref ID J:18138]

Ishibashi S; Perrey S; Chen Z; Osuga Ji; Shimada M; Ohashi K; Harada K; Yazaki Y; Yamada N. 1996. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271(37):22422-7. [PubMed: 8798405]  [MGI Ref ID J:35377]

Ishikawa K; Sugawara D; Wang Xp; Suzuki K; Itabe H; Maruyama Y; Lusis AJ. 2001. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88(5):506-12. [PubMed: 11249874]  [MGI Ref ID J:115392]

Iwaki T; Donahue DL; Castellino FJ. 2007. High levels of LDL-cholesterol rescue the neonatal mortality associated with afibrinogenemia in mice. J Thromb Haemost 5(3):624-6. [PubMed: 17155952]  [MGI Ref ID J:135942]

Iwaki T; Sandoval-Cooper MJ; Brechmann M; Ploplis VA; Castellino FJ. 2006. A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice. Blood 107(10):3883-91. [PubMed: 16434491]  [MGI Ref ID J:132734]

Jagavelu K; Tietge UJ; Gaestel M; Drexler H; Schieffer B; Bavendiek U. 2007. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice. Circ Res 101(11):1104-12. [PubMed: 17885219]  [MGI Ref ID J:142788]

Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X. 1998. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest 101(4):905-12. [PubMed: 9466986]  [MGI Ref ID J:46009]

Jiang XC; Qin S; Qiao C; Kawano K; Lin M; Skold A; Xiao X; Tall AR. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7(7):847-52. [PubMed: 11433351]  [MGI Ref ID J:70250]

Jiang XC; Tall AR; Qin S; Lin M; Schneider M; Lalanne F; Deckert V; Desrumaux C; Athias A; Witztum JL; Lagrost L. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem 277(35):31850-6. [PubMed: 12105225]  [MGI Ref ID J:120468]

Johansson F; Kramer F; Barnhart S; Kanter JE; Vaisar T; Merrill RD; Geng L; Oka K; Chan L; Chait A; Heinecke JW; Bornfeldt KE. 2008. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. Proc Natl Acad Sci U S A 105(6):2082-7. [PubMed: 18252823]  [MGI Ref ID J:143961]

Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N. 2008. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences. Arterioscler Thromb Vasc Biol 28(10):1745-52. [PubMed: 18617647]  [MGI Ref ID J:159802]

Johnson LA; Arbones-Mainar JM; Fox RG; Pendse AA; Altenburg MK; Kim HS; Maeda N. 2011. Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. Diabetes 60(9):2285-94. [PubMed: 21810592]  [MGI Ref ID J:189275]

Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J. 2014. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis 64:150-62. [PubMed: 24412220]  [MGI Ref ID J:211613]

Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH. 2007. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest 117(1):165-74. [PubMed: 17200716]  [MGI Ref ID J:117439]

Jones C; Hammer RE; Li WP; Cohen JC; Hobbs HH; Herz J. 2003. Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia. J Biol Chem 278(31):29024-30. [PubMed: 12746448]  [MGI Ref ID J:84694]

Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98(10):2259-67. [PubMed: 8941642]  [MGI Ref ID J:65146]

Joseph SB; McKilligin E; Pei L; Watson MA; Collins AR; Laffitte BA; Chen M; Noh G; Goodman J; Hagger GN; Tran J; Tippin TK; Wang X; Lusis AJ; Hsueh WA; Law RE; Collins JL; Willson TM; Tontonoz P. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 99(11):7604-9. [PubMed: 12032330]  [MGI Ref ID J:76860]

Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB Jr. 2006. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem 281(44):33053-65. [PubMed: 16928680]  [MGI Ref ID J:117282]

Kadl A; Meher AK; Sharma PR; Lee MY; Doran AC; Johnstone SR; Elliott MR; Gruber F; Han J; Chen W; Kensler T; Ravichandran KS; Isakson BE; Wamhoff BR; Leitinger N. 2010. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 107(6):737-46. [PubMed: 20651288]  [MGI Ref ID J:175024]

Kanter JE; Kramer F; Barnhart S; Averill MM; Vivekanandan-Giri A; Vickery T; Li LO; Becker L; Yuan W; Chait A; Braun KR; Potter-Perigo S; Sanda S; Wight TN; Pennathur S; Serhan CN; Heinecke JW; Coleman RA; Bornfeldt KE. 2012. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A 109(12):E715-24. [PubMed: 22308341]  [MGI Ref ID J:182631]

Kanter JE; Tang C; Oram JF; Bornfeldt KE. 2012. Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages. Biochim Biophys Acta 1821(3):358-64. [PubMed: 22020260]  [MGI Ref ID J:182368]

Kanters E; Gijbels MJ; van der Made I; Vergouwe MN; Heeringa P; Kraal G; Hofker MH; de Winther MP. 2004. Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103(3):934-40. [PubMed: 14512319]  [MGI Ref ID J:87639]

Kanters E; Pasparakis M; Gijbels MJ; Vergouwe MN; Partouns-Hendriks I; Fijneman RJ; Clausen BE; Forster I; Kockx MM; Rajewsky K; Kraal G; Hofker MH; de Winther MP. 2003. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112(8):1176-85. [PubMed: 14561702]  [MGI Ref ID J:86163]

Karagiannides I; Abdou R; Tzortzopoulou A; Voshol PJ; Kypreos KE. 2008. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS J 275(19):4796-809. [PubMed: 18754772]  [MGI Ref ID J:142460]

Karasawa T; Takahashi A; Saito R; Sekiya M; Igarashi M; Iwasaki H; Miyahara S; Koyasu S; Nakagawa Y; Ishii K; Matsuzaka T; Kobayashi K; Yahagi N; Takekoshi K; Sone H; Yatoh S; Suzuki H; Yamada N; Shimano H. 2011. Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 31(8):1788-95. [PubMed: 21546605]  [MGI Ref ID J:191862]

Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE. 2011. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice. FEBS J 278(17):3119-29. [PubMed: 21740524]  [MGI Ref ID J:190789]

Kassel KM; Sullivan BP; Cui W; Copple BL; Luyendyk JP. 2012. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established Fatty liver disease. Am J Pathol 181(4):1287-95. [PubMed: 22841818]  [MGI Ref ID J:188704]

Kassim SH; Li H; Vandenberghe LH; Hinderer C; Bell P; Marchadier D; Wilson A; Cromley D; Redon V; Yu H; Wilson JM; Rader DJ. 2010. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis. PLoS One 5(10):e13424. [PubMed: 20976059]  [MGI Ref ID J:166224]

Katsouri L; Georgopoulos S. 2011. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model. PLoS One 6(7):e21880. [PubMed: 21755005]  [MGI Ref ID J:174945]

Kaufmann BA; Carr CL; Belcik JT; Xie A; Yue Q; Chadderdon S; Caplan ES; Khangura J; Bullens S; Bunting S; Lindner JR. 2010. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol 30(1):54-9. [PubMed: 19834105]  [MGI Ref ID J:171802]

Kawashiri Ma; Zhang Y; Usher D; Reilly M; Pure E; Rader DJ. 2001. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice. J Lipid Res 42(6):943-50. [PubMed: 11369802]  [MGI Ref ID J:69834]

Kennedy A; Gruen ML; Gutierrez DA; Surmi BK; Orr JS; Webb CD; Hasty AH. 2012. Impact of macrophage inflammatory protein-1alpha deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion. PLoS One 7(2):e31508. [PubMed: 22359597]  [MGI Ref ID J:185223]

Kennedy DJ; Kuchibhotla S; Westfall KM; Silverstein RL; Morton RE; Febbraio M. 2011. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res 89(3):604-13. [PubMed: 21088116]  [MGI Ref ID J:186882]

Kennedy DJ; Kuchibhotla SD; Guy E; Park YM; Nimako G; Vanegas D; Morton RE; Febbraio M. 2009. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice. Arterioscler Thromb Vasc Biol 29(10):1481-7. [PubMed: 19608973]  [MGI Ref ID J:167807]

Keren P; George J; Shaish A; Levkovitz H; Janakovic Z; Afek A; Goldberg I; Kopolovic J; Keren G; Harats D. 2000. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49(6):1064-9. [PubMed: 10866061]  [MGI Ref ID J:62295]

Khan OM; Akula MK; Skalen K; Karlsson C; Stahlman M; Young SG; Boren J; Bergo MO. 2013. Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice. Circulation 127(7):782-90. [PubMed: 23334894]  [MGI Ref ID J:210275]

Kim HS; Ullevig SL; Zamora D; Lee CF; Asmis R. 2012. Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. Proc Natl Acad Sci U S A 109(41):E2803-12. [PubMed: 22991462]  [MGI Ref ID J:190103]

King LM; Francomano CA. 2001. Characterization of a human gene encoding nucleosomal binding protein nsbp1. Genomics 71(2):163-73. [PubMed: 11161810]  [MGI Ref ID J:67578]

King VL; Cassis LA; Daugherty A. 2007. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. Am J Pathol 171(6):2040-7. [PubMed: 18055554]  [MGI Ref ID J:128948]

King VL; Szilvassy SJ; Daugherty A. 2002. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arterioscler Thromb Vasc Biol 22(3):456-61. [PubMed: 11884290]  [MGI Ref ID J:103308]

King VL; Szilvassy SJ; Daugherty A. 2002. Interleukin-4 deficiency promotes gallstone formation. J Lipid Res 43(5):768-71. [PubMed: 11971948]  [MGI Ref ID J:76258]

Kinnunen K; Heinonen SE; Kalesnykas G; Laidinen S; Uusitalo-Jarvinen H; Uusitalo H; Yla-Herttuala S. 2013. LDLR-/-ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retina. Mol Vis 19:1723-33. [PubMed: 23922490]  [MGI Ref ID J:205300]

Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP. 2007. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115(15):2065-75. [PubMed: 17404153]  [MGI Ref ID J:135371]

Kjolby M; Andersen OM; Breiderhoff T; Fjorback AW; Pedersen KM; Madsen P; Jansen P; Heeren J; Willnow TE; Nykjaer A. 2010. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 12(3):213-23. [PubMed: 20816088]  [MGI Ref ID J:166369]

Klingenberg R; Gerdes N; Badeau RM; Gistera A; Strodthoff D; Ketelhuth DF; Lundberg AM; Rudling M; Nilsson SK; Olivecrona G; Zoller S; Lohmann C; Luscher TF; Jauhiainen M; Sparwasser T; Hansson GK. 2013. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 123(3):1323-34. [PubMed: 23426179]  [MGI Ref ID J:196393]

Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N. 2004. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochim Biophys Acta 1684(1-3):8-17. [PubMed: 15450205]  [MGI Ref ID J:92554]

Ko KW; Paul A; Ma K; Li L; Chan L. 2005. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res 46(12):2586-94. [PubMed: 16199802]  [MGI Ref ID J:106132]

Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L. 1996. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem 271(12):6852-60. [PubMed: 8636110]  [MGI Ref ID J:32102]

Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K. 2012. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice. Circ Res 111(10):1274-85. [PubMed: 22927332]  [MGI Ref ID J:212625]

Kovacs A; Tornvall P; Nilsson R; Tegner J; Hamsten A; Bjorkegren J. 2007. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A 104(34):13768-73. [PubMed: 17702862]  [MGI Ref ID J:124095]

Koya T; Miyazaki T; Watanabe T; Shichiri M; Atsumi T; Kim-Kaneyama JR; Miyazaki A. 2012. Salusin-beta accelerates inflammatory responses in vascular endothelial cells via NF-kappaB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 303(1):H96-105. [PubMed: 22561298]  [MGI Ref ID J:189056]

Kozarsky KF; Donahee MH; Glick JM; Krieger M; Rader DJ. 2000. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 20(3):721-7. [PubMed: 10712397]  [MGI Ref ID J:61288]

Kraemer FB; Shen WJ; Patel S; Osuga J; Ishibashi S; Azhar S. 2007. The LDL receptor is not necessary for acute adrenal steroidogenesis in mouse adrenocortical cells. Am J Physiol Endocrinol Metab 292(2):E408-12. [PubMed: 16985254]  [MGI Ref ID J:143674]

Krishna SM; Seto SW; Moxon JV; Rush C; Walker PJ; Norman PE; Golledge J. 2012. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol 181(2):706-18. [PubMed: 22698985]  [MGI Ref ID J:186431]

Kruit JK; Kremer PH; Dai L; Tang R; Ruddle P; de Haan W; Brunham LR; Verchere CB; Hayden MR. 2010. Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice. Diabetologia 53(6):1110-9. [PubMed: 20229095]  [MGI Ref ID J:159879]

Kubo N; Boisvert WA; Ballantyne CM; Curtiss LK. 2000. Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice J Lipid Res 41(7):1060-6. [PubMed: 10884286]  [MGI Ref ID J:63447]

Kulinski A; Rustaeus S; Vance JE. 2002. Microsomal Triacylglycerol Transfer Protein Is Required for Lumenal Accretion of Triacylglycerol Not Associated with ApoB, as Well as for ApoB Lipidation. J Biol Chem 277(35):31516-25. [PubMed: 12072432]  [MGI Ref ID J:78774]

Kumar AP; Piedrafita FJ; Reynolds WF. 2004. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. J Biol Chem 279(9):8300-15. [PubMed: 14668325]  [MGI Ref ID J:130052]

Kunjathoor VV; Chiu DS; O'Brien KD; LeBoeuf RC. 2002. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 22(3):462-8. [PubMed: 11884291]  [MGI Ref ID J:103309]

Kwak BR; Veillard N; Pelli G; Mulhaupt F; James RW; Chanson M; Mach F. 2003. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 107(7):1033-9. [PubMed: 12600918]  [MGI Ref ID J:103052]

Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI. 2003. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype. Biochemistry 42(33):9841-53. [PubMed: 12924933]  [MGI Ref ID J:115687]

Kypreos KE; Zannis VI. 2006. LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice. J Lipid Res 47(3):521-9. [PubMed: 16339113]  [MGI Ref ID J:107556]

Lagace TA; Curtis DE; Garuti R; McNutt MC; Park SW; Prather HB; Anderson NN; Ho YK; Hammer RE; Horton JD. 2006. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice. J Clin Invest 116(11):2995-3005. [PubMed: 17080197]  [MGI Ref ID J:114949]

Lai CF; Seshadri V; Huang K; Shao JS; Cai J; Vattikuti R; Schumacher A; Loewy AP; Denhardt DT; Rittling SR; Towler DA. 2006. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 98(12):1479-89. [PubMed: 16709900]  [MGI Ref ID J:122625]

Lambert G; Jarnoux AL; Pineau T; Pape O; Chetiveaux M; Laboisse C; Krempf M; Costet P. 2006. Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor. Endocrinology 147(10):4985-95. [PubMed: 16794006]  [MGI Ref ID J:129548]

Lamharzi N; Renard CB; Kramer F; Pennathur S; Heinecke JW; Chait A; Bornfeldt KE. 2004. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 53(12):3217-25. [PubMed: 15561953]  [MGI Ref ID J:94609]

Lammers B; Chandak PG; Aflaki E; Van Puijvelde GH; Radovic B; Hildebrand RB; Meurs I; Out R; Kuiper J; Van Berkel TJ; Kolb D; Haemmerle G; Zechner R; Levak-Frank S; Van Eck M; Kratky D. 2011. Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 31(1):67-73. [PubMed: 21030715]  [MGI Ref ID J:184190]

Lammers B; Zhao Y; Foks AC; Hildebrand RB; Kuiper J; Van Berkel TJ; Van Eck M. 2012. Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice. PLoS One 7(10):e48080. [PubMed: 23133551]  [MGI Ref ID J:192253]

Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M. 2011. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE. PLoS One 6(10):e26095. [PubMed: 22022523]  [MGI Ref ID J:178098]

Lampropoulou A; Zannis VI; Kypreos KE. 2012. Pharmacodynamic and pharmacokinetic analysis of apoE4 [L261A, W264A, F265A, L268A, V269A], a recombinant apolipoprotein E variant with improved biological properties. Biochem Pharmacol 84(11):1451-8. [PubMed: 22985620]  [MGI Ref ID J:193572]

Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL. 2006. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol 26(2):347-52. [PubMed: 16293797]  [MGI Ref ID J:127960]

Larsson SL; Skogsberg J; Bjorkegren J. 2004. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver. J Biol Chem 279(2):831-6. [PubMed: 14583618]  [MGI Ref ID J:124544]

Laurila A; Cole SP; Merat S; Obonyo M; Palinski W; Fierer J; Witztum JL. 2001. High-fat, high-cholesterol diet increases the incidence of gastritis in LDL receptor-negative mice. Arterioscler Thromb Vasc Biol 21(6):991-6. [PubMed: 11397709]  [MGI Ref ID J:103300]

Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A. 2012. Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression. Sci Transl Med 4(148):148ra115. [PubMed: 22914621]  [MGI Ref ID J:187220]

Lee CH; Chawla A; Urbiztondo N; Liao D; Boisvert WA; Evans RM; Curtiss LK. 2003. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302(5644):453-7. [PubMed: 12970571]  [MGI Ref ID J:122915]

Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK. 2009. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem 284(20):13735-45. [PubMed: 19318355]  [MGI Ref ID J:149912]

Lee RG; Kelley KL; Sawyer JK; Farese RV Jr; Parks JS; Rudel LL. 2004. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Circ Res 95(10):998-1004. [PubMed: 15486318]  [MGI Ref ID J:103854]

Lee RG; Shah R; Sawyer JK; Hamilton RL; Parks JS; Rudel LL. 2005. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice. J Lipid Res 46(6):1205-12. [PubMed: 15805543]  [MGI Ref ID J:128885]

Lee SJ; Grosskopf I; Choi SY; Cooper AD. 2004. Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158->Cys), and E3-Leiden. J Lipid Res 45(12):2199-210. [PubMed: 15466367]  [MGI Ref ID J:94176]

Lemmens KJ; van de Wier B; Koek GH; Kohler E; Drittij MJ; van der Vijgh WJ; Bast A; Haenen GR. 2015. The flavonoid monoHER promotes the adaption to oxidative stress during the onset of NAFLD. Biochem Biophys Res Commun 456(1):179-82. [PubMed: 25462563]  [MGI Ref ID J:220261]

Leppanen P; Koota S; Kholova I; Koponen J; Fieber C; Eriksson U; Alitalo K; Yla-Herttuala S. 2005. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice. Circulation 112(9):1347-52. [PubMed: 16129816]  [MGI Ref ID J:118230]

Leung VW; Yun S; Botto M; Mason JC; Malik TH; Song W; Paixao-Cavalcante D; Pickering MC; Boyle JJ; Haskard DO. 2009. Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 175(4):1757-67. [PubMed: 19729477]  [MGI Ref ID J:153060]

Levin MC; Jirholt P; Wramstedt A; Johansson ME; Lundberg AM; Trajkovska MG; Stahlman M; Fogelstrand P; Brisslert M; Fogelstrand L; Yan ZQ; Hansson GK; Bjorkbacka H; Olofsson SO; Boren J. 2011. Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation. Circ Res 109(11):1210-8. [PubMed: 21959219]  [MGI Ref ID J:196562]

Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO. 2009. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120(5):417-26. [PubMed: 19620499]  [MGI Ref ID J:166420]

Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK. 2000. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106(4):523-31. [PubMed: 10953027]  [MGI Ref ID J:64040]

Li L; Hossain MA; Sadat S; Hager L; Liu L; Tam L; Schroer S; Huogen L; Fantus IG; Connelly PW; Woo M; Ng DS. 2011. Lecithin Cholesterol Acyltransferase Null Mice Are Protected from Diet-induced Obesity and Insulin Resistance in a Gender-specific Manner through Multiple Pathways. J Biol Chem 286(20):17809-20. [PubMed: 21454561]  [MGI Ref ID J:172680]

Li L; Naples M; Song H; Yuan R; Ye F; Shafi S; Adeli K; Ng DS. 2007. LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling. Am J Physiol Endocrinol Metab 293(2):E587-94. [PubMed: 17551001]  [MGI Ref ID J:123371]

Li L; Thompson PA; Kitchens RL. 2008. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res 49(8):1782-93. [PubMed: 18497424]  [MGI Ref ID J:138430]

Li R; Mittelstein D; Kam W; Pakbin P; Du Y; Tintut Y; Navab M; Sioutas C; Hsiai T. 2013. Atmospheric ultrafine particles promote vascular calcification via the NF-kappaB signaling pathway. Am J Physiol Cell Physiol 304(4):C362-9. [PubMed: 23242187]  [MGI Ref ID J:194848]

Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR. 2009. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res 105(11):1072-82. [PubMed: 19834009]  [MGI Ref ID J:170144]

Li Y; Xu S; Mihaylova MM; Zheng B; Hou X; Jiang B; Park O; Luo Z; Lefai E; Shyy JY; Gao B; Wierzbicki M; Verbeuren TJ; Shaw RJ; Cohen RA; Zang M. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13(4):376-88. [PubMed: 21459323]  [MGI Ref ID J:172248]

Li Z; Basterr MJ; Hailemariam TK; Hojjati MR; Lu S; Liu J; Liu R; Zhou H; Jiang XC. 2005. The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis. Biochim Biophys Acta 1735(2):130-4. [PubMed: 15967715]  [MGI Ref ID J:124540]

Lian J; Quiroga AD; Li L; Lehner R. 2012. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice. Circ Res 111(8):982-90. [PubMed: 22872154]  [MGI Ref ID J:212633]

Liang CP; Han S; Li G; Tabas I; Tall AR. 2012. Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment. Diabetes 61(10):2609-20. [PubMed: 22751695]  [MGI Ref ID J:208519]

Liao X; Sluimer JC; Wang Y; Subramanian M; Brown K; Pattison JS; Robbins J; Martinez J; Tabas I. 2012. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 15(4):545-53. [PubMed: 22445600]  [MGI Ref ID J:184210]

Lichtman AH; Clinton SK; Iiyama K; Connelly PW; Libby P; Cybulsky MI. 1999. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 19(8):1938-44. [PubMed: 10446074]  [MGI Ref ID J:129810]

Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A. 2006. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides. Biochim Biophys Acta 1761(9):1070-7. [PubMed: 16935026]  [MGI Ref ID J:116584]

Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A. 2004. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J Lipid Res 45(5):805-11. [PubMed: 14993244]  [MGI Ref ID J:89308]

Lieu HD; Withycombe SK; Walker Q; Rong JX; Walzem RL; Wong JS; Hamilton RL; Fisher EA; Young SG. 2003. Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation 107(9):1315-21. [PubMed: 12628954]  [MGI Ref ID J:91722]

Lightle S; Tosheva R; Lee A; Queen-Baker J; Boyanovsky B; Shedlofsky S; Nikolova-Karakashian M. 2003. Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch Biochem Biophys 419(2):120-8. [PubMed: 14592455]  [MGI Ref ID J:113578]

Lillis AP; Greenlee MC; Mikhailenko I; Pizzo SV; Tenner AJ; Strickland DK; Bohlson SS. 2008. Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis. J Immunol 181(1):364-73. [PubMed: 18566402]  [MGI Ref ID J:137404]

Lim H; Kim YU; Sun H; Lee JH; Reynolds JM; Hanabuchi S; Wu H; Teng BB; Chung Y. 2014. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 40(1):153-65. [PubMed: 24412615]  [MGI Ref ID J:209392]

Lim HY; Thiam CH; Yeo KP; Bisoendial R; Hii CS; McGrath KC; Tan KW; Heather A; Alexander JS; Angeli V. 2013. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab 17(5):671-84. [PubMed: 23663736]  [MGI Ref ID J:199273]

Lim RS; Suhalim JL; Miyazaki-Anzai S; Miyazaki M; Levi M; Potma EO; Tromberg BJ. 2011. Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res 52(12):2177-86. [PubMed: 21949051]  [MGI Ref ID J:178544]

Lim WS; Timmins JM; Seimon TA; Sadler A; Kolodgie FD; Virmani R; Tabas I. 2008. Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation 117(7):940-51. [PubMed: 18227389]  [MGI Ref ID J:145081]

Lin J; Li H; Yang M; Ren J; Huang Z; Han F; Huang J; Ma J; Zhang D; Zhang Z; Wu J; Huang D; Qiao M; Jin G; Wu Q; Huang Y; Du J; Han J. 2013. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 3(1):200-10. [PubMed: 23333278]  [MGI Ref ID J:196325]

Lin JZ; Martagon AJ; Hsueh WA; Baxter JD; Gustafsson JA; Webb P; Phillips KJ. 2012. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. Endocrinology 153(12):6136-44. [PubMed: 23087171]  [MGI Ref ID J:192628]

Lingrel JB; Pilcher-Roberts R; Basford JE; Manoharan P; Neumann J; Konaniah ES; Srinivasan R; Bogdanov VY; Hui DY. 2012. Myeloid-specific Kruppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis. Circ Res 110(10):1294-302. [PubMed: 22474254]  [MGI Ref ID J:212516]

Linton MF; Babaev VR; Gleaves LA; Fazio S. 1999. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J Biol Chem 274(27):19204-10. [PubMed: 10383427]  [MGI Ref ID J:56080]

Lipinski MJ; Campbell KA; Duong SQ; Welch TJ; Garmey JC; Doran AC; Skaflen MD; Oldham SN; Kelly KA; McNamara CA. 2012. Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 32(12):2855-61. [PubMed: 23042815]  [MGI Ref ID J:208316]

Liu B; Li H; Repa JJ; Turley SD; Dietschy JM. 2008. Genetic variations and treatments that affect the lifespan of the NPC1 mouse. J Lipid Res 49(3):663-9. [PubMed: 18077828]  [MGI Ref ID J:133425]

Liu B; Xie C; Richardson JA; Turley SD; Dietschy JM. 2007. Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease. J Lipid Res 48(8):1710-23. [PubMed: 17476031]  [MGI Ref ID J:123778]

Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC. 2009. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res 105(3):295-303. [PubMed: 19590047]  [MGI Ref ID J:164932]

Lloyd DJ; Helmering J; Kaufman SA; Turk J; Silva M; Vasquez S; Weinstein D; Johnston B; Hale C; Veniant MM. 2011. A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face. PLoS One 6(4):e18800. [PubMed: 21533112]  [MGI Ref ID J:172393]

Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Veniant MM. 2008. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Am J Physiol Endocrinol Metab 294(3):E496-505. [PubMed: 18160459]  [MGI Ref ID J:133453]

Lo JC; Wang Y; Tumanov AV; Bamji M; Yao Z; Reardon CA; Getz GS; Fu YX. 2007. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 316(5822):285-8. [PubMed: 17431181]  [MGI Ref ID J:120962]

Lo Sasso G; Murzilli S; Salvatore L; D'Errico I; Petruzzelli M; Conca P; Jiang ZY; Calabresi L; Parini P; Moschetta A. 2010. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 12(2):187-93. [PubMed: 20674863]  [MGI Ref ID J:163075]

Loeffler B; Heeren J; Blaeser M; Radner H; Kayser D; Aydin B; Merkel M. 2007. Lipoprotein lipase-facilitated uptake of LDL is mediated by the LDL receptor. J Lipid Res 48(2):288-98. [PubMed: 17090659]  [MGI Ref ID J:118187]

Loeper S; Asa SL; Ezzat S. 2008. Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiation. Cancer Res 68(10):3715-23. [PubMed: 18483254]  [MGI Ref ID J:135021]

Lowbeer C; Forsberg AM; Tokuno S; Hemdahl AL; Gustafsson SA; Valen G. 2004. Cardiac troponin T content in heart and skeletal muscle and in blood samples from ApoE/LDL receptor double knockout mice. Clin Chim Acta 344(1-2):73-8. [PubMed: 15149873]  [MGI Ref ID J:105262]

Lu H; Boustany-Kari CM; Daugherty A; Cassis LA. 2007. Angiotensin II increases adipose angiotensinogen expression. Am J Physiol Endocrinol Metab 292(5):E1280-7. [PubMed: 17213477]  [MGI Ref ID J:121237]

Lu H; Rateri DL; Feldman DL; Jr RJ; Fukamizu A; Ishida J; Oesterling EG; Cassis LA; Daugherty A. 2008. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 118(3):984-93. [PubMed: 18274671]  [MGI Ref ID J:135297]

Lu J; Cheng H; Atti E; Shih DM; Demer LL; Tintut Y. 2013. Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice. Biochem Biophys Res Commun 431(1):19-24. [PubMed: 23291186]  [MGI Ref ID J:198076]

Lu X; Xia M; Endresz V; Faludi I; Mundkur L; Gonczol E; Chen D; Kakkar VV. 2012. Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice. Arterioscler Thromb Vasc Biol 32(10):2358-71. [PubMed: 22837469]  [MGI Ref ID J:207883]

Luchtefeld M; Grothusen C; Gagalick A; Jagavelu K; Schuett H; Tietge UJ; Pabst O; Grote K; Drexler H; Forster R; Schieffer B. 2010. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation 122(16):1621-8. [PubMed: 20921438]  [MGI Ref ID J:179485]

Ludewig B; Jaggi M; Dumrese T; Brduscha-Riem K; Odermatt B; Hengartner H; Zinkernagel RM. 2001. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses. J Immunol 166(5):3369-76. [PubMed: 11207293]  [MGI Ref ID J:126478]

Lukasova M; Malaval C; Gille A; Kero J; Offermanns S. 2011. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121(3):1163-73. [PubMed: 21317532]  [MGI Ref ID J:172039]

Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK. 2013. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc Res 99(2):364-73. [PubMed: 23417039]  [MGI Ref ID J:218663]

Luo N; Liu J; Chung BH; Yang Q; Klein RL; Garvey WT; Fu Y. 2010. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 59(4):791-9. [PubMed: 20350970]  [MGI Ref ID J:164323]

Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C. 2010. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 207(2):391-404. [PubMed: 20100871]  [MGI Ref ID J:157760]

Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y. 2012. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet. PLoS One 7(4):e35835. [PubMed: 22558236]  [MGI Ref ID J:187279]

MacArthur JM; Bishop JR; Stanford KI; Wang L; Bensadoun A; Witztum JL; Esko JD. 2007. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117(1):153-64. [PubMed: 17200715]  [MGI Ref ID J:117455]

MacDonald ML; Singaraja RR; Bissada N; Ruddle P; Watts R; Karasinska JM; Gibson WT; Fievet C; Vance JE; Staels B; Hayden MR. 2008. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. J Lipid Res 49(1):217-29. [PubMed: 17960025]  [MGI Ref ID J:130278]

MacDonald ML; van Eck M; Hildebrand RB; Wong BW; Bissada N; Ruddle P; Kontush A; Hussein H; Pouladi MA; Chapman MJ; Fievet C; van Berkel TJ; Staels B; McManus BM; Hayden MR. 2009. Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 29(3):341-7. [PubMed: 19095997]  [MGI Ref ID J:160858]

MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE. 2006. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. Am J Pathol 168(6):2064-73. [PubMed: 16723719]  [MGI Ref ID J:109123]

Mach F; Sukhova GK; Michetti M; Libby P; Michetti P. 2002. Influence of Helicobacter pylori infection during atherogenesis in vivo in mice. Circ Res 90(1):E1-4. [PubMed: 11786527]  [MGI Ref ID J:109711]

Machado RM; Stefano JT; Oliveira CP; Mello ES; Ferreira FD; Nunes VS; de Lima VM; Quintao EC; Catanozi S; Nakandakare ER; Lottenberg AM. 2010. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr 140(6):1127-32. [PubMed: 20357081]  [MGI Ref ID J:160756]

Madenspacher JH; Draper DW; Smoak KA; Li H; Griffiths GL; Suratt BT; Wilson MD; Rudel LL; Fessler MB. 2010. Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J Immunol 185(3):1660-9. [PubMed: 20581153]  [MGI Ref ID J:162471]

Maganto-Garcia E; Tarrio ML; Grabie N; Bu DX; Lichtman AH. 2011. Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 124(2):185-95. [PubMed: 21690490]  [MGI Ref ID J:186295]

Major AS; Fazio S; Linton MF. 2002. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 22(11):1892-8. [PubMed: 12426221]  [MGI Ref ID J:103218]

Malik TH; Cortini A; Carassiti D; Boyle JJ; Haskard DO; Botto M. 2010. The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 122(19):1948-56. [PubMed: 20974996]  [MGI Ref ID J:179480]

Mallat Z; Gojova A; Sauzeau V; Brun V; Silvestre JS; Esposito B; Merval R; Groux H; Loirand G; Tedgui A. 2003. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res 93(9):884-8. [PubMed: 14525807]  [MGI Ref ID J:115653]

Malloy SI; Altenburg MK; Knouff C; Lanningham-Foster L; Parks JS; Maeda N. 2004. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler Thromb Vasc Biol 24(1):91-7. [PubMed: 12969990]  [MGI Ref ID J:146721]

Marquart TJ; Wu J; Lusis AJ; Baldan A. 2013. Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 33(3):455-8. [PubMed: 23288159]  [MGI Ref ID J:216897]

Marsh MM; Walker VR; Curtiss LK; Banka CL. 1999. Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 40(5):893-900. [PubMed: 10224158]  [MGI Ref ID J:54588]

Martens GW; Vallerskog T; Kornfeld H. 2012. Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity. J Leukoc Biol 91(6):849-57. [PubMed: 22227965]  [MGI Ref ID J:184951]

Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG. 2000. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice. J Lipid Res 41(2):205-13. [PubMed: 10681404]  [MGI Ref ID J:120545]

Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL ; Breslow JL ; Tall AR. 1997. A mouse model with features of familial combined hyperlipidemia. Science 275(5298):391-4. [PubMed: 8994037]  [MGI Ref ID J:37861]

Masucci-Magoulas L; Plump A; Jiang XC; Walsh A; Breslow JL; Tall AR. 1996. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. J Clin Invest 97(1):154-61. [PubMed: 8550828]  [MGI Ref ID J:111394]

Matasconi M; Parini P; Angelin B; Rudling M. 2005. Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment. Biochim Biophys Acta 1736(3):221-7. [PubMed: 16185916]  [MGI Ref ID J:102525]

Matt U; Sharif O; Martins R; Furtner T; Langeberg L; Gawish R; Elbau I; Zivkovic A; Lakovits K; Oskolkova O; Doninger B; Vychytil A; Perkmann T; Schabbauer G; Binder CJ; Bochkov VN; Scott JD; Knapp S. 2013. WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. J Clin Invest 123(7):3014-24. [PubMed: 23934128]  [MGI Ref ID J:201609]

Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA. 2009. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 119(16):2188-95. [PubMed: 19380618]  [MGI Ref ID J:166493]

McCaffrey TA; Fu C; Du B; Eksinar S; Kent KC; Bush H Jr; Kreiger K; Rosengart T; Cybulsky MI; Silverman ES; Collins T. 2000. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis [see comments] J Clin Invest 105(5):653-62. [PubMed: 10712437]  [MGI Ref ID J:60968]

McGillicuddy CJ; Carrier MJ; Weinberg PD. 2001. Distribution of lipid deposits around aortic branches of mice lacking LDL receptors and apolipoprotein E. Arterioscler Thromb Vasc Biol 21(7):1220-5. [PubMed: 11451755]  [MGI Ref ID J:103203]

McMillen TS; Heinecke JW; LeBoeuf RC. 2005. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111(21):2798-804. [PubMed: 15911707]  [MGI Ref ID J:112270]

Mehrabian M; Allayee H; Wong J; Shi W; Wang XP; Shaposhnik Z; Funk CD; Lusis AJ. 2002. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91(2):120-6. [PubMed: 12142344]  [MGI Ref ID J:109703]

Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T. 2007. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100(11):1634-42. [PubMed: 17478727]  [MGI Ref ID J:130794]

Meiler S; Baumer Y; Huang Z; Hoffmann FW; Fredericks GJ; Rose AH; Norton RL; Hoffmann PR; Boisvert WA. 2013. Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis. J Leukoc Biol 93(5):771-80. [PubMed: 23444136]  [MGI Ref ID J:200795]

Melchior JT; Sawyer JK; Kelley KL; Shah R; Wilson MD; Hantgan RR; Rudel LL. 2013. LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis. J Lipid Res 54(9):2495-503. [PubMed: 23804810]  [MGI Ref ID J:200774]

Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD. 1999. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19(5):1223-30. [PubMed: 10323773]  [MGI Ref ID J:103205]

Merat S; Fruebis J; Sutphin M; Silvestre M; Reaven PD. 2000. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis. J Gerontol A Biol Sci Med Sci 55(2):B85-94. [PubMed: 10737683]  [MGI Ref ID J:61164]

Merched A; Tollefson K; Chan L. 2010. Beta2 integrins modulate the initiation and progression of atherosclerosis in low-density lipoprotein receptor knockout mice. Cardiovasc Res 85(4):853-63. [PubMed: 19843511]  [MGI Ref ID J:172548]

Merkel M; Velez-Carrasco W; Hudgins LC; Breslow JL. 2001. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci U S A 98(23):13294-9. [PubMed: 11606787]  [MGI Ref ID J:72580]

Methia N; Andre P; Denis CV; Economopoulos M; Wagner DD. 2001. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 98(5):1424-8. [PubMed: 11520791]  [MGI Ref ID J:106677]

Meurs I; Calpe-Berdiel L; Habets KL; Zhao Y; Korporaal SJ; Mommaas AM; Josselin E; Hildebrand RB; Ye D; Out R; Kuiper J; Van Berkel TJ; Chimini G; Van Eck M. 2012. Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1. PLoS One 7(3):e30984. [PubMed: 22403608]  [MGI Ref ID J:186854]

Meyer JM; Ji A; Cai L; van der Westhuyzen DR. 2014. Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation. J Lipid Res 55(8):1648-1656. [PubMed: 24891335]  [MGI Ref ID J:214992]

Mihara K; Spansier M; Rooseboom M; Smit MJ; Dokter W. 2007. Functional replacement of murine CXCR2 by its human homologue in the development of atherosclerosis in LDLR knockout mice. Biol Pharm Bull 30(7):1231-6. [PubMed: 17603159]  [MGI Ref ID J:124372]

Milanski M; Arruda AP; Coope A; Ignacio-Souza LM; Nunez CE; Roman EA; Romanatto T; Pascoal LB; Caricilli AM; Torsoni MA; Prada PO; Saad MJ; Velloso LA. 2012. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61(6):1455-62. [PubMed: 22522614]  [MGI Ref ID J:196822]

Millar JS; Maugeais C; Fuki IV; Rader DJ. 2002. Normal production rate of apolipoprotein B in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 22(6):989-94. [PubMed: 12067909]  [MGI Ref ID J:103299]

Miller JD; Chu Y; Castaneda LE; Serrano KM; Brooks RM; Heistad DD. 2013. Vascular function during prolonged progression and regression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 33(3):459-65. [PubMed: 23307875]  [MGI Ref ID J:216887]

Miller JD; Weiss RM; Serrano KM; Brooks RM 2nd; Berry CJ; Zimmerman K; Young SG; Heistad DD. 2009. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation 119(20):2693-701. [PubMed: 19433756]  [MGI Ref ID J:166428]

Minahk C; Kim KW; Nelson R; Trigatti B; Lehner R; Vance DE. 2008. Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes. J Biol Chem 283(10):6449-58. [PubMed: 18175806]  [MGI Ref ID J:133757]

Missiou A; Kostlin N; Varo N; Rudolf P; Aichele P; Ernst S; Munkel C; Walter C; Stachon P; Sommer B; Pfeifer D; Zirlik K; MacFarlane L; Wolf D; Tsitsikov E; Bode C; Libby P; Zirlik A. 2010. Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121(18):2033-44. [PubMed: 20421522]  [MGI Ref ID J:172624]

Missiou A; Rudolf P; Stachon P; Wolf D; Varo N; Aichele P; Colberg C; Hoppe N; Ernst S; Munkel C; Walter C; Sommer B; Hilgendorf I; Nakano H; Bode C; Zirlik A. 2010. TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ Res 107(6):757-66. [PubMed: 20651286]  [MGI Ref ID J:175026]

Mitchell PL; Karakach TK; Currie DL; McLeod RS. 2012. t-10, c-12 CLA dietary supplementation inhibits atherosclerotic lesion development despite adverse cardiovascular and hepatic metabolic marker profiles. PLoS One 7(12):e52634. [PubMed: 23285120]  [MGI Ref ID J:195756]

Miyazaki T; Taketomi Y; Takimoto M; Lei XF; Arita S; Kim-Kaneyama JR; Arata S; Ohata H; Ota H; Murakami M; Miyazaki A. 2011. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Circulation 124(23):2522-32. [PubMed: 22064597]  [MGI Ref ID J:193805]

Moerland M; Samyn H; van Gent T; Jauhiainen M; Metso J; van Haperen R; Grosveld F; van Tol A; de Crom R. 2007. Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice. J Lipid Res 48(12):2622-31. [PubMed: 17761633]  [MGI Ref ID J:129970]

Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R. 2008. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis. Arterioscler Thromb Vasc Biol 28(7):1277-82. [PubMed: 18421000]  [MGI Ref ID J:159813]

Mollmark J; Ravi S; Sun B; Shipman S; Buitendijk M; Simons M; Mulligan-Kehoe MJ. 2011. Antiangiogenic activity of rPAI-1(23) promotes vasa vasorum regression in hypercholesterolemic mice through a plasmin-dependent mechanism. Circ Res 108(12):1419-28. [PubMed: 21546607]  [MGI Ref ID J:185688]

Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ. 2012. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 32(11):2644-51. [PubMed: 22982464]  [MGI Ref ID J:207880]

Mooij HL; Bernelot Moens SJ; Gordts PL; Stanford KI; Foley EM; van den Boogert MA; Witjes JJ; Hassing HC; Tanck MW; van de Sande MA; Levels JH; Kastelein JJ; Stroes ES; Dallinga-Thie GM; Esko JD; Nieuwdorp M. 2015. Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans. J Lipid Res 56(3):665-73. [PubMed: 25568062]  [MGI Ref ID J:220029]

Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ. 2005. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ Res 97(8):763-71. [PubMed: 16151025]  [MGI Ref ID J:114636]

Moreira EL; Aguiar AS Jr; de Carvalho CR; Santos DB; de Oliveira J; de Bem AF; Xikota JC; Walz R; Farina M; Prediger RD. 2013. Effects of lifestyle modifications on cognitive impairments in a mouse model of hypercholesterolemia. Neurosci Lett 541:193-8. [PubMed: 23470631]  [MGI Ref ID J:199546]

Moreira EL; de Oliveira J; Dutra MF; Santos DB; Goncalves CA; Goldfeder EM; de Bem AF; Prediger RD; Aschner M; Farina M. 2012. Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease? Toxicol Sci 130(2):373-82. [PubMed: 22903822]  [MGI Ref ID J:192657]

Mori N; Horie Y; Nimura Y; Wolf R; Granger DN. 2000. Hepatic microvascular responses to ischemia-reperfusion in low-density lipoprotein receptor knockout mice. Am J Physiol Gastrointest Liver Physiol 279(6):G1257-64. [PubMed: 11093949]  [MGI Ref ID J:108060]

Mortimer BC; Beveridge DJ; Martins IJ; Redgrave TG. 1995. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway. J Biol Chem 270(48):28767-76. [PubMed: 7499399]  [MGI Ref ID J:29909]

Mulder M; Jansen PJ; Janssen BJ; van de Berg WD; van der Boom H; Havekes LM; de Kloet RE; Ramaekers FC; Blokland A. 2004. Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol Dis 16(1):212-9. [PubMed: 15207278]  [MGI Ref ID J:120389]

Mulder M; Koopmans G; Wassink G; Al Mansouri G; Simard ML; Havekes LM; Prickaerts J; Blokland A. 2007. LDL receptor deficiency results in decreased cell proliferation and presynaptic bouton density in the murine hippocampus. Neurosci Res 59(3):251-6. [PubMed: 17720268]  [MGI Ref ID J:127270]

Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM. 2011. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice. J Lipid Res 52(5):885-96. [PubMed: 21343632]  [MGI Ref ID J:180930]

Mullick AE; Soldau K; Kiosses WB; Bell TA 3rd; Tobias PS; Curtiss LK. 2008. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205(2):373-83. [PubMed: 18250194]  [MGI Ref ID J:131783]

Mullick AE; Tobias PS; Curtiss LK. 2005. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115(11):3149-56. [PubMed: 16211093]  [MGI Ref ID J:102502]

Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW. 2009. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 58(10):2198-210. [PubMed: 19592617]  [MGI Ref ID J:154397]

Mulvihill EE; Assini JM; Lee JK; Allister EM; Sutherland BG; Koppes JB; Sawyez CG; Edwards JY; Telford DE; Charbonneau A; St-Pierre P; Marette A; Huff MW. 2011. Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance. Diabetes 60(5):1446-57. [PubMed: 21471511]  [MGI Ref ID J:171813]

Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV. 2013. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice. PLoS One 8(3):e58364. [PubMed: 23505495]  [MGI Ref ID J:199840]

Muratoglu SC; Belgrave S; Lillis AP; Migliorini M; Robinson S; Smith E; Zhang L; Strickland DK. 2011. Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-beta signaling pathway. PLoS One 6(12):e28846. [PubMed: 22174911]  [MGI Ref ID J:182253]

Murphy AJ; Akhtari M; Tolani S; Pagler T; Bijl N; Kuo CL; Wang M; Sanson M; Abramowicz S; Welch C; Bochem AE; Kuivenhoven JA; Yvan-Charvet L; Tall AR. 2011. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 121(10):4138-49. [PubMed: 21968112]  [MGI Ref ID J:178453]

Murphy AJ; Bijl N; Yvan-Charvet L; Welch CB; Bhagwat N; Reheman A; Wang Y; Shaw JA; Levine RL; Ni H; Tall AR; Wang N. 2013. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 19(5):586-94. [PubMed: 23584088]  [MGI Ref ID J:198517]

Nagareddy PR; Murphy AJ; Stirzaker RA; Hu Y; Yu S; Miller RG; Ramkhelawon B; Distel E; Westerterp M; Huang LS; Schmidt AM; Orchard TJ; Fisher EA; Tall AR; Goldberg IJ. 2013. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 17(5):695-708. [PubMed: 23663738]  [MGI Ref ID J:199272]

Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ. 2006. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113(1):90-7. [PubMed: 16365197]  [MGI Ref ID J:121508]

Nakai Y; Iwabuchi K; Fujii S; Ishimori N; Dashtsoodol N; Watano K; Mishima T; Iwabuchi C; Tanaka S; Bezbradica JS; Nakayama T; Taniguchi M; Miyake S; Yamamura T; Kitabatake A; Joyce S; Van Kaer L; Onoe K. 2004. Natural killer T cells accelerate atherogenesis in mice. Blood 104(7):2051-9. [PubMed: 15113755]  [MGI Ref ID J:93754]

Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y. 2013. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Biochem Biophys Res Commun 433(1):47-51. [PubMed: 23485468]  [MGI Ref ID J:201227]

Nakamura T; Ruiz-Lozano P; Lindner V; Yabe D; Taniwaki M; Furukawa Y; Kobuke K; Tashiro K; Lu Z; Andon NL; Schaub R; Matsumori A; Sasayama S; Chien KR; Honjo T. 1999. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 274(32):22476-83. [PubMed: 10428823]  [MGI Ref ID J:56624]

Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L. 1998. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression. Arterioscler Thromb Vasc Biol 18(5):747-55. [PubMed: 9598833]  [MGI Ref ID J:48202]

Nakaya H; Summers BD; Nicholson AC; Gotto AM Jr; Hajjar DP; Han J. 2009. Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. Am J Pathol 174(6):2007-14. [PubMed: 19435790]  [MGI Ref ID J:148764]

Nassir F; Xie Y; Patterson BW; Luo J; Davidson NO. 2004. Hepatic secretion of small lipoprotein particles in apobec-1-/- mice is regulated by the LDL receptor. J Lipid Res 45(9):1649-59. [PubMed: 15145984]  [MGI Ref ID J:121192]

Nathan L; Shi W; Dinh H; Mukherjee TK; Wang X; Lusis AJ; Chaudhuri G. 2001. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A 98(6):3589-93. [PubMed: 11248122]  [MGI Ref ID J:80921]

Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ ; Castellani LW ; Brennan ML ; Lusis AJ ; Fogelman AM ; La Du BN. 1997. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio [published erratum appears in J Clin Invest 1997 Jun 15;99(12):3043] J Clin Invest 99(8):2005-19. [PubMed: 9109446]  [MGI Ref ID J:40285]

Nawrocki AR; Hofmann SM; Teupser D; Basford JE; Durand JL; Jelicks LA; Woo CW; Kuriakose G; Factor SM; Tanowitz HB; Hui DY; Tabas I; Scherer PE. 2010. Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 30(6):1159-65. [PubMed: 20299691]  [MGI Ref ID J:180866]

Netea MG; Demacker PN; Kullberg BJ; Boerman OC; Verschueren I; Stalenhoef AF; van der Meer JW. 1996. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 97(6):1366-72. [PubMed: 8617867]  [MGI Ref ID J:31997]

Netea MG; Joosten LA; Keuter M; Wagener F; Stalenhoef AF; van der Meer JW; Kullberg BJ. 2009. Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection. PLoS ONE 4(1):e4237. [PubMed: 19156198]  [MGI Ref ID J:144972]

Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW. 2004. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance. J Biol Chem 279(9):7636-42. [PubMed: 14668345]  [MGI Ref ID J:89015]

Ngai YF; Quong WL; Glier MB; Glavas MM; Babich SL; Innis SM; Kieffer TJ; Gibson WT. 2010. Ldlr-/- mice display decreased susceptibility to Western-type diet-induced obesity due to increased thermogenesis. Endocrinology 151(11):5226-36. [PubMed: 20881250]  [MGI Ref ID J:168347]

Nishizawa T; Kanter JE; Kramer F; Barnhart S; Shen X; Vivekanandan-Giri A; Wall VZ; Kowitz J; Devaraj S; O'Brien KD; Pennathur S; Tang J; Miyaoka RS; Raines EW; Bornfeldt KE. 2014. Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis. Cell Rep 7(2):356-65. [PubMed: 24726364]  [MGI Ref ID J:211813]

Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA. 2007. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 115(4):501-8. [PubMed: 17242282]  [MGI Ref ID J:130151]

Nookaew I; Gabrielsson BG; Holmang A; Sandberg AS; Nielsen J. 2010. Identifying molecular effects of diet through systems biology: influence of herring diet on sterol metabolism and protein turnover in mice. PLoS One 5(8):. [PubMed: 20808764]  [MGI Ref ID J:164017]

Nuotio-Antar AM; Hachey DL; Hasty AH. 2007. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 293(6):E1517-28. [PubMed: 17878220]  [MGI Ref ID J:145108]

O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC. 2005. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 25(4):785-90. [PubMed: 15692094]  [MGI Ref ID J:110024]

Okamoto R; Gery S; Gombart AF; Wang X; Castellani LW; Akagi T; Chen S; Arditi M; Ho Q; Lusis AJ; Li Q; Koeffler HP. 2014. Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice. PLoS One 9(1):e85341. [PubMed: 24489659]  [MGI Ref ID J:211106]

Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y. 2012. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J Biol Chem 287(23):19229-41. [PubMed: 22500026]  [MGI Ref ID J:186208]

Okazaki H; Tazoe F; Okazaki S; Isoo N; Tsukamoto K; Sekiya M; Yahagi N; Iizuka Y; Ohashi K; Kitamine T; Tozawa R; Inaba T; Yagyu H; Okazaki M; Shimano H; Shibata N; Arai H; Nagai RZ; Kadowaki T; Osuga J; Ishibashi S. 2006. Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver. J Lipid Res 47(9):1950-8. [PubMed: 16741291]  [MGI Ref ID J:114485]

Oliveira HC; Cosso RG; Alberici LC; Maciel EN; Salerno AG; Dorighello GG; Velho JA; de Faria EC; Vercesi AE. 2005. Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J 19(2):278-80. [PubMed: 15569776]  [MGI Ref ID J:105088]

Orozco LD; Kapturczak MH; Barajas B; Wang X; Weinstein MM; Wong J; Deshane J; Bolisetty S; Shaposhnik Z; Shih DM; Agarwal A; Lusis AJ; Araujo JA. 2007. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100(12):1703-11. [PubMed: 17495224]  [MGI Ref ID J:137771]

Osono Y; Woollett LA; Herz J; Dietschy JM. 1995. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest 95(3):1124-32. [PubMed: 7883961]  [MGI Ref ID J:23579]

Osuga J; Yonemoto M; Yamada N; Shimano H; Yagyu H; Ohashi K; Harada K; Kamei T; Yazaki Y; Ishibashi S. 1998. Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. J Clin Invest 102(2):386-94. [PubMed: 9664080]  [MGI Ref ID J:115142]

Ou ZJ; Li L; Liao XL; Wang YM; Hu XX; Zhang QL; Wang ZP; Yu H; Zhang X; Hu P; Xu YQ; Liang QL; Ou JS; Luo G. 2012. Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia. Am J Physiol Endocrinol Metab 303(6):E683-94. [PubMed: 22535745]  [MGI Ref ID J:189438]

Out R; Hoekstra M; Habets K; Meurs I; de Waard V; Hildebrand RB; Wang Y; Chimini G; Kuiper J; Van Berkel TJ; Van Eck M. 2008. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler Thromb Vasc Biol 28(2):258-64. [PubMed: 18006857]  [MGI Ref ID J:147678]

Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M. 2006. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 26(10):2295-300. [PubMed: 16857950]  [MGI Ref ID J:128052]

Overton CD; Yancey PG; Major AS; Linton MF; Fazio S. 2007. Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ Res 100(5):670-7. [PubMed: 17303763]  [MGI Ref ID J:133698]

Owens AP 3rd; Passam FH; Antoniak S; Marshall SM; McDaniel AL; Rudel L; Williams JC; Hubbard BK; Dutton JA; Wang J; Tobias PS; Curtiss LK; Daugherty A; Kirchhofer D; Luyendyk JP; Moriarty PM; Nagarajan S; Furie BC; Furie B; Johns DG; Temel RE; Mackman N. 2012. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 122(2):558-68. [PubMed: 22214850]  [MGI Ref ID J:184381]

Owens AP 3rd; Rateri DL; Howatt DA; Moore KJ; Tobias PS; Curtiss LK; Lu H; Cassis LA; Daugherty A. 2011. MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4. Arterioscler Thromb Vasc Biol 31(12):2813-9. [PubMed: 21960563]  [MGI Ref ID J:191452]

Paim BA; Velho JA; Castilho RF; Oliveira HC; Vercesi AE. 2008. Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement. Free Radic Biol Med 44(3):444-51. [PubMed: 17991444]  [MGI Ref ID J:130348]

Pan JH; Sukhova GK; Yang JT; Wang B; Xie T; Fu H; Zhang Y; Satoskar AR; David JR; Metz CN; Bucala R; Fang K; Simon DI; Chapman HA; Libby P; Shi GP. 2004. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109(25):3149-53. [PubMed: 15197138]  [MGI Ref ID J:102201]

Pan X; Jiang XC; Hussain MM. 2013. Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice. Circulation 128(16):1758-69. [PubMed: 24014832]  [MGI Ref ID J:218726]

Parathath S; Grauer L; Huang LS; Sanson M; Distel E; Goldberg IJ; Fisher EA. 2011. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 60(6):1759-69. [PubMed: 21562077]  [MGI Ref ID J:177946]

Park SH; Sui Y; Gizard F; Xu J; Rios-Pilier J; Helsley RN; Han SS; Zhou C. 2012. Myeloid-specific IkappaB kinase beta deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 32(12):2869-76. [PubMed: 23023371]  [MGI Ref ID J:207877]

Parks BW; Gambill GP; Lusis AJ; Kabarowski JH. 2005. Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. J Lipid Res 46(7):1405-15. [PubMed: 15834123]  [MGI Ref ID J:100498]

Parks BW; Lusis AJ; Kabarowski JH. 2006. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 26(12):2703-9. [PubMed: 16990555]  [MGI Ref ID J:128044]

Parks BW; Srivastava R; Yu S; Kabarowski JH. 2009. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells. Arterioscler Thromb Vasc Biol 29(4):539-47. [PubMed: 19164809]  [MGI Ref ID J:159778]

Paulson KE; Zhu SN; Chen M; Nurmohamed S; Jongstra-Bilen J; Cybulsky MI. 2010. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 106(2):383-90. [PubMed: 19893012]  [MGI Ref ID J:170071]

Persson L; Boren J; Nicoletti A; Hansson GK; Pekna M. 2005. Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system. Clin Exp Immunol 142(3):441-5. [PubMed: 16297155]  [MGI Ref ID J:107602]

Persson L; Boren J; Robertson AK; Wallenius V; Hansson GK; Pekna M. 2004. Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 24(6):1062-7. [PubMed: 15059809]  [MGI Ref ID J:102339]

Picataggi A; Lim GF; Kent AP; Millar JS; Rader DJ; Stylianou IM. 2013. A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice. Mamm Genome :. [PubMed: 23722970]  [MGI Ref ID J:199101]

Pinkaew D; Hutadilok-Towatana N; Teng BB; Mahabusarakam W; Fujise K. 2012. Morelloflavone, a biflavonoid inhibitor of migration-related kinases, ameliorates atherosclerosis in mice. Am J Physiol Heart Circ Physiol 302(2):H451-8. [PubMed: 22058152]  [MGI Ref ID J:181657]

Pinkaew D; Le RJ; Chen Y; Eltorky M; Teng BB; Fujise K. 2013. Fortilin reduces apoptosis in macrophages and promotes atherosclerosis. Am J Physiol Heart Circ Physiol 305(10):H1519-29. [PubMed: 24043250]  [MGI Ref ID J:204609]

Plat J; Beugels I; Gijbels MJ; de Winther MP; Mensink RP. 2006. Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. J Lipid Res 47(12):2762-71. [PubMed: 16957178]  [MGI Ref ID J:117204]

Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR. 1999. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 19(4):1105-10. [PubMed: 10195942]  [MGI Ref ID J:55980]

Podrez EA; Byzova TV; Febbraio M; Salomon RG; Ma Y; Valiyaveettil M; Poliakov E; Sun M; Finton PJ; Curtis BR; Chen J; Zhang R; Silverstein RL; Hazen SL. 2007. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13(9):1086-95. [PubMed: 17721545]  [MGI Ref ID J:125153]

Poduri A; Owens AP 3rd; Howatt DA; Moorleghen JJ; Balakrishnan A; Cassis LA; Daugherty A. 2012. Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One 7(10):e48462. [PubMed: 23119030]  [MGI Ref ID J:192277]

Pols TW; Nomura M; Harach T; Lo Sasso G; Oosterveer MH; Thomas C; Rizzo G; Gioiello A; Adorini L; Pellicciari R; Auwerx J; Schoonjans K. 2011. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 14(6):747-57. [PubMed: 22152303]  [MGI Ref ID J:179660]

Postea O; Vasina EM; Cauwenberghs S; Projahn D; Liehn EA; Lievens D; Theelen W; Kramp BK; Butoi ED; Soehnlein O; Heemskerk JW; Ludwig A; Weber C; Koenen RR. 2012. Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler Thromb Vasc Biol 32(5):1186-93. [PubMed: 22383701]  [MGI Ref ID J:196930]

Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z. 2004. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 24(8):1474-8. [PubMed: 15178562]  [MGI Ref ID J:102225]

Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C. 2013. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Arterioscler Thromb Vasc Biol 33(10):2297-305. [PubMed: 23887641]  [MGI Ref ID J:222227]

Powell-Braxton L; Veniant M; Latvala RD; Hirano KI; Won WB; Ross J; Dybdal N; Zlot CH; Young SG; Davidson NO. 1998. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet [see comments] Nat Med 4(8):934-8. [PubMed: 9701246]  [MGI Ref ID J:49125]

Pratico D; Cyrus T; Li H; FitzGerald GA. 2000. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis Blood 96(12):3823-6. [PubMed: 11090066]  [MGI Ref ID J:66258]

Pratico D; Rokach J; Tangirala RK. 1999. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J Neurochem 73(2):736-41. [PubMed: 10428071]  [MGI Ref ID J:111985]

Pratico D; Tillmann C; Zhang ZB; Li H; FitzGerald GA. 2001. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci U S A 98(6):3358-63. [PubMed: 11248083]  [MGI Ref ID J:68091]

Preusch MR; Rattazzi M; Albrecht C; Merle U; Tuckermann J; Schutz G; Blessing E; Zoppellaro G; Pauletto P; Krempien R; Rosenfeld ME; Katus HA; Bea F. 2008. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis. Arterioscler Thromb Vasc Biol 28(12):2158-64. [PubMed: 18787189]  [MGI Ref ID J:159796]

Qian YW; Schmidt RJ; Zhang Y; Chu S; Lin A; Wang H; Wang X; Beyer TP; Bensch WR; Li W; Ehsani ME; Lu D; Konrad RJ; Eacho PI; Moller DE; Karathanasis SK; Cao G. 2007. Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis. J Lipid Res 48(7):1488-98. [PubMed: 17449864]  [MGI Ref ID J:122491]

Qiang L; Lin HV; Kim-Muller JY; Welch CL; Gu W; Accili D. 2011. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab 14(6):758-67. [PubMed: 22078933]  [MGI Ref ID J:179674]

Qiang L; Tsuchiya K; Kim-Muller JY; Lin HV; Welch C; Accili D. 2012. Increased atherosclerosis and endothelial dysfunction in mice bearing constitutively deacetylated alleles of Foxo1 gene. J Biol Chem 287(17):13944-51. [PubMed: 22389493]  [MGI Ref ID J:184477]

Qiu H; Gabrielsen A; Agardh HE; Wan M; Wetterholm A; Wong CH; Hedin U; Swedenborg J; Hansson GK; Samuelsson B; Paulsson-Berne G; Haeggstrom JZ. 2006. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A 103(21):8161-6. [PubMed: 16698924]  [MGI Ref ID J:110208]

Qu A; Shah YM; Manna SK; Gonzalez FJ. 2012. Disruption of endothelial peroxisome proliferator-activated receptor gamma accelerates diet-induced atherogenesis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 32(1):65-73. [PubMed: 22015658]  [MGI Ref ID J:195979]

Quan G; Xie C; Dietschy JM; Turley SD. 2003. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 146(1-2):87-98. [PubMed: 14643015]  [MGI Ref ID J:86935]

Radonjic M; Wielinga PY; Wopereis S; Kelder T; Goelela VS; Verschuren L; Toet K; van Duyvenvoorde W; van der Werff van der Vat B; Stroeve JH; Cnubben N; Kooistra T; van Ommen B; Kleemann R. 2013. Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice. PLoS One 8(2):e56122. [PubMed: 23457508]  [MGI Ref ID J:198285]

Raikwar NS; Cho WK; Bowen RF; Deeg MA. 2006. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab 290(3):E463-70. [PubMed: 16219662]  [MGI Ref ID J:106052]

Ramirez C; Sierra S; Tercero I; Vazquez JA; Pineda A; Manrique T; Burgos JS. 2011. ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. PLoS One 6(7):e22712. [PubMed: 21829488]  [MGI Ref ID J:175834]

Ramsey SA; Vengrenyuk Y; Menon P; Podolsky I; Feig JE; Aderem A; Fisher EA; Gold ES. 2014. Epigenome-guided analysis of the transcriptome of plaque macrophages during atherosclerosis regression reveals activation of the Wnt signaling pathway. PLoS Genet 10(12):e1004828. [PubMed: 25474352]  [MGI Ref ID J:222183]

Rashid S; Curtis DE; Garuti R; Anderson NN; Bashmakov Y; Ho YK; Hammer RE; Moon YA; Horton JD. 2005. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A 102(15):5374-9. [PubMed: 15805190]  [MGI Ref ID J:97836]

Rateri DL; Davis FM; Balakrishnan A; Howatt DA; Moorleghen JJ; O'Connor WN; Charnigo R; Cassis LA; Daugherty A. 2014. Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms. Am J Pathol 184(9):2586-95. [PubMed: 25038458]  [MGI Ref ID J:213954]

Rateri DL; Moorleghen JJ; Balakrishnan A; Owens AP 3rd; Howatt DA; Subramanian V; Poduri A; Charnigo R; Cassis LA; Daugherty A. 2011. Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice. Circ Res 108(5):574-81. [PubMed: 21252156]  [MGI Ref ID J:170230]

Rateri DL; Moorleghen JJ; Knight V; Balakrishnan A; Howatt DA; Cassis LA; Daugherty A. 2012. Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice. PLoS One 7(12):e51483. [PubMed: 23236507]  [MGI Ref ID J:195549]

Ratliff EP; Gutierrez A; Davis RA. 2006. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia. J Lipid Res 47(7):1513-20. [PubMed: 16609145]  [MGI Ref ID J:112052]

Rayner KJ; Suarez Y; Davalos A; Parathath S; Fitzgerald ML; Tamehiro N; Fisher EA; Moore KJ; Fernandez-Hernando C. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328(5985):1570-3. [PubMed: 20466885]  [MGI Ref ID J:160971]

Recinos A rd; Carr BK; Bartos DB; Boldogh I; Carmical JR; Belalcazar LM; Brasier AR. 2004. Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. Physiol Genomics 19(1):131-42. [PubMed: 15238619]  [MGI Ref ID J:106239]

Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM. 2004. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Arterioscler Thromb Vasc Biol 24(9):1676-81. [PubMed: 15242861]  [MGI Ref ID J:102220]

Reiterer G; MacDonald R; Browning JD; Morrow J; Matveev SV; Daugherty A; Smart E; Toborek M; Hennig B. 2005. Zinc deficiency increases plasma lipids and atherosclerotic markers in LDL-receptor-deficient mice. J Nutr 135(9):2114-8. [PubMed: 16140885]  [MGI Ref ID J:106652]

Renard CB; Kramer F; Johansson F; Lamharzi N; Tannock LR; von Herrath MG; Chait A; Bornfeldt KE. 2004. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114(5):659-68. [PubMed: 15343384]  [MGI Ref ID J:92597]

Rensen SS; Bieghs V; Xanthoulea S; Arfianti E; Bakker JA; Shiri-Sverdlov R; Hofker MH; Greve JW; Buurman WA. 2012. Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS One 7(12):e52411. [PubMed: 23285030]  [MGI Ref ID J:195762]

Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thusen JH. 2014. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Cardiovasc Res 101(2):277-87. [PubMed: 24220638]  [MGI Ref ID J:219538]

Repa JJ; Li H; Frank-Cannon TC; Valasek MA; Turley SD; Tansey MG; Dietschy JM. 2007. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J Neurosci 27(52):14470-80. [PubMed: 18160655]  [MGI Ref ID J:130969]

Repa JJ; Turley SD; Quan G; Dietschy JM. 2005. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res 46(4):779-89. [PubMed: 15654122]  [MGI Ref ID J:98574]

Rinninger F; Heine M; Singaraja R; Hayden M; Brundert M; Ramakrishnan R; Heeren J. 2014. High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice. J Lipid Res 55(9):1914-24. [PubMed: 24954421]  [MGI Ref ID J:214973]

Robbins CS; Chudnovskiy A; Rauch PJ; Figueiredo JL; Iwamoto Y; Gorbatov R; Etzrodt M; Weber GF; Ueno T; van Rooijen N; Mulligan-Kehoe MJ; Libby P; Nahrendorf M; Pittet MJ; Weissleder R; Swirski FK. 2012. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 125(2):364-74. [PubMed: 22144566]  [MGI Ref ID J:193795]

Robbins CS; Hilgendorf I; Weber GF; Theurl I; Iwamoto Y; Figueiredo JL; Gorbatov R; Sukhova GK; Gerhardt LM; Smyth D; Zavitz CC; Shikatani EA; Parsons M; van Rooijen N; Lin HY; Husain M; Libby P; Nahrendorf M; Weissleder R; Swirski FK. 2013. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19(9):1166-72. [PubMed: 23933982]  [MGI Ref ID J:201890]

Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Wilcox L; Ramsamy TA; Whitman SC. 2008. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice. Cardiovasc Res 78(1):167-74. [PubMed: 18192239]  [MGI Ref ID J:140276]

Rohlmann A; Gotthardt M; Hammer RE; Herz J. 1998. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 101(3):689-95. [PubMed: 9449704]  [MGI Ref ID J:67929]

Romeo GR; Moulton KS; Kazlauskas A. 2007. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circ Res 101(4):357-67. [PubMed: 17615372]  [MGI Ref ID J:140294]

Rong S; Cao Q; Liu M; Seo J; Jia L; Boudyguina E; Gebre AK; Colvin PL; Smith TL; Murphy RC; Mishra N; Parks JS. 2012. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J Lipid Res 53(4):686-95. [PubMed: 22279185]  [MGI Ref ID J:184947]

Roselaar SE; Kakkanathu PX; Daugherty A. 1996. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 16(8):1013-8. [PubMed: 8696940]  [MGI Ref ID J:111962]

Rotllan N; Chamorro-Jorganes A; Araldi E; Wanschel AC; Aryal B; Aranda JF; Goedeke L; Salerno AG; Ramirez CM; Sessa WC; Suarez Y; Fernandez-Hernando C. 2015. Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis. FASEB J 29(2):597-610. [PubMed: 25392271]  [MGI Ref ID J:218205]

Roubtsova A; Munkonda MN; Awan Z; Marcinkiewicz J; Chamberland A; Lazure C; Cianflone K; Seidah NG; Prat A. 2011. Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue. Arterioscler Thromb Vasc Biol 31(4):785-91. [PubMed: 21273557]  [MGI Ref ID J:184166]

Rousselet E; Marcinkiewicz J; Kriz J; Zhou A; Hatten ME; Prat A; Seidah NG. 2011. PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke. J Lipid Res 52(7):1383-91. [PubMed: 21518694]  [MGI Ref ID J:174826]

Rudling M; Angelin B. 2001. Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice. FASEB J 15(8):1350-6. [PubMed: 11387232]  [MGI Ref ID J:120519]

Rudolf M; Winkler B; Aherrahou Z; Doehring LC; Kaczmarek P; Schmidt-Erfurth U. 2005. Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br J Ophthalmol 89(12):1627-30. [PubMed: 16299144]  [MGI Ref ID J:116908]

Ruotsalainen AK; Inkala M; Partanen ME; Lappalainen JP; Kansanen E; Makinen PI; Heinonen SE; Laitinen HM; Heikkila J; Vatanen T; Horkko S; Yamamoto M; Yla-Herttuala S; Jauhiainen M; Levonen AL. 2013. The absence of macrophage Nrf2 promotes early atherogenesis. Cardiovasc Res 98(1):107-15. [PubMed: 23341579]  [MGI Ref ID J:210429]

Sag D; Cekic C; Wu R; Linden J; Hedrick CC. 2015. The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat Commun 6:6354. [PubMed: 25724068]  [MGI Ref ID J:221785]

Saito R; Matsuzaka T; Karasawa T; Sekiya M; Okada N; Igarashi M; Matsumori R; Ishii K; Nakagawa Y; Iwasaki H; Kobayashi K; Yatoh S; Takahashi A; Sone H; Suzuki H; Yahagi N; Yamada N; Shimano H. 2011. Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 31(9):1973-9. [PubMed: 21817094]  [MGI Ref ID J:191842]

Sakai K; Tiebel O; Ljungberg MC; Sullivan M; Lee HJ; Terashima T; Li R; Kobayashi K; Lu HC; Chan L; Oka K. 2009. A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. Brain Res 1276:11-21. [PubMed: 19393635]  [MGI Ref ID J:157221]

Sakamoto N; Rosenberg AS. 2011. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells. J Immunol 186(8):5004-11. [PubMed: 21402897]  [MGI Ref ID J:172521]

Samyn H; Moerland M; van Gent T; van Haperen R; Metso J; Grosveld F; Jauhiainen M; van Tol A; de Crom R. 2008. Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study. J Lipid Res 49(12):2504-12. [PubMed: 18711210]  [MGI Ref ID J:142969]

Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH. 1998. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci U S A 95(8):4544-9. [PubMed: 9539774]  [MGI Ref ID J:47464]

Saraswathi V; Morrow JD; Hasty AH. 2009. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice. J Nutr 139(12):2380-6. [PubMed: 19864403]  [MGI Ref ID J:154774]

Schiller NK; Black AS; Bradshaw GP; Bonnet DJ; Curtiss LK. 2004. Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice. J Lipid Res 45(8):1398-409. [PubMed: 15175354]  [MGI Ref ID J:91367]

Schiller NK; Boisvert WA; Curtiss LK. 2002. Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations. Arterioscler Thromb Vasc Biol 22(8):1341-6. [PubMed: 12171798]  [MGI Ref ID J:103214]

Schmidt-Erfurth U; Rudolf M; Funk M; Hofmann-Rummelt C; Franz-Haas NS; Aherrahrou Z; Schlotzer-Schrehardt U. 2008. Ultrastructural changes in a murine model of graded Bruch membrane lipoidal degeneration and corresponding VEGF164 detection. Invest Ophthalmol Vis Sci 49(1):390-8. [PubMed: 18172117]  [MGI Ref ID J:132498]

Schneider F; Sukhova GK; Aikawa M; Canner J; Gerdes N; Tang SM; Shi GP; Apte SS; Libby P. 2008. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 117(7):931-9. [PubMed: 18250269]  [MGI Ref ID J:145079]

Schneider JG; Finck BN; Ren J; Standley KN; Takagi M; Maclean KH; Bernal-Mizrachi C; Muslin AJ; Kastan MB; Semenkovich CF. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4(5):377-89. [PubMed: 17084711]  [MGI Ref ID J:129761]

Schonbeck U; Sukhova GK; Shimizu K; Mach F; Libby P. 2000. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice [see comments] Proc Natl Acad Sci U S A 97(13):7458-63. [PubMed: 10861012]  [MGI Ref ID J:63076]

Schreyer SA; Vick C; Lystig TC; Mystkowski P; LeBoeuf RC. 2002. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282(1):E207-14. [PubMed: 11739102]  [MGI Ref ID J:75609]

Schroeter MR; Leifheit-Nestler M; Hubert A; Schumann B; Gluckermann R; Eschholz N; Kruger N; Lutz S; Hasenfuss G; Konstantinides S; Schafer K. 2013. Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains. Cardiovasc Res 99(3):555-65. [PubMed: 23723060]  [MGI Ref ID J:218655]

Sehayek E; Ono JG; Duncan EM; Batta AK; Salen G; Shefer S; Neguyen LB; Yang K; Lipkin M; Breslow JL. 2001. Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice. J Lipid Res 42(8):1250-6. [PubMed: 11483626]  [MGI Ref ID J:70721]

Seidelmann SB; Kuo C; Pleskac N; Molina J; Sayers S; Li R; Zhou J; Johnson P; Braun K; Chan C; Teupser D; Breslow JL; Wight TN; Tall AR; Welch CL. 2008. Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican. Arterioscler Thromb Vasc Biol 28(12):2180-6. [PubMed: 18818413]  [MGI Ref ID J:159792]

Seimon TA; Nadolski MJ; Liao X; Magallon J; Nguyen M; Feric NT; Koschinsky ML; Harkewicz R; Witztum JL; Tsimikas S; Golenbock D; Moore KJ; Tabas I. 2010. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12(5):467-82. [PubMed: 21035758]  [MGI Ref ID J:167910]

Sekiya M; Osuga J; Nagashima S; Ohshiro T; Igarashi M; Okazaki H; Takahashi M; Tazoe F; Wada T; Ohta K; Takanashi M; Kumagai M; Nishi M; Takase S; Yahagi N; Yagyu H; Ohashi K; Nagai R; Kadowaki T; Furukawa Y; Ishibashi S. 2009. Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. Cell Metab 10(3):219-28. [PubMed: 19723498]  [MGI Ref ID J:152385]

Semenkovich CF; Coleman T; Daugherty A. 1998. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J Lipid Res 39(6):1141-51. [PubMed: 9643345]  [MGI Ref ID J:48030]

Senokuchi T; Liang CP; Seimon TA; Han S; Matsumoto M; Banks AS; Paik JH; DePinho RA; Accili D; Tabas I; Tall AR. 2008. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 57(11):2967-76. [PubMed: 18728232]  [MGI Ref ID J:142468]

Shah Z; Kampfrath T; Deiuliis JA; Zhong J; Pineda C; Ying Z; Xu X; Lu B; Moffatt-Bruce S; Durairaj R; Sun Q; Mihai G; Maiseyeu A; Rajagopalan S. 2011. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation 124(21):2338-49. [PubMed: 22007077]  [MGI Ref ID J:189450]

Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA. 2011. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol 31(8):1821-33. [PubMed: 21597007]  [MGI Ref ID J:191858]

Shaposhnik Z; Wang X; Lusis AJ. 2010. Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis. J Lipid Res 51(7):1962-70. [PubMed: 20194110]  [MGI Ref ID J:162834]

Shaposhnik Z; Wang X; Weinstein M; Bennett BJ; Lusis AJ. 2007. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 27(3):621-7. [PubMed: 17158354]  [MGI Ref ID J:130538]

Sharabi Y; Grossman E; Sherer Y; Shaish A; Levkovitz H; Bitzur R; Harats D. 2000. The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice. Pathobiology 68(6):270-4. [PubMed: 11493760]  [MGI Ref ID J:71167]

Sherer Y; Shoenfeld Y; Shaish A; Levkovitz H; Bitzur R; Harats D. 2000. Suppression of atherogenesis in female low-density lipoprotein receptor knockout mice following magnesium fortification of drinking water: the importance of diet. Pathobiology 68(2):93-8. [PubMed: 10878506]  [MGI Ref ID J:63520]

Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ. 2004. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Biochem Biophys Res Commun 317(1):223-9. [PubMed: 15047172]  [MGI Ref ID J:88891]

Shih DM; Shaposhnik Z; Meng Y; Rosales M; Wang X; Wu J; Ratiner B; Zadini F; Zadini G; Lusis AJ. 2013. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice. FASEB J 27(9):3805-17. [PubMed: 23752203]  [MGI Ref ID J:201179]

Shih DM; Xia YR; Wang XP; Wang SS; Bourquard N; Fogelman AM; Lusis AJ; Reddy ST. 2007. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res 100(8):1200-7. [PubMed: 17379834]  [MGI Ref ID J:135375]

Shimada M; Ishibashi S; Inaba T; Yagyu H; Harada K; Osuga JI; Ohashi K; Yazaki Y; Yamada N. 1996. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci U S A 93(14):7242-6. [PubMed: 8692976]  [MGI Ref ID J:34082]

Sigel S; Bunk S; Meergans T; Doninger B; Stich K; Stulnig T; Derfler K; Hoffmann J; Deininger S; von Aulock S; Knapp S. 2012. Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice. Eur J Immunol 42(11):2983-9. [PubMed: 22806614]  [MGI Ref ID J:188717]

Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Yla-Herttuala S; Roivainen A; Knuuti J. 2011. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice. Arterioscler Thromb Vasc Biol 31(5):1011-5. [PubMed: 21372297]  [MGI Ref ID J:191482]

Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R. 2013. Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A 110(36):14771-6. [PubMed: 23959870]  [MGI Ref ID J:200976]

Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB. 2004. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice. Clin Sci (Lond) 106(4):421-32. [PubMed: 14717654]  [MGI Ref ID J:105456]

Sjoland H; Eitzman DT; Gordon D; Westrick R; Nabel EG; Ginsburg D. 2000. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 20(3):846-52. [PubMed: 10712412]  [MGI Ref ID J:61287]

Skogsberg J; Dicker A; Ryden M; Astrom G; Nilsson R; Bhuiyan H; Vitols S; Mairal A; Langin D; Alberts P; Walum E; Tegner J; Hamsten A; Arner P; Bjorkegren J. 2008. ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes. PLoS ONE 3(11):e3771. [PubMed: 19020660]  [MGI Ref ID J:143905]

Skogsberg J; Lundstrom J; Kovacs A; Nilsson R; Noori P; Maleki S; Kohler M; Hamsten A; Tegner J; Bjorkegren J. 2008. Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet 4(3):e1000036. [PubMed: 18369455]  [MGI Ref ID J:136835]

Solca C; Pandit B; Yu H; Tint GS; Patel SB. 2007. Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse. Mol Genet Metab 91(1):7-14. [PubMed: 17197219]  [MGI Ref ID J:121454]

Sommerville LJ; Kelemen SE; Autieri MV. 2008. Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice. Arterioscler Thromb Vasc Biol 28(1):47-53. [PubMed: 17991871]  [MGI Ref ID J:147519]

Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS. 2006. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism. Am J Physiol Endocrinol Metab 290(1):E17-E25. [PubMed: 16105858]  [MGI Ref ID J:104219]

Song L; Leung C; Schindler C. 2001. Lymphocytes are important in early atherosclerosis. J Clin Invest 108(2):251-9. [PubMed: 11457878]  [MGI Ref ID J:118405]

Sontag TJ; Chellan B; Bhanvadia CV; Getz GS; Reardon CA. 2015. Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis. J Lipid Res 56(2):470-83. [PubMed: 25465389]  [MGI Ref ID J:219836]

Sontag TJ; Chellan B; Getz GS; Reardon CA. 2013. Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res 54(9):2515-24. [PubMed: 23812556]  [MGI Ref ID J:200771]

Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ. 2012. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice. Biochim Biophys Acta 1821(3):502-12. [PubMed: 21944998]  [MGI Ref ID J:182370]

Souza JC; Vanzela EC; Ribeiro RA; Rezende LF; de Oliveira CA; Carneiro EM; Oliveira HC; Boschero AC. 2013. Cholesterol reduction ameliorates glucose-induced calcium handling and insulin secretion in islets from low-density lipoprotein receptor knockout mice. Biochim Biophys Acta 1831(4):769-75. [PubMed: 23298460]  [MGI Ref ID J:199048]

Spady DK; Cuthbert JA; Willard MN; Meidell RS. 1998. Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced. J Biol Chem 273(1):126-32. [PubMed: 9417056]  [MGI Ref ID J:45043]

Spann NJ; Garmire LX; McDonald JG; Myers DS; Milne SB; Shibata N; Reichart D; Fox JN; Shaked I; Heudobler D; Raetz CR; Wang EW; Kelly SL; Sullards MC; Murphy RC; Merrill AH Jr; Brown HA; Dennis EA; Li AC; Ley K; Tsimikas S; Fahy E; Subramaniam S; Quehenberger O; Russell DW; Glass CK. 2012. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151(1):138-52. [PubMed: 23021221]  [MGI Ref ID J:188262]

Stachon P; Missiou A; Walter C; Varo N; Colberg C; Wolf D; Buchner M; von Zur Muhlen C; Zirlik K; Bode C; Zirlik A. 2010. Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans. PLoS One 5(7):e11589. [PubMed: 20644648]  [MGI Ref ID J:163110]

Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD. 2009. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest 119(11):3236-45. [PubMed: 19805913]  [MGI Ref ID J:154621]

Stanic AK; Stein CM; Morgan AC; Fazio S; Linton MF; Wakeland EK; Olsen NJ; Major AS. 2006. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc Natl Acad Sci U S A 103(18):7018-23. [PubMed: 16636270]  [MGI Ref ID J:109461]

Staprans I; Pan XM; Rapp JH; Grunfeld C; Feingold KR. 2000. Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20(3):708-14. [PubMed: 10712395]  [MGI Ref ID J:103278]

Steffens S; Burger F; Pelli G; Dean Y; Elson G; Kosco-Vilbois M; Chatenoud L; Mach F. 2006. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 114(18):1977-84. [PubMed: 17043169]  [MGI Ref ID J:127202]

Stein CS; Martins I; Davidson BL. 2000. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade J Gene Med 2(1):41-51. [PubMed: 10765504]  [MGI Ref ID J:62368]

Stein S; Oosterveer MH; Mataki C; Xu P; Lemos V; Havinga R; Dittner C; Ryu D; Menzies KJ; Wang X; Perino A; Houten SM; Melchior F; Schoonjans K. 2014. SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport. Cell Metab 20(4):603-13. [PubMed: 25176150]  [MGI Ref ID J:215556]

Steiner T; Francescut L; Byrne S; Hughes T; Jayanthi A; Guschina I; Harwood J; Cianflone K; Stover C; Francis S. 2014. Protective role for properdin in progression of experimental murine atherosclerosis. PLoS One 9(3):e92404. [PubMed: 24667818]  [MGI Ref ID J:215053]

Strack AM; Carballo-Jane E; Wang SP; Xue J; Ping X; McNamara LA; Thankappan A; Price O; Wolff M; Wu TJ; Kawka D; Mariano M; Burton C; Chang CH; Chen J; Menke J; Luell S; Zycband EI; Tong X; Raubertas R; Sparrow CP; Hubbard B; Woods J; O'Neill G; Waters MG; Sitlani A. 2013. Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis. J Lipid Res 54(1):177-88. [PubMed: 23103473]  [MGI Ref ID J:192168]

Strom A; Olin AI; Aspberg A; Hultgardh-Nilsson A. 2006. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res 69(3):755-63. [PubMed: 16409997]  [MGI Ref ID J:105710]

Subbaiah PV; Jiang XC; Belikova NA; Aizezi B; Huang ZH; Reardon CA. 2012. Regulation of plasma cholesterol esterification by sphingomyelin: Effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity. Biochim Biophys Acta 1821(6):908-13. [PubMed: 22370449]  [MGI Ref ID J:185003]

Subramanian M; Thorp E; Hansson GK; Tabas I. 2013. Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J Clin Invest 123(1):179-88. [PubMed: 23257360]  [MGI Ref ID J:194509]

Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A. 2011. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52(9):1626-35. [PubMed: 21690266]  [MGI Ref ID J:175559]

Subramanian S; Han CY; Chiba T; McMillen TS; Wang SA; Haw A rd; Kirk EA; O'Brien KD; Chait A. 2008. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28(4):685-91. [PubMed: 18239153]  [MGI Ref ID J:149038]

Subramanian V; Golledge J; Ijaz T; Bruemmer D; Daugherty A. 2010. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}. Circ Res 107(8):953-8. [PubMed: 20798360]  [MGI Ref ID J:178193]

Subramanian V; Moorleghen JJ; Balakrishnan A; Howatt DA; Chishti AH; Uchida HA. 2013. Calpain-2 compensation promotes angiotensin II-induced ascending and abdominal aortic aneurysms in calpain-1 deficient mice. PLoS One 8(8):e72214. [PubMed: 23977256]  [MGI Ref ID J:206427]

Sugiyama E; Tanaka N; Nakajima T; Kamijo Y; Yokoyama S; Li Y; Gonzalez FJ; Aoyama T. 2006. Haploinsufficiency in the PPARalpha and LDL receptor genes leads to gender- and age-specific obesity and hyperinsulinemia. Biochem Biophys Res Commun 350(2):370-6. [PubMed: 17011521]  [MGI Ref ID J:116049]

Sui Y; Park SH; Xu J; Monette S; Helsley RN; Han SS; Zhou C. 2014. IKKbeta links vascular inflammation to obesity and atherosclerosis. J Exp Med 211(5):869-86. [PubMed: 24799533]  [MGI Ref ID J:211281]

Sukhova GK; Zhang Y; Pan JH; Wada Y; Yamamoto T; Naito M; Kodama T; Tsimikas S; Witztum JL; Lu ML; Sakara Y; Chin MT; Libby P; Shi GP. 2003. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 111(6):897-906. [PubMed: 12639996]  [MGI Ref ID J:82520]

Sun H; Samarghandi A; Zhang N; Yao Z; Xiong M; Teng BB. 2012. Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor. Arterioscler Thromb Vasc Biol 32(7):1585-95. [PubMed: 22580899]  [MGI Ref ID J:186176]

Sun J; Hartvigsen K; Chou MY; Zhang Y; Sukhova GK; Zhang J; Lopez-Ilasaca M; Diehl CJ; Yakov N; Harats D; George J; Witztum JL; Libby P; Ploegh H; Shi GP. 2010. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 122(8):808-20. [PubMed: 20697023]  [MGI Ref ID J:178588]

Sun J; Sukhova GK; Wolters PJ; Yang M; Kitamoto S; Libby P; MacFarlane LA; Mallen-St Clair J; Shi GP. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13(6):719-24. [PubMed: 17546038]  [MGI Ref ID J:125116]

Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y. 2009. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Cardiovasc Res 82(2):371-81. [PubMed: 19176597]  [MGI Ref ID J:162198]

Surmi BK; Atkinson RD; Gruen ML; Coenen KR; Hasty AH. 2008. The role of macrophage leptin receptor in aortic root lesion formation. Am J Physiol Endocrinol Metab 294(3):E488-95. [PubMed: 18182468]  [MGI Ref ID J:133462]

Tacken PJ; Teusink B; Jong MC; Harats D; Havekes LM; van Dijk KW; Hofker MH. 2000. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice J Lipid Res 41(12):2055-62. [PubMed: 11108739]  [MGI Ref ID J:66431]

Tadin-Strapps M; Peterson LB; Cumiskey AM; Rosa RL; Mendoza VH; Castro-Perez J; Puig O; Zhang L; Strapps WR; Yendluri S; Andrews L; Pickering V; Rice J; Luo L; Chen Z; Tep S; Ason B; Somers EP; Sachs AB; Bartz SR; Tian J; Chin J; Hubbard BK; Wong KK; Mitnaul LJ. 2011. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids. J Lipid Res 52(6):1084-97. [PubMed: 21398511]  [MGI Ref ID J:180925]

Takata Y; Liu J; Yin F; Collins AR; Lyon CJ; Lee CH; Atkins AR; Downes M; Barish GD; Evans RM; Hsueh WA; Tangirala RK. 2008. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci U S A 105(11):4277-82. [PubMed: 18337495]  [MGI Ref ID J:133474]

Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clement K; Holvoet P; Tedgui A; Mallat Z. 2007. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 27(12):2691-8. [PubMed: 17690315]  [MGI Ref ID J:147531]

Taleb S; Romain M; Ramkhelawon B; Uyttenhove C; Pasterkamp G; Herbin O; Esposito B; Perez N; Yasukawa H; Van Snick J; Yoshimura A; Tedgui A; Mallat Z. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 206(10):2067-77. [PubMed: 19737863]  [MGI Ref ID J:153361]

Taneja D; Thompson J; Wilson P; Brandewie K; Schaefer L; Mitchell B; Tannock LR. 2010. Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J Lipid Res 51(6):1464-70. [PubMed: 20110440]  [MGI Ref ID J:161500]

Tang EH; Shimizu K; Christen T; Rocha VZ; Shvartz E; Tesmenitsky Y; Sukhova G; Shi GP; Libby P. 2011. Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions. Cardiovasc Res 89(1):234-43. [PubMed: 20736236]  [MGI Ref ID J:167790]

Tang EH; Shvartz E; Shimizu K; Rocha VZ; Zheng C; Fukuda D; Shi GP; Sukhova G; Libby P. 2011. Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 31(2):261-9. [PubMed: 21088251]  [MGI Ref ID J:184180]

Tang JJ; Li JG; Qi W; Qiu WW; Li PS; Li BL; Song BL. 2011. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab 13(1):44-56. [PubMed: 21195348]  [MGI Ref ID J:169478]

Tang M; Cyrus T; Yao Y; Vocun L; Pratico D. 2005. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice. Circulation 112(18):2867-74. [PubMed: 16267259]  [MGI Ref ID J:116835]

Tang SY; Monslow J; Todd L; Lawson J; Pure E; FitzGerald GA. 2014. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation 129(17):1761-9. [PubMed: 24519928]  [MGI Ref ID J:221694]

Tangirala RK; Bischoff ED; Joseph SB; Wagner BL; Walczak R; Laffitte BA; Daige CL; Thomas D; Heyman RA; Mangelsdorf DJ; Wang X; Lusis AJ; Tontonoz P; Schulman IG. 2002. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A 99(18):11896-901. [PubMed: 12193651]  [MGI Ref ID J:125452]

Tangirala RK; Pratico D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Pure E; Rader DJ. 2001. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 276(1):261-6. [PubMed: 11024044]  [MGI Ref ID J:66833]

Tangirala RK; Rubin EM; Palinski W. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36(11):2320-8. [PubMed: 8656070]  [MGI Ref ID J:29950]

Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ. 2007. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 116(11):1267-73. [PubMed: 17709636]  [MGI Ref ID J:139845]

Tavori H; Fan D; Blakemore JL; Yancey PG; Ding L; Linton MF; Fazio S. 2013. Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation. Circulation 127(24):2403-13. [PubMed: 23690465]  [MGI Ref ID J:211389]

Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Muller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J. 2007. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice. Biochem Biophys Res Commun 361(3):574-9. [PubMed: 17669363]  [MGI Ref ID J:124271]

Tep S; Mihaila R; Freeman A; Pickering V; Huyhn F; Tadin-Strapps M; Stracks A; Hubbard B; Caldwell J; Flanagan WM; Kuklin NA; Ason B. 2012. Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing. J Lipid Res 53(5):859-67. [PubMed: 22355095]  [MGI Ref ID J:184930]

Terasaka N; Wang N; Yvan-Charvet L; Tall AR. 2007. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci U S A 104(38):15093-8. [PubMed: 17846428]  [MGI Ref ID J:125197]

Terasaka N; Yu S; Yvan-Charvet L; Wang N; Mzhavia N; Langlois R; Pagler T; Li R; Welch CL; Goldberg IJ; Tall AR. 2008. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 118(11):3701-13. [PubMed: 18924609]  [MGI Ref ID J:144580]

Terrand J; Bruban V; Zhou L; Gong W; El Asmar Z; May P; Zurhove K; Haffner P; Philippe C; Woldt E; Matz RL; Gracia C; Metzger D; Auwerx J; Herz J; Boucher P. 2009. LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J Biol Chem 284(1):381-8. [PubMed: 18990694]  [MGI Ref ID J:146007]

Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J. 2008. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice. Arterioscler Thromb Vasc Biol 28(11):2009-15. [PubMed: 18787185]  [MGI Ref ID J:159797]

Teupser D; Pavlides S; Tan M; Gutierrez-Ramos JC; Kolbeck R; Breslow JL. 2004. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci U S A 101(51):17795-800. [PubMed: 15596719]  [MGI Ref ID J:95279]

Teupser D; Tan M; Persky AD; Breslow JL. 2006. Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice. Proc Natl Acad Sci U S A 103(1):123-8. [PubMed: 16380418]  [MGI Ref ID J:104621]

Teupser D; Weber O; Rao TN; Sass K; Thiery J; Fehling HJ. 2011. No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice. J Biol Chem 286(8):6272-9. [PubMed: 21149301]  [MGI Ref ID J:170409]

Teusink B; Mensenkamp AR; van der Boom H; Kuipers F; van Dijk KW; Havekes LM. 2001. Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor. J Biol Chem 276(44):40693-7. [PubMed: 11546779]  [MGI Ref ID J:119460]

Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA. 2011. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 31(4):758-65. [PubMed: 21252069]  [MGI Ref ID J:184167]

Thirumangalakudi L; Prakasam A; Zhang R; Bimonte-Nelson H; Sambamurti K; Kindy MS; Bhat NR. 2008. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 106(1):475-85. [PubMed: 18410513]  [MGI Ref ID J:137264]

Thompson J; Wilson P; Brandewie K; Taneja D; Schaefer L; Mitchell B; Tannock LR. 2011. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol 179(3):1179-87. [PubMed: 21723246]  [MGI Ref ID J:176327]

Thorp E; Li G; Seimon TA; Kuriakose G; Ron D; Tabas I. 2009. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. Cell Metab 9(5):474-81. [PubMed: 19416717]  [MGI Ref ID J:148485]

Tian J; Pei H; Sanders JM; Angle JF; Sarembock IJ; Matsumoto AH; Helm GA; Shi W. 2006. Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice. Biochem Biophys Res Commun 345(3):1004-9. [PubMed: 16712797]  [MGI Ref ID J:109645]

Tiebel O; Oka K; Robinson K; Sullivan M; Martinez J; Nakamuta M; Ishimura-Oka K; Chan L. 1999. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis 145(2):239-51. [PubMed: 10488949]  [MGI Ref ID J:59491]

Tietge UJ; Pratico D; Ding T; Funk CD; Hildebrand RB; Van Berkel T; Van Eck M. 2005. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress. J Lipid Res 46(8):1604-14. [PubMed: 15897607]  [MGI Ref ID J:100744]

Tilley RE; Pedersen B; Pawlinski R; Sato Y; Erlich JH; Shen Y; Day S; Huang Y; Eitzman DT; Boisvert WA; Curtiss LK; Fay WP; Mackman N. 2006. Atherosclerosis in mice is not affected by a reduction in tissue factor expression. Arterioscler Thromb Vasc Biol 26(3):555-62. [PubMed: 16385085]  [MGI Ref ID J:127980]

Tokuno S; Hinokiyama K; Tokuno K; Lowbeer C; Hansson LO; Valen G. 2002. Spontaneous ischemic events in the brain and heart adapt the hearts of severely atherosclerotic mice to ischemia. Arterioscler Thromb Vasc Biol 22(6):995-1001. [PubMed: 12067910]  [MGI Ref ID J:102937]

Towler DA; Bidder M; Latifi T; Coleman T; Semenkovich CF. 1998. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 273(46):30427-34. [PubMed: 9804809]  [MGI Ref ID J:50962]

Tozawa R; Ishibashi S; Osuga J; Yagyu H; Oka T; Chen Z; Ohashi K; Perrey S; Shionoiri F; Yahagi N; Harada K; Gotoda T; Yazaki Y; Yamada N. 1999. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem 274(43):30843-8. [PubMed: 10521476]  [MGI Ref ID J:58231]

Truong TQ; Auger A; Denizeau F; Brissette L. 2000. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Biochim Biophys Acta 1484(2-3):307-15. [PubMed: 10760479]  [MGI Ref ID J:61821]

Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ. 2013. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-kappaB pathway. Cardiovasc Res 100(3):501-10. [PubMed: 24225494]  [MGI Ref ID J:219537]

Tsuchiya K; Westerterp M; Murphy AJ; Subramanian V; Ferrante AW Jr; Tall AR; Accili D. 2013. Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ Res 112(7):992-1003. [PubMed: 23420833]  [MGI Ref ID J:213325]

Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W. 2009. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes 58(8):1739-48. [PubMed: 19509018]  [MGI Ref ID J:154414]

Twisk J; Gillian-Daniel DL; Tebon A; Wang L; Barrett PH; Attie AD. 2000. The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest 105(4):521-32. [PubMed: 10683382]  [MGI Ref ID J:60664]

Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A. 2011. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 31(12):2845-52. [PubMed: 21868698]  [MGI Ref ID J:191466]

Umans L; Overbergh L; Serneels L; Tesseur I; Van Leuven F. 1999. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E. Biol Reprod 61(5):1216-25. [PubMed: 10529267]  [MGI Ref ID J:107547]

Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A. 2013. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res 112(10):1345-54. [PubMed: 23501697]  [MGI Ref ID J:213314]

Valenta DT; Bulgrien JJ; Bonnet DJ; Curtiss LK. 2008. Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency. J Lipid Res 49(1):24-32. [PubMed: 17928634]  [MGI Ref ID J:130081]

Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ. 2004. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 165(3):785-94. [PubMed: 15331403]  [MGI Ref ID J:92320]

Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ. 2007. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice. Circ Res 100(5):678-85. [PubMed: 17293475]  [MGI Ref ID J:133704]

Van den Bergh A; Vanderper A; Vangheluwe P; Desjardins F; Nevelsteen I; Verreth W; Wuytack F; Holvoet P; Flameng W; Balligand JL; Herijgers P. 2008. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res 77(2):371-9. [PubMed: 18006491]  [MGI Ref ID J:161915]

VanderLaan PA; Reardon CA; Thisted RA; Getz GS. 2009. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res 50(3):376-85. [PubMed: 18957695]  [MGI Ref ID J:149089]

Varadhachary AS; Monestier M; Salgame P. 2001. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cell Immunol 213(1):45-51. [PubMed: 11747355]  [MGI Ref ID J:115363]

Vasandani C; Kafrouni AI; Caronna A; Bashmakov Y; Gotthardt M; Horton JD; Spady DK. 2002. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J Lipid Res 43(5):772-84. [PubMed: 11971949]  [MGI Ref ID J:124748]

Veniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG. 2000. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100 J Clin Invest 106(12):1501-10. [PubMed: 11120757]  [MGI Ref ID J:66424]

Veniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D ; Herz J ; Young SG. 1998. Lipoprotein clearance mechanisms in LDL receptor-deficient Apo-B48-only and Apo-B100-only mice. J Clin Invest 102(8):1559-68. [PubMed: 9788969]  [MGI Ref ID J:51022]

Verschuren L; Kooistra T; Bernhagen J; Voshol PJ; Ouwens DM; van Erk M; de Vries-van der Weij J; Leng L; van Bockel JH; van Dijk KW; Fingerle-Rowson G; Bucala R; Kleemann R. 2009. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105(1):99-107. [PubMed: 19478200]  [MGI Ref ID J:164757]

Vikramadithyan RK; Hu Y; Noh HL; Liang CP; Hallam K; Tall AR; Ramasamy R; Goldberg IJ. 2005. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest 115(9):2434-43. [PubMed: 16127462]  [MGI Ref ID J:100916]

Vikramadithyan RK; Kako Y; Chen G; Hu Y; Arikawa-Hirasawa E; Yamada Y; Goldberg IJ. 2004. Atherosclerosis in perlecan heterozygous mice. J Lipid Res 45(10):1806-12. [PubMed: 15258195]  [MGI Ref ID J:93619]

Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M. 2007. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler Thromb Vasc Biol 27(3):578-86. [PubMed: 17170377]  [MGI Ref ID J:148673]

Von Der Thusen JH; Kuiper J; Fekkes ML; De Vos P; Van Berkel TJ; Biessen EA. 2001. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 15(14):2730-2. [PubMed: 11687507]  [MGI Ref ID J:73161]

Voorend M; van der Ven AJ; Mulder M; Lodder J; Steinbusch HW; Bruggeman CA. 2010. Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice. Neurobiol Aging 31(10):1766-73. [PubMed: 19027992]  [MGI Ref ID J:165244]

Wang J; Sjoberg S; Tang TT; Oorni K; Wu W; Liu C; Secco B; Tia V; Sukhova GK; Fernandes C; Lesner A; Kovanen PT; Libby P; Cheng X; Shi GP. 2014. Cathepsin G activity lowers plasma LDL and reduces atherosclerosis. Biochim Biophys Acta 1842(11):2174-83. [PubMed: 25092171]  [MGI Ref ID J:218470]

Wang M; Lee E; Song W; Ricciotti E; Rader DJ; Lawson JA; Pure E; FitzGerald GA. 2008. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117(10):1302-9. [PubMed: 18285567]  [MGI Ref ID J:148450]

Wang M; Zukas AM; Hui Y; Ricciotti E; Pure E; FitzGerald GA. 2006. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci U S A 103(39):14507-12. [PubMed: 16973753]  [MGI Ref ID J:114545]

Wang MD; Kiss RS; Franklin V; McBride HM; Whitman SC; Marcel YL. 2007. Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways. J Lipid Res 48(3):633-45. [PubMed: 17148552]  [MGI Ref ID J:120283]

Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH. 2010. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res 106(6):1117-28. [PubMed: 20167927]  [MGI Ref ID J:171036]

Wang Z; Nicholls SJ; Rodriguez ER; Kummu O; Horkko S; Barnard J; Reynolds WF; Topol EJ; DiDonato JA; Hazen SL. 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13(10):1176-84. [PubMed: 17828273]  [MGI Ref ID J:129923]

Wang ZH; Shang YY; Zhang S; Zhong M; Wang XP; Deng JT; Pan J; Zhang Y; Zhang W. 2012. Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice. Diabetes 61(2):463-73. [PubMed: 22275087]  [MGI Ref ID J:196759]

Wanschel A; Seibert T; Hewing B; Ramkhelawon B; Ray TD; van Gils JM; Rayner KJ; Feig JE; O'Brien ER; Fisher EA; Moore KJ. 2013. Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler Thromb Vasc Biol 33(5):886-93. [PubMed: 23430613]  [MGI Ref ID J:217969]

Webb NR; Bostrom MA; Szilvassy SJ; van der Westhuyzen DR; Daugherty A; de Beer FC. 2003. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 23(2):263-8. [PubMed: 12588769]  [MGI Ref ID J:127990]

Weber C; Meiler S; Doring Y; Koch M; Drechsler M; Megens RT; Rowinska Z; Bidzhekov K; Fecher C; Ribechini E; van Zandvoort MA; Binder CJ; Jelinek I; Hristov M; Boon L; Jung S; Korn T; Lutz MB; Forster I; Zenke M; Hieronymus T; Junt T; Zernecke A. 2011. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest 121(7):2898-910. [PubMed: 21633167]  [MGI Ref ID J:175665]

Wei S; Wang H; Zhang G; Lu Y; An X; Ren S; Wang Y; Chen Y; White JG; Zhang C; Simon DI; Wu C; Li Z; Huo Y. 2013. Platelet IkappaB kinase-beta deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibalpha shedding. Arterioscler Thromb Vasc Biol 33(2):241-8. [PubMed: 23241410]  [MGI Ref ID J:216903]

Weng S; Sprague JE; Oh J; Riek AE; Chin K; Garcia M; Bernal-Mizrachi C. 2013. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 8(1):e54625. [PubMed: 23349943]  [MGI Ref ID J:195839]

Weng S; Zemany L; Standley KN; Novack DV; La Regina M; Bernal-Mizrachi C; Coleman T; Semenkovich CF. 2003. Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice. Proc Natl Acad Sci U S A 100(11):6730-5. [PubMed: 12746502]  [MGI Ref ID J:83615]

Westerterp M; Koetsveld J; Yu S; Han S; Li R; Goldberg IJ; Welch CL; Tall AR. 2010. Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report. Arterioscler Thromb Vasc Biol 30(11):2103-5. [PubMed: 20705913]  [MGI Ref ID J:183210]

Westerterp M; Murphy AJ; Wang M; Pagler TA; Vengrenyuk Y; Kappus MS; Gorman DJ; Nagareddy PR; Zhu X; Abramowicz S; Parks JS; Welch C; Fisher EA; Wang N; Yvan-Charvet L; Tall AR. 2013. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ Res 112(11):1456-65. [PubMed: 23572498]  [MGI Ref ID J:213300]

Westmuckett AD; Moore KL. 2009. Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 29(11):1730-6. [PubMed: 19679829]  [MGI Ref ID J:167800]

Whitman SC; Rateri DL; Szilvassy SJ; Cornicelli JA; Daugherty A. 2002. Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology. J Lipid Res 43(8):1201-8. [PubMed: 12177164]  [MGI Ref ID J:78922]

Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A. 2012. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition. Arterioscler Thromb Vasc Biol 32(6):1418-26. [PubMed: 22516063]  [MGI Ref ID J:197090]

Wilhelm AJ; Zabalawi M; Grayson JM; Weant AE; Major AS; Owen J; Bharadwaj M; Walzem R; Chan L; Oka K; Thomas MJ; Sorci-Thomas MG. 2009. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol 29(6):843-9. [PubMed: 19286630]  [MGI Ref ID J:162193]

Wilhelm AJ; Zabalawi M; Owen JS; Shah D; Grayson JM; Major AS; Bhat S; Gibbs DP Jr; Thomas MJ; Sorci-Thomas MG. 2010. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem 285(46):36158-69. [PubMed: 20833724]  [MGI Ref ID J:166862]

Willnow TE; Armstrong SA; Hammer RE; Herz J. 1995. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc Natl Acad Sci U S A 92(10):4537-41. [PubMed: 7538675]  [MGI Ref ID J:43736]

Wilund KR; Yu L; Xu F; Hobbs HH; Cohen JC. 2004. High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-/- mice. J Lipid Res 45(8):1429-36. [PubMed: 15175362]  [MGI Ref ID J:91353]

Witting PK; Pettersson K; Ostlund-Lindqvist AM; Westerlund C; Eriksson AW; Stocker R. 1999. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J 13(6):667-75. [PubMed: 10094927]  [MGI Ref ID J:54037]

Wolfrum C; Poy MN; Stoffel M. 2005. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11(4):418-22. [PubMed: 15793583]  [MGI Ref ID J:97550]

Wong CW; Burger F; Pelli G; Mach F; Kwak BR. 2003. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes 10(4-6):395-400. [PubMed: 14681047]  [MGI Ref ID J:103076]

Wouters K; van Bilsen M; van Gorp PJ; Bieghs V; Lutjohann D; Kerksiek A; Staels B; Hofker MH; Shiri-Sverdlov R. 2010. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice. FEBS Lett 584(5):1001-5. [PubMed: 20114046]  [MGI Ref ID J:157585]

Wu D; Yang H; Xiang W; Zhou L; Shi M; Julies G; Laplante JM; Ballard BR; Guo Z. 2005. Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res 46(7):1380-7. [PubMed: 15863839]  [MGI Ref ID J:100500]

Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB Jr; Santamarina-Fojo S. 2004. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. J Biol Chem 279(22):22913-25. [PubMed: 15044450]  [MGI Ref ID J:90718]

Wu L; Vikramadithyan R; Yu S; Pau C; Hu Y; Goldberg IJ; Dansky HM. 2006. Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis. J Lipid Res 47(10):2215-22. [PubMed: 16840797]  [MGI Ref ID J:116491]

Xanthoulea S; Thelen M; Pottgens C; Gijbels MJ; Lutgens E; de Winther MP. 2009. Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS One 4(7):e6113. [PubMed: 19582157]  [MGI Ref ID J:151487]

Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X. 2013. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development. PLoS One 8(12):e81056. [PubMed: 24349031]  [MGI Ref ID J:211155]

Xie C; Burns DK; Turley SD; Dietschy JM. 2000. Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J Neuropathol Exp Neurol 59(12):1106-17. [PubMed: 11138930]  [MGI Ref ID J:104996]

Xie C; Richardson JA; Turley SD; Dietschy JM. 2006. Cholesterol substrate pools and steroid hormone levels are normal in the face of mutational inactivation of NPC1 protein. J Lipid Res 47(5):953-63. [PubMed: 16461760]  [MGI Ref ID J:109000]

Xie C; Turley SD; Dietschy JM. 2000. Centripetal cholesterol flow from the extrahepatic organs through the liver is normal in mice with mutated niemann-pick type C protein (NPC1) J Lipid Res 41(8):1278-89. [PubMed: 10946016]  [MGI Ref ID J:64028]

Xie C; Turley SD; Dietschy JM. 1999. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. Proc Natl Acad Sci U S A 96(21):11992-7. [PubMed: 10518564]  [MGI Ref ID J:76735]

Xu Y; Arai H; Murayama T; Kita T; Yokode M. 2007. Hypercholesterolemia contributes to the development of atherosclerosis and vascular remodeling by recruiting bone marrow-derived cells in cuff-induced vascular injury. Biochem Biophys Res Commun 363(3):782-7. [PubMed: 17897625]  [MGI Ref ID J:127338]

Yagyu H; Kitamine T; Osuga J; Tozawa R; Chen Z; Kaji Y; Oka T; Perrey S; Tamura Y; Ohashi K; Okazaki H; Yahagi N; Shionoiri F; Iizuka Y; Harada K; Shimano H; Yamashita H; Gotoda T; Yamada N; Ishibashi S. 2000. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 275(28):21324-30. [PubMed: 10777503]  [MGI Ref ID J:63468]

Yan D; Jauhiainen M; Hildebrand RB; Willems van Dijk K; Van Berkel TJ; Ehnholm C; Van Eck M; Olkkonen VM. 2007. Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 27(7):1618-24. [PubMed: 17478758]  [MGI Ref ID J:134908]

Yan D; Navab M; Bruce C; Fogelman AM; Jiang XC. 2004. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. J Lipid Res 45(10):1852-8. [PubMed: 15258196]  [MGI Ref ID J:93620]

Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S. 2011. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent. Circulation 124(4):454-64. [PubMed: 21730304]  [MGI Ref ID J:186294]

Yang X; Peterson L; Thieringer R; Deignan JL; Wang X; Zhu J; Wang S; Zhong H; Stepaniants S; Beaulaurier J; Wang IM; Rosa R; Cumiskey AM; Luo JM; Luo Q; Shah K; Xiao J; Nickle D; Plump A; Schadt EE; Lusis AJ; Lum PY. 2010. Identification and validation of genes affecting aortic lesions in mice. J Clin Invest 120(7):2414-22. [PubMed: 20577049]  [MGI Ref ID J:163781]

Ye D; Meurs I; Ohigashi M; Calpe-Berdiel L; Habets KL; Zhao Y; Kubo Y; Yamaguchi A; Van Berkel TJ; Nishi T; Van Eck M. 2010. Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice. Biochem Biophys Res Commun 395(3):387-94. [PubMed: 20382126]  [MGI Ref ID J:160341]

Ye D; Zhao Y; Hildebrand RB; Singaraja RR; Hayden MR; Van Berkel TJ; Van Eck M. 2011. The dynamics of macrophage infiltration into the arterial wall during atherosclerotic lesion development in low-density lipoprotein receptor knockout mice. Am J Pathol 178(1):413-22. [PubMed: 21224078]  [MGI Ref ID J:168077]

Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE. 2008. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. J Biol Chem 283(37):25650-9. [PubMed: 18644789]  [MGI Ref ID J:142162]

Yokoyama M; Seo T; Park T; Yagyu H; Hu Y; Son NH; Augustus AS; Vikramadithyan RK; Ramakrishnan R; Pulawa LK; Eckel RH; Goldberg IJ. 2007. Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle. J Lipid Res 48(3):646-55. [PubMed: 17189607]  [MGI Ref ID J:120271]

Yoon J; Subramanian S; Ding Y; Wang S; Goodspeed L; Sullivan B; Kim J; O'Brien KD; Chait A. 2011. Chronic insulin therapy reduces adipose tissue macrophage content in LDL-receptor-deficient mice. Diabetologia :. [PubMed: 21327868]  [MGI Ref ID J:169596]

Yoshimatsu M; Terasaki Y; Sakashita N; Kiyota E; Sato H; van der Laan LJ; Takeya M. 2004. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol 85(6):335-43. [PubMed: 15566430]  [MGI Ref ID J:104609]

Yu F; Du F; Wang Y; Huang S; Miao R; Major AS; Murphy EA; Fu M; Fan D. 2013. Bone marrow deficiency of MCPIP1 results in severe multi-organ inflammation but diminishes atherogenesis in hyperlipidemic mice. PLoS One 8(11):e80089. [PubMed: 24223214]  [MGI Ref ID J:209217]

Yu KC; Chen W; Cooper AD. 2001. LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. J Clin Invest 107(11):1387-94. [PubMed: 11390420]  [MGI Ref ID J:69912]

Yu KC; Jiang Y; Chen W; Cooper AD. 2000. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E J Lipid Res 41(11):1715-27. [PubMed: 11060341]  [MGI Ref ID J:65695]

Yu Y; Lucitt MB; Stubbe J; Cheng Y; Friis UG; Hansen PB; Jensen BL; Smyth EM; FitzGerald GA. 2009. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci U S A 106(19):7985-90. [PubMed: 19416858]  [MGI Ref ID J:148401]

Yvan-Charvet L; Pagler T; Gautier EL; Avagyan S; Siry RL; Han S; Welch CL; Wang N; Randolph GJ; Snoeck HW; Tall AR. 2010. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328(5986):1689-93. [PubMed: 20488992]  [MGI Ref ID J:161310]

Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 117(12):3900-8. [PubMed: 17992262]  [MGI Ref ID J:130777]

Zabalawi M; Bharadwaj M; Horton H; Cline M; Willingham M; Thomas MJ; Sorci-Thomas MG. 2007. Inflammation and skin cholesterol in LDLr-/-, apoA-I-/- mice: link between cholesterol homeostasis and self-tolerance? J Lipid Res 48(1):52-65. [PubMed: 17071966]  [MGI Ref ID J:117480]

Zabalawi M; Bhat S; Loughlin T; Thomas MJ; Alexander E; Cline M; Bullock B; Willingham M; Sorci-Thomas MG. 2003. Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am J Pathol 163(3):1201-13. [PubMed: 12937162]  [MGI Ref ID J:85174]

Zaid A; Roubtsova A; Essalmani R; Marcinkiewicz J; Chamberland A; Hamelin J; Tremblay M; Jacques H; Jin W; Davignon J; Seidah NG; Prat A. 2008. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology 48(2):646-54. [PubMed: 18666258]  [MGI Ref ID J:169834]

Zernecke A; Bot I; Djalali-Talab Y; Shagdarsuren E; Bidzhekov K; Meiler S; Krohn R; Schober A; Sperandio M; Soehnlein O; Bornemann J; Tacke F; Biessen EA; Weber C. 2008. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 102(2):209-17. [PubMed: 17991882]  [MGI Ref ID J:145593]

Zhang C; An J; Strickland DK; Yepes M. 2009. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am J Pathol 174(2):586-94. [PubMed: 19147818]  [MGI Ref ID J:144185]

Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H. 2012. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res 111(1):37-49. [PubMed: 22628578]  [MGI Ref ID J:212656]

Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B. 2008. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 117(3):421-8. [PubMed: 18158360]  [MGI Ref ID J:145089]

Zhang X; Thatcher SE; Rateri DL; Bruemmer D; Charnigo R; Daugherty A; Cassis LA. 2012. Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ Res 110(11):e73-85. [PubMed: 22539767]  [MGI Ref ID J:212660]

Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG. 2012. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 122(5):1688-99. [PubMed: 22484817]  [MGI Ref ID J:184536]

Zhang Y; Wang X; Vales C; Lee FY; Lee H; Lusis AJ; Edwards PA. 2006. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 26(10):2316-21. [PubMed: 16825595]  [MGI Ref ID J:128055]

Zhao B; Song J; Chow WN; St Clair RW; Rudel LL; Ghosh S. 2007. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J Clin Invest 117(10):2983-92. [PubMed: 17885686]  [MGI Ref ID J:127535]

Zhao L; Cuff CA; Moss E; Wille U; Cyrus T; Klein EA; Pratico D; Rader DJ; Hunter CA; Pure E; Funk CD. 2002. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 277(38):35350-6. [PubMed: 12122008]  [MGI Ref ID J:79120]

Zhao Y; Pennings M; Hildebrand RB; Ye D; Calpe-Berdiel L; Out R; Kjerrulf M; Hurt-Camejo E; Groen AK; Hoekstra M; Jessup W; Chimini G; Van Berkel TJ; Van Eck M. 2010. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet. Circ Res 107(12):e20-31. [PubMed: 21071707]  [MGI Ref ID J:178508]

Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE. 2009. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice. Arterioscler Thromb Vasc Biol 29(9):1349-55. [PubMed: 19520976]  [MGI Ref ID J:167813]

Zhao Y; Ye D; Wang J; Calpe-Berdiel L; Azzis SB; Van Berkel TJ; Van Eck M. 2011. Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice. Am J Pathol 179(3):1522-32. [PubMed: 21741939]  [MGI Ref ID J:179953]

Zhou C; Pridgen B; King N; Xu J; Breslow JL. 2011. Hyperglycemic Ins2AkitaLdlr-/- mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease. J Lipid Res 52(8):1483-93. [PubMed: 21606463]  [MGI Ref ID J:174983]

Zhou L; Choi HY; Li WP; Xu F; Herz J. 2009. LRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol export. PLoS One 4(8):e6853. [PubMed: 19718435]  [MGI Ref ID J:152391]

Zhou L; Takayama Y; Boucher P; Tallquist MD; Herz J. 2009. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One 4(9):e6922. [PubMed: 19742316]  [MGI Ref ID J:153626]

Zhou L; Yang H; Lin X; Okoro EU; Guo Z. 2012. Cholecystokinin elevates mouse plasma lipids. PLoS One 7(12):e51011. [PubMed: 23300532]  [MGI Ref ID J:195734]

Zhou L; Yang H; Okoro EU; Guo Z. 2014. Up-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemia. J Biol Chem 289(19):12989-99. [PubMed: 24692543]  [MGI Ref ID J:214128]

Zhou Q; Mei Y; Shoji T; Han X; Kaminski K; Oh GT; Ongusaha PP; Zhang K; Schmitt H; Moser M; Bode C; Liao JK. 2012. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis. Circulation 126(18):2236-47. [PubMed: 23011471]  [MGI Ref ID J:210071]

Zhou X; He W; Huang Z; Gotto AM Jr; Hajjar DP; Han J. 2008. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism. J Biol Chem 283(4):2129-38. [PubMed: 18029360]  [MGI Ref ID J:130725]

Zhu L; Stalker TJ; Fong KP; Jiang H; Tran A; Crichton I; Lee EK; Neeves KB; Maloney SF; Kikutani H; Kumanogoh A; Pure E; Diamond SL; Brass LF. 2009. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler Thromb Vasc Biol 29(7):1039-45. [PubMed: 19390055]  [MGI Ref ID J:167817]

Zhu SN; Chen M; Jongstra-Bilen J; Cybulsky MI. 2009. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J Exp Med 206(10):2141-9. [PubMed: 19752185]  [MGI Ref ID J:153507]

Zirlik A; Maier C; Gerdes N; MacFarlane L; Soosairajah J; Bavendiek U; Ahrens I; Ernst S; Bassler N; Missiou A; Patko Z; Aikawa M; Schonbeck U; Bode C; Libby P; Peter K. 2007. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115(12):1571-80. [PubMed: 17372166]  [MGI Ref ID J:133045]

Zotes TM; Arias CF; Fuster JJ; Spada R; Perez-Yague S; Hirsch E; Wymann M; Carrera AC; Andres V; Barber DF. 2013. PI3K p110gamma deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions. PLoS One 8(8):e72674. [PubMed: 23991137]  [MGI Ref ID J:204917]

de Claro RA; Zhu X; Tang J; Morgan-Stevenson V; Schwartz BR; Iwata A; Liles WC; Raines EW; Harlan JM. 2011. Hematopoietic Fas Deficiency Does Not Affect Experimental Atherosclerotic Lesion Formation despite Inducing a Proatherogenic State. Am J Pathol 178(6):2931-7. [PubMed: 21550016]  [MGI Ref ID J:173162]

de Haan W; Out R; Berbee JF; van der Hoogt CC; van Dijk KW; van Berkel TJ; Romijn JA; Jukema JW; Havekes LM; Rensen PC. 2008. Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. Biochem Biophys Res Commun 377(4):1294-8. [PubMed: 18992221]  [MGI Ref ID J:143183]

de Nooijer R; Bot I; von der Thusen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA. 2009. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol 29(2):188-94. [PubMed: 19095996]  [MGI Ref ID J:163799]

de Oliveira J; Hort MA; Moreira EL; Glaser V; Ribeiro-do-Valle RM; Prediger RD; Farina M; Latini A; de Bem AF. 2011. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience 197:99-106. [PubMed: 21945034]  [MGI Ref ID J:184047]

de Souza JC; de Oliveira CA; Carneiro EM; Boschero AC; de Oliveira HC. 2010. Cholesterol toxicity in pancreatic islets from LDL receptor-deficient mice. Diabetologia 53(11):2461-2; author reply 2463-4. [PubMed: 20694455]  [MGI Ref ID J:166652]

van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH. 1999. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression. Arterioscler Thromb Vasc Biol 19(12):2945-51. [PubMed: 10591674]  [MGI Ref ID J:59826]

van Eck M; Bos IS; Kaminski WE; Orso E; Rothe G; Twisk J; Bottcher A; Van Amersfoort ES; Christiansen-Weber TA; Fung-Leung WP; Van Berkel TJ; Schmitz G. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 99(9):6298-303. [PubMed: 11972062]  [MGI Ref ID J:76337]

van Es T; van Puijvelde GH; Ramos OH; Segers FM; Joosten LA; van den Berg WB; Michon IM; de Vos P; van Berkel TJ; Kuiper J. 2009. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 388(2):261-5. [PubMed: 19660432]  [MGI Ref ID J:152718]

van Gils JM; Derby MC; Fernandes LR; Ramkhelawon B; Ray TD; Rayner KJ; Parathath S; Distel E; Feig JL; Alvarez-Leite JI; Rayner AJ; McDonald TO; O'Brien KD; Stuart LM; Fisher EA; Lacy-Hulbert A; Moore KJ. 2012. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 13(2):136-43. [PubMed: 22231519]  [MGI Ref ID J:181210]

van Kampen E; Jaminon A; van Berkel TJ; Van Eck M. 2014. Diet-induced (epigenetic) changes in bone marrow augment atherosclerosis. J Leukoc Biol 96(5):833-41. [PubMed: 25024399]  [MGI Ref ID J:220135]

van Leeuwen M; Kemna MJ; de Winther MP; Boon L; Duijvestijn AM; Henatsch D; Bos NA; Gijbels MJ; Tervaert JW. 2013. Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice. PLoS One 8(7):e68039. [PubMed: 23874490]  [MGI Ref ID J:204410]

van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J. 2006. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 114(18):1968-76. [PubMed: 17060383]  [MGI Ref ID J:127201]

van Vlijmen BJ; Rohlmann A; Page ST; Bensadoun A; Bos IS; van Berkel TJ; Havekes LM; Herz J. 1999. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J Biol Chem 274(49):35219-26. [PubMed: 10575007]  [MGI Ref ID J:58704]

van Vlijmen BJ; van Dijk KW; van't Hof HB; van Gorp PJ; van der Zee A; van der Boom H; Breuer ML; Hofker MH; Havekes LM. 1996. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice. J Biol Chem 271(48):30595-602. [PubMed: 8940032]  [MGI Ref ID J:37473]

van der Hoogt CC; Berbee JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC. 2006. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice. Biochim Biophys Acta 1761(2):213-20. [PubMed: 16478678]  [MGI Ref ID J:110564]

Lepob related

Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B. 2010. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. J Biol Chem 285(47):36759-67. [PubMed: 20851881]  [MGI Ref ID J:167021]

Abe KC; Mori MA; Pesquero JB. 2007. Leptin deficiency leads to the regulation of kinin receptors expression in mice. Regul Pept 138(2-3):56-8. [PubMed: 17184856]  [MGI Ref ID J:137078]

Ablamunits V; Cohen Y; Brazee IB; Gaetz HP; Vinson C; Klebanov S. 2006. Susceptibility to Induced and Spontaneous Carcinogenesis Is Increased in Fatless A-ZIP/F-1 but not in Obese ob/ob Mice. Cancer Res 66(17):8897-902. [PubMed: 16951207]  [MGI Ref ID J:112412]

Ahima RS; Prabakaran D; Flier JS. 1998. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest 101(5):1020-7. [PubMed: 9486972]  [MGI Ref ID J:118976]

Ai D; Baez JM; Jiang H; Conlon DM; Hernandez-Ono A; Frank-Kamenetsky M; Milstein S; Fitzgerald K; Murphy AJ; Woo CW; Strong A; Ginsberg HN; Tabas I; Rader DJ; Tall AR. 2012. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J Clin Invest 122(5):1677-87. [PubMed: 22466652]  [MGI Ref ID J:184540]

Ait-Omar A; Monteiro-Sepulveda M; Poitou C; Le Gall M; Cotillard A; Gilet J; Garbin K; Houllier A; Chateau D; Lacombe A; Veyrie N; Hugol D; Tordjman J; Magnan C; Serradas P; Clement K; Leturque A; Brot-Laroche E. 2011. GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice. Diabetes 60(10):2598-607. [PubMed: 21852673]  [MGI Ref ID J:189265]

Akasheh RT; Pini M; Pang J; Fantuzzi G. 2013. Increased adiposity in annexin A1-deficient mice. PLoS One 8(12):e82608. [PubMed: 24312665]  [MGI Ref ID J:209746]

Akpinar P; Kuwajima S; Krutzfeldt J; Stoffel M. 2005. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab 2(6):385-97. [PubMed: 16330324]  [MGI Ref ID J:129667]

Alapatt P; Guo F; Komanetsky SM; Wang S; Cai J; Sargsyan A; Rodriguez Diaz E; Bacon BT; Aryal P; Graham TE. 2013. Liver retinol transporter and receptor for serum retinol-binding protein (RBP4). J Biol Chem 288(2):1250-65. [PubMed: 23105095]  [MGI Ref ID J:210500]

Albarado DC; McClaine J; Stephens JM; Mynatt RL; Ye J; Bannon AW; Richards WG; Butler AA. 2004. Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology 145(1):243-52. [PubMed: 14551222]  [MGI Ref ID J:96671]

Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingstrom G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Bjorkstrand E; Abrahmsen LB. 2003. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144(11):4755-62. [PubMed: 12960099]  [MGI Ref ID J:87239]

Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS. 2008. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294(5):E918-27. [PubMed: 18334608]  [MGI Ref ID J:135996]

Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H. 2009. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis. J Bone Miner Res 24(2):294-304. [PubMed: 18847327]  [MGI Ref ID J:168527]

Alon T; Friedman JM. 2006. Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. J Neurosci 26(2):389-97. [PubMed: 16407534]  [MGI Ref ID J:104264]

Altarejos JY; Goebel N; Conkright MD; Inoue H; Xie J; Arias CM; Sawchenko PE; Montminy M. 2008. The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med 14(10):1112-7. [PubMed: 18758446]  [MGI Ref ID J:142448]

Amano SU; Cohen JL; Vangala P; Tencerova M; Nicoloro SM; Yawe JC; Shen Y; Czech MP; Aouadi M. 2014. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab 19(1):162-71. [PubMed: 24374218]  [MGI Ref ID J:210550]

Anand A; Chada K. 2000. In vivo modulation of Hmgic reduces obesity. Nat Genet 24(4):377-80. [PubMed: 10742101]  [MGI Ref ID J:61493]

Ando H; Kumazaki M; Motosugi Y; Ushijima K; Maekawa T; Ishikawa E; Fujimura A. 2011. Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 152(4):1347-54. [PubMed: 21285316]  [MGI Ref ID J:173868]

Aouadi M; Laurent K; Prot M; Le Marchand-Brustel Y; Binetruy B; Bost F. 2006. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55(2):281-9. [PubMed: 16443758]  [MGI Ref ID J:106432]

Aouadi M; Vangala P; Yawe JC; Tencerova M; Nicoloro SM; Cohen JL; Shen Y; Czech MP. 2014. Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance. Am J Physiol Endocrinol Metab 307(4):E374-83. [PubMed: 24986598]  [MGI Ref ID J:215463]

Araujo TG; Oliveira AG; Carvalho BM; Guadagnini D; Protzek AO; Carvalheira JB; Boschero AC; Saad MJ. 2012. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Endocrinology 153(12):5760-9. [PubMed: 23024263]  [MGI Ref ID J:192374]

Arble DM; Holland J; Ottaway N; Sorrell J; Pressler JW; Morano R; Woods SC; Seeley RJ; Herman JP; Sandoval DA; Perez-Tilve D. 2015. The melanocortin-4 receptor integrates circadian light cues and metabolism. Endocrinology 156(5):1685-91. [PubMed: 25730108]  [MGI Ref ID J:222118]

Arble DM; Vitaterna MH; Turek FW. 2011. Rhythmic leptin is required for weight gain from circadian desynchronized feeding in the mouse. PLoS One 6(9):e25079. [PubMed: 21949859]  [MGI Ref ID J:177674]

Ariyasu H; Takaya K; Hosoda H; Iwakura H; Ebihara K; Mori K; Ogawa Y; Hosoda K; Akamizu T; Kojima M; Kangawa K; Nakao K. 2002. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 143(9):3341-50. [PubMed: 12193546]  [MGI Ref ID J:81463]

Arteaga-Solis E; Zee T; Emala CW; Vinson C; Wess J; Karsenty G. 2013. Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma. Cell Metab 17(1):35-48. [PubMed: 23312282]  [MGI Ref ID J:195073]

Arvaniti K; Huang Q; Richard D. 2001. Effects of Leptin and Corticosterone on the Expression of Corticotropin-Releasing Hormone, Agouti-Related Protein, and Proopiomelanocortin in the Brain of ob/ob Mouse. Neuroendocrinology 73(4):227-36. [PubMed: 11340336]  [MGI Ref ID J:69137]

Asakawa A; Inui A; Ueno N; Makino S; Fujino MA; Kasuga M. 1999. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice [see comments] Gastroenterology 116(6):1287-92. [PubMed: 10348810]  [MGI Ref ID J:57224]

Askari B; Wietecha T; Hudkins KL; Fox EJ; O'Brien KD; Kim J; Nguyen TQ; Alpers CE. 2014. Effects of CP-900691, a novel peroxisome proliferator-activated receptor alpha, agonist on diabetic nephropathy in the BTBR ob/ob mouse. Lab Invest 94(8):851-62. [PubMed: 24955894]  [MGI Ref ID J:213864]

Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW. 2015. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21. Endocrinology 156(6):2087-102. [PubMed: 25774553]  [MGI Ref ID J:222169]

Asterholm IW; McDonald J; Blanchard PG; Sinha M; Xiao Q; Mistry J; Rutkowski JM; Deshaies Y; Brekken RA; Scherer PE. 2012. Lack of "immunological fitness" during fasting in metabolically challenged animals. J Lipid Res 53(7):1254-67. [PubMed: 22504909]  [MGI Ref ID J:186271]

Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH. 2008. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Am J Physiol Endocrinol Metab 294(2):E284-90. [PubMed: 18029445]  [MGI Ref ID J:133332]

Avall K; Ali Y; Leibiger IB; Leibiger B; Moede T; Paschen M; Dicker A; Dare E; Kohler M; Ilegems E; Abdulreda MH; Graham M; Crooke RM; Tay VS; Refai E; Nilsson SK; Jacob S; Selander L; Berggren PO; Juntti-Berggren L. 2015. Apolipoprotein CIII links islet insulin resistance to beta-cell failure in diabetes. Proc Natl Acad Sci U S A 112(20):E2611-9. [PubMed: 25941406]  [MGI Ref ID J:221652]

Babak T; Garrett-Engele P; Armour CD; Raymond CK; Keller MP; Chen R; Rohl CA; Johnson JM; Attie AD; Fraser HB; Schadt EE. 2010. Genetic validation of whole-transcriptome sequencing for mapping expression affected by cis-regulatory variation. BMC Genomics 11:473. [PubMed: 20707912]  [MGI Ref ID J:163832]

Back M; Sultan A; Ovchinnikova O; Hansson GK. 2007. 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 100(7):946-9. [PubMed: 17379835]  [MGI Ref ID J:133901]

Badman MK; Kennedy AR; Adams AC; Pissios P; Maratos-Flier E. 2009. A Very Low Carbohydrate Ketogenic Diet Improves Glucose Tolerance in ob/ob Mice Independent of Weight Loss. Am J Physiol Endocrinol Metab :. [PubMed: 19738035]  [MGI Ref ID J:159570]

Baffy G; Zhang CY; Glickman JN; Lowell BB. 2002. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 35(4):753-61. [PubMed: 11915020]  [MGI Ref ID J:106023]

Bailly-Maitre B; Belgardt BF; Jordan SD; Coornaert B; von Freyend MJ; Kleinridders A; Mauer J; Cuddy M; Kress CL; Willmes D; Essig M; Hampel B; Protzer U; Reed JC; Bruning JC. 2010. Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. J Biol Chem 285(9):6198-207. [PubMed: 19996103]  [MGI Ref ID J:159765]

Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H. 2006. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 21(10):1600-7. [PubMed: 16995815]  [MGI Ref ID J:128105]

Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM. 2005. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J Bone Miner Res 20(10):1851-7. [PubMed: 16160743]  [MGI Ref ID J:128137]

Balland E; Dam J; Langlet F; Caron E; Steculorum S; Messina A; Rasika S; Falluel-Morel A; Anouar Y; Dehouck B; Trinquet E; Jockers R; Bouret SG; Prevot V. 2014. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab 19(2):293-301. [PubMed: 24506870]  [MGI Ref ID J:210650]

Bandsma RH; Grefhorst A; van Dijk TH; van der Sluijs FH; Hammer A; Reijngoud DJ; Kuipers F. 2004. Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice. Diabetologia 47(11):2022-31. [PubMed: 15599701]  [MGI Ref ID J:107197]

Bandyopadhyay GK; Vu CU; Gentile S; Lee H; Biswas N; Chi NW; O'Connor DT; Mahata SK. 2012. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling. J Biol Chem 287(27):23141-51. [PubMed: 22535963]  [MGI Ref ID J:188389]

Banerjee SK; McGaffin KR; Pastor-Soler NM; Ahmad F. 2009. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 84(1):111-8. [PubMed: 19509029]  [MGI Ref ID J:172485]

Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM. 2015. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma. Nature 517(7534):391-5. [PubMed: 25409143]  [MGI Ref ID J:217537]

Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM. 2003. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108(6):754-9. [PubMed: 12885755]  [MGI Ref ID J:103063]

Barouch LA; Gao D; Chen L; Miller KL; Xu W; Phan AC; Kittleson MM; Minhas KM; Berkowitz DE; Wei C; Hare JM. 2006. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 98(1):119-24. [PubMed: 16339484]  [MGI Ref ID J:118064]

Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Wurtele M; Bader M; Pesquero JB; Araujo RC. 2012. Bradykinin inhibits hepatic gluconeogenesis in obese mice. Lab Invest 92(10):1419-27. [PubMed: 22868909]  [MGI Ref ID J:188609]

Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Ribeiro RA; Vanzela EC; Lanzoni VP; Barros FC; Moraes MR; Mori MA; Bacurau RF; Wurtele M; Boschero AC; Carneiro EM; Bader M; Pesquero JB; Araujo RC. 2012. Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genes. PLoS One 7(7):e40573. [PubMed: 22829877]  [MGI Ref ID J:189589]

Basantani MK; Sitnick MT; Cai L; Brenner DS; Gardner NP; Li JZ; Schoiswohl G; Yang K; Kumari M; Gross RW; Zechner R; Kershaw EE. 2011. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 52(2):318-29. [PubMed: 21068004]  [MGI Ref ID J:168857]

Batra A; Pietsch J; Fedke I; Glauben R; Okur B; Stroh T; Zeitz M; Siegmund B. 2007. Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes. Am J Pathol 170(6):1931-41. [PubMed: 17525261]  [MGI Ref ID J:122150]

Becerril S; Rodriguez A; Catalan V; Sainz N; Ramirez B; Collantes M; Penuelas I; Gomez-Ambrosi J; Fruhbeck G. 2010. Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function. PLoS One 5(6):e10962. [PubMed: 20532036]  [MGI Ref ID J:161815]

Bechtold DA; Sidibe A; Saer BR; Li J; Hand LE; Ivanova EA; Darras VM; Dam J; Jockers R; Luckman SM; Loudon AS. 2012. A Role for the Melatonin-Related Receptor GPR50 in Leptin Signaling, Adaptive Thermogenesis, and Torpor. Curr Biol 22(1):70-7. [PubMed: 22197240]  [MGI Ref ID J:180291]

Beck Jorgensen S; O'Neill HM; Hewitt K; Kemp BE; Steinberg GR. 2009. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 52(11):2395-404. [PubMed: 19688337]  [MGI Ref ID J:154477]

Begin-Heick N. 1994. Liver beta-adrenergic receptors, G proteins, and adenylyl cyclase activity in obesity-diabetes syndromes. Am J Physiol 266(6 Pt 1):C1664-72. [PubMed: 8023896]  [MGI Ref ID J:18963]

Begriche K; Letteron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B. 2008. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab 294(5):E939-51. [PubMed: 18349116]  [MGI Ref ID J:136084]

Bellefontaine N; Chachlaki K; Parkash J; Vanacker C; Colledge W; d'Anglemont de Tassigny X; Garthwaite J; Bouret SG; Prevot V. 2014. Leptin-dependent neuronal NO signaling in the preoptic hypothalamus facilitates reproduction. J Clin Invest 124(6):2550-9. [PubMed: 24812663]  [MGI Ref ID J:212751]

Benzler J; Andrews ZB; Pracht C; Stohr S; Shepherd PR; Grattan DR; Tups A. 2013. Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice. Endocrinology 154(12):4737-45. [PubMed: 24105484]  [MGI Ref ID J:205145]

Benzler J; Ganjam GK; Kruger M; Pinkenburg O; Kutschke M; Stohr S; Steger J; Koch CE; Olkrug R; Schwartz MW; Shepherd PR; Grattan DR; Tups A. 2012. Hypothalamic glycogen synthase kinase 3beta has a central role in the regulation of food intake and glucose metabolism. Biochem J 447(1):175-84. [PubMed: 22849606]  [MGI Ref ID J:191319]

Berk PD; Zhou S; Kiang C; Stump DD; Fan X; Bradbury MW. 1999. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 274(40):28626-31. [PubMed: 10497230]  [MGI Ref ID J:57965]

Bezy O; Tran TT; Pihlajamaki J; Suzuki R; Emanuelli B; Winnay J; Mori MA; Haas J; Biddinger SB; Leitges M; Goldfine AB; Patti ME; King GL; Kahn CR. 2011. PKCdelta regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest 121(6):2504-17. [PubMed: 21576825]  [MGI Ref ID J:173902]

Bhat GK; Hamm ML; Igietseme JU; Mann DR. 2003. Does leptin mediate the effect of photoperiod on immune function in mice? Biol Reprod 69(1):30-6. [PubMed: 12606383]  [MGI Ref ID J:84031]

Bhatnagar S; Oler AT; Rabaglia ME; Stapleton DS; Schueler KL; Truchan NA; Worzella SL; Stoehr JP; Clee SM; Yandell BS; Keller MP; Thurmond DC; Attie AD. 2011. Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS Genet 7(10):e1002323. [PubMed: 21998599]  [MGI Ref ID J:178002]

Bi L; Chiang JY; Ding WX; Dunn W; Roberts B; Li T. 2013. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res 54(10):2754-62. [PubMed: 23904453]  [MGI Ref ID J:202622]

Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR. 2006. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes 55(7):2032-41. [PubMed: 16804073]  [MGI Ref ID J:111873]

Bie J; Zhao B; Marqueen KE; Wang J; Szomju B; Ghosh S. 2012. Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice. Am J Physiol Endocrinol Metab 302(10):E1283-91. [PubMed: 22395110]  [MGI Ref ID J:186860]

Bina KG; Cincotta AH. 2000. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71(1):68-78. [PubMed: 10644901]  [MGI Ref ID J:60273]

Bjorbaek C; Elmquist JK; Frantz JD; Shoelson SE; Flier JS. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1(4):619-25. [PubMed: 9660946]  [MGI Ref ID J:119803]

Bjursell M; Gerdin AK; Ploj K; Svensson D; Svensson L; Oscarsson J; Snaith M; Tornell J; Bohlooly-Y M. 2006. Melanin-concentrating hormone receptor 1 deficiency increases insulin sensitivity in obese leptin-deficient mice without affecting body weight. Diabetes 55(3):725-33. [PubMed: 16505236]  [MGI Ref ID J:106845]

Blum B; Roose AN; Barrandon O; Maehr R; Arvanites AC; Davidow LS; Davis JC; Peterson QP; Rubin LL; Melton DA. 2014. Reversal of beta cell de-differentiation by a small molecule inhibitor of the TGFbeta pathway. Elife 3:e02809. [PubMed: 25233132]  [MGI Ref ID J:218054]

Bobe G; Barrett KG; Mentor-Marcel RA; Saffiotti U; Young MR; Colburn NH; Albert PS; Bennink MR; Lanza E. 2008. Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr Cancer 60(3):373-81. [PubMed: 18444172]  [MGI Ref ID J:138534]

Bock T; Pakkenberg B; Buschard K. 2003. Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52(7):1716-22. [PubMed: 12829638]  [MGI Ref ID J:84295]

Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG Jr; Eitzman DT. 2007. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 27(1):70-6. [PubMed: 17095713]  [MGI Ref ID J:135034]

Bonnavion P; Jackson AC; Carter ME; de Lecea L. 2015. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses. Nat Commun 6:6266. [PubMed: 25695914]  [MGI Ref ID J:221792]

Borg ML; Omran SF; Weir J; Meikle PJ; Watt MJ. 2012. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice. J Physiol 590(Pt 17):4377-89. [PubMed: 22674717]  [MGI Ref ID J:200055]

Borthwick EB; Burchell A; Coughtrie MW. 1995. Differential expression of hepatic oestrogen, phenol and dehydroepiandrosterone sulphotransferases in genetically obese diabetic (ob/ob) male and female mice. J Endocrinol 144(1):31-7. [PubMed: 7891022]  [MGI Ref ID J:22650]

Boston BA; Blaydon KM; Varnerin J; Cone RD. 1997. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278(5343):1641-4. [PubMed: 9374468]  [MGI Ref ID J:44399]

Bouchard G; Johnson D; Carver T; Paigen B; Carey MC. 2002. Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk. J Lipid Res 43(7):1105-13. [PubMed: 12091495]  [MGI Ref ID J:88773]

Boudina S; Sena S; O'Neill BT; Tathireddy P; Young ME; Abel ED. 2005. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112(17):2686-95. [PubMed: 16246967]  [MGI Ref ID J:116841]

Bouhidel O; Pons S; Souktani R; Zini R; Berdeaux A; Ghaleh B. 2008. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295(4):H1580-6. [PubMed: 18689499]  [MGI Ref ID J:141317]

Boundy VA; Cincotta AH. 2000. Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice. Am J Physiol Regul Integr Comp Physiol 279(2):R505-14. [PubMed: 10938239]  [MGI Ref ID J:94672]

Bouret SG; Draper SJ; Simerly RB. 2004. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304(5667):108-10. [PubMed: 15064420]  [MGI Ref ID J:90241]

Breslow MJ; An Y; Berkowitz DE. 1997. Beta-3 adrenoceptor (beta-3AR) expression in leptin treated OB/OB mice. Life Sci 61(1):59-64. [PubMed: 9200670]  [MGI Ref ID J:41326]

Breslow MJ; Min-Lee K; Brown DR; Chacko VP; Palmer D; Berkowitz DE. 1999. Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 276(3 Pt 1):E443-9. [PubMed: 10070008]  [MGI Ref ID J:53833]

Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R. 2010. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 120(12):4316-31. [PubMed: 21084751]  [MGI Ref ID J:171868]

Briggs DI; Lockie SH; Benzler J; Wu Q; Stark R; Reichenbach A; Hoy AJ; Lemus MB; Coleman HA; Parkington HC; Tups A; Andrews ZB. 2014. Evidence that diet-induced hyperleptinemia, but not hypothalamic gliosis, causes ghrelin resistance in NPY/AgRP neurons of male mice. Endocrinology 155(7):2411-22. [PubMed: 24742194]  [MGI Ref ID J:214257]

Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA. 2002. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. Mol Genet Metab 75(3):219-26. [PubMed: 11914033]  [MGI Ref ID J:94662]

Brun P; Castagliuolo I; Leo VD; Buda A; Pinzani M; Palu G; Martines D. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292(2):G518-25. [PubMed: 17023554]  [MGI Ref ID J:124815]

Bruno RS; Dugan CE; Smyth JA; DiNatale DA; Koo SI. 2008. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 138(2):323-31. [PubMed: 18203899]  [MGI Ref ID J:133407]

Bruton JD; Katz A; Lannergren J; Abbate F; Westerblad H. 2002. Regulation of myoplasmic Ca(2+) in genetically obese (ob/ob) mouse single skeletal muscle fibres. Pflugers Arch 444(6):692-9. [PubMed: 12355168]  [MGI Ref ID J:106205]

Bunger L; Forsting J; McDonald KL; Horvat S; Duncan J; Hochscheid S; Baile CA; Hill WG; Speakman JR. 2003. Long-term divergent selection on fatness in mice indicates a regulation system independent of leptin production and reception. FASEB J 17(1):85-7. [PubMed: 12424222]  [MGI Ref ID J:118012]

Burcelin R; Kamohara S; Li J; Tannenbaum GS; Charron MJ; Friedman JM. 1999. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 48(6):1264-9. [PubMed: 10342814]  [MGI Ref ID J:55776]

Busso N; So A; Chobaz-Peclat V; Morard C; Martinez-Soria E; Talabot-Ayer D; Gabay C. 2002. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168(2):875-82. [PubMed: 11777985]  [MGI Ref ID J:73743]

Butler AA; Marks DL; Fan W; Kuhn CM; Bartolome M; Cone RD. 2001. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 4(6):605-11. [PubMed: 11369941]  [MGI Ref ID J:69814]

Campfield LA; Smith FJ; Guisez Y; Devos R; Burn P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks [see comments] Science 269(5223):546-9. [PubMed: 7624778]  [MGI Ref ID J:29160]

Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470-81. [PubMed: 18305141]  [MGI Ref ID J:136880]

Cao H; Maeda K; Gorgun CZ; Kim HJ; Park SY; Shulman GI; Kim JK; Hotamisligil GS. 2006. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice. Diabetes 55(7):1915-22. [PubMed: 16804058]  [MGI Ref ID J:111878]

Cao L; Liu X; Lin EJ; Wang C; Choi EY; Riban V; Lin B; During MJ. 2010. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 142(1):52-64. [PubMed: 20603014]  [MGI Ref ID J:167939]

Cariou B; Capitaine N; Le Marcis V; Vega N; Bereziat V; Kergoat M; Laville M; Girard J; Vidal H; Burnol AF. 2004. Increased adipose tissue expression of Grb14 in several models of insulin resistance. FASEB J 18(9):965-7. [PubMed: 15059968]  [MGI Ref ID J:118114]

Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk TH; Grefhorst A; Abdelkarim M; Caron S; Torpier G; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B. 2006. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281(16):11039-49. [PubMed: 16446356]  [MGI Ref ID J:110560]

Carley AN; Severson DL. 2005. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734(2):112-26. [PubMed: 15904868]  [MGI Ref ID J:99066]

Carobbio S; Hagen RM; Lelliott CJ; Slawik M; Medina-Gomez G; Tan CY; Sicard A; Atherton HJ; Barbarroja N; Bjursell M; Bohlooly-Y M; Virtue S; Tuthill A; Lefai E; Laville M; Wu T; Considine RV; Vidal H; Langin D; Oresic M; Tinahones FJ; Fernandez-Real JM;Griffin JL; Sethi JK; Lopez M; Vidal-Puig A. 2013. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 62(11):3697-708. [PubMed: 23919961]  [MGI Ref ID J:208931]

Chakraborty S; Sachdev A; Salton SR; Chakraborty TR. 2008. Stereological analysis of estrogen receptor expression in the hypothalamic arcuate nucleus of ob/ob and agouti mice. Brain Res 1217:86-95. [PubMed: 18502406]  [MGI Ref ID J:138366]

Chan JY; Luzuriaga J; Bensellam M; Biden TJ; Laybutt DR. 2013. Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in beta-cell gene expression and progression to diabetes. Diabetes 62(5):1557-68. [PubMed: 23274897]  [MGI Ref ID J:208583]

Chang BH; Li L; Saha P; Chan L. 2010. Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice. J Lipid Res 51(8):2132-42. [PubMed: 20424269]  [MGI Ref ID J:162936]

Charalambous M; Da Rocha ST; Radford EJ; Medina-Gomez G; Curran S; Pinnock SB; Ferron SR; Vidal-Puig A; Ferguson-Smith AC. 2014. DLK1/PREF1 regulates nutrient metabolism and protects from steatosis. Proc Natl Acad Sci U S A 111(45):16088-93. [PubMed: 25349437]  [MGI Ref ID J:216767]

Charlton HM. 1984. Mouse mutants as models in endocrine research. Q J Exp Physiol 69(4):655-76. [PubMed: 6393185]  [MGI Ref ID J:7702]

Chavey C; Lazennec G; Lagarrigue S; Clape C; Iankova I; Teyssier J; Annicotte JS; Schmidt J; Mataki C; Yamamoto H; Sanches R; Guma A; Stich V; Vitkova M; Jardin-Watelet B; Renard E; Strieter R; Tuthill A; Hotamisligil GS; Vidal-Puig A; Zorzano A; Langin D; Fajas L. 2009. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab 9(4):339-49. [PubMed: 19356715]  [MGI Ref ID J:148169]

Cheema SK; Clandinin MT. 1996. Diet fat alters expression of genes for enzymes of lipogenesis in lean and obese mice. Biochim Biophys Acta 1299(3):284-8. [PubMed: 8597582]  [MGI Ref ID J:31603]

Chehab FF; Lim ME; Lu R. 1996. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12(3):318-20. [PubMed: 8589726]  [MGI Ref ID J:31761]

Chen HC; Ladha Z; Farese RV Jr. 2002. Deficiency of acyl coenzyme a:diacylglycerol acyltransferase 1 increases leptin sensitivity in murine obesity models. Endocrinology 143(8):2893-8. [PubMed: 12130553]  [MGI Ref ID J:78337]

Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV Jr. 2002. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. J Clin Invest 109(8):1049-55. [PubMed: 11956242]  [MGI Ref ID J:76091]

Chen HL; Romsos DR. 1996. Dexamethasone rapidly increases hypothalamic neuropeptide Y secretion in adrenalectomized ob/ob mice. Am J Physiol 271(1 Pt 1):E151-8. [PubMed: 8760093]  [MGI Ref ID J:34501]

Chen HL; Romsos DR. 1994. Type II glucocorticoid receptors in the CNS regulate metabolism in ob/ob mice independent of protein synthesis. Am J Physiol 266(3 Pt 1):E427-32. [PubMed: 8166263]  [MGI Ref ID J:17505]

Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A. 2008. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J 22(10):3581-94. [PubMed: 18552236]  [MGI Ref ID J:140264]

Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A. 2008. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 57(4):938-44. [PubMed: 18171713]  [MGI Ref ID J:135529]

Chen JL; Lu XJ; Zou KL; Ye K. 2014. Kruppel-like factor 2 promotes liver steatosis through upregulation of CD36. J Lipid Res 55(1):32-40. [PubMed: 23861552]  [MGI Ref ID J:203965]

Chen JY; Tsai PJ; Tai HC; Tsai RL; Chang YT; Wang MC; Chiou YW; Yeh ML; Tang MJ; Lam CF; Shiesh SC; Li YH; Tsai WC; Chou CH; Lin LJ; Wu HL; Tsai YS. 2013. Increased aortic stiffness and attenuated lysyl oxidase activity in obesity. Arterioscler Thromb Vasc Biol 33(4):839-46. [PubMed: 23413430]  [MGI Ref ID J:217970]

Chen NG; Romsos DR. 1995. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 136(2):505-11. [PubMed: 7835283]  [MGI Ref ID J:22634]

Chen NG; Tassava TM; Romsos DR. 1993. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low. J Nutr 123(9):1567-74. [PubMed: 8360782]  [MGI Ref ID J:14402]

Chen W; Chang B; Wu X; Li L; Sleeman M; Chan L. 2013. Inactivation of Plin4 downregulates Plin5 and reduces cardiac lipid accumulation in mice. Am J Physiol Endocrinol Metab 304(7):E770-9. [PubMed: 23423172]  [MGI Ref ID J:195987]

Chen Z; Morris DL; Jiang L; Liu Y; Rui L. 2014. SH2B1 in beta-cells promotes insulin expression and glucose metabolism in mice. Mol Endocrinol 28(5):696-705. [PubMed: 24645678]  [MGI Ref ID J:214138]

Chen Z; Newberry EP; Norris JY; Xie Y; Luo J; Kennedy SM; Davidson NO. 2008. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J Lipid Res 49(9):2013-22. [PubMed: 18519977]  [MGI Ref ID J:139764]

Chen Z; Shen H; Sun C; Yin L; Tang F; Zheng P; Liu Y; Brink R; Rui L. 2015. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am J Physiol Endocrinol Metab 308(6):E460-9. [PubMed: 25628422]  [MGI Ref ID J:220716]

Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN. 2012. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione. J Biol Chem 287(28):23537-48. [PubMed: 22621923]  [MGI Ref ID J:188864]

Cheng A; Uetani N; Simoncic PD; Chaubey VP; Lee-Loy A; McGlade CJ; Kennedy BP; Tremblay ML. 2002. Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B. Dev Cell 2(4):497-503. [PubMed: 11970899]  [MGI Ref ID J:75969]

Cheng Z; Guo S; Copps K; Dong X; Kollipara R; Rodgers JT; Depinho RA; Puigserver P; White MF. 2009. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 15(11):1307-11. [PubMed: 19838201]  [MGI Ref ID J:154295]

Cheung SY; Huang Y; Kwan HY; Chung HY; Yao X. 2015. Activation of transient receptor potential vanilloid 3 channel suppresses adipogenesis. Endocrinology 156(6):2074-86. [PubMed: 25774551]  [MGI Ref ID J:222171]

Chiarreotto-Ropelle EC; Pauli LS; Katashima CK; Pimentel GD; Picardi PK; Silva VR; de Souza CT; Prada PO; Cintra DE; Carvalheira JB; Ropelle ER; Pauli JR. 2013. Acute exercise suppresses hypothalamic PTP1B protein level and improves insulin and leptin signaling in obese rats. Am J Physiol Endocrinol Metab 305(5):E649-59. [PubMed: 23880311]  [MGI Ref ID J:203888]

Chiba T; Han CY; Vaisar T; Shimokado K; Kargi A; Chen MH; Wang S; McDonald TO; O'Brien KD; Heinecke JW; Chait A. 2009. Serum amyloid A3 does not contribute to circulating SAA levels. J Lipid Res 50(7):1353-62. [PubMed: 19286646]  [MGI Ref ID J:158176]

Chiu CH; Lin WD; Huang SY; Lee YH. 2004. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev 18(16):1970-5. [PubMed: 15289464]  [MGI Ref ID J:91840]

Cho KW; Zhou Y; Sheng L; Rui L. 2011. Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Mol Cell Biol 31(3):450-7. [PubMed: 21135134]  [MGI Ref ID J:170422]

Choo HJ; Kim JH; Kwon OB; Lee CS; Mun JY; Han SS; Yoon YS; Yoon G; Choi KM; Ko YG. 2006. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49(4):784-91. [PubMed: 16501941]  [MGI Ref ID J:107887]

Christoffersen C; Bollano E; Lindegaard ML; Bartels ED; Goetze JP; Andersen CB; Nielsen LB. 2003. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144(8):3483-90. [PubMed: 12865329]  [MGI Ref ID J:84820]

Chu MJ; Hickey AJ; Tagaloa S; Zhang L; Dare AJ; MacDonald JR; Yeong ML; Bartlett AS; Phillips AR. 2014. Ob/ob mouse livers show decreased oxidative phosphorylation efficiencies and anaerobic capacities after cold ischemia. PLoS One 9(6):e100609. [PubMed: 24956382]  [MGI Ref ID J:216824]

Chua S Jr; Liu SM; Li Q; Yang L; Thassanapaff VT; Fisher P. 2002. Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB- Lepr (db)) and obese (DBA- Lep (ob)) mice. Diabetologia 45(7):976-90. [PubMed: 12136396]  [MGI Ref ID J:78850]

Chung J; Koo K; Lian F; Hu KQ; Ernst H; Wang XD. 2012. Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice. J Nutr 142(3):405-10. [PubMed: 22259190]  [MGI Ref ID J:181923]

Chung WK; Belfi K; Chua M; Wiley J; Mackintosh R; Nicolson M; Boozer CN; Leibel RL. 1998. Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice. Am J Physiol 274(4 Pt 2):R985-90. [PubMed: 9575960]  [MGI Ref ID J:47168]

Cipolletta D; Cohen P; Spiegelman BM; Benoist C; Mathis D. 2015. Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARgamma effects. Proc Natl Acad Sci U S A 112(2):482-7. [PubMed: 25550516]  [MGI Ref ID J:218908]

Cipolletta D; Feuerer M; Li A; Kamei N; Lee J; Shoelson SE; Benoist C; Mathis D. 2012. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486(7404):549-53. [PubMed: 22722857]  [MGI Ref ID J:186708]

Clark EA; Shultz LD; Pollack SB. 1981. Mutations in mice that influence natural killer (NK) cell activity. Immunogenetics 12(5-6):601-13. [PubMed: 6971254]  [MGI Ref ID J:6485]

Claycombe K; King LE; Fraker PJ. 2008. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci U S A 105(6):2017-21. [PubMed: 18250302]  [MGI Ref ID J:131806]

Cleary MP; Bergstrom HM; Dodge TL; Getzin SC; Jacobson MK; Phillips FC. 2001. Restoration of fertility in young obese (Lep(ob) Lep(ob)) male mice with low dose recombinant mouse leptin treatment. Int J Obes Relat Metab Disord 25(1):95-7. [PubMed: 11244463]  [MGI Ref ID J:68694]

Cleary MP; Phillips FC; Getzin SC; Jacobson TL; Jacobson MK; Christensen TA; Juneja SC; Grande JP; Maihle NJ. 2003. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 77(3):205-15. [PubMed: 12602920]  [MGI Ref ID J:81933]

Clee SM; Nadler ST; Attie AD. 2005. Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes. Am J Ther 12(6):491-8. [PubMed: 16280642]  [MGI Ref ID J:106121]

Clouthier DE; Comerford SA; Hammer RE. 1997. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest 100(11):2697-713. [PubMed: 9389733]  [MGI Ref ID J:135399]

Coleman DL. 1973. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9(4):294-8. [PubMed: 4767369]  [MGI Ref ID J:5401]

Coleman DL. 1982. Thermogenesis in diabetes-obesity syndromes in mutant mice. Diabetologia 22(3):205-11. [PubMed: 7075918]  [MGI Ref ID J:6756]

Coleman DL; Hummel KP. 1973. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 9(4):287-93. [PubMed: 4588246]  [MGI Ref ID J:5400]

Collin M; Hakansson-Ovesjo ML; Misane I; Ogren SO; Meister B. 2000. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Brain Res Mol Brain Res 81(1-2):51-61. [PubMed: 11000478]  [MGI Ref ID J:109340]

Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE. 2014. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. Endocrinology 155(7):2545-54. [PubMed: 24708244]  [MGI Ref ID J:214266]

Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW. 1994. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8(4):518-27. [PubMed: 7914350]  [MGI Ref ID J:17709]

Collins S; Surwit RS. 1996. Pharmacologic manipulation of ob expression in a dietary model of obesity. J Biol Chem 271(16):9437-40. [PubMed: 8621612]  [MGI Ref ID J:33332]

Cooksey RC; Jones D; Gabrielsen S; Huang J; Simcox JA; Luo B; Soesanto Y; Rienhoff H; Abel ED; McClain DA. 2010. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab 298(6):E1236-43. [PubMed: 20354157]  [MGI Ref ID J:162955]

Cope K; Risby T; Diehl AM. 2000. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119(5):1340-7. [PubMed: 11054393]  [MGI Ref ID J:94789]

Cottrell EC; Martin-Gronert MS; Fernandez-Twinn DS; Luan J; Berends LM; Ozanne SE. 2011. Leptin-independent programming of adult body weight and adiposity in mice. Endocrinology 152(2):476-82. [PubMed: 21209019]  [MGI Ref ID J:173885]

Cowerd RB; Asmar MM; Alderman JM; Alderman EA; Garland AL; Busby WH; Bodnar WM; Rusyn I; Medoff BD; Tisch R; Mayer-Davis E; Swenberg JA; Zeisel SH; Combs TP. 2010. Adiponectin lowers glucose production by increasing SOGA. Am J Pathol 177(4):1936-45. [PubMed: 20813965]  [MGI Ref ID J:165436]

Crepin D; Benomar Y; Riffault L; Amine H; Gertler A; Taouis M. 2014. The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment. Mol Cell Endocrinol 384(1-2):1-11. [PubMed: 24394757]  [MGI Ref ID J:211951]

Cretenet G; Le Clech M; Gachon F. 2010. Circadian clock-coordinated 12 Hr period rhythmic activation of the IRE1alpha pathway controls lipid metabolism in mouse liver. Cell Metab 11(1):47-57. [PubMed: 20074527]  [MGI Ref ID J:157002]

Cristino L; Busetto G; Imperatore R; Ferrandino I; Palomba L; Silvestri C; Petrosino S; Orlando P; Bentivoglio M; Mackie K; Di Marzo V. 2013. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci U S A 110(24):E2229-38. [PubMed: 23630288]  [MGI Ref ID J:197326]

Davis DB; Lavine JA; Suhonen JI; Krautkramer KA; Rabaglia ME; Sperger JM; Fernandez LA; Yandell BS; Keller MP; Wang IM; Schadt EE; Attie AD. 2010. FoxM1 is up-regulated by obesity and stimulates beta-cell proliferation. Mol Endocrinol 24(9):1822-34. [PubMed: 20660304]  [MGI Ref ID J:182843]

De Rosa V; Procaccini C; Cali G; Pirozzi G; Fontana S; Zappacosta S; La Cava A; Matarese G. 2007. A Key Role of Leptin in the Control of Regulatory T Cell Proliferation. Immunity 26(2):241-255. [PubMed: 17307705]  [MGI Ref ID J:118425]

Della-Fera MA; Choi YH; Hartzell DL; Duan J; Hamrick M; Baile CA. 2005. Sensitivity of ob/ob mice to leptin-induced adipose tissue apoptosis. Obes Res 13(9):1540-7. [PubMed: 16222056]  [MGI Ref ID J:114433]

Delporte ML; El Mkadem SA; Quisquater M; Brichard SM. 2004. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am J Physiol Endocrinol Metab 287(3):E446-53. [PubMed: 15126241]  [MGI Ref ID J:95406]

Deng J; Hua K; Caveney EJ; Takahashi N; Harp JB. 2006. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochem Biophys Res Commun 339(3):923-31. [PubMed: 16329991]  [MGI Ref ID J:104136]

Deng T; Lyon CJ; Minze LJ; Lin J; Zou J; Liu JZ; Ren Y; Yin Z; Hamilton DJ; Reardon PR; Sherman V; Wang HY; Phillips KJ; Webb P; Wong ST; Wang RF; Hsueh WA. 2013. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 17(3):411-22. [PubMed: 23473035]  [MGI Ref ID J:198135]

Deng ZB; Poliakov A; Hardy RW; Clements R; Liu C; Liu Y; Wang J; Xiang X; Zhang S; Zhuang X; Shah SV; Sun D; Michalek S; Grizzle WE; Garvey T; Mobley J; Zhang HG. 2009. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58(11):2498-505. [PubMed: 19675137]  [MGI Ref ID J:154383]

Deveaux V; Cadoudal T; Ichigotani Y; Teixeira-Clerc F; Louvet A; Manin S; Nhieu JT; Belot MP; Zimmer A; Even P; Cani PD; Knauf C; Burcelin R; Bertola A; Le Marchand-Brustel Y; Gual P; Mallat A; Lotersztajn S. 2009. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One 4(6):e5844. [PubMed: 19513120]  [MGI Ref ID J:150201]

Diaz-Delfin J; Morales M; Caelles C. 2007. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway. Diabetes 56(7):1865-71. [PubMed: 17416798]  [MGI Ref ID J:126454]

Dickie MM; Lane PW. 1957. [Linkage of ob to L.G. XI] Mouse News Lett 17:52.  [MGI Ref ID J:159]

Ding H; Zhang Y; Xu C; Hou D; Li J; Zhang Y; Peng W; Zen K; Zhang CY; Jiang X. 2014. Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B. Diabetologia 57(10):2145-54. [PubMed: 24985145]  [MGI Ref ID J:216994]

Dixon D; Horton J; Haseman JK; Talley F; Greenwell A; Nettesheim P; Hook GE; Maronpot RR. 1991. Histomorphology and ultrastructure of spontaneous pulmonary neoplasms in strain A mice. Exp Lung Res 17(2):131-55. [PubMed: 1646706]  [MGI Ref ID J:27691]

Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM. 2005. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 288(3):E599-607. [PubMed: 15562249]  [MGI Ref ID J:96073]

Dobrzyn P; Dobrzyn A; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM. 2004. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 101(17):6409-14. [PubMed: 15096593]  [MGI Ref ID J:89545]

Dokmanovic-Chouinard M; Chung WK; Chevre JC; Watson E; Yonan J; Wiegand B; Bromberg Y; Wakae N; Wright CV; Overton J; Ghosh S; Sathe GM; Ammala CE; Brown KK; Ito R; LeDuc C; Solomon K; Fischer SG; Leibel RL. 2008. Positional cloning of 'Lisch-Like', a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet 4(7):e1000137. [PubMed: 18654634]  [MGI Ref ID J:138216]

Donato J Jr; Cravo RM; Frazao R; Gautron L; Scott MM; Lachey J; Castro IA; Margatho LO; Lee S; Lee C; Richardson JA; Friedman J; Chua S Jr; Coppari R; Zigman JM; Elmquist JK; Elias CF. 2011. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. J Clin Invest 121(1):355-68. [PubMed: 21183787]  [MGI Ref ID J:171840]

Donato J Jr; Frazao R; Fukuda M; Vianna CR; Elias CF. 2010. Leptin induces phosphorylation of neuronal nitric oxide synthase in defined hypothalamic neurons. Endocrinology 151(11):5415-27. [PubMed: 20881244]  [MGI Ref ID J:165660]

Dong B; Saha PK; Huang W; Chen W; Abu-Elheiga LA; Wakil SJ; Stevens RD; Ilkayeva O; Newgard CB; Chan L; Moore DD. 2009. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A 106(44):18831-6. [PubMed: 19850873]  [MGI Ref ID J:154669]

Dong F; Zhang X; Yang X; Esberg LB; Yang H; Zhang Z; Culver B; Ren J. 2006. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J Endocrinol 188(1):25-36. [PubMed: 16394172]  [MGI Ref ID J:104171]

Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG. 2006. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55(12):3335-43. [PubMed: 17130477]  [MGI Ref ID J:121015]

Dubuc PU. 1992. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity. Am J Physiol 263(3 Pt 1):E550-5. [PubMed: 1415535]  [MGI Ref ID J:2939]

Ducy P; Amling M; Takeda S; Priemel M; Schilling AF; Beil FT; Shen J; Vinson C; Rueger JM; Karsenty G. 2000. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2):197-207. [PubMed: 10660043]  [MGI Ref ID J:60001]

El-Salhy M. 1998. Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 35(4):194-8. [PubMed: 9934817]  [MGI Ref ID J:55590]

Elefteriou F; Ahn JD; Takeda S; Starbuck M; Yang X; Liu X; Kondo H; Richards WG; Bannon TW; Noda M; Clement K; Vaisse C; Karsenty G. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434(7032):514-20. [PubMed: 15724149]  [MGI Ref ID J:97566]

Elefteriou F; Takeda S; Ebihara K; Magre J; Patano N; Kim CA; Ogawa Y; Liu X; Ware SM; Craigen WJ; Robert JJ; Vinson C; Nakao K; Capeau J; Karsenty G. 2004. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A 101(9):3258-63. [PubMed: 14978271]  [MGI Ref ID J:88655]

Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y. 2006. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol 209(1):121-8. [PubMed: 16482497]  [MGI Ref ID J:107706]

Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y. 2006. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. J Pathol 208(1):74-81. [PubMed: 16261527]  [MGI Ref ID J:104032]

Ellingsgaard H; Hauselmann I; Schuler B; Habib AM; Baggio LL; Meier DT; Eppler E; Bouzakri K; Wueest S; Muller YD; Hansen AM; Reinecke M; Konrad D; Gassmann M; Reimann F; Halban PA; Gromada J; Drucker DJ; Gribble FM; Ehses JA; Donath MY. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17(11):1481-9. [PubMed: 22037645]  [MGI Ref ID J:179825]

Emanuelli B; Eberle D; Suzuki R; Kahn CR. 2008. Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proc Natl Acad Sci U S A 105(9):3545-50. [PubMed: 18296638]  [MGI Ref ID J:132675]

Endo H; Hosono K; Uchiyama T; Sakai E; Sugiyama M; Takahashi H; Nakajima N; Wada K; Takeda K; Nakagama H; Nakajima A. 2011. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60(10):1363-71. [PubMed: 21406387]  [MGI Ref ID J:194453]

Erickson JC; Hollopeter G; Palmiter RD. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274(5293):1704-7. [PubMed: 8939859]  [MGI Ref ID J:37106]

Erickson JC; Hollopeter G; Palmiter RD. 1997. On raising energy expenditure in ob/ob mice Science 276(5315):1132-3. [PubMed: 9173544]  [MGI Ref ID J:40381]

Esterhazy D; Stutzer I; Wang H; Rechsteiner MP; Beauchamp J; Dobeli H; Hilpert H; Matile H; Prummer M; Schmidt A; Lieske N; Boehm B; Marselli L; Bosco D; Kerr-Conte J; Aebersold R; Spinas GA; Moch H; Migliorini C; Stoffel M. 2011. Bace2 Is a beta Cell-Enriched Protease that Regulates Pancreatic beta Cell Function and Mass. Cell Metab 14(3):365-77. [PubMed: 21907142]  [MGI Ref ID J:176653]

Evans AA; Hughes S; Smith ME. 1995. Delta-opioid peptide receptors in muscles from obese diabetic and normal mice. Peptides 16(2):361-4. [PubMed: 7784267]  [MGI Ref ID J:24888]

Evans ZP; Ellett JD; Schmidt MG; Schnellmann RG; Chavin KD. 2008. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem 283(13):8573-9. [PubMed: 18086675]  [MGI Ref ID J:135165]

Evans ZP; Palanisamy AP; Sutter AG; Ellett JD; Ramshesh VK; Attaway H; Schmidt MG; Schnellmann RG; Chavin KD. 2012. Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation. Am J Physiol Gastrointest Liver Physiol 302(3):G336-42. [PubMed: 22094601]  [MGI Ref ID J:183315]

Everard A; Lazarevic V; Derrien M; Girard M; Muccioli GG; Neyrinck AM; Possemiers S; Van Holle A; Francois P; de Vos WM; Delzenne NM; Schrenzel J; Cani PD. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60(11):2775-86. [PubMed: 21933985]  [MGI Ref ID J:189479]

Everitt H; Hu M; Ajmo JM; Rogers CQ; Liang X; Zhang R; Yin H; Choi A; Bennett ES; You M. 2013. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am J Physiol Gastrointest Liver Physiol 304(1):G38-47. [PubMed: 23139221]  [MGI Ref ID J:194691]

Ewart-Toland A; Mounzih K; Qiu J; Chehab FF. 1999. Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140(2):732-8. [PubMed: 9927300]  [MGI Ref ID J:52903]

Faggioni R; Fantuzzi G; Gabay C; Moser A; Dinarello CA; Feingold KR ; Grunfeld C. 1999. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276(1 Pt 2):R136-42. [PubMed: 9887187]  [MGI Ref ID J:52477]

Faggioni R; Fuller J; Moser A; Feingold KR; Grunfeld C. 1997. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am J Physiol 273(1 Pt 2):R181-6. [PubMed: 9249548]  [MGI Ref ID J:41966]

Faggioni R; Jones-Carson J; Reed DA; Dinarello CA; Feingold KR; Grunfeld C; Fantuzzi G. 2000. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A 97(5):2367-72. [PubMed: 10681432]  [MGI Ref ID J:60929]

Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD. 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome [see comments] Nature 385(6612):165-8. [PubMed: 8990120]  [MGI Ref ID J:37848]

Fauconnier J; Andersson DC; Zhang SJ; Lanner JT; Wibom R; Katz A; Bruton JD; Westerblad H. 2007. Effects of palmitate on Ca(2+) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes 56(4):1136-42. [PubMed: 17229941]  [MGI Ref ID J:122121]

Ferrante AW Jr; Thearle M; Liao T; Leibel RL. 2001. Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes 50(10):2268-78. [PubMed: 11574408]  [MGI Ref ID J:71975]

Ferrara CT; Wang P; Neto EC; Stevens RD; Bain JR; Wenner BR; Ilkayeva OR; Keller MP; Blasiole DA; Kendziorski C; Yandell BS; Newgard CB; Attie AD. 2008. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet 4(3):e1000034. [PubMed: 18369453]  [MGI Ref ID J:134375]

Feuerer M; Herrero L; Cipolletta D; Naaz A; Wong J; Nayer A; Lee J; Goldfine AB; Benoist C; Shoelson S; Mathis D. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930-9. [PubMed: 19633656]  [MGI Ref ID J:152186]

Finger BC; Dinan TG; Cryan JF. 2010. Progressive ratio responding in an obese mouse model: Effects of fenfluramine. Neuropharmacology 59(7-8):619-26. [PubMed: 20727362]  [MGI Ref ID J:178515]

Fleig SV; Choi SS; Yang L; Jung Y; Omenetti A; VanDongen HM; Huang J; Sicklick JK; Diehl AM. 2007. Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice. Lab Invest 87(12):1227-39. [PubMed: 17952094]  [MGI Ref ID J:128723]

Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD. 2007. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 56(5):1228-39. [PubMed: 17369521]  [MGI Ref ID J:122081]

Frank S; Stallmeyer B; Kampfer H; Kolb N; Pfeilschifter J. 2000. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106(4):501-9. [PubMed: 10953025]  [MGI Ref ID J:112351]

Fransson L; Rosengren V; Saha TK; Grankvist N; Islam T; Honkanen RE; Sjoholm A; Ortsater H. 2014. Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and beta-cells. Mol Cell Endocrinol 383(1-2):126-36. [PubMed: 24361515]  [MGI Ref ID J:211851]

Fraser DC; Srivastava J; Woodward CJ; Simpson AE; Jones RB. 1998. A molecular investigation of the obese phenotype in the Aston University strain of ob/ob mice and the Japanese Kuo Kondo mice. Int J Obes Relat Metab Disord 22(2):193-4. [PubMed: 9504329]  [MGI Ref ID J:45748]

Frohnert BI; Long EK; Hahn WS; Bernlohr DA. 2014. Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation. Diabetes 63(1):89-100. [PubMed: 24062247]  [MGI Ref ID J:208916]

Fruhbeck G; Aguado M; Martinez JA. 1997. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 240(3):590-4. [PubMed: 9398609]  [MGI Ref ID J:44321]

Fu L; John LM; Adams SH; Yu XX; Tomlinson E; Renz M; Williams PM; Soriano R; Corpuz R; Moffat B; Vandlen R; Simmons L; Foster J; Stephan JP; Tsai SP; Stewart TA. 2004. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145(6):2594-603. [PubMed: 14976145]  [MGI Ref ID J:133073]

Fu S; Yang L; Li P; Hofmann O; Dicker L; Hide W; Lin X; Watkins SM; Ivanov AR; Hotamisligil GS. 2011. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473(7348):528-31. [PubMed: 21532591]  [MGI Ref ID J:172129]

Fujii Y; Okada A; Yasui T; Niimi K; Hamamoto S; Hirose M; Kubota Y; Tozawa K; Hayashi Y; Kohri K. 2013. Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS One 8(4):e61343. [PubMed: 23630583]  [MGI Ref ID J:200567]

Fujimoto W; Shiuchi T; Miki T; Minokoshi Y; Takahashi Y; Takeuchi A; Kimura K; Saito M; Iwanaga T; Seino S. 2007. Dmbx1 is essential in agouti-related protein action. Proc Natl Acad Sci U S A 104(39):15514-9. [PubMed: 17873059]  [MGI Ref ID J:125193]

Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H. 2014. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J Immunol 192(3):979-84. [PubMed: 24391210]  [MGI Ref ID J:207299]

Fukuda D; Aikawa E; Swirski FK; Novobrantseva TI; Kotelianski V; Gorgun CZ; Chudnovskiy A; Yamazaki H; Croce K; Weissleder R; Aster JC; Hotamisligil GS; Yagita H; Aikawa M. 2012. Notch ligand Delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A 109(27):E1868-77. [PubMed: 22699504]  [MGI Ref ID J:186429]

Fulton S; Pissios P; Manchon RP; Stiles L; Frank L; Pothos EN; Maratos-Flier E; Flier JS. 2006. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51(6):811-22. [PubMed: 16982425]  [MGI Ref ID J:113646]

Funato H; Tsai AL; Willie JT; Kisanuki Y; Williams SC; Sakurai T; Yanagisawa M. 2009. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 9(1):64-76. [PubMed: 19117547]  [MGI Ref ID J:144346]

Galgani M; Procaccini C; De Rosa V; Carbone F; Chieffi P; La Cava A; Matarese G. 2010. Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J Immunol 185(12):7474-9. [PubMed: 21078910]  [MGI Ref ID J:167460]

Galvez BG ; San Martin N ; Rodriguez C. 2009. TNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice. PLoS ONE 4(2):e4444. [PubMed: 19214223]  [MGI Ref ID J:146626]

Gao D; Wei C; Chen L; Huang J; Yang S; Diehl AM. 2004. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 287(5):G1070-7. [PubMed: 15231485]  [MGI Ref ID J:96152]

Gao H; Bryzgalova G; Hedman E; Khan A; Efendic S; Gustafsson JA; Dahlman-Wright K. 2006. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol 20(6):1287-99. [PubMed: 16627594]  [MGI Ref ID J:108950]

Gao J; He J; Shi X; Stefanovic-Racic M; Xu M; O'Doherty RM; Garcia-Ocana A; Xie W. 2012. Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes. Diabetes 61(6):1543-51. [PubMed: 22438574]  [MGI Ref ID J:196848]

Gao Q; Jia Y; Yang G; Zhang X; Boddu PC; Petersen B; Narsingam S; Zhu YJ; Thimmapaya B; Kanwar YS; Reddy JK. 2015. PPARalpha-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. Am J Pathol 185(5):1396-408. [PubMed: 25773177]  [MGI Ref ID J:220678]

Gao Y; Ottaway N; Schriever SC; Legutko B; Garcia-Caceres C; de la Fuente E; Mergen C; Bour S; Thaler JP; Seeley RJ; Filosa J; Stern JE; Perez-Tilve D; Schwartz MW; Tschop MH; Yi CX. 2014. Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 62(1):17-25. [PubMed: 24166765]  [MGI Ref ID J:203061]

Garcia-Guerra L; Nieto-Vazquez I; Vila-Bedmar R; Jurado-Pueyo M; Zalba G; Diez J; Murga C; Fernandez-Veledo S; Mayor F Jr; Lorenzo M. 2010. G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 59(10):2407-17. [PubMed: 20627936]  [MGI Ref ID J:169625]

Garris DR. 2004. Ultrastructural analysis of progressive endometrial hypercytolipidemia induced by obese (ob/ob) and diabetes (db/db) genotype mutations: structural basis of female reproductive tract involution. Tissue Cell 36(1):19-28. [PubMed: 14729450]  [MGI Ref ID J:102445]

Garris DR; Garris BL. 2004. Genomic modulation of diabetes (db/db) and obese (ob/ob) mutation-induced hypercytolipidemia: cytochemical basis of female reproductive tract involution. Cell Tissue Res 316(2):233-41. [PubMed: 15024641]  [MGI Ref ID J:105101]

Gautam D; Gavrilova O; Jeon J; Pack S; Jou W; Cui Y; Li JH; Wess J. 2006. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab 4(5):363-75. [PubMed: 17084710]  [MGI Ref ID J:129745]

Gavrilescu LC; Butcher BA; Del Rio L; Taylor GA; Denkers EY. 2004. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection. Infect Immun 72(3):1257-64. [PubMed: 14977926]  [MGI Ref ID J:88582]

Gavrilova O; Barr V; Marcus-Samuels B; Reitman M. 1997. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Biol Chem 272(48):30546-51. [PubMed: 9374549]  [MGI Ref ID J:44331]

Gavrilova O; Leon LR; Marcus-Samuels B; Mason MM; Castle AL; Refetoff S; Vinson C; Reitman ML. 1999. Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 96(25):14623-8. [PubMed: 10588755]  [MGI Ref ID J:58946]

Gazit V; Weymann A; Hartman E; Finck BN; Hruz PW; Tzekov A; Rudnick DA. 2010. Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 52(6):2109-17. [PubMed: 20967828]  [MGI Ref ID J:204049]

Ge F; Zhou S; Hu C; Lobdell H th; Berk PD. 2010. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. Am J Physiol Gastrointest Liver Physiol 299(4):G855-66. [PubMed: 20595619]  [MGI Ref ID J:165834]

Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C. 2014. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension. Am J Physiol Renal Physiol 307(3):F317-25. [PubMed: 24944269]  [MGI Ref ID J:212183]

Gentric G; Maillet V; Paradis V; Couton D; L'Hermitte A; Panasyuk G; Fromenty B; Celton-Morizur S; Desdouets C. 2015. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Invest 125(3):981-92. [PubMed: 25621497]  [MGI Ref ID J:220381]

Gerin I; Louis GW; Zhang X; Prestwich TC; Kumar TR; Myers MG Jr; Macdougald OA; Nothnick WB. 2009. Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1. Endocrinology 150(4):1697-704. [PubMed: 19036876]  [MGI Ref ID J:158084]

Getchell TV; Kwong K; Saunders CP; Stromberg AJ; Getchell ML. 2006. Leptin regulates olfactory-mediated behavior in ob/ob mice. Physiol Behav 87(5):848-56. [PubMed: 16549076]  [MGI Ref ID J:112820]

Gettys TW; Watson PM; Seger L; Padgett M; Taylor IL. 1997. Adrenalectomy after weaning restores beta3-adrenergic receptor expression in white adipocytes from C57BL/6J-ob/ob mice. Endocrinology 138(7):2697-704. [PubMed: 9202206]  [MGI Ref ID J:41996]

Ghamari-Langroudi M; Srisai D; Cone RD. 2011. Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin. Proc Natl Acad Sci U S A 108(1):355-60. [PubMed: 21169216]  [MGI Ref ID J:169023]

Gimenez-Cassina A; Garcia-Haro L; Choi CS; Osundiji MA; Lane EA; Huang H; Yildirim MA; Szlyk B; Fisher JK; Polak K; Patton E; Wiwczar J; Godes M; Lee DH; Robertson K; Kim S; Kulkarni A; Distefano A; Samuel V; Cline G; Kim YB; Shulman GI; Danial NN. 2014. Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab 19(2):272-84. [PubMed: 24506868]  [MGI Ref ID J:210651]

Gimeno RE; Dembski M; Weng X; Deng N; Shyjan AW; Gimeno CJ; Iris F; Ellis SJ; Woolf EA; Tartaglia LA. 1997. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 46(5):900-6. [PubMed: 9133562]  [MGI Ref ID J:40062]

Giordano A; Murano I; Mondini E; Perugini J; Smorlesi A; Severi I; Barazzoni R; Scherer PE; Cinti S. 2013. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res 54(9):2423-36. [PubMed: 23836106]  [MGI Ref ID J:200764]

Gloaguen I; Costa P; Demartis A; Lazzaro D; Di Marco A; Graziani R ; Paonessa G ; Chen F ; Rosenblum CI ; Van der Ploeg LH ; Cortese R ; Ciliberto G ; Laufer R. 1997. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proc Natl Acad Sci U S A 94(12):6456-61. [PubMed: 9177239]  [MGI Ref ID J:40976]

Golson ML; Bush WS; Brissova M. 2014. Automated quantification of pancreatic beta-cell mass. Am J Physiol Endocrinol Metab 306(12):E1460-7. [PubMed: 24760991]  [MGI Ref ID J:214769]

Gonzalez-Periz A; Horrillo R; Ferre N; Gronert K; Dong B; Moran-Salvador E; Titos E; Martinez-Clemente M; Lopez-Parra M; Arroyo V; Claria J. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23(6):1946-57. [PubMed: 19211925]  [MGI Ref ID J:150547]

Goren I; Kampfer H; Muller E; Schiefelbein D; Pfeilschifter J; Frank S. 2006. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 126(3):628-37. [PubMed: 16410783]  [MGI Ref ID J:106761]

Goren I; Kampfer H; Podda M; Pfeilschifter J; Frank S. 2003. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 52(11):2821-32. [PubMed: 14578302]  [MGI Ref ID J:86305]

Goren I; Muller E; Pfeilschifter J; Frank S. 2006. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol 168(3):765-77. [PubMed: 16507892]  [MGI Ref ID J:106484]

Goren I; Pfeilschifter J; Frank S. 2014. Uptake of neutrophil-derived ym1 protein distinguishes wound macrophages in the absence of interleukin-4 signaling in murine wound healing. Am J Pathol 184(12):3249-61. [PubMed: 25307347]  [MGI Ref ID J:216580]

Goudriaan JR; Tacken PJ; Dahlmans VE; Gijbels MJ; van Dijk KW; Havekes LM; Jong MC. 2001. Protection from obesity in mice lacking the VLDL receptor. Arterioscler Thromb Vasc Biol 21(9):1488-93. [PubMed: 11557677]  [MGI Ref ID J:102939]

Graham MJ; Lee RG; Bell TA 3rd; Fu W; Mullick AE; Alexander VJ; Singleton W; Viney N; Geary R; Su J; Baker BF; Burkey J; Crooke ST; Crooke RM. 2013. Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res 112(11):1479-90. [PubMed: 23542898]  [MGI Ref ID J:213303]

Gray SL; Nora ED; Grosse J; Manieri M; Stoeger T; Medina-Gomez G; Burling K; Wattler S; Russ A; Yeo GS; Chatterjee VK; O'Rahilly S; Voshol PJ; Cinti S; Vidal-Puig A. 2006. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55(10):2669-77. [PubMed: 17003330]  [MGI Ref ID J:116568]

Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F. 2005. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 289(5):E829-38. [PubMed: 15941783]  [MGI Ref ID J:102451]

Gropler MC; Harris TE; Hall AM; Wolins NE; Gross RW; Han X; Chen Z; Finck BN. 2009. Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J Biol Chem 284(11):6763-72. [PubMed: 19136718]  [MGI Ref ID J:148371]

Grosbellet E; Gourmelen S; Pevet P; Criscuolo F; Challet E. 2015. Leptin normalizes photic synchronization in male ob/ob mice, via indirect effects on the suprachiasmatic nucleus. Endocrinology 156(3):1080-90. [PubMed: 25521581]  [MGI Ref ID J:221508]

Gruen ML; Plummer MR; Zhang W; Posey KA; Linton M; Fazio S; Hasty AH. 2005. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res 46(9):2007-14. [PubMed: 15995171]  [MGI Ref ID J:100492]

Grueter CE; van Rooij E; Johnson BA; DeLeon SM; Sutherland LB; Qi X; Gautron L; Elmquist JK; Bassel-Duby R; Olson EN. 2012. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149(3):671-83. [PubMed: 22541436]  [MGI Ref ID J:186193]

Gundewar S; Calvert JW; Elrod JW; Lefer DJ. 2007. Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes. Am J Physiol Heart Circ Physiol 293(4):H2462-71. [PubMed: 17630348]  [MGI Ref ID J:126117]

Guo KY; Halo P; Leibel RL; Zhang Y. 2004. Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol 287(1):R112-9. [PubMed: 15001430]  [MGI Ref ID J:109323]

Guo T; Bond ND; Jou W; Gavrilova O; Portas J; McPherron AC. 2012. Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy. Diabetes 61(10):2414-23. [PubMed: 22596054]  [MGI Ref ID J:208455]

Gupte A; Mora S. 2006. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes. Biochem Biophys Res Commun 342(3):751-7. [PubMed: 16494846]  [MGI Ref ID J:106781]

Gustavsson N; Abedi G; Larsson-Nyren G; Lindstrom P. 2006. Timing of Ca2+ response in pancreatic beta-cells is related to mitochondrial mass. Biochem Biophys Res Commun 340(4):1119-24. [PubMed: 16414347]  [MGI Ref ID J:104995]

Hahm S; Fekete C; Mizuno TM; Windsor J; Yan H; Boozer CN; Lee C; Elmquist JK; Lechan RM; Mobbs CV; Salton SR. 2002. VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting. J Neurosci 22(16):6929-38. [PubMed: 12177191]  [MGI Ref ID J:124244]

Hajri T; Hall AM; Jensen DR; Pietka TA; Drover VA; Tao H; Eckel R; Abumrad NA. 2007. CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 56(7):1872-80. [PubMed: 17440173]  [MGI Ref ID J:126461]

Hakansson-Ovesjo ML; Collin M; Meister B. 2000. Down-regulated STAT3 messenger ribonucleic acid and STAT3 protein in the hypothalamic arcuate nucleus of the obese leptin-deficient (ob/ob) mouse Endocrinology 141(11):3946-55. [PubMed: 11089524]  [MGI Ref ID J:65568]

Halaas JL; Gajiwala KS; Maffei M; Cohen SL; Chait BT; Rabinowitz D; Lallone RL; Burley SK; Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene [see comments] Science 269(5223):543-6. [PubMed: 7624777]  [MGI Ref ID J:29161]

Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Veniant MM; Xu J. 2012. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 153(1):69-80. [PubMed: 22067317]  [MGI Ref ID J:181652]

Hall AM; Brunt EM; Chen Z; Viswakarma N; Reddy JK; Wolins NE; Finck BN. 2010. Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice. J Lipid Res 51(3):554-63. [PubMed: 19749180]  [MGI Ref ID J:159055]

Haller EW; Wittmers LE Jr; Haller IV; Regal RR. 1999. The obese gene is expressed in lean littermates of the genetically obese mouse (C57BL/6J ob/ob). Am J Physiol 276(4 Pt 1):E762-5. [PubMed: 10198314]  [MGI Ref ID J:54704]

Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML. 2004. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145(7):3258-64. [PubMed: 15059949]  [MGI Ref ID J:90742]

Hamm ML; Bhat GK; Thompson WE; Mann DR. 2004. Folliculogenesis is impaired and granulosa cell apoptosis is increased in leptin-deficient mice. Biol Reprod 71(1):66-72. [PubMed: 14985253]  [MGI Ref ID J:91001]

Hamrick MW; Pennington C; Newton D; Xie D; Isales C. 2004. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34(3):376-83. [PubMed: 15003785]  [MGI Ref ID J:88559]

Han CY; Subramanian S; Chan CK; Omer M; Chiba T; Wight TN; Chait A. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56(9):2260-73. [PubMed: 17563062]  [MGI Ref ID J:126587]

Han YM; Kang GM; Byun K; Ko HW; Kim J; Shin MS; Kim HK; Gil SY; Yu JH; Lee B; Kim MS. 2014. Leptin-promoted cilia assembly is critical for normal energy balance. J Clin Invest 124(5):2193-7. [PubMed: 24667636]  [MGI Ref ID J:212773]

Hao M; Head WS; Gunawardana SC; Hasty AH; Piston DW. 2007. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 56(9):2328-38. [PubMed: 17575085]  [MGI Ref ID J:126584]

Harris RB. 1999. Parabiosis between db/db and ob/ob or db/+ mice. Endocrinology 140(1):138-45. [PubMed: 9886818]  [MGI Ref ID J:114258]

Harris RB; Hausman DB; Bartness TJ. 2002. Compensation for partial lipectomy in mice with genetic alterations of leptin and its receptor subtypes. Am J Physiol Regul Integr Comp Physiol 283(5):R1094-103. [PubMed: 12376403]  [MGI Ref ID J:113622]

Harris RB; Zhou J; Redmann SM Jr; Smagin GN; Smith SR; Rodgers E; Zachwieja JJ. 1998. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 139(1):8-19. [PubMed: 9421392]  [MGI Ref ID J:44829]

Hasegawa T; Ito Y; Wijeweera J; Liu J; Malle E; Farhood A; McCuskey RS; Jaeschke H. 2007. Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol 292(5):G1385-95. [PubMed: 17307725]  [MGI Ref ID J:122631]

Hasty AH; Shimano H; Osuga Ji; Namatame I; Takahashi A; Yahagi N; Perrey S; Iizuka Y; Tamura Y; Amemiya-Kudo M; Yoshikawa T; Okazaki H; Ohashi K; Harada K; Matsuzaka T; Sone H; Gotoda T; Nagai R; Ishibashi S; Yamada N. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276(40):37402-8. [PubMed: 11445560]  [MGI Ref ID J:72027]

Hawke Z; Ivanov TR; Bechtold DA; Dhillon H; Lowell BB; Luckman SM. 2009. PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling. J Neurosci 29(47):14828-35. [PubMed: 19940178]  [MGI Ref ID J:158472]

Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M. 2008. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7. Am J Physiol Regul Integr Comp Physiol 295(1):R123-32. [PubMed: 18480244]  [MGI Ref ID J:148644]

He J; Gao J; Xu M; Ren S; Stefanovic-Racic M; O'Doherty RM; Xie W. 2013. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 62(6):1876-87. [PubMed: 23349477]  [MGI Ref ID J:208575]

Hedbacker K; Birsoy K; Wysocki RW; Asilmaz E; Ahima RS; Farooqi IS; Friedman JM. 2010. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 11(1):11-22. [PubMed: 20074524]  [MGI Ref ID J:157004]

Heep H; Wedemeyer C; Wegner A; Hofmeister S; von Knoch M. 2008. Differences in trabecular bone of leptin-deficient ob/ob mice in response to biomechanical loading. Int J Biol Sci 4(3):169-75. [PubMed: 18566694]  [MGI Ref ID J:161105]

Heffernan M; Summers RJ; Thorburn A; Ogru E; Gianello R; Jiang WJ; Ng FM. 2001. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology 142(12):5182-9. [PubMed: 11713213]  [MGI Ref ID J:115409]

Hemi R; Yochananov Y; Barhod E; Kasher-Meron M; Karasik A; Tirosh A; Kanety H. 2011. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes 60(4):1134-45. [PubMed: 21386087]  [MGI Ref ID J:171748]

Henderson RB; Hobbs JA; Mathies M; Hogg N. 2003. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102(1):328-35. [PubMed: 12623845]  [MGI Ref ID J:115516]

Henkel JS; Beers DR; Siklos L; Appel SH. 2006. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 31(3):427-37. [PubMed: 16337133]  [MGI Ref ID J:106862]

Herberg L; Coleman DL. 1977. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26(1):59-99. [PubMed: 834144]  [MGI Ref ID J:5759]

Herrero L; Shapiro H; Nayer A; Lee J; Shoelson SE. 2010. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 107(1):240-5. [PubMed: 20007767]  [MGI Ref ID J:156490]

Hick RW; Gruver AL; Ventevogel MS; Haynes BF; Sempowski GD. 2006. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol 177(1):169-76. [PubMed: 16785512]  [MGI Ref ID J:134403]

Hinoi E; Gao N; Jung DY; Yadav V; Yoshizawa T; Myers MG Jr; Chua SC Jr; Kim JK; Kaestner KH; Karsenty G. 2008. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 183(7):1235-42. [PubMed: 19103808]  [MGI Ref ID J:145998]

Hinoi E; Iezaki T; Ozaki K; Yoneda Y. 2014. Nuclear factor-kappaB is a common upstream signal for growth differentiation factor-5 expression in brown adipocytes exposed to pro-inflammatory cytokines and palmitate. Biochem Biophys Res Commun 452(4):974-9. [PubMed: 25223801]  [MGI Ref ID J:220087]

Hinoi E; Nakamura Y; Takada S; Fujita H; Iezaki T; Hashizume S; Takahashi S; Odaka Y; Watanabe T; Yoneda Y. 2014. Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure. Diabetes 63(1):162-75. [PubMed: 24062245]  [MGI Ref ID J:208918]

Hirasawa T; Ohara T; Makino S. 1997. Genetic typing of the mouse ob mutation by PCR and restriction enzyme analysis. Exp Anim 46(1):75-8. [PubMed: 9027475]  [MGI Ref ID J:41265]

Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I. 2009. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc Res 84(1):164-72. [PubMed: 19505930]  [MGI Ref ID J:172486]

Hirosumi J; Tuncman G; Chang L; Gorgun CZ; Uysal KT; Maeda K; Karin M; Hotamisligil GS. 2002. A central role for JNK in obesity and insulin resistance. Nature 420(6913):333-6. [PubMed: 12447443]  [MGI Ref ID J:80452]

Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I. 2011. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler Thromb Vasc Biol 31(4):792-9. [PubMed: 21233451]  [MGI Ref ID J:184170]

Hochgeschwender U; Costa JL; Reed P; Bui S; Brennan MB. 2003. Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin. Endocrinology 144(12):5194-202. [PubMed: 12970157]  [MGI Ref ID J:87246]

Hoggard N; Cruickshank M; Moar KM; Barrett P; Bashir S; Miller JD. 2009. Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone. J Mol Endocrinol 43(4):171-7. [PubMed: 19491194]  [MGI Ref ID J:163437]

Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE. 2013. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17(5):790-7. [PubMed: 23663742]  [MGI Ref ID J:199268]

Howard JK; Lord GM; Matarese G; Vendetti S; Ghatei MA; Ritter MA; Lechler RI; Bloom SR. 1999. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104(8):1051-9. [PubMed: 10525043]  [MGI Ref ID J:58102]

Howell JJ; Stoffel M. 2009. Nuclear export-independent inhibition of Foxa2 by insulin. J Biol Chem 284(37):24816-24. [PubMed: 19589781]  [MGI Ref ID J:155259]

Hsu A; Aronoff DM; Phipps J; Goel D; Mancuso P. 2007. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol 150(2):332-9. [PubMed: 17822444]  [MGI Ref ID J:126350]

Hu X; Wu R; Jiang Z; Wang L; Chen P; Zhang L; Yang L; Wu Y; Chen H; Chen H; Xu Y; Zhou Y; Huang X; Webster KA; Yu H; Wang J. 2014. Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning. Stem Cells 32(10):2702-13. [PubMed: 24989835]  [MGI Ref ID J:218496]

Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK. 2012. Sustained activation of PPARalpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 26(2):628-38. [PubMed: 22009939]  [MGI Ref ID J:180625]

Huang SL; Yu RT; Gong J; Feng Y; Dai YL; Hu F; Hu YH; Tao YD; Leng Y. 2012. Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia 55(5):1469-81. [PubMed: 22095235]  [MGI Ref ID J:183727]

Huang W; Bansode RR; Bal NC; Mehta M; Mehta KD. 2012. Protein kinase Cbeta deficiency attenuates obesity syndrome of ob/ob mice by promoting white adipose tissue remodeling. J Lipid Res 53(3):368-78. [PubMed: 22210924]  [MGI Ref ID J:183125]

Hudkins KL; Pichaiwong W; Wietecha T; Kowalewska J; Banas MC; Spencer MW; Muhlfeld A; Koelling M; Pippin JW; Shankland SJ; Askari B; Rabaglia ME; Keller MP; Attie AD; Alpers CE. 2010. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 21(9):1533-42. [PubMed: 20634301]  [MGI Ref ID J:185261]

Huh JY; Kim JI; Park YJ; Hwang IJ; Lee YS; Sohn JH; Lee SK; Alfadda AA; Kim SS; Choi SH; Lee DS; Park SH; Seong RH; Choi CS; Kim JB. 2013. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol 33(2):328-39. [PubMed: 23149942]  [MGI Ref ID J:194102]

Hwang JH; Kim DW; Jo EJ; Kim YK; Jo YS; Park JH; Yoo SK; Park MK; Kwak TH; Kho YL; Han J; Choi HS; Lee SH; Kim JM; Lee I; Kyung T; Jang C; Chung J; Kweon GR; Shong M. 2009. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes 58(4):965-74. [PubMed: 19136651]  [MGI Ref ID J:151045]

Hyogo H; Roy S; Cohen DE. 2003. Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice. J Lipid Res 44(6):1232-40. [PubMed: 12671032]  [MGI Ref ID J:120674]

INGALLS AM; DICKIE MM; SNELL GD. 1950. Obese, a new mutation in the house mouse. J Hered 41(12):317-8. [PubMed: 14824537]  [MGI Ref ID J:13066]

Iizuka K; Miller B; Uyeda K. 2006. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab 291(2):E358-64. [PubMed: 16705063]  [MGI Ref ID J:111374]

Ikejima S; Sasaki S; Sashinami H; Mori F; Ogawa Y; Nakamura T; Abe Y; Wakabayashi K; Suda T; Nakane A. 2005. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 54(1):182-9. [PubMed: 15616027]  [MGI Ref ID J:105107]

Ikels K; Kuschel S; Fischer J; Kaisers W; Eberhard D; Ruther U. 2014. FTO is a relevant factor for the development of the metabolic syndrome in mice. PLoS One 9(8):e105349. [PubMed: 25144618]  [MGI Ref ID J:219118]

Ilan Y; Maron R; Tukpah AM; Maioli TU; Murugaiyan G; Yang K; Wu HY; Weiner HL. 2010. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A 107(21):9765-70. [PubMed: 20445103]  [MGI Ref ID J:160555]

Ilegems E; Dicker A; Speier S; Sharma A; Bahow A; Edlund PK; Leibiger IB; Berggren PO. 2013. Reporter islets in the eye reveal the plasticity of the endocrine pancreas. Proc Natl Acad Sci U S A 110(51):20581-6. [PubMed: 24248353]  [MGI Ref ID J:205112]

Imajo K; Fujita K; Yoneda M; Nozaki Y; Ogawa Y; Shinohara Y; Kato S; Mawatari H; Shibata W; Kitani H; Ikejima K; Kirikoshi H; Nakajima N; Saito S; Maeyama S; Watanabe S; Wada K; Nakajima A. 2012. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab 16(1):44-54. [PubMed: 22768838]  [MGI Ref ID J:187402]

Inami Y; Yamashina S; Izumi K; Ueno T; Tanida I; Ikejima K; Watanabe S. 2011. Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression. Biochem Biophys Res Commun 412(4):618-25. [PubMed: 21856284]  [MGI Ref ID J:177536]

Ioffe E; Moon B; Connolly E; Friedman JM. 1998. Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci U S A 95(20):11852-7. [PubMed: 9751754]  [MGI Ref ID J:50145]

Irles E; Neco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal A; Quesada I. 2015. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes. Mol Cell Endocrinol 404:46-55. [PubMed: 25633666]  [MGI Ref ID J:220333]

Ishii M; Fei H; Friedman JM. 2003. Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci U S A 100(18):10540-5. [PubMed: 12925742]  [MGI Ref ID J:94820]

Itateyama E; Chiba S; Sakata T; Yoshimatsu H. 2003. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain. Exp Biol Med (Maywood) 228(10):1132-7. [PubMed: 14610251]  [MGI Ref ID J:103056]

Ito A; Suganami T; Yamauchi A; Degawa-Yamauchi M; Tanaka M; Kouyama R; Kobayashi Y; Nitta N; Yasuda K; Hirata Y; Kuziel WA; Takeya M; Kanegasaki S; Kamei Y; Ogawa Y. 2008. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem 283(51):35715-23. [PubMed: 18977759]  [MGI Ref ID J:143770]

Iwaniec UT; Dube MG; Boghossian S; Song H; Helferich WG; Turner RT; Kalra SP. 2009. Body mass influences cortical bone mass independent of leptin signaling. Bone 44(3):404-12. [PubMed: 19095090]  [MGI Ref ID J:146053]

Jager J; Corcelle V; Gremeaux T; Laurent K; Waget A; Pages G; Binetruy B; Le Marchand-Brustel Y; Burcelin R; Bost F; Tanti JF. 2010. Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia :. [PubMed: 20953578]  [MGI Ref ID J:165782]

Jager J; Gremeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF. 2010. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Diabetes 59(1):61-70. [PubMed: 19808894]  [MGI Ref ID J:164170]

Jang M; Romsos DR. 1998. Neuropeptide Y and corticotropin-releasing hormone concentrations within specific hypothalamic regions of lean but not ob/ob mice respond to food-deprivation and refeeding. J Nutr 128(12):2520-5. [PubMed: 9868202]  [MGI Ref ID J:52175]

Jansen HJ; van Essen P; Koenen T; Joosten LA; Netea MG; Tack CJ; Stienstra R. 2012. Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology 153(12):5866-74. [PubMed: 23117929]  [MGI Ref ID J:192841]

Jatoi A; Cleary MP; Tee CM; Nguyen PL. 2001. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice. Ann Nutr Metab 45(3):116-20. [PubMed: 11423703]  [MGI Ref ID J:70639]

Jeffery E; Church CD; Holtrup B; Colman L; Rodeheffer MS. 2015. Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nat Cell Biol 17(4):376-85. [PubMed: 25730471]  [MGI Ref ID J:220886]

Jetton TL; Liang Y; Cincotta AH. 2001. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Metabolism 50(11):1377-84. [PubMed: 11699060]  [MGI Ref ID J:72803]

Jheng HF; Tsai PJ; Guo SM; Kuo LH; Chang CS; Su IJ; Chang CR; Tsai YS. 2012. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 32(2):309-19. [PubMed: 22083962]  [MGI Ref ID J:183663]

Ji Y; Sun S; Xu A; Bhargava P; Yang L; Lam KS; Gao B; Lee CH; Kersten S; Qi L. 2012. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 287(17):13561-71. [PubMed: 22396530]  [MGI Ref ID J:184470]

Jiao P; Chen Q; Shah S; Du J; Tao B; Tzameli I; Yan W; Xu H. 2009. Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58(1):104-15. [PubMed: 18835938]  [MGI Ref ID J:147249]

Jiao Y; George SK; Zhao Q; Hulver MW; Hutson SM; Bishop CE; Lu B. 2012. Mex3c mutation reduces adiposity and increases energy expenditure. Mol Cell Biol 32(21):4350-62. [PubMed: 22927639]  [MGI Ref ID J:189249]

Jo YH; Chen YJ; Chua SC Jr; Talmage DA; Role LW. 2005. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48(6):1055-66. [PubMed: 16364907]  [MGI Ref ID J:107590]

Johnson PR; Hirsch J. 1972. Cellularity of adipose depots in six strains of genetically obese mice. J Lipid Res 13(1):2-11. [PubMed: 5059196]  [MGI Ref ID J:5253]

Joost HG; Schurmann A. 2014. The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models. Mamm Genome 25(9-10):401-12. [PubMed: 24752583]  [MGI Ref ID J:216848]

Jurgens HS; Schurmann A; Kluge R; Ortmann S; Klaus S; Joost HG; Tschop MH. 2006. Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. Physiol Genomics 25(2):234-41. [PubMed: 16614459]  [MGI Ref ID J:144124]

Kaddai V; Jager J; Gonzalez T; Najem-Lendom R; Bonnafous S; Tran A; Le Marchand-Brustel Y; Gual P; Tanti JF; Cormont M. 2009. Involvement of TNF-alpha in abnormal adipocyte and muscle sortilin expression in obese mice and humans. Diabetologia 52(5):932-40. [PubMed: 19219422]  [MGI Ref ID J:148209]

Kaiyala KJ; Morton GJ; Leroux BG; Ogimoto K; Wisse B; Schwartz MW. 2010. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59(7):1657-66. [PubMed: 20413511]  [MGI Ref ID J:169354]

Kajimura D; Lee HW; Riley KJ; Arteaga-Solis E; Ferron M; Zhou B; Clarke CJ; Hannun YA; DePinho RA; Guo EX; Mann JJ; Karsenty G. 2013. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 17(6):901-15. [PubMed: 23684624]  [MGI Ref ID J:199264]

Kamei N; Tobe K; Suzuki R; Ohsugi M; Watanabe T; Kubota N; Ohtsuka-Kowatari N; Kumagai K; Sakamoto K; Kobayashi M; Yamauchi T; Ueki K; Oishi Y; Nishimura S; Manabe I; Hashimoto H; Ohnishi Y; Ogata H; Tokuyama K; Tsunoda M; Ide T; Murakami K; Nagai R; Kadowaki T. 2006. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281(36):26602-14. [PubMed: 16809344]  [MGI Ref ID J:116947]

Kampfer H; Pfeilschifter J; Frank S. 2003. Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair. J Invest Dermatol 121(6):1544-51. [PubMed: 14675208]  [MGI Ref ID J:120040]

Kampfer H; Schmidt R; Geisslinger G; Pfeilschifter J; Frank S. 2005. Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. Diabetes 54(5):1543-51. [PubMed: 15855344]  [MGI Ref ID J:105193]

Kaneko K; Yamada T; Tsukita S; Takahashi K; Ishigaki Y; Oka Y; Katagiri H. 2009. Obesity alters circadian expressions of molecular clock genes in the brainstem. Brain Res 1263:58-68. [PubMed: 19401184]  [MGI Ref ID J:148090]

Kaplan ML; Oh SS. 1991. Oxygen consumption of muscles from ob/ob and Ay/a strains of obese mice. Int J Obes 15(12):809-12. [PubMed: 1794923]  [MGI Ref ID J:613]

Kaplan ML; Trout JR; Leveille GA. 1976. Adipocyte size distribution in ob/ob mice during preobese and obese phases of development. Proc Soc Exp Biol Med 153(3):476-82. [PubMed: 1013161]  [MGI Ref ID J:5765]

Kapur S; Amoui M; Kesavan C; Wang X; Mohan S; Baylink DJ; Lau KH. 2010. Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains. J Biol Chem 285(48):37607-18. [PubMed: 20851886]  [MGI Ref ID J:167342]

Katiyar SK; Meeran SM. 2007. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. Free Radic Biol Med 42(2):299-310. [PubMed: 17189835]  [MGI Ref ID J:117222]

Ke Y; Qiu J; Ogus S; Shen WJ; Kraemer FB; Chehab FF. 2003. Overexpression of leptin in transgenic mice leads to decreased basal lipolysis, PKA activity, and perilipin levels. Biochem Biophys Res Commun 312(4):1165-70. [PubMed: 14651995]  [MGI Ref ID J:94674]

Kebede M; Favaloro J; Gunton JE; Laybutt DR; Shaw M; Wong N; Fam BC; Aston-Mourney K; Rantzau C; Zulli A; Proietto J; Andrikopoulos S. 2008. Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 57(7):1887-95. [PubMed: 18375435]  [MGI Ref ID J:138232]

Kemp JG; Blazev R; Stephenson DG; Stephenson GM. 2009. Morphological and biochemical alterations of skeletal muscles from the genetically obese (ob/ob) mouse. Int J Obes (Lond) 33(8):831-41. [PubMed: 19528970]  [MGI Ref ID J:151518]

Kern TS; Tang J; Berkowitz BA. 2010. Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 16:2121-31. [PubMed: 21139688]  [MGI Ref ID J:168105]

Kerouz NJ; Horsch D; Pons S; Kahn CR. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100(12):3164-72. [PubMed: 9399964]  [MGI Ref ID J:44906]

Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD. 1997. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11(5):630-7. [PubMed: 9139806]  [MGI Ref ID J:40012]

Khan A; Efendic S. 1995. Evidence that increased glucose cycling in islets of diabetic ob/ob mice is a primary feature of the disease. Am J Physiol 269(4 Pt 1):E623-6. [PubMed: 7485473]  [MGI Ref ID J:29436]

Khan A; Ostenson CG; Berggren PO; Efendic S. 1992. Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice. Am J Physiol 263(4 Pt 1):E663-6. [PubMed: 1384356]  [MGI Ref ID J:3045]

Khan A; Zong-Chao L; Efendic S; Landau BR. 1998. Glucose-6-phosphatase activity in the hypothalamus of the ob/ob mouse. Metabolism 47(6):627-9. [PubMed: 9627357]  [MGI Ref ID J:48045]

Khan T; Muise ES; Iyengar P; Wang ZV; Chandalia M; Abate N; Zhang BB; Bonaldo P; Chua S; Scherer PE. 2009. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29(6):1575-91. [PubMed: 19114551]  [MGI Ref ID J:145762]

Kharitonenkov A; Shiyanova TL; Koester A; Ford AM; Micanovic R; Galbreath EJ; Sandusky GE; Hammond LJ; Moyers JS; Owens RA; Gromada J; Brozinick JT; Hawkins ED; Wroblewski VJ; Li DS; Mehrbod F; Jaskunas SR; Shanafelt AB. 2005. FGF-21 as a novel metabolic regulator. J Clin Invest 115(6):1627-35. [PubMed: 15902306]  [MGI Ref ID J:99202]

Kiechl S; Wittmann J; Giaccari A; Knoflach M; Willeit P; Bozec A; Moschen AR; Muscogiuri G; Sorice GP; Kireva T; Summerer M; Wirtz S; Luther J; Mielenz D; Billmeier U; Egger G; Mayr A; Oberhollenzer F; Kronenberg F; Orthofer M; Penninger JM; Meigs JB; Bonora E; Tilg H; Willeit J; Schett G. 2013. Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med 19(3):358-63. [PubMed: 23396210]  [MGI Ref ID J:196304]

Kim HA; Park WJ; Jeong HS; Lee HE; Lee SH; Kwon NS; Baek KJ; Kim DS; Yun HY. 2012. Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23. Biochim Biophys Acta 1821(6):914-22. [PubMed: 22405860]  [MGI Ref ID J:184988]

Kim HK; Youn BS; Shin MS; Namkoong C; Park KH; Baik JH; Kim JB; Park JY; Lee KU; Kim YB; Kim MS. 2010. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes 59(11):2772-80. [PubMed: 20798332]  [MGI Ref ID J:169731]

Kim JY; van de Wall E; Laplante M; Azzara A; Trujillo ME; Hofmann SM; Schraw T; Durand JL; Li H; Li G; Jelicks LA; Mehler MF; Hui DY; Deshaies Y; Shulman GI; Schwartz GJ; Scherer PE. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117(9):2621-37. [PubMed: 17717599]  [MGI Ref ID J:127420]

Kim SG; Lee B; Kim DH; Kim J; Lee S; Lee SK; Lee JW. 2013. Control of energy balance by hypothalamic gene circuitry involving two nuclear receptors, neuron-derived orphan receptor 1 and glucocorticoid receptor. Mol Cell Biol 33(19):3826-34. [PubMed: 23897430]  [MGI Ref ID J:205020]

Kim SH; Kim KH; Kim HK; Kim MJ; Back SH; Konishi M; Itoh N; Lee MS. 2015. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 58(4):809-18. [PubMed: 25537833]  [MGI Ref ID J:220750]

Kim SY; Lim JH; Choi SW; Kim M; Kim ST; Kim MS; Cho YS; Chun E; Lee KY. 2010. Preferential effects of leptin on CD4 T cells in central and peripheral immune system are critically linked to the expression of leptin receptor. Biochem Biophys Res Commun 394(3):562-8. [PubMed: 20227394]  [MGI Ref ID J:159235]

Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS. 2008. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57(2):306-14. [PubMed: 17909097]  [MGI Ref ID J:132418]

Kimple ME; Keller MP; Rabaglia MR; Pasker RL; Neuman JC; Truchan NA; Brar HK; Attie AD. 2013. Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Diabetes 62(6):1904-12. [PubMed: 23349487]  [MGI Ref ID J:208569]

Kirchner H; Heppner KM; Holland J; Kabra D; Tschop MH; Pfluger PT. 2013. Ablation of ghrelin O-acyltransferase does not improve glucose intolerance or body adiposity in mice on a leptin-deficient ob/ob background. PLoS One 8(4):e61822. [PubMed: 23630616]  [MGI Ref ID J:200880]

Kishida Y; Hirao M; Tamai N; Nampei A; Fujimoto T; Nakase T; Shimizu N; Yoshikawa H; Myoui A. 2005. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone 37(5):607-21. [PubMed: 16039170]  [MGI Ref ID J:102535]

Kitade H; Sawamoto K; Nagashimada M; Inoue H; Yamamoto Y; Sai Y; Takamura T; Yamamoto H; Miyamoto K; Ginsberg HN; Mukaida N; Kaneko S; Ota T. 2012. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61(7):1680-90. [PubMed: 22474027]  [MGI Ref ID J:203177]

Kleinridders A; Lauritzen HP; Ussar S; Christensen JH; Mori MA; Bross P; Kahn CR. 2013. Leptin regulation of Hsp60 impacts hypothalamic insulin signaling. J Clin Invest :. [PubMed: 24084737]  [MGI Ref ID J:203991]

Knight ZA; Hannan KS; Greenberg ML; Friedman JM. 2010. Hyperleptinemia is required for the development of leptin resistance. PLoS One 5(6):e11376. [PubMed: 20613882]  [MGI Ref ID J:161999]

Koch C; Augustine RA; Steger J; Ganjam GK; Benzler J; Pracht C; Lowe C; Schwartz MW; Shepherd PR; Anderson GM; Grattan DR; Tups A. 2010. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 30(48):16180-7. [PubMed: 21123564]  [MGI Ref ID J:166745]

Koenen TB; Stienstra R; van Tits LJ; de Graaf J; Stalenhoef AF; Joosten LA; Tack CJ; Netea MG. 2011. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60(2):517-24. [PubMed: 21270263]  [MGI Ref ID J:169785]

Komori T; Morikawa Y; Tamura S; Doi A; Nanjo K; Senba E. 2005. Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob/ob mice under basal conditions. Brain Res 1049(1):34-42. [PubMed: 15925330]  [MGI Ref ID J:99184]

Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y. 2014. Deficiency of oncostatin M receptor beta (OSMRbeta) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice. J Biol Chem 289(20):13821-37. [PubMed: 24695736]  [MGI Ref ID J:214124]

Kondo T; Kahn CR. 2004. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 279(36):37997-8006. [PubMed: 15201286]  [MGI Ref ID J:92558]

Konstantinides S; Schafer K; Koschnick S; Loskutoff DJ. 2001. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108(10):1533-40. [PubMed: 11714745]  [MGI Ref ID J:109859]

Kordonowy LL; Burg E; Lenox CC; Gauthier LM; Petty JM; Antkowiak M; Palvinskaya T; Ubags N; Rincon M; Dixon AE; Vernooy JH; Fessler MB; Poynter ME; Suratt BT. 2012. Obesity is associated with neutrophil dysfunction and attenuation of murine acute lung injury. Am J Respir Cell Mol Biol 47(1):120-7. [PubMed: 22427537]  [MGI Ref ID J:199772]

Kraus D; Yang Q; Kong D; Banks AS; Zhang L; Rodgers JT; Pirinen E; Pulinilkunnil TC; Gong F; Wang YC; Cen Y; Sauve AA; Asara JM; Peroni OD; Monia BP; Bhanot S; Alhonen L; Puigserver P; Kahn BB. 2014. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508(7495):258-62. [PubMed: 24717514]  [MGI Ref ID J:208844]

Krauss S; Zhang CY; Scorrano L; Dalgaard LT; St-Pierre J; Grey ST; Lowell BB. 2003. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112(12):1831-42. [PubMed: 14679178]  [MGI Ref ID J:118472]

Krautkramer KA; Linnemann AK; Fontaine DA; Whillock AL; Harris TW; Schleis GJ; Truchan NA; Marty-Santos L; Lavine JA; Cleaver O; Kimple ME; Davis DB. 2013. Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 beta-cell line. Am J Physiol Endocrinol Metab 305(5):E600-10. [PubMed: 23860123]  [MGI Ref ID J:203187]

Krutzfeldt J; Stoffel M. 2010. Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice. Diabetologia 53(1):123-7. [PubMed: 19898815]  [MGI Ref ID J:156548]

Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T. 2006. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281(13):8748-55. [PubMed: 16431926]  [MGI Ref ID J:111576]

Kubota N; Yamauchi T; Tobe K; Kadowaki T. 2006. Adiponectin-dependent and -independent pathways in insulin-sensitizing and antidiabetic actions of thiazolidinediones. Diabetes 55 Suppl 2:S32-8.  [MGI Ref ID J:120995]

Kulkarni RN; Wang ZL; Wang RM; Hurley JD; Smith DM; Ghatei MA ; Withers DJ ; Gardiner JV ; Bailey CJ ; Bloom SR. 1997. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100(11):2729-36. [PubMed: 9389736]  [MGI Ref ID J:45259]

Kumadaki S; Karasawa T; Matsuzaka T; Ema M; Nakagawa Y; Nakakuki M; Saito R; Yahagi N; Iwasaki H; Sone H; Takekoshi K; Yatoh S; Kobayashi K; Takahashi A; Suzuki H; Takahashi S; Yamada N; Shimano H. 2011. Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7alpha (Fbw7alpha) causes hepatosteatosis through Kruppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor gamma2 (PPARgamma2) pathway but not SREBP-1c protein in mice. J Biol Chem 286(47):40835-46. [PubMed: 21911492]  [MGI Ref ID J:180713]

Kumar KG; Trevaskis JL; Lam DD; Sutton GM; Koza RA; Chouljenko VN; Kousoulas KG; Rogers PM; Kesterson RA; Thearle M; Ferrante AW Jr; Mynatt RL; Burris TP; Dong JZ; Halem HA; Culler MD; Heisler LK; Stephens JM; Butler AA. 2008. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8(6):468-81. [PubMed: 19041763]  [MGI Ref ID J:144378]

Kumpers P; Gueler F; Rong S; Mengel M; Tossidou I; Peters I; Haller H; Schiffer M. 2007. Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. Am J Physiol Renal Physiol 293(4):F1355-62. [PubMed: 17686962]  [MGI Ref ID J:145120]

Kuo LE; Kitlinska JB; Tilan JU; Li L; Baker SB; Johnson MD; Lee EW; Burnett MS; Fricke ST; Kvetnansky R; Herzog H; Zukowska Z. 2007. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13(7):803-11. [PubMed: 17603492]  [MGI Ref ID J:125084]

Kuo LH; Tsai PJ; Jiang MJ; Chuang YL; Yu L; Lai KT; Tsai YS. 2010. Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia :. [PubMed: 20967535]  [MGI Ref ID J:166051]

Kurrasch DM; Cheung CC; Lee FY; Tran PV; Hata K; Ingraham HA. 2007. The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci 27(50):13624-34. [PubMed: 18077674]  [MGI Ref ID J:130568]

Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fievet C; Staels B. 2006. Peroxisome Proliferator-Activated Receptor {alpha} Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets. Diabetes 55(6):1605-13. [PubMed: 16731822]  [MGI Ref ID J:111882]

Lalonde J; Samson P; Poulin S; Deshaies Y; Richard D. 2004. Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice. Physiol Behav 80(4):415-20. [PubMed: 14741225]  [MGI Ref ID J:96339]

Lambert PD; Anderson KD; Sleeman MW; Wong V; Tan J; Hijarunguru A; Corcoran TL; Murray JD; Thabet KE; Yancopoulos GD; Wiegand SJ. 2001. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci U S A 98(8):4652-7. [PubMed: 11259650]  [MGI Ref ID J:68826]

Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD. 2003. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes 52(3):688-700. [PubMed: 12606510]  [MGI Ref ID J:148466]

Lan H; Stoehr JP; Nadler ST; Schueler KL; Yandell BS; Attie AD. 2003. Dimension reduction for mapping mRNA abundance as quantitative traits. Genetics 164(4):1607-14. [PubMed: 12930764]  [MGI Ref ID J:119260]

Lang JE; Williams ES; Mizgerd JP; Shore SA. 2008. Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol 294(5):L1013-20. [PubMed: 18359888]  [MGI Ref ID J:136626]

Lanner JT; Katz A; Tavi P; Sandstrom ME; Zhang SJ; Wretman C; James S; Fauconnier J; Lannergren J; Bruton JD; Westerblad H. 2006. The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes 55(7):2077-83. [PubMed: 16804078]  [MGI Ref ID J:111855]

Laposky AD; Shelton J; Bass J; Dugovic C; Perrino N; Turek FW. 2006. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 290(4):R894-903. [PubMed: 16293682]  [MGI Ref ID J:115771]

Laque A; Zhang Y; Gettys S; Nguyen TA; Bui K; Morrison CD; Munzberg H. 2013. Leptin receptor neurons in the mouse hypothalamus are colocalized with the neuropeptide galanin and mediate anorexigenic leptin action. Am J Physiol Endocrinol Metab 304(9):E999-E1011. [PubMed: 23482448]  [MGI Ref ID J:198129]

Larcher F; Del Rio M; Serrano F; Segovia JC; Ramirez A; Meana A; Page A; Abad JL; Gonzalez MA; Bueren J; Bernad A; Jorcano JL. 2001. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. FASEB J 15(9):1529-38. [PubMed: 11427484]  [MGI Ref ID J:115148]

Latham JR; Pathirathna S; Jagodic MM; Joo Choe W; Levin ME; Nelson MT; Yong Lee W; Krishnan K; Covey DF; Todorovic SM; Jevtovic-Todorovic V. 2009. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58(11):2656-65. [PubMed: 19651818]  [MGI Ref ID J:154387]

Lavine JA; Raess PW; Stapleton DS; Rabaglia ME; Suhonen JI; Schueler KL; Koltes JE; Dawson JA; Yandell BS; Samuelson LC; Beinfeld MC; Davis DB; Hellerstein MK; Keller MP; Attie AD. 2010. Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival. Endocrinology 151(8):3577-88. [PubMed: 20534724]  [MGI Ref ID J:163942]

Lawrence CB; Brough D; Knight EM. 2012. Obese mice exhibit an altered behavioural and inflammatory response to lipopolysaccharide. Dis Model Mech 5(5):649-59. [PubMed: 22328591]  [MGI Ref ID J:187492]

Leavens KF; Easton RM; Shulman GI; Previs SF; Birnbaum MJ. 2009. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 10(5):405-18. [PubMed: 19883618]  [MGI Ref ID J:155432]

Leckstrom A; Kim ER; Wong D; Mizuno TM. 2009. Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway. Diabetes 58(1):87-94. [PubMed: 18984739]  [MGI Ref ID J:149651]

Leclercq IA; Field J; Enriquez A; Farrell GC; Robertson GR. 2000. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun 268(2):337-44. [PubMed: 10679205]  [MGI Ref ID J:60404]

Lee FY; Li Y; Yang EK; Yang SQ; Lin HZ; Trush MA; Dannenberg AJ; Diehl AM. 1999. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol 276(2 Pt 1):C386-94. [PubMed: 9950766]  [MGI Ref ID J:53122]

Lee J; Sun C; Zhou Y; Lee J; Gokalp D; Herrema H; Park SW; Davis RJ; Ozcan U. 2011. p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis. Nat Med 17(10):1251-60. [PubMed: 21892182]  [MGI Ref ID J:177561]

Lee JH; Budanov AV; Talukdar S; Park EJ; Park HL; Park HW; Bandyopadhyay G; Li N; Aghajan M; Jang I; Wolfe AM; Perkins GA; Ellisman MH; Bier E; Scadeng M; Foretz M; Viollet B; Olefsky J; Karin M. 2012. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metab 16(3):311-21. [PubMed: 22958918]  [MGI Ref ID J:189021]

Lee JW; Romsos DR. 2001. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age. Exp Biol Med (Maywood) 226(10):906-11. [PubMed: 11682696]  [MGI Ref ID J:103303]

Lee MH; Lee JU; Joung KH; Kim YK; Ryu MJ; Lee SE; Kim SJ; Chung HK; Choi MJ; Chang JY; Lee SH; Kweon GR; Kim HJ; Kim KS; Kim SM; Jo YS; Park J; Cheng SY; Shong M. 2015. Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans. Endocrinology 156(3):1181-93. [PubMed: 25555091]  [MGI Ref ID J:221925]

Lee SH; Huang H; Choi K; Lee DH; Shi J; Liu T; Chun KH; Seo JA; Lima IS; Zabolotny JM; Wei L; Kim YB. 2014. ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance. Am J Physiol Endocrinol Metab 306(3):E332-43. [PubMed: 24326423]  [MGI Ref ID J:208371]

Lee YS; Park MS; Choung JS; Kim SS; Oh HH; Choi CS; Ha SY; Kang Y; Kim Y; Jun HS. 2012. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 55(9):2456-68. [PubMed: 22722451]  [MGI Ref ID J:189199]

Lefebvre B; Benomar Y; Guedin A; Langlois A; Hennuyer N; Dumont J; Bouchaert E; Dacquet C; Penicaud L; Casteilla L; Pattou F; Ktorza A; Staels B; Lefebvre P. 2010. Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans. J Clin Invest 120(5):1454-68. [PubMed: 20364085]  [MGI Ref ID J:161483]

Leigh FS; Kaufman LN; Young JB. 1992. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. Int J Obes Relat Metab Disord 16(8):597-604. [PubMed: 1382044]  [MGI Ref ID J:4033]

Leinninger GM; Jo YH; Leshan RL; Louis GW; Yang H; Barrera JG; Wilson H; Opland DM; Faouzi MA; Gong Y; Jones JC; Rhodes CJ; Chua S Jr; Diano S; Horvath TL; Seeley RJ; Becker JB; Munzberg H; Myers MG Jr. 2009. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 10(2):89-98. [PubMed: 19656487]  [MGI Ref ID J:151971]

Leonardi R; Rock CO; Jackowski S. 2014. Pank1 deletion in leptin-deficient mice reduces hyperglycaemia and hyperinsulinaemia and modifies global metabolism without affecting insulin resistance. Diabetologia 57(7):1466-75. [PubMed: 24781151]  [MGI Ref ID J:213743]

Leshan RL; Opland DM; Louis GW; Leinninger GM; Patterson CM; Rhodes CJ; Munzberg H; Myers MG Jr. 2010. Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J Neurosci 30(16):5713-23. [PubMed: 20410123]  [MGI Ref ID J:159836]

Levi J; Huynh FK; Denroche HC; Neumann UH; Glavas MM; Covey SD; Kieffer TJ. 2012. Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Diabetologia 55(3):752-62. [PubMed: 22202803]  [MGI Ref ID J:181709]

Levin N; Nelson C; Gurney A; Vandlen R; de Sauvage F. 1996. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 93(4):1726-30. [PubMed: 8643697]  [MGI Ref ID J:31728]

Li D; Zhang Y; Xu L; Zhou L; Wang Y; Xue B; Wen Z; Li P; Sang J. 2010. Regulation of gene expression by FSP27 in white and brown adipose tissue. BMC Genomics 11:446. [PubMed: 20649970]  [MGI Ref ID J:162769]

Li G; Mongillo M; Chin KT; Harding H; Ron D; Marks AR; Tabas I. 2009. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol 186(6):783-92. [PubMed: 19752026]  [MGI Ref ID J:153833]

Li J; Grigoryev DN; Ye SQ; Thorne L; Schwartz AR; Smith PL; O'Donnell CP; Polotsky VY. 2005. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99(5):1643-8. [PubMed: 16037401]  [MGI Ref ID J:116867]

Li J; Thorne LN; Punjabi NM; Sun CK; Schwartz AR; Smith PL; Marino RL; Rodriguez A; Hubbard WC; O'Donnell CP; Polotsky VY. 2005. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97(7):698-706. [PubMed: 16123334]  [MGI Ref ID J:114630]

Li L; Pan R; Li R; Niemann B; Aurich AC; Chen Y; Rohrbach S. 2011. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes 60(1):157-67. [PubMed: 20929977]  [MGI Ref ID J:170176]

Li M; Kim DH; Tsenovoy PL; Peterson SJ; Rezzani R; Rodella LF; Aronow WS; Ikehara S; Abraham NG. 2008. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57(6):1526-35. [PubMed: 18375438]  [MGI Ref ID J:136899]

Li N; Young MM; Bailey CJ; Smith ME. 1999. NMDA and AMPA glutamate receptor subtypes in the thoracic spinal cord in lean and obese-diabetic ob/ob mice. Brain Res 849(1-2):34-44. [PubMed: 10592285]  [MGI Ref ID J:59144]

Li Q; Hosaka T; Harada N; Nakaya Y; Funaki M. 2013. Activation of Akt through 5-HT2A receptor ameliorates serotonin-induced degradation of insulin receptor substrate-1 in adipocytes. Mol Cell Endocrinol 365(1):25-35. [PubMed: 22975078]  [MGI Ref ID J:193789]

Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR. 2009. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res 105(11):1072-82. [PubMed: 19834009]  [MGI Ref ID J:170144]

Li SY; Yang X; Ceylan-Isik AF; Du M; Sreejayan N; Ren J. 2006. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca(2+)-ATPase and myosin heavy chain isozyme switch. Diabetologia 49(6):1434-46. [PubMed: 16612592]  [MGI Ref ID J:111488]

Li T; Francl JM; Boehme S; Ochoa A; Zhang Y; Klaassen CD; Erickson SK; Chiang JY. 2012. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem 287(3):1861-73. [PubMed: 22144677]  [MGI Ref ID J:180806]

Li X; Ge H; Weiszmann J; Hecht R; Li YS; Veniant MM; Xu J; Wu X; Lindberg R; Li Y. 2009. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. FEBS Lett 583(19):3230-4. [PubMed: 19751733]  [MGI Ref ID J:153762]

Li X; Grundy SM; Patel SB. 1997. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. J Lipid Res 38(7):1277-88. [PubMed: 9254055]  [MGI Ref ID J:41954]

Li Y; Nie Y; Helou Y; Ding G; Feng B; Xu G; Salomon A; Xu H. 2013. Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammation. Diabetes 62(7):2396-409. [PubMed: 23520131]  [MGI Ref ID J:208665]

Li Z; Lin H; Yang S; Diehl AM. 2002. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 123(4):1304-10. [PubMed: 12360490]  [MGI Ref ID J:79334]

Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM. 2004. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40(2):434-41. [PubMed: 15368448]  [MGI Ref ID J:105439]

Li Z; Schmidt SF; Friedman JM. 2013. Developmental role for endocannabinoid signaling in regulating glucose metabolism and growth. Diabetes 62(7):2359-67. [PubMed: 23423572]  [MGI Ref ID J:208547]

Liang Y; Cincotta AH. 2001. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice. Int J Obes Relat Metab Disord 25(5):698-704. [PubMed: 11360153]  [MGI Ref ID J:69134]

Liew CW; Boucher J; Cheong JK; Vernochet C; Koh HJ; Mallol C; Townsend K; Langin D; Kawamori D; Hu J; Tseng YH; Hellerstein MK; Farmer SR; Goodyear L; Doria A; Bluher M; Hsu SI; Kulkarni RN. 2013. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med 19(2):217-26. [PubMed: 23291629]  [MGI Ref ID J:194928]

Lijnen HR; Christiaens V; Scroyen I; Voros G; Tjwa M; Carmeliet P; Collen D. 2006. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55(10):2698-704. [PubMed: 17003333]  [MGI Ref ID J:116580]

Lim G; Wang S; Zhang Y; Tian Y; Mao J. 2009. Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest 119(2):295-304. [PubMed: 19139561]  [MGI Ref ID J:146170]

Lim MA; Bence KK; Sandesara I; Andreux P; Auwerx J; Ishibashi J; Seale P; Kalb RG. 2014. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet 23(18):4995-5008. [PubMed: 24833719]  [MGI Ref ID J:214320]

Lin MH; Romsos DR; Akera T; Leveille GA. 1979. Na+,K+-ATPase enzyme units in skeletal muscle and liver of 14-day-old lean and obese (ob/ob) mice. Proc Soc Exp Biol Med 161(3):235-8. [PubMed: 223169]  [MGI Ref ID J:6182]

Liu J; Liang S; Liu X; Brown JA; Newman KE; Sunkara M; Morris AJ; Bhatnagar S; Li X; Pujol A; Graf GA. 2012. The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid. J Lipid Res 53(6):1071-9. [PubMed: 22493092]  [MGI Ref ID J:184905]

Liu Q; Bai C; Chen F; Wang R; MacDonald T; Gu M; Zhang Q; Morsy MA ; Caskey CT. 1998. Uncoupling protein-3: a muscle-specific gene upregulated by leptin in ob/ob mice. Gene 207(1):1-7. [PubMed: 9511737]  [MGI Ref ID J:45946]

Liu T; Zhang Y; Liu Y; Wang Y; Jia H; Kang M; Luo X; Caballero D; Gonzalez J; Sherwood L; Nunez V; Wang D; Woods A; Schultz PG; Wang F. 2015. Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists. Proc Natl Acad Sci U S A 112(5):1356-61. [PubMed: 25605877]  [MGI Ref ID J:219568]

Liu Y; Michael MD; Kash S; Bensch WR; Monia BP; Murray SF; Otto KA; Syed SK; Bhanot S; Sloop KW; Sullivan JM; Reifel-Miller A. 2007. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148(2):683-92. [PubMed: 17068142]  [MGI Ref ID J:129554]

Liu Y; Millar JS; Cromley DA; Graham M; Crooke R; Billheimer JT; Rader DJ. 2008. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice. Biochim Biophys Acta 1781(3):97-104. [PubMed: 18252207]  [MGI Ref ID J:133527]

Liu Y; Yu Y; Matarese G; La Cava A. 2012. Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J Immunol 188(5):2070-3. [PubMed: 22291185]  [MGI Ref ID J:181358]

Liu YL; Emilsson V; Cawthorne MA. 1997. Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice. FEBS Lett 411(2-3):351-5. [PubMed: 9271234]  [MGI Ref ID J:42130]

Lloyd DJ; Helmering J; Kaufman SA; Turk J; Silva M; Vasquez S; Weinstein D; Johnston B; Hale C; Veniant MM. 2011. A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face. PLoS One 6(4):e18800. [PubMed: 21533112]  [MGI Ref ID J:172393]

Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Veniant MM. 2008. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Am J Physiol Endocrinol Metab 294(3):E496-505. [PubMed: 18160459]  [MGI Ref ID J:133453]

Lloyd DJ; St Jean DJ Jr; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; GalbreathEJ; Vonderfecht SL; Wang M; Jordan SR; Veniant MM; Hale C. 2013. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors. Nature 504(7480):437-40. [PubMed: 24226772]  [MGI Ref ID J:207760]

Loffreda S; Yang SQ; Lin HZ; Karp CL; Brengman ML; Wang DJ; Klein AS; Bulkley GB; Bao C; Noble PW; Lane MD; Diehl AM. 1998. Leptin regulates proinflammatory immune responses. FASEB J 12(1):57-65. [PubMed: 9438411]  [MGI Ref ID J:115105]

Loftus TM; Kuhajda FP; Lane MD. 1998. Insulin depletion leads to adipose-specific cell death in obese but not lean mice. Proc Natl Acad Sci U S A 95(24):14168-72. [PubMed: 9826672]  [MGI Ref ID J:51283]

Loh K; Fukushima A; Zhang X; Galic S; Briggs D; Enriori PJ; Simonds S; Wiede F; Reichenbach A; Hauser C; Sims NA; Bence KK; Zhang S; Zhang ZY; Kahn BB; Neel BG; Andrews ZB; Cowley MA; Tiganis T. 2011. Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14(5):684-99. [PubMed: 22000926]  [MGI Ref ID J:179621]

Long EK; Hellberg K; Foncea R; Hertzel AV; Suttles J; Bernlohr DA. 2013. Fatty acids induce leukotriene C4 synthesis in macrophages in a fatty acid binding protein-dependent manner. Biochim Biophys Acta 1831(7):1199-207. [PubMed: 23583845]  [MGI Ref ID J:202397]

Long EK; Olson DM; Bernlohr DA. 2013. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner. Free Radic Biol Med 63:390-8. [PubMed: 23726997]  [MGI Ref ID J:205169]

Lopez-Parra M; Titos E; Horrillo R; Ferre N; Gonzalez-Periz A; Martinez-Clemente M; Planaguma A; Masferrer J; Arroyo V; Claria J. 2008. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. J Lipid Res 49(12):2513-23. [PubMed: 18645210]  [MGI Ref ID J:142866]

Lord GM; Matarese G; Howard JK; Baker RJ; Bloom SR; Lechler RI. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897-901. [PubMed: 9732873]  [MGI Ref ID J:49623]

Louis GW; Leinninger GM; Rhodes CJ; Myers MG Jr. 2010. Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons. J Neurosci 30(34):11278-87. [PubMed: 20739548]  [MGI Ref ID J:163528]

Lu FL; Johnston RA; Flynt L; Theman TA; Terry RD; Schwartzman IN; Lee A; Shore SA. 2006. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol 290(5):L856-65. [PubMed: 16373670]  [MGI Ref ID J:115772]

Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X. 2014. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARalpha. J Clin Invest 124(8):3501-13. [PubMed: 25003192]  [MGI Ref ID J:213849]

Lubitz I; Haroutunian V; Katsel P; Leroith D; Landa N; Castel D; Shaish A; Shnerb R; Schnaider-Beeri M. 2014. Non-viability of crossing the Alzheimer mouse model Tg2576 with the type 2 diabetes mouse model ob/ob. Neurobiol Aging 35(7):e19-20. [PubMed: 24581479]  [MGI Ref ID J:213837]

Lumeng CN; Bodzin JL; Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175-84. [PubMed: 17200717]  [MGI Ref ID J:117438]

Luo X; Hutley LJ; Webster JA; Kim YH; Liu DF; Newell FS; Widberg CH; Bachmann A; Turner N; Schmitz-Peiffer C; Prins JB; Yang GS; Whitehead JP. 2012. Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors. Diabetes 61(1):124-36. [PubMed: 22187378]  [MGI Ref ID J:191512]

Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD. 2007. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Am J Physiol Endocrinol Metab 292(3):E891-9. [PubMed: 17122091]  [MGI Ref ID J:118904]

Luque RM; Kineman RD. 2006. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147(6):2754-63. [PubMed: 16513828]  [MGI Ref ID J:129482]

Luque RM; Kineman RD; Tena-Sempere M. 2007. Regulation of hypothalamic expression of KiSS-1 and GPR54 genes by metabolic factors: analyses using mouse models and a cell line. Endocrinology 148(10):4601-11. [PubMed: 17595226]  [MGI Ref ID J:129475]

Lustig Y; Barhod E; Ashwal-Fluss R; Gordin R; Shomron N; Baruch-Umansky K; Hemi R; Karasik A; Kanety H. 2014. RNA-binding protein PTB and microRNA-221 coregulate AdipoR1 translation and adiponectin signaling. Diabetes 63(2):433-45. [PubMed: 24130336]  [MGI Ref ID J:209020]

Lynch CJ; Zhou Q; Shyng SL; Heal DJ; Cheetham SC; Dickinson K; Gregory P; Firnges M; Nordheim U; Goshorn S; Reiche D; Turski L; Antel J. 2012. Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels. Am J Physiol Endocrinol Metab 302(5):E540-51. [PubMed: 22167524]  [MGI Ref ID J:184649]

Ma X; Lin Y; Lin L; Qin G; Pereira FA; Haymond MW; Butte NF; Sun Y. 2012. Ablation of ghrelin receptor in leptin-deficient ob/ob mice has paradoxical effects on glucose homeostasis when compared with ablation of ghrelin in ob/ob mice. Am J Physiol Endocrinol Metab 303(3):E422-31. [PubMed: 22669248]  [MGI Ref ID J:187287]

MacDonald S; Smith ME; Bailey CJ. 1998. Expression of beta-endorphin and its receptors in the spinal cord of obese-diabetic ob/ob mice. Neurosci Lett 248(2):85-8. [PubMed: 9654348]  [MGI Ref ID J:107948]

MacDougald OA; Hwang CS; Fan H; Lane MD. 1995. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 92(20):9034-7. [PubMed: 7568067]  [MGI Ref ID J:29081]

Macia L; Delacre M; Abboud G; Ouk TS; Delanoye A; Verwaerde C; Saule P; Wolowczuk I. 2006. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol 177(9):5997-6006. [PubMed: 17056524]  [MGI Ref ID J:140529]

Maeda K; Uysal KT; Makowski L; Gorgun CZ; Atsumi G; Parker RA; Bruning J; Hertzel AV; Bernlohr DA; Hotamisligil GS. 2003. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52(2):300-7. [PubMed: 12540600]  [MGI Ref ID J:81609]

Maeda T; Kiguchi N; Kobayashi Y; Ikuta T; Ozaki M; Kishioka S. 2009. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci U S A 106(31):13076-81. [PubMed: 19620723]  [MGI Ref ID J:152019]

Maglich JM; Lobe DC; Moore JT. 2009. The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. J Lipid Res 50(3):439-45. [PubMed: 18941143]  [MGI Ref ID J:149091]

Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV. 2000. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice Diabetes 49(11):1917-23. [PubMed: 11078460]  [MGI Ref ID J:65482]

Malik NM; Carter ND; Murray JF; Scaramuzzi RJ; Wilson CA; Stock MJ. 2001. Leptin requirement for conception, implantation, and gestation in the mouse. Endocrinology 142(12):5198-202. [PubMed: 11713215]  [MGI Ref ID J:94783]

Mancuso P; Gottschalk A; Phare SM; Peters-Golden M; Lukacs NW; Huffnagle GB. 2002. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 168(8):4018-24. [PubMed: 11937559]  [MGI Ref ID J:75906]

Maness LM; Banks WA; Kastin AJ. 2000. Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice Brain Res 873(1):165-7. [PubMed: 10915826]  [MGI Ref ID J:63732]

Manolescu DC; Sima A; Bhat PV. 2010. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J Nutr 140(2):311-6. [PubMed: 20032483]  [MGI Ref ID J:156441]

Mansuy-Aubert V; Zhou QL; Xie X; Gong Z; Huang JY; Khan AR; Aubert G; Candelaria K; Thomas S; Shin DJ; Booth S; Baig SM; Bilal A; Hwang D; Zhang H; Lovell-Badge R; Smith SR; Awan FR; Jiang ZY. 2013. Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab 17(4):534-48. [PubMed: 23562077]  [MGI Ref ID J:198973]

Marcelin G; Liu SM; Li X; Schwartz GJ; Chua S. 2012. Genetic control of ATGL-mediated lipolysis modulates adipose triglyceride stores in leptin-deficient mice. J Lipid Res 53(5):964-72. [PubMed: 22383686]  [MGI Ref ID J:184915]

Mari M; Caballero F; Colell A; Morales A; Caballeria J; Fernandez A; Enrich C; Fernandez-Checa JC; Garcia-Ruiz C. 2006. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4(3):185-98. [PubMed: 16950136]  [MGI Ref ID J:129725]

Marion V; Mockel A; De Melo C; Obringer C; Claussmann A; Simon A; Messaddeq N; Durand M; Dupuis L; Loeffler JP; King P; Mutter-Schmidt C; Petrovsky N; Stoetzel C; Dollfus H. 2012. BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response. Cell Metab 16(3):363-77. [PubMed: 22958920]  [MGI Ref ID J:189019]

Mark AL; Shaffer RA; Correia ML; Morgan DA; Sigmund CD; Haynes WG. 1999. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 17(12 Pt 2):1949-53. [PubMed: 10703894]  [MGI Ref ID J:61305]

Marsh DJ; Hollopeter G; Kafer KE; Palmiter RD. 1998. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4(6):718-21. [PubMed: 9623983]  [MGI Ref ID J:87803]

Marti A; Novo FJ; Martinez-Anso E; Zaratiegui M; Aguado M; Martinez JA. 1998. Leptin gene transfer into muscle increases lipolysis and oxygen consumption in white fat tissue in ob/ob mice. Biochem Biophys Res Commun 246(3):859-62. [PubMed: 9618302]  [MGI Ref ID J:47997]

Martinez-Garcia C; Izquierdo A; Velagapudi V; Vivas Y; Velasco I; Campbell M; Burling K; Cava F; Ros M; Oresic M; Vidal-Puig A; Medina-Gomez G. 2012. Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech 5(5):636-48. [PubMed: 22773754]  [MGI Ref ID J:186778]

Masjkur J; Arps-Forker C; Poser SW; Nikolakopoulou P; Toutouna L; Chenna R; Chavakis T; Chatzigeorgiou A; Chen LS; Dubrovska A; Choudhary P; Uphues I; Mark M; Bornstein SR; Androutsellis-Theotokis A. 2014. Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release. J Biol Chem 289(51):35503-16. [PubMed: 25371201]  [MGI Ref ID J:218260]

Matarese G; Di Giacomo A; Sanna V; Lord GM; Howard JK; Di Tuoro A; Bloom SR; Lechler RI; Zappacosta S; Fontana S. 2001. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166(10):5909-16. [PubMed: 11342605]  [MGI Ref ID J:69350]

Matsubara T; Mita A; Minami K; Hosooka T; Kitazawa S; Takahashi K; Tamori Y; Yokoi N; Watanabe M; Matsuo E; Nishimura O; Seino S. 2012. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab 15(1):38-50. [PubMed: 22225875]  [MGI Ref ID J:182323]

Matsunuma A; Horiuchi N. 2007. Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1alpha-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys 463(1):118-27. [PubMed: 17400175]  [MGI Ref ID J:123347]

Matsusue K; Aibara D; Hayafuchi R; Matsuo K; Takiguchi S; Gonzalez FJ; Yamano S. 2014. Hepatic PPARgamma and LXRalpha independently regulate lipid accumulation in the livers of genetically obese mice. FEBS Lett 588(14):2277-81. [PubMed: 24857376]  [MGI Ref ID J:211650]

Matsusue K; Gavrilova O; Lambert G; Brewer HB Jr; Ward JM; Inoue Y; LeRoith D; Gonzalez FJ. 2004. Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol Endocrinol 18(11):2751-64. [PubMed: 15319454]  [MGI Ref ID J:93579]

Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B Jr; Reitman ML; Gonzalez FJ. 2003. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111(5):737-47. [PubMed: 12618528]  [MGI Ref ID J:82439]

Matsusue K; Kusakabe T; Noguchi T; Takiguchi S; Suzuki T; Yamano S; Gonzalez FJ. 2008. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 7(4):302-11. [PubMed: 18396136]  [MGI Ref ID J:134335]

Matsuzaka T; Shimano H; Yahagi N; Kato T; Atsumi A; Yamamoto T; Inoue N; Ishikawa M; Okada S; Ishigaki N; Iwasaki H; Iwasaki Y; Karasawa T; Kumadaki S; Matsui T; Sekiya M; Ohashi K; Hasty AH; Nakagawa Y; Takahashi A; Suzuki H; Yatoh S; Sone H; Toyoshima H; Osuga J; Yamada N. 2007. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med 13(10):1193-202. [PubMed: 17906635]  [MGI Ref ID J:130031]

Mazumder PK; O'Neill BT; Roberts MW; Buchanan J; Yun UJ; Cooksey RC; Boudina S; Abel ED. 2004. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53(9):2366-74. [PubMed: 15331547]  [MGI Ref ID J:107188]

McGaffin KR; Sun CK; Rager JJ; Romano LC; Zou B; Mathier MA; O'Doherty RM; McTiernan CF; O'Donnell CP. 2008. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 77(1):54-63. [PubMed: 18006469]  [MGI Ref ID J:161919]

McNay DE; Briancon N; Kokoeva MV; Maratos-Flier E; Flier JS. 2012. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J Clin Invest 122(1):142-52. [PubMed: 22201680]  [MGI Ref ID J:184391]

McPherron AC; Lee SJ. 2002. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109(5):595-601. [PubMed: 11877467]  [MGI Ref ID J:75344]

McQuaid TS; Saleh MC; Joseph JW; Gyulkhandanyan A; Manning-Fox JE; Maclellan JD; Wheeler MB; Chan CB. 2006. cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing {beta}-cells. J Endocrinol 190(3):669-80. [PubMed: 17003268]  [MGI Ref ID J:112890]

Mcginnis R; Walker J; Margules D; Aird F; Redei E. 1992. Dysregulation of the hypothalamus-pituitary-adrenal axis in male and female, genetically obese (ob/ob) mice J Neuroendocrinol 4(6):765-771.  [MGI Ref ID J:13151]

Medina-Gomez G; Gray SL; Yetukuri L; Shimomura K; Virtue S; Campbell M; Curtis RK; Jimenez-Linan M; Blount M; Yeo GS; Lopez M; Seppanen-Laakso T; Ashcroft FM; Oresic M; Vidal-Puig A. 2007. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3(4):e64. [PubMed: 17465682]  [MGI Ref ID J:121534]

Melia HP; Andrews JF; McBennett SM; Porter RK. 1999. Effects of acute leptin administration on the differences in proton leak rate in liver mitochondria from ob/ob mice compared to lean controls. FEBS Lett 458(2):261-4. [PubMed: 10481077]  [MGI Ref ID J:57725]

Memon RA; Grunfeld C; Moser AH; Feingold KR. 1994. Fatty acid synthesis in obese insulin resistant diabetic mice. Horm Metab Res 26(2):85-7. [PubMed: 8200619]  [MGI Ref ID J:17499]

Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR. 2000. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice [In Process Citation] Endocrinology 141(11):4021-31. [PubMed: 11089532]  [MGI Ref ID J:65569]

Mercer JG; Moar KM; Hoggard N. 1998. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology 139(1):29-34. [PubMed: 9421394]  [MGI Ref ID J:44828]

Mercer JG; Moar KM; Rayner DV; Trayhurn P; Hoggard N. 1997. Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice. FEBS Lett 402(2-3):185-8. [PubMed: 9037192]  [MGI Ref ID J:38333]

Metzger JM; Gagen K; Raustad KA; Yang L; White A; Wang SP; Craw S; Liu P; Lanza T; Lin LS; Nargund RP; Guan XM; Strack AM; Reitman ML. 2010. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments. Am J Physiol Endocrinol Metab 299(5):E816-24. [PubMed: 20807840]  [MGI Ref ID J:171384]

Miao J; Ling AV; Manthena PV; Gearing ME; Graham MJ; Crooke RM; Croce KJ; Esquejo RM; Clish CB; Vicent D; Biddinger SB. 2015. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun 6:6498. [PubMed: 25849138]  [MGI Ref ID J:222740]

Miao J; Xiao Z; Kanamaluru D; Min G; Yau PM; Veenstra TD; Ellis E; Strom S; Suino-Powell K; Xu HE; Kemper JK. 2009. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 23(8):986-96. [PubMed: 19390091]  [MGI Ref ID J:147941]

Miller AM; Asquith DL; Hueber AJ; Anderson LA; Holmes WM; McKenzie AN; Xu D; Sattar N; McInnes IB; Liew FY. 2010. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 107(5):650-8. [PubMed: 20634488]  [MGI Ref ID J:175027]

Minhas KM; Khan SA; Raju SV; Phan AC; Gonzalez DR; Skaf MW; Lee K; Tejani AD; Saliaris AP; Barouch LA; O'Donnell CP; Emala CW; Berkowitz DE; Hare JM. 2005. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy. J Physiol 565(Pt 2):463-74. [PubMed: 15760936]  [MGI Ref ID J:112489]

Minn AH; Lan H; Rabaglia ME; Harlan DM; Peculis BA; Attie AD; Shalev A. 2005. Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance. Mol Endocrinol 19(3):794-803. [PubMed: 15550470]  [MGI Ref ID J:96491]

Mistry AM; Helferich W; Romsos DR. 1994. Elevated neuronal c-Fos-like immunoreactivity and messenger ribonucleic acid (mRNA) in genetically obese (ob/ob) mice. Brain Res 666(1):53-60. [PubMed: 7889367]  [MGI Ref ID J:21819]

Mistry AM; Swick AG; Romsos DR. 1997. Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. J Nutr 127(10):2065-72. [PubMed: 9311966]  [MGI Ref ID J:43304]

Mitra R; Nogee DP; Zechner JF; Yea K; Gierasch CM; Kovacs A; Medeiros DM; Kelly DP; Duncan JG. 2012. The transcriptional coactivators, PGC-1alpha and beta, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance. J Mol Cell Cardiol 52(3):701-10. [PubMed: 22080103]  [MGI Ref ID J:183668]

Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y. 2011. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, Fatty liver, and type 2 diabetes. J Biol Chem 286(32):28544-55. [PubMed: 21669879]  [MGI Ref ID J:175924]

Miyawaki K; Yamada Y; Ban N; Ihara Y; Tsukiyama K; Zhou H; Fujimoto S; Oku A; Tsuda K; Toyokuni S; Hiai H; Mizunoya W; Fushiki T; Holst JJ; Makino M; Tashita A; Kobara Y; Tsubamoto Y; Jinnouchi T; Jomori T; Seino Y. 2002. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8(7):738-42. [PubMed: 12068290]  [MGI Ref ID J:77483]

Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM. 2009. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice. Biochem Biophys Res Commun 380(4):818-22. [PubMed: 19338759]  [MGI Ref ID J:147343]

Mizuno TM; Kelley KA; Pasinetti GM; Roberts JL; Mobbs CV. 2003. Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 52(11):2675-83. [PubMed: 14578285]  [MGI Ref ID J:86303]

Mizuno TM; Kleopoulos SP; Bergen HT; Roberts JL; Priest CA; Mobbs CV. 1998. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47(2):294-7. [PubMed: 9519731]  [MGI Ref ID J:45531]

Moloney F; Toomey S; Noone E; Nugent A; Allan B; Loscher CE; Roche HM. 2007. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 56(3):574-82. [PubMed: 17327424]  [MGI Ref ID J:122028]

Moon YA; Liang G; Xie X; Frank-Kamenetsky M; Fitzgerald K; Koteliansky V; Brown MS; Goldstein JL; Horton JD. 2012. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab 15(2):240-6. [PubMed: 22326225]  [MGI Ref ID J:182284]

Mooney MH; Abdel-Wahab YH; McKillop AM; O'Harte FP; Flatt PR. 2002. Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models. Biochim Biophys Acta 1569(1-3):75-80. [PubMed: 11853960]  [MGI Ref ID J:75727]

Moraes-Vieira PM; Larocca RA; Bassi EJ; Peron JP; Andrade-Oliveira V; Wasinski F; Araujo R; Thornley T; Quintana FJ; Basso AS; Strom TB; Camara NO. 2014. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol 44(3):794-806. [PubMed: 24271843]  [MGI Ref ID J:209083]

Mori A; Sakurai H; Choo MK; Obi R; Koizumi K; Yoshida C; Shimada Y; Saiki I. 2006. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer 119(12):2760-7. [PubMed: 16998795]  [MGI Ref ID J:117826]

Mori MA; Araujo RC; Reis FC; Sgai DG; Fonseca RG; Barros CC; Merino VF; Passadore M; Barbosa AM; Ferrari B; Carayon P; Castro CH; Shimuta SI; Luz J; Bascands JL; Schanstra JP; Even PC; Oliveira SM; Bader M; Pesquero JB. 2008. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes 57(6):1491-500. [PubMed: 18332096]  [MGI Ref ID J:136924]

Morita M; Oike Y; Nagashima T; Kadomatsu T; Tabata M; Suzuki T; Nakamura T; Yoshida N; Okada M; Yamamoto T. 2011. Obesity resistance and increased hepatic expression of catabolism-related mRNAs in Cnot3+/- mice. EMBO J 30(22):4678-91. [PubMed: 21897366]  [MGI Ref ID J:180033]

Morton GJ; Kaiyala KJ; Fisher JD; Ogimoto K; Schwartz MW; Wisse BE. 2011. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. Am J Physiol Endocrinol Metab 300(2):E392-401. [PubMed: 21062956]  [MGI Ref ID J:172324]

Morton GJ; Matsen ME; Bracy DP; Meek TH; Nguyen HT; Stefanovski D; Bergman RN; Wasserman DH; Schwartz MW. 2013. FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest :. [PubMed: 24084738]  [MGI Ref ID J:203990]

Mu J; Qureshi SA; Brady EJ; Muise ES; Candelore MR; Jiang G; Li Z; Wu MS; Yang X; Dallas-Yang Q; Miller C; Xiong Y; Langdon RB; Parmee ER; Zhang BB. 2012. Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist. PLoS One 7(11):e49572. [PubMed: 23185367]  [MGI Ref ID J:194789]

Muurling M; van den Hoek AM; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ. 2004. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res 45(1):9-16. [PubMed: 14523051]  [MGI Ref ID J:87976]

Muzzin P; Eisensmith RC; Copeland KC; Woo SL. 1996. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci U S A 93(25):14804-8. [PubMed: 8962136]  [MGI Ref ID J:37249]

Nadeau JH. 2003. Modifier genes and protective alleles in humans and mice. Curr Opin Genet Dev 13(3):290-5. [PubMed: 12787792]  [MGI Ref ID J:88012]

Nagareddy PR; Kraakman M; Masters SL; Stirzaker RA; Gorman DJ; Grant RW; Dragoljevic D; Hong ES; Abdel-Latif A; Smyth SS; Choi SH; Korner J; Bornfeldt KE; Fisher EA; Dixit VD; Tall AR; Goldberg IJ; Murphy AJ. 2014. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab 19(5):821-35. [PubMed: 24807222]  [MGI Ref ID J:215261]

Najjar SM; Yang Y; Fernstrom MA; Lee SJ; Deangelis AM; Rjaily GA; Al-Share QY; Dai T; Miller TA; Ratnam S; Ruch RJ; Smith S; Lin SH; Beauchemin N; Oyarce AM. 2005. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2(1):43-53. [PubMed: 16054098]  [MGI Ref ID J:129840]

Nakagawa Y; Satoh A; Yabe S; Furusawa M; Tokushige N; Tezuka H; Mikami M; Iwata W; Shingyouchi A; Matsuzaka T; Kiwata S; Fujimoto Y; Shimizu H; Danno H; Yamamoto T; Ishii K; Karasawa T; Takeuchi Y; Iwasaki H; Shimada M; Kawakami Y; Urayama O; Sone H; Takekoshi K; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Yamada N; Shimano H. 2014. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes. Endocrinology 155(12):4706-19. [PubMed: 25233440]  [MGI Ref ID J:219686]

Nakagawa Y; Shimano H; Yoshikawa T; Ide T; Tamura M; Furusawa M; Yamamoto T; Inoue N; Matsuzaka T; Takahashi A; Hasty AH; Suzuki H; Sone H; Toyoshima H; Yahagi N; Yamada N. 2006. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 12(1):107-113. [PubMed: 16327801]  [MGI Ref ID J:104468]

Nakahara K; Bannai M; Maruyama K; Suzuki Y; Okame R; Murakami N. 2013. Characterization of a novel genetically obese mouse model demonstrating early onset hyperphagia and hyperleptinemia. Am J Physiol Endocrinol Metab 305(3):E451-63. [PubMed: 23736543]  [MGI Ref ID J:203210]

Nakamura T; Arduini A; Baccaro B; Furuhashi M; Hotamisligil GS. 2014. Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes 63(2):526-34. [PubMed: 24150608]  [MGI Ref ID J:209018]

Nakanishi N; Nakagawa Y; Tokushige N; Aoki N; Matsuzaka T; Ishii K; Yahagi N; Kobayashi K; Yatoh S; Takahashi A; Suzuki H; Urayama O; Yamada N; Shimano H. 2009. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 385(4):492-6. [PubMed: 19460359]  [MGI Ref ID J:151242]

Narvekar P; Berriel Diaz M; Krones-Herzig A; Hardeland U; Strzoda D; Stohr S; Frohme M; Herzig S. 2009. Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice. Diabetes 58(5):1040-9. [PubMed: 19188430]  [MGI Ref ID J:151130]

Nassir F; Adewole OL; Brunt EM; Abumrad NA. 2013. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice. J Lipid Res 54(11):2988-97. [PubMed: 23964120]  [MGI Ref ID J:203442]

Naveilhan P; Svensson L; Nystrom S; Ekstrand AJ; Ernfors P. 2002. Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides 23(6):1087-91. [PubMed: 12126735]  [MGI Ref ID J:102651]

Nawrocki AR; Rajala MW; Tomas E; Pajvani UB; Saha AK; Trumbauer ME; Pang Z; Chen AS; Ruderman NB; Chen H; Rossetti L; Scherer PE. 2006. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281(5):2654-60. [PubMed: 16326714]  [MGI Ref ID J:107486]

Neels JG; Badeanlou L; Hester KD; Samad F. 2009. Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. J Biol Chem 284(31):20692-8. [PubMed: 19494115]  [MGI Ref ID J:153182]

Neels JG; Pandey M; Hotamisligil GS; Samad F. 2006. Autoamplification of tumor necrosis factor-alpha: a potential mechanism for the maintenance of elevated tumor necrosis factor-alpha in male but not female obese mice. Am J Pathol 168(2):435-44. [PubMed: 16436658]  [MGI Ref ID J:106303]

Nelson JD; LeBoeuf RC; Bomsztyk K. 2011. Direct recruitment of insulin receptor and ERK signaling cascade to insulin-inducible gene loci. Diabetes 60(1):127-37. [PubMed: 20929976]  [MGI Ref ID J:170177]

Neumann UH; Chen S; Tam YY; Baker RK; Covey SD; Cullis PR; Kieffer TJ. 2014. IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice. Endocrinology 155(3):716-25. [PubMed: 24424049]  [MGI Ref ID J:208807]

Newberry EP; Kennedy SM; Xie Y; Luo J; Crooke RM; Graham MJ; Fu J; Piomelli D; Davidson NO. 2012. Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice. J Lipid Res 53(4):744-54. [PubMed: 22327204]  [MGI Ref ID J:184941]

Newhall KJ; Cummings DE; Nolan MA; McKnight GS. 2005. Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse. Mol Endocrinol 19(4):982-91. [PubMed: 15618289]  [MGI Ref ID J:97181]

Nishimura S; Manabe I; Nagasaki M; Seo K; Yamashita H; Hosoya Y; Ohsugi M; Tobe K; Kadowaki T; Nagai R; Sugiura S. 2008. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118(2):710-21. [PubMed: 18202748]  [MGI Ref ID J:131401]

Nishina PM; Lowe S; Wang J; Paigen B. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43(5):549-53. [PubMed: 8177042]  [MGI Ref ID J:18161]

Nishina PM; Naggert JK; Verstuyft J; Paigen B. 1994. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43(5):554-8. [PubMed: 8177043]  [MGI Ref ID J:19043]

Nisoli E; Briscini L; Giordano A; Tonello C; Wiesbrock SM; Uysal KT; Cinti S; Carruba MO; Hotamisligil GS. 2000. Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity. Proc Natl Acad Sci U S A 97(14):8033-8. [PubMed: 10884431]  [MGI Ref ID J:126631]

O'Donnell CP; Tankersley CG; Polotsky VP; Schwartz AR; Smith PL. 2000. Leptin, obesity, and respiratory function. Respir Physiol 119(2-3):163-70. [PubMed: 10722859]  [MGI Ref ID J:61254]

Oben JA; Roskams T; Yang S; Lin H; Sinelli N; Li Z; Torbenson M; Thomas SA; Diehl AM. 2003. Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun 308(2):284-92. [PubMed: 12901866]  [MGI Ref ID J:85049]

Obstfeld AE; Sugaru E; Thearle M; Francisco AM; Gayet C; Ginsberg HN; Ables EV; Ferrante AW Jr. 2010. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 59(4):916-25. [PubMed: 20103702]  [MGI Ref ID J:164331]

Oh CM; Namkung J; Go Y; Shong KE; Kim K; Kim H; Park BY; Lee HW; Jeon YH; Song J; Shong M; Yadav VK; Karsenty G; Kajimura S; Lee IK; Park S; Kim H. 2015. Regulation of systemic energy homeostasis by serotonin in adipose tissues. Nat Commun 6:6794. [PubMed: 25864946]  [MGI Ref ID J:222728]

Oh SS; Kaplan ML. 1995. Early treatment of obese (ob/ob) mice with triiodothyronine increases oxidative metabolism in muscle but not in brown adipose tissue or liver. J Nutr 125(1):112-24. [PubMed: 7815168]  [MGI Ref ID J:22377]

Oh SS; Kaplan ML. 1994. Early treatment of obese (ob/ob) mice with triiodothyronine increases oxygen consumption and temperature and decreases body fat content. Proc Soc Exp Biol Med 207(3):260-7. [PubMed: 7800681]  [MGI Ref ID J:22025]

Oh YS; Khil LY; Cho KA; Ryu SJ; Ha MK; Cheon GJ; Lee TS; Yoon JW; Jun HS; Park SC. 2008. A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia 51(6):1025-34. [PubMed: 18408913]  [MGI Ref ID J:137899]

Ohman MK; Shen Y; Obimba CI; Wright AP; Warnock M; Lawrence DA; Eitzman DT. 2008. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117(6):798-805. [PubMed: 18212290]  [MGI Ref ID J:145083]

Ohnishi M; Kato S; Akiyoshi J; Atfi A; Razzaque MS. 2011. Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions. FASEB J 25(6):2031-9. [PubMed: 21382979]  [MGI Ref ID J:172880]

Ohnishi M; Kato S; Razzaque MS. 2011. Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice. Biochem Biophys Res Commun 415(3):434-8. [PubMed: 22037453]  [MGI Ref ID J:178747]

Oishi K; Ohkura N; Wakabayashi M; Shirai H; Sato K; Matsuda J; Atsumi G; Ishida N. 2006. CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J Thromb Haemost 4(8):1774-80. [PubMed: 16879220]  [MGI Ref ID J:135847]

Okada T; Nishizawa H; Kurata A; Tamba S; Sonoda M; Yasui A; Kuroda Y; Hibuse T; Maeda N; Kihara S; Hadama T; Tobita K; Akamatsu S; Maeda K; Shimomura I; Funahashi T. 2008. URB is abundantly expressed in adipose tissue and dysregulated in obesity. Biochem Biophys Res Commun 367(2):370-6. [PubMed: 18178152]  [MGI Ref ID J:131031]

Okamoto K; Kakuma T; Fukuchi S; Masaki T; Sakata T; Yoshimatsu H. 2006. Sterol regulatory element binding protein (SREBP)-1 expression in brain is affected by age but not by hormones or metabolic changes. Brain Res 1081(1):19-27. [PubMed: 16554040]  [MGI Ref ID J:108103]

Oler AT; Attie AD. 2008. A rapid, microplate SNP genotype assay for the leptinob allele. J Lipid Res 49(5):1126-9. [PubMed: 18272929]  [MGI Ref ID J:133040]

Olson DP; Pulinilkunnil T; Cline GW; Shulman GI; Lowell BB. 2010. Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake. Proc Natl Acad Sci U S A 107(16):7598-603. [PubMed: 20368432]  [MGI Ref ID J:159285]

Ordway D; Henao-Tamayo M; Smith E; Shanley C; Harton M; Troudt J; Bai X; Basaraba RJ; Orme IM; Chan ED. 2008. Animal model of Mycobacterium abscessus lung infection. J Leukoc Biol 83(6):1502-11. [PubMed: 18310351]  [MGI Ref ID J:136571]

Ostertag A; Jones A; Rose AJ; Liebert M; Kleinsorg S; Reimann A; Vegiopoulos A; Berriel Diaz M; Strzoda D; Yamamoto M; Satoh T; Akira S; Herzig S. 2010. Control of adipose tissue inflammation through TRB1. Diabetes 59(8):1991-2000. [PubMed: 20522600]  [MGI Ref ID J:169640]

Otoda T; Takamura T; Misu H; Ota T; Murata S; Hayashi H; Takayama H; Kikuchi A; Kanamori T; Shima KR; Lan F; Takeda T; Kurita S; Ishikura K; Kita Y; Iwayama K; Kato K; Uno M; Takeshita Y; Yamamoto M; Tokuyama K; Iseki S; Tanaka K; Kaneko S. 2013. Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver. Diabetes 62(3):811-24. [PubMed: 23209186]  [MGI Ref ID J:208595]

Oury F; Khrimian L; Denny CA; Gardin A; Chamouni A; Goeden N; Huang YY; Lee H; Srinivas P; Gao XB; Suyama S; Langer T; Mann JJ; Horvath TL; Bonnin A; Karsenty G. 2013. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 155(1):228-41. [PubMed: 24074871]  [MGI Ref ID J:205218]

Ozcan L; Cristina de Souza J; Harari AA; Backs J; Olson EN; Tabas I. 2013. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab 18(6):803-15. [PubMed: 24268736]  [MGI Ref ID J:206150]

Ozcan L; Ergin AS; Lu A; Chung J; Sarkar S; Nie D; Myers MG Jr; Ozcan U. 2009. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 9(1):35-51. [PubMed: 19117545]  [MGI Ref ID J:144347]

Ozcan L; Wong CC; Li G; Xu T; Pajvani U; Park SK; Wronska A; Chen BX; Marks AR; Fukamizu A; Backs J; Singer HA; Yates JR 3rd; Accili D; Tabas I. 2012. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 15(5):739-51. [PubMed: 22503562]  [MGI Ref ID J:184607]

Padmalayam I; Hasham S; Saxena U; Pillarisetti S. 2009. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes 58(3):600-8. [PubMed: 19074983]  [MGI Ref ID J:146930]

Paglialunga S; Fisette A; Yan Y; Deshaies Y; Brouillette JF; Pekna M; Cianflone K. 2008. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol Endocrinol Metab 294(3):E521-9. [PubMed: 18160458]  [MGI Ref ID J:133454]

Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D. 2013. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med 19(8):1054-60. [PubMed: 23832089]  [MGI Ref ID J:199992]

Pajvani UB; Shawber CJ; Samuel VT; Birkenfeld AL; Shulman GI; Kitajewski J; Accili D. 2011. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 17(8):961-7. [PubMed: 21804540]  [MGI Ref ID J:174593]

Pajvani UB; Trujillo ME; Combs TP; Iyengar P; Jelicks L; Roth KA; Kitsis RN; Scherer PE. 2005. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11(7):797-803. [PubMed: 15965483]  [MGI Ref ID J:99639]

Pan D; Mao C; Zou T; Yao AY; Cooper MP; Boyartchuk V; Wang YX. 2012. The histone demethylase Jhdm1a regulates hepatic gluconeogenesis. PLoS Genet 8(6):e1002761. [PubMed: 22719268]  [MGI Ref ID J:187067]

Pang Z; Nakagami H; Osako MK; Koriyama H; Nakagami F; Tomioka H; Shimamura M; Kurinami H; Takami Y; Morishita R; Rakugi H. 2014. Therapeutic vaccine against DPP4 improves glucose metabolism in mice. Proc Natl Acad Sci U S A 111(13):E1256-63. [PubMed: 24639549]  [MGI Ref ID J:207292]

Panzhinskiy E; Hua Y; Culver B; Ren J; Nair S. 2013. Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes. Diabetologia 56(3):598-607. [PubMed: 23178931]  [MGI Ref ID J:194636]

Park J; Rho HK; Kim KH; Choe SS; Lee YS; Kim JB. 2005. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol 25(12):5146-57. [PubMed: 15923630]  [MGI Ref ID J:99224]

Park KW; Waki H; Villanueva CJ; Monticelli LA; Hong C; Kang S; Macdougald OA; Goldrath AW; Tontonoz P. 2008. Inhibitor of DNA Binding 2 Is a Small Molecule-Inducible Modulator of Peroxisome Proliferator-Activated Receptor-{gamma} Expression and Adipocyte Differentiation. Mol Endocrinol 22(9):2038-48. [PubMed: 18562627]  [MGI Ref ID J:138276]

Park SW; Zhou Y; Lee J; Lu A; Sun C; Chung J; Ueki K; Ozcan U. 2010. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat Med 16(4):429-37. [PubMed: 20348926]  [MGI Ref ID J:159304]

Park SY; Kim KH; Seo KW; Bae JU; Kim YH; Lee SJ; Lee WS; Kim CD. 2014. Resistin derived from diabetic perivascular adipose tissue up-regulates vascular expression of osteopontin via the AP-1 signalling pathway. J Pathol 232(1):87-97. [PubMed: 24089355]  [MGI Ref ID J:203984]

Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR. 2006. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice. J Endocrinol 191(1):93-100. [PubMed: 17065392]  [MGI Ref ID J:114957]

Parker JC; VanVolkenburg MA; Nardone NA; Hargrove DM; Andrews KM. 1997. Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III. Biochem Biophys Res Commun 236(3):665-9. [PubMed: 9245710]  [MGI Ref ID J:42064]

Parton LE; Ye CP; Coppari R; Enriori PJ; Choi B; Zhang CY; Xu C; Vianna CR; Balthasar N; Lee CE; Elmquist JK; Cowley MA; Lowell BB. 2007. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449(7159):228-32. [PubMed: 17728716]  [MGI Ref ID J:125165]

Patel M; Gleason A; O'Malley S; Connolly B; Suresch D; Virostko J; Phillips N; Lin SA; Chen TB; Klimas M; Hargreaves RJ; Sur C; Williams DL Jr; Powers AC; Bednar B. 2014. Non-invasive bioluminescence imaging of beta-cell function in obese-hyperglycemic [ob/ob] mice. PLoS One 9(9):e106693. [PubMed: 25198535]  [MGI Ref ID J:221524]

Patsouris D; Li PP; Thapar D; Chapman J; Olefsky JM; Neels JG. 2008. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8(4):301-9. [PubMed: 18840360]  [MGI Ref ID J:143426]

Paz JC; Park SH; Phillips N; Matsumura S; Tsai WW; Kasper L; Brindle PK; Zhang G; Zhou MM; Wright PE; Montminy M. 2014. Combinatorial regulation of a signal-dependent activator by phosphorylation and acetylation. Proc Natl Acad Sci U S A 111(48):17116-21. [PubMed: 25404345]  [MGI Ref ID J:216728]

Pelleymounter MA; Cullen MJ; Baker MB; Hecht R; Winters D; Boone T; Collins F. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice [see comments] Science 269(5223):540-3. [PubMed: 7624776]  [MGI Ref ID J:29162]

Peng XG; Ju S; Fang F; Wang Y; Fang K; Cui X; Liu G; Li P; Mao H; Teng GJ. 2013. Comparison of brown and white adipose tissue fat fractions in ob, seipin, and Fsp27 gene knockout mice by chemical shift-selective imaging and (1)H-MR spectroscopy. Am J Physiol Endocrinol Metab 304(2):E160-7. [PubMed: 23149622]  [MGI Ref ID J:195942]

Peng XG; X5f6d X65b0 X6842; Ju S; X5c45 X80dc X7ea2; Qin Y; X79e6 X96e8 X59e3; Fang F; X65b9 X82b3; Cui X; X5d14 X946b; Liu G; X5218 X56fd X5e86; Ni Y; X502a X4ee5 X6210; Teng GJ; X6ed5 X768b X519b. 2011. Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy. J Lipid Res 52(10):1847-1855. [PubMed: 21737754]  [MGI Ref ID J:176075]

Perera HK; Caldwell ME; Hayes-Patterson D; Teng L; Peshavaria M; Jetton TL; Labosky PA. 2006. Expression and shifting subcellular localization of the transcription factor, Foxd3, in embryonic and adult pancreas. Gene Expr Patterns 6(8):971-7. [PubMed: 16750430]  [MGI Ref ID J:112316]

Pessentheiner AR; Pelzmann HJ; Walenta E; Schweiger M; Groschner LN; Graier WF; Kolb D; Uno K; Miyazaki T; Nitta A; Rieder D; Prokesch A; Bogner-Strauss JG. 2013. NAT8L (N-acetyltransferase 8-like) accelerates lipid turnover and increases energy expenditure in brown adipocytes. J Biol Chem 288(50):36040-51. [PubMed: 24155240]  [MGI Ref ID J:207207]

Petrolonis AJ; Yang Q; Tummino PJ; Fish SM; Prack AE; Jain S; Parsons TF; Li P; Dales NA; Ge L; Langston SP; Schuller AG; An WF; Tartaglia LA; Chen H; Hong SB. 2004. Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP). J Biol Chem 279(14):13976-83. [PubMed: 14722102]  [MGI Ref ID J:124542]

Phan LK; Chung WK; Leibel RL. 2006. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity. Am J Physiol Endocrinol Metab 291(3):E611-20. [PubMed: 16638826]  [MGI Ref ID J:112364]

Phan LK; Lin F; LeDuc CA; Chung WK; Leibel RL. 2002. The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. J Clin Invest 110(10):1449-59. [PubMed: 12438443]  [MGI Ref ID J:80182]

Pini M; Rhodes DH; Castellanos KJ; Hall AR; Cabay RJ; Chennuri R; Grady EF; Fantuzzi G. 2012. Role of IL-6 in the resolution of pancreatitis in obese mice. J Leukoc Biol 91(6):957-66. [PubMed: 22427681]  [MGI Ref ID J:184912]

Pinto S; Roseberry AG; Liu H; Diano S; Shanabrough M; Cai X; Friedman JM; Horvath TL. 2004. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304(5667):110-5. [PubMed: 15064421]  [MGI Ref ID J:90242]

Plaisancie P; Ducroc R; El Homsi M; Tsocas A; Guilmeau S; Zoghbi S; Thibaudeau O; Bado A. 2006. Luminal leptin activates mucin-secreting goblet cells in the large bowel. Am J Physiol Gastrointest Liver Physiol 290(4):G805-12. [PubMed: 16455789]  [MGI Ref ID J:109110]

Polotsky VY; Li J; Punjabi NM; Rubin AE; Smith PL; Schwartz AR; O'Donnell CP. 2003. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552(Pt 1):253-64. [PubMed: 12878760]  [MGI Ref ID J:105382]

Polotsky VY; Wilson JA; Smaldone MC; Haines AS; Hurn PD; Tankersley CG; Smith PL; Schwartz AR; O'Donnell CP. 2001. Female gender exacerbates respiratory depression in leptin-deficient obesity. Am J Respir Crit Care Med 164(8 Pt 1):1470-5. [PubMed: 11704598]  [MGI Ref ID J:94673]

Pons S; Martin V; Portal L; Zini R; Morin D; Berdeaux A; Ghaleh B. 2013. Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. J Mol Cell Cardiol 54:82-9. [PubMed: 23201226]  [MGI Ref ID J:194190]

Popescu IR; Helleboid-Chapman A; Lucas A; Vandewalle B; Dumont J; Bouchaert E; Derudas B; Kerr-Conte J; Caron S; Pattou F; Staels B. 2010. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett 584(13):2845-51. [PubMed: 20447400]  [MGI Ref ID J:161322]

Poy MN; Hausser J; Trajkovski M; Braun M; Collins S; Rorsman P; Zavolan M; Stoffel M. 2009. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 106(14):5813-8. [PubMed: 19289822]  [MGI Ref ID J:147572]

Pralong FP; Gonzales C; Voirol MJ; Palmiter RD; Brunner HR; Gaillard RC; Seydoux J; Pedrazzini T. 2002. The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J 16(7):712-4. [PubMed: 11978737]  [MGI Ref ID J:120451]

Prawitt J; Abdelkarim M; Stroeve JH; Popescu I; Duez H; Velagapudi VR; Dumont J; Bouchaert E; van Dijk TH; Lucas A; Dorchies E; Daoudi M; Lestavel S; Gonzalez FJ; Oresic M; Cariou B; Kuipers F; Caron S; Staels B. 2011. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 60(7):1861-71. [PubMed: 21593203]  [MGI Ref ID J:186756]

Prieur X; Mok CY; Velagapudi VR; Nunez V; Fuentes L; Montaner D; Ishikawa K; Camacho A; Barbarroja N; O'Rahilly S; Sethi JK; Dopazo J; Oresic M; Ricote M; Vidal-Puig A. 2011. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 60(3):797-809. [PubMed: 21266330]  [MGI Ref ID J:170128]

Procaccini C; De Rosa V; Galgani M; Abanni L; Cali G; Porcellini A; Carbone F; Fontana S; Horvath TL; La Cava A; Matarese G. 2010. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33(6):929-41. [PubMed: 21145759]  [MGI Ref ID J:167293]

Procaccini C; De Rosa V; Galgani M; Carbone F; Cassano S; Greco D; Qian K; Auvinen P; Cali G; Stallone G; Formisano L; La Cava A; Matarese G. 2012. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol 189(6):2941-53. [PubMed: 22904304]  [MGI Ref ID J:189915]

Purushotham A; Wendel AA; Liu LF; Belury MA. 2007. Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J Lipid Res 48(2):444-52. [PubMed: 17050906]  [MGI Ref ID J:118228]

Qi L; Saberi M; Zmuda E; Wang Y; Altarejos J; Zhang X; Dentin R; Hedrick S; Bandyopadhyay G; Hai T; Olefsky J; Montminy M. 2009. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab 9(3):277-86. [PubMed: 19254572]  [MGI Ref ID J:147096]

Qi Y; Nie Z; Lee YS; Singhal NS; Scherer PE; Lazar MA; Ahima RS. 2006. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55(11):3083-90. [PubMed: 17065346]  [MGI Ref ID J:116550]

Qiang L; Lin HV; Kim-Muller JY; Welch CL; Gu W; Accili D. 2011. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab 14(6):758-67. [PubMed: 22078933]  [MGI Ref ID J:179674]

Qiao L; Lee B; Kinney B; Yoo HS; Shao J. 2011. Energy intake and adiponectin gene expression. Am J Physiol Endocrinol Metab 300(5):E809-16. [PubMed: 21325106]  [MGI Ref ID J:172309]

Qiu J; Ogus S; Mounzih K; Ewart-Toland A; Chehab FF. 2001. Leptin-deficient mice backcrossed to the BALB/cJ genetic background have reduced adiposity, enhanced fertility, normal body temperature, and severe diabetes. Endocrinology 142(8):3421-5. [PubMed: 11459786]  [MGI Ref ID J:94784]

Quan W; Hur KY; Lim Y; Oh SH; Lee JC; Kim KH; Kim GH; Kim SW; Kim HL; Lee MK; Kim KW; Kim J; Komatsu M; Lee MS. 2012. Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice. Diabetologia 55(2):392-403. [PubMed: 22075916]  [MGI Ref ID J:181812]

Quennell JH; Howell CS; Roa J; Augustine RA; Grattan DR; Anderson GM. 2011. Leptin deficiency and diet-induced obesity reduce hypothalamic kisspeptin expression in mice. Endocrinology 152(4):1541-50. [PubMed: 21325051]  [MGI Ref ID J:173859]

Rafael J; Herling AW. 2000. Leptin effect in ob/ob mice under thermoneutral conditions depends not necessarily on central satiation. Am J Physiol Regul Integr Comp Physiol 278(3):R790-5. [PubMed: 10712302]  [MGI Ref ID J:60885]

Raines SM; Richards OC; Schneider LR; Schueler KL; Rabaglia ME; Oler AT; Stapleton DS; Genove G; Dawson JA; Betsholtz C; Attie AD. 2011. Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity. Am J Physiol Endocrinol Metab 301(3):E517-26. [PubMed: 21673305]  [MGI Ref ID J:182196]

Rajala MW; Qi Y; Patel HR; Takahashi N; Banerjee R; Pajvani UB; Sinha MK; Gingerich RL; Scherer PE; Ahima RS. 2004. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53(7):1671-9. [PubMed: 15220189]  [MGI Ref ID J:107202]

Raju SV; Zheng M; Schuleri KH; Phan AC; Bedja D; Saraiva RM; Yiginer O; Vandegaer K; Gabrielson KL; O'donnell CP; Berkowitz DE; Barouch LA; Hare JM. 2006. Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity. Proc Natl Acad Sci U S A 103(11):4222-7. [PubMed: 16537512]  [MGI Ref ID J:107586]

Ramadori G; Lee CE; Bookout AL; Lee S; Williams KW; Anderson J; Elmquist JK; Coppari R. 2008. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 28(40):9989-96. [PubMed: 18829956]  [MGI Ref ID J:143464]

Ranieri SC; Fusco S; Panieri E; Labate V; Mele M; Tesori V; Ferrara AM; Maulucci G; De Spirito M; Martorana GE; Galeotti T; Pani G. 2010. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proc Natl Acad Sci U S A 107(30):13420-5. [PubMed: 20624962]  [MGI Ref ID J:162570]

Rashid A; Wu TC; Huang CC; Chen CH; Lin HZ; Yang SQ; Lee FY; Diehl AM. 1999. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29(4):1131-8. [PubMed: 10094957]  [MGI Ref ID J:55979]

Rentsch J; Levens N; Chiesi M. 1995. Recombinant ob-gene product reduces food intake in fasted mice. Biochem Biophys Res Commun 214(1):131-6. [PubMed: 7669033]  [MGI Ref ID J:28578]

Ribas V; Drew BG; Le JA; Soleymani T; Daraei P; Sitz D; Mohammad L; Henstridge DC; Febbraio MA; Hewitt SC; Korach KS; Bensinger SJ; Hevener AL. 2011. Myeloid-specific estrogen receptor {alpha} deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci U S A 108(39):16457-62. [PubMed: 21900603]  [MGI Ref ID J:176674]

Ribeiro AC; Ceccarini G; Dupre C; Friedman JM; Pfaff DW; Mark AL. 2011. Contrasting effects of leptin on food anticipatory and total locomotor activity. PLoS One 6(8):e23364. [PubMed: 21853117]  [MGI Ref ID J:176508]

Riser BL; Najmabadi F; Garchow K; Barnes JL; Peterson DR; Sukowski EJ. 2014. Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy. Am J Pathol 184(11):2908-21. [PubMed: 25193594]  [MGI Ref ID J:216375]

Ro S; Park C; Jin J; Zheng H; Blair PJ; Redelman D; Ward SM; Yan W; Sanders KM. 2010. A model to study the phenotypic changes of interstitial cells of Cajal in gastrointestinal diseases. Gastroenterology 138(3):1068-78.e1-2. [PubMed: 19917283]  [MGI Ref ID J:168676]

Robertson S; Ishida-Takahashi R; Tawara I; Hu J; Patterson CM; Jones JC; Kulkarni RN; Myers MG Jr. 2010. Insufficiency of Janus kinase 2-autonomous leptin receptor signals for most physiologic leptin actions. Diabetes 59(4):782-90. [PubMed: 20068132]  [MGI Ref ID J:164339]

Rodero MP; Hodgson SS; Hollier B; Combadiere C; Khosrotehrani K. 2013. Reduced Il17a expression distinguishes a Ly6c(lo)MHCII(hi) macrophage population promoting wound healing. J Invest Dermatol 133(3):783-92. [PubMed: 23235530]  [MGI Ref ID J:196510]

Rodriguez-Cuenca S; Carobbio S; Velagapudi VR; Barbarroja N; Moreno-Navarrete JM; Tinahones FJ; Fernandez-Real JM; Oresic M; Vidal-Puig A. 2012. Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol 32(8):1555-65. [PubMed: 22310664]  [MGI Ref ID J:183680]

Rogove AD; Lu W; Tsirka SE. 2002. Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration. Cell Death Differ 9(8):801-6. [PubMed: 12107823]  [MGI Ref ID J:115569]

Rong X; Albert CJ; Hong C; Duerr MA; Chamberlain BT; Tarling EJ; Ito A; Gao J; Wang B; Edwards PA; Jung ME; Ford DA; Tontonoz P. 2013. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metab 18(5):685-97. [PubMed: 24206663]  [MGI Ref ID J:206173]

Ropelle ER; Flores MB; Cintra DE; Rocha GZ; Pauli JR; Morari J; de Souza CT; Moraes JC; Prada PO; Guadagnini D; Marin RM; Oliveira AG; Augusto TM; Carvalho HF; Velloso LA; Saad MJ; Carvalheira JB. 2010. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 8(8):. [PubMed: 20808781]  [MGI Ref ID J:166779]

Ropelle ER; Pauli JR; Fernandes MF; Rocco SA; Marin RM; Morari J; Souza KK; Dias MM; Gomes-Marcondes MC; Gontijo JA; Franchini KG; Velloso LA; Saad MJ; Carvalheira JB. 2008. A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 57(3):594-605. [PubMed: 18057094]  [MGI Ref ID J:132294]

Roseberry AG; Liu H; Jackson AC; Cai X; Friedman JM. 2004. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41(5):711-22. [PubMed: 15003171]  [MGI Ref ID J:88691]

Roseberry AG; Painter T; Mark GP; Williams JT. 2007. Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci 27(26):7021-7. [PubMed: 17596451]  [MGI Ref ID J:122961]

Ruddle NH; Conta BS; Leinwand L; Kozak C; Ruddle F; Besmer P; Baltimore D. 1978. Assignment of the receptor for ecotropic murine leukemia virus to mouse chromosome 5. J Exp Med 148(2):451-65. [PubMed: 212501]  [MGI Ref ID J:6045]

Rulifson IC; Majeti JZ; Xiong Y; Hamburger A; Lee KJ; Miao L; Lu M; Gardner J; Gong Y; Wu H; Case R; Yeh WC; Richards WG; Baribault H; Li Y. 2014. Inhibition of secreted frizzled-related protein 5 improves glucose metabolism. Am J Physiol Endocrinol Metab 307(12):E1144-52. [PubMed: 25370851]  [MGI Ref ID J:218529]

Ruschke K; Ebelt H; Kloting N; Boettger T; Raum K; Bluher M; Braun T. 2009. Defective peripheral nerve development is linked to abnormal architecture and metabolic activity of adipose tissue in Nscl-2 mutant mice. PLoS ONE 4(5):e5516. [PubMed: 19436734]  [MGI Ref ID J:148882]

Russell ST; Tisdale MJ. 2012. Role of beta-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-alpha2-glycoprotien (ZAG). Biochim Biophys Acta 1821(4):590-9. [PubMed: 22227600]  [MGI Ref ID J:182566]

Sabeva NS; Rouse EJ; Graf GA. 2007. Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. J Biol Chem 282(31):22397-405. [PubMed: 17561514]  [MGI Ref ID J:124801]

Sahai A; Malladi P; Pan X; Paul R; Melin-Aldana H; Green RM; Whitington PF. 2004. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287(5):G1035-43. [PubMed: 15256362]  [MGI Ref ID J:96143]

Sainsbury A; Schwarzer C; Couzens M; Herzog H. 2002. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51(12):3420-7. [PubMed: 12453895]  [MGI Ref ID J:107169]

Sainsbury A; Schwarzer C; Couzens M; Jenkins A; Oakes SR; Ormandy CJ; Herzog H. 2002. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev 16(9):1077-88. [PubMed: 12000791]  [MGI Ref ID J:76479]

Sainz N; Rodriguez A; Catalan V; Becerril S; Ramirez B; Lancha A; Burgos-Ramos E; Gomez-Ambrosi J; Fruhbeck G. 2012. Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice. PLoS One 7(1):e29389. [PubMed: 22253718]  [MGI Ref ID J:184323]

Sajan MP; Ivey RA; Lee MC; Farese RV. 2015. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation. J Lipid Res 56(1):70-80. [PubMed: 25395359]  [MGI Ref ID J:217398]

Sakamaki J; Fu A; Reeks C; Baird S; Depatie C; Al Azzabi M; Bardeesy N; Gingras AC; Yee SP; Screaton RA. 2014. Role of the SIK2-p35-PJA2 complex in pancreatic beta-cell functional compensation. Nat Cell Biol 16(3):234-44. [PubMed: 24561619]  [MGI Ref ID J:212985]

Sakkou M; Wiedmer P; Anlag K; Hamm A; Seuntjens E; Ettwiller L; Tschop MH; Treier M. 2007. A role for brain-specific homeobox factor bsx in the control of hyperphagia and locomotory behavior. Cell Metab 5(6):450-63. [PubMed: 17550780]  [MGI Ref ID J:122746]

Saleh J; Blevins JE; Havel PJ; Barrett JA; Gietzen DW; Cianflone K. 2001. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord 25(5):705-13. [PubMed: 11360154]  [MGI Ref ID J:69140]

Saleh MC; Wheeler MB; Chan CB. 2006. Endogenous islet uncoupling protein-2 expression and loss of glucose homeostasis in ob/ob mice. J Endocrinol 190(3):659-67. [PubMed: 17003267]  [MGI Ref ID J:112889]

Samad F; Hester KD; Yang G; Hannun YA; Bielawski J. 2006. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55(9):2579-87. [PubMed: 16936207]  [MGI Ref ID J:116590]

Samad F; Pandey M; Loskutoff DJ. 1998. Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A 95(13):7591-6. [PubMed: 9636194]  [MGI Ref ID J:48272]

Samad F; Uysal KT; Wiesbrock SM; Pandey M; Hotamisligil GS; Loskutoff DJ. 1999. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A 96(12):6902-7. [PubMed: 10359811]  [MGI Ref ID J:55722]

Saraiva RM; Minhas KM; Zheng M; Pitz E; Treuer A; Gonzalez D; Schuleri KH; Vandegaer KM; Barouch LA; Hare JM. 2007. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice. Nitric Oxide 16(3):331-8. [PubMed: 17307368]  [MGI Ref ID J:124484]

Saraswathi V; Morrow JD; Hasty AH. 2009. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice. J Nutr 139(12):2380-6. [PubMed: 19864403]  [MGI Ref ID J:154774]

Sato S; Hanada R; Kimura A; Abe T; Matsumoto T; Iwasaki M; Inose H; Ida T; Mieda M; Takeuchi Y; Fukumoto S; Fujita T; Kato S; Kangawa K; Kojima M; Shinomiya K; Takeda S. 2007. Central control of bone remodeling by neuromedin U. Nat Med 13(10):1234-40. [PubMed: 17873881]  [MGI Ref ID J:129930]

Sato S; Ogura Y; Tajrishi MM; Kumar A. 2015. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. FASEB J 29(3):988-1002. [PubMed: 25466899]  [MGI Ref ID J:219637]

Sato S; Sakurai T; Ogasawara J; Takahashi M; Izawa T; Imaizumi K; Taniguchi N; Ohno H; Kizaki T. 2014. A circadian clock gene, Rev-erbalpha, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. J Immunol 192(1):407-17. [PubMed: 24307731]  [MGI Ref ID J:207168]

Sawada N; Jiang A; Takizawa F; Safdar A; Manika A; Tesmenitsky Y; Kang KT; Bischoff J; Kalwa H; Sartoretto JL; Kamei Y; Benjamin LE; Watada H; Ogawa Y; Higashikuni Y; Kessinger CW; Jaffer FA; Michel T; Sata M; Croce K; Tanaka R; Arany Z. 2014. Endothelial PGC-1alpha mediates vascular dysfunction in diabetes. Cell Metab 19(2):246-58. [PubMed: 24506866]  [MGI Ref ID J:210653]

Schafer K; Fujisawa K; Konstantinides S; Loskutoff DJ. 2001. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 15(10):1840-2. [PubMed: 11481248]  [MGI Ref ID J:70695]

Schneider JG; Finck BN; Ren J; Standley KN; Takagi M; Maclean KH; Bernal-Mizrachi C; Muslin AJ; Kastan MB; Semenkovich CF. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4(5):377-89. [PubMed: 17084711]  [MGI Ref ID J:129761]

Schurmann C; Goren I; Linke A; Pfeilschifter J; Frank S. 2014. Deregulated unfolded protein response in chronic wounds of diabetic ob/ob mice: a potential connection to inflammatory and angiogenic disorders in diabetes-impaired wound healing. Biochem Biophys Res Commun 446(1):195-200. [PubMed: 24583133]  [MGI Ref ID J:219132]

Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D Jr; Woods SC; Seeley RJ; Weigle DS. 1996. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45(4):531-5. [PubMed: 8603777]  [MGI Ref ID J:32265]

Schwartz MW; Erickson JC; Baskin DG; Palmiter RD. 1998. Effect of fasting and leptin deficiency on hypothalamic neuropeptide Y gene transcription in vivo revealed by expression of a lacZ reporter gene. Endocrinology 139(5):2629-35. [PubMed: 9564880]  [MGI Ref ID J:114273]

Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ. 2000. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes 49(9):1552-60. [PubMed: 10969840]  [MGI Ref ID J:64159]

Segal-Lieberman G; Bradley RL; Kokkotou E; Carlson M; Trombly DJ; Wang X; Bates S; Myers MG Jr; Flier JS; Maratos-Flier E. 2003. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci U S A 100(17):10085-90. [PubMed: 12897241]  [MGI Ref ID J:85176]

Seimon TA; Nadolski MJ; Liao X; Magallon J; Nguyen M; Feric NT; Koschinsky ML; Harkewicz R; Witztum JL; Tsimikas S; Golenbock D; Moore KJ; Tabas I. 2010. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12(5):467-82. [PubMed: 21035758]  [MGI Ref ID J:167910]

Sekiya M; Osuga J; Okazaki H; Yahagi N; Harada K; Shen WJ; Tamura Y; Tomita S; Iizuka Y; Ohashi K; Okazaki M; Sata M; Nagai R; Fujita T; Shimano H; Kraemer FB; Yamada N; Ishibashi S. 2004. Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lep ob/ob mice. J Biol Chem 279(15):15084-90. [PubMed: 14752112]  [MGI Ref ID J:89519]

Sekiya M; Osuga J; Yahagi N; Okazaki H; Tamura Y; Igarashi M; Takase S; Harada K; Okazaki S; Iizuka Y; Ohashi K; Yagyu H; Okazaki M; Gotoda T; Nagai R; Kadowaki T; Shimano H; Yamada N; Ishibashi S. 2008. Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis. J Lipid Res 49(8):1829-38. [PubMed: 18480494]  [MGI Ref ID J:138444]

Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H. 2003. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38(6):1529-39. [PubMed: 14647064]  [MGI Ref ID J:106018]

Sekiya M; Yahagi N; Tamura Y; Okazaki H; Igarashi M; Ohta K; Takanashi M; Kumagai M; Takase S; Nishi M; Takeuchi Y; Izumida Y; Kubota M; Ohashi K; Iizuka Y; Yagyu H; Gotoda T; Nagai R; Shimano H; Yamada N; Kadowaki T; Ishibashi S; Osuga J. 2009. Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lep ob/ob mice. Biochem Biophys Res Commun 387(3):511-5. [PubMed: 19619509]  [MGI Ref ID J:152537]

Sell H; Berger JP; Samson P; Castriota G; Lalonde J; Deshaies Y; Richard D. 2004. Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Endocrinology 145(8):3925-34. [PubMed: 15131020]  [MGI Ref ID J:105624]

Sennello JA; Fayad R; Morris AM; Eckel RH; Asilmaz E; Montez J; Friedman JM; Dinarello CA; Fantuzzi G. 2005. Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146(5):2157-64. [PubMed: 15677756]  [MGI Ref ID J:109480]

Sennello JA; Fayad R; Pini M; Gove ME; Ponemone V; Cabay RJ; Siegmund B; Dinarello CA; Fantuzzi G. 2008. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proc Natl Acad Sci U S A 105(23):8085-90. [PubMed: 18515422]  [MGI Ref ID J:137046]

Senokuchi T; Liang CP; Seimon TA; Han S; Matsumoto M; Banks AS; Paik JH; DePinho RA; Accili D; Tabas I; Tall AR. 2008. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 57(11):2967-76. [PubMed: 18728232]  [MGI Ref ID J:142468]

Seth RK; Kumar A; Das S; Kadiiska MB; Michelotti G; Diehl AM; Chatterjee S. 2013. Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice. Toxicol Sci 134(2):291-303. [PubMed: 23640861]  [MGI Ref ID J:206893]

Sha H; He Y; Chen H; Wang C; Zenno A; Shi H; Yang X; Zhang X; Qi L. 2009. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab 9(6):556-64. [PubMed: 19490910]  [MGI Ref ID J:149823]

Sha H; Yang L; Liu M; Xia S; Liu Y; Liu F; Kersten S; Qi L. 2014. Adipocyte spliced form of X-box-binding protein 1 promotes adiponectin multimerization and systemic glucose homeostasis. Diabetes 63(3):867-79. [PubMed: 24241534]  [MGI Ref ID J:208982]

Shafrir E; Ziv E. 2009. A useful list of spontaneously arising animal models of obesity and diabetes. Am J Physiol Endocrinol Metab 296(6):E1450-2. [PubMed: 19468077]  [MGI Ref ID J:149667]

Sharma A; Bartell SM; Baile CA; Chen B; Podolsky RH; McIndoe RA; She JX. 2010. Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice. PLoS One 5(8):. [PubMed: 20808936]  [MGI Ref ID J:164008]

Sharma SD; Katiyar SK. 2010. Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol 244(3):328-35. [PubMed: 20122948]  [MGI Ref ID J:160387]

Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310(5754):1642-6. [PubMed: 16308421]  [MGI Ref ID J:104202]

Shemesh A; Abdulla A; Yang F; Chua SC; Pessin JE; Zong H. 2014. The antidepressant trans-2-phenylcyclopropylamine protects mice from high-fat-diet-induced obesity. PLoS One 9(2):e89199. [PubMed: 24586592]  [MGI Ref ID J:213762]

Shen L; Tso P; Woods SC; Clegg DJ; Barber KL; Carey K; Liu M. 2008. Brain apolipoprotein E: an important regulator of food intake in rats. Diabetes 57(8):2092-8. [PubMed: 18559657]  [MGI Ref ID J:141777]

Sheng L; Cho KW; Zhou Y; Shen H; Rui L. 2011. Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid beta-oxidation. J Biol Chem 286(44):38128-35. [PubMed: 21908604]  [MGI Ref ID J:178167]

Sheng L; Zhou Y; Chen Z; Ren D; Cho KW; Jiang L; Shen H; Sasaki Y; Rui L. 2012. NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med 18(6):943-9. [PubMed: 22581287]  [MGI Ref ID J:187458]

Shi H; Kokoeva MV; Inouye K; Tzameli I; Yin H; Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116(11):3015-25. [PubMed: 17053832]  [MGI Ref ID J:114608]

Shi H; Tzameli I; Bjorbaek C; Flier JS. 2004. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 279(33):34733-40. [PubMed: 15181014]  [MGI Ref ID J:121205]

Shigemura N; Ohta R; Kusakabe Y; Miura H; Hino A; Koyano K; Nakashima K; Ninomiya Y. 2004. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures. Endocrinology 145(2):839-47. [PubMed: 14592964]  [MGI Ref ID J:96388]

Shimomura I; Bashmakov Y; Horton JD. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274(42):30028-32. [PubMed: 10514488]  [MGI Ref ID J:58018]

Shimomura I; Matsuda M; Hammer RE; Bashmakov Y; Brown MS; Goldstein JL. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6(1):77-86. [PubMed: 10949029]  [MGI Ref ID J:63895]

Shutter JR; Graham M; Kinsey AC; Scully S; Luthy R; Stark KL. 1997. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11(5):593-602. [PubMed: 9119224]  [MGI Ref ID J:39234]

Siegmund B; Lehr HA; Fantuzzi G. 2002. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122(7):2011-25. [PubMed: 12055606]  [MGI Ref ID J:109852]

Siegmund B; Sennello JA; Lehr HA; Batra A; Fedke I; Zeitz M; Fantuzzi G. 2004. Development of intestinal inflammation in double IL-10- and leptin-deficient mice. J Leukoc Biol 76(4):782-6. [PubMed: 15240754]  [MGI Ref ID J:93117]

Silvani A; Bastianini S; Berteotti C; Franzini C; Lenzi P; Lo Martire V; Zoccoli G. 2009. Sleep modulates hypertension in leptin-deficient obese mice. Hypertension 53(2):251-5. [PubMed: 19114642]  [MGI Ref ID J:164998]

Silver DL; Jiang XC; Tall AR. 1999. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 274(7):4140-6. [PubMed: 9933608]  [MGI Ref ID J:115228]

Silver DL; Wang N; Tall AR. 2000. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest 105(2):151-9. [PubMed: 10642593]  [MGI Ref ID J:124840]

Singh A; Wirtz M; Parker N; Hogan M; Strahler J; Michailidis G; Schmidt S; Vidal-Puig A; Diano S; Andrews P; Brand MD; Friedman J. 2009. Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc Natl Acad Sci U S A 106(31):13100-5. [PubMed: 19622746]  [MGI Ref ID J:152013]

Singhal NS; Patel RT; Qi Y; Lee YS; Ahima RS. 2008. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295(2):E331-8. [PubMed: 18505833]  [MGI Ref ID J:139905]

Sjoholm A; Arkhammar P; Berggren PO; Andersson A. 2001. Polyamines in pancreatic islets of obese-hyperglycemic (ob/ob) mice of different ages. Am J Physiol Cell Physiol 280(2):C317-23. [PubMed: 11208527]  [MGI Ref ID J:68066]

Sloan C; Tuinei J; Nemetz K; Frandsen J; Soto J; Wride N; Sempokuya T; Alegria L; Bugger H; Abel ED. 2011. Central Leptin Signaling Is Required to Normalize Myocardial Fatty Acid Oxidation Rates in Caloric-Restricted ob/ob Mice. Diabetes 60(5):1424-34. [PubMed: 21441440]  [MGI Ref ID J:171744]

Snell GD. 1951. Mutant stock V Mouse News Lett 5:29.  [MGI Ref ID J:178288]

So JS; Hur KY; Tarrio M; Ruda V; Frank-Kamenetsky M; Fitzgerald K; Koteliansky V; Lichtman AH; Iwawaki T; Glimcher LH; Lee AH. 2012. Silencing of lipid metabolism genes through IRE1alpha-mediated mRNA decay lowers plasma lipids in mice. Cell Metab 16(4):487-99. [PubMed: 23040070]  [MGI Ref ID J:190921]

Solinas G; Naugler W; Galimi F; Lee MS; Karin M. 2006. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A 103(44):16454-9. [PubMed: 17050683]  [MGI Ref ID J:116088]

Song DD; Chen Y; Li ZY; Guan YF; Zou DJ; Miao CY. 2013. Protein tyrosine phosphatase 1B inhibits adipocyte differentiation and mediates TNFalpha action in obesity. Biochim Biophys Acta 1831(8):1368-76. [PubMed: 23711960]  [MGI Ref ID J:202539]

Sorensen H; Brand CL; Neschen S; Holst JJ; Fosgerau K; Nishimura E; Shulman GI. 2006. Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice. Diabetes 55(10):2843-8. [PubMed: 17003351]  [MGI Ref ID J:116540]

Soukas A; Cohen P; Socci ND; Friedman JM. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14(8):963-80. [PubMed: 10783168]  [MGI Ref ID J:61962]

Steinberg GR; Michell BJ; van Denderen BJ; Watt MJ; Carey AL; Fam BC; Andrikopoulos S; Proietto J; Gorgun CZ; Carling D; Hotamisligil GS; Febbraio MA; Kay TW; Kemp BE. 2006. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 4(6):465-74. [PubMed: 17141630]  [MGI Ref ID J:129774]

Steinberg GR; Watt MJ; Ernst M; Birnbaum MJ; Kemp BE; Jorgensen SB. 2009. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity. Diabetes 58(4):829-39. [PubMed: 19136654]  [MGI Ref ID J:151044]

Stienstra R; Joosten LA; Koenen T; van Tits B; van Diepen JA; van den Berg SA; Rensen PC; Voshol PJ; Fantuzzi G; Hijmans A; Kersten S; Muller M; van den Berg WB; van Rooijen N; Wabitsch M; Kullberg BJ; van der Meer JW; Kanneganti T; Tack CJ; Netea MG. 2010. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12(6):593-605. [PubMed: 21109192]  [MGI Ref ID J:168117]

Stockebrand M; Sauter K; Neu A; Isbrandt D; Choe CU. 2013. Differential regulation of AMPK activation in leptin- and creatine-deficient mice. FASEB J 27(10):4147-4156. [PubMed: 23825223]  [MGI Ref ID J:201173]

Stoehr JP; Nadler ST; Schueler KL; Rabaglia ME; Yandell BS; Metz SA; Attie AD. 2000. Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci Diabetes 49(11):1946-54. [PubMed: 11078464]  [MGI Ref ID J:65486]

Stratigopoulos G; Padilla SL; Leduc CA; Watson E; Hattersley AT; McCarthy MI; Zeltser LM; Chung WK; Leibel RL. 2008. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 294(4):R1185-96. [PubMed: 18256137]  [MGI Ref ID J:133509]

Suganami E; Takagi H; Ohashi H; Suzuma K; Suzuma I; Oh H; Watanabe D; Ojima T; Suganami T; Fujio Y; Nakao K; Ogawa Y; Yoshimura N. 2004. Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 53(9):2443-8. [PubMed: 15331557]  [MGI Ref ID J:92072]

Suganami T; Yuan X; Shimoda Y; Uchio-Yamada K; Nakagawa N; Shirakawa I; Usami T; Tsukahara T; Nakayama K; Miyamoto Y; Yasuda K; Matsuda J; Kamei Y; Kitajima S; Ogawa Y. 2009. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 105(1):25-32. [PubMed: 19478204]  [MGI Ref ID J:164755]

Sugita H; Fujimoto M; Yasukawa T; Shimizu N; Sugita M; Yasuhara S; Martyn JA; Kaneki M. 2005. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 280(14):14203-11. [PubMed: 15805118]  [MGI Ref ID J:98746]

Suh JM; Jonker JW; Ahmadian M; Goetz R; Lackey D; Osborn O; Huang Z; Liu W; Yoshihara E; van Dijk TH; Havinga R; Fan W; Yin YQ; Yu RT; Liddle C; Atkins AR; Olefsky JM; Mohammadi M; Downes M; Evans RM. 2014. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature 513(7518):436-9. [PubMed: 25043058]  [MGI Ref ID J:217106]

Sun L; Xie H; Mori MA; Alexander R; Yuan B; Hattangadi SM; Liu Q; Kahn CR; Lodish HF. 2011. Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 13(8):958-65. [PubMed: 21743466]  [MGI Ref ID J:174421]

Sun S; Xia S; Ji Y; Kersten S; Qi L. 2012. The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61(6):1471-8. [PubMed: 22415881]  [MGI Ref ID J:196855]

Sun XY; Hayashi Y; Xu S; Kanou Y; Takagishi Y; Tang YP; Murata Y. 2011. Inactivation of the Rcan2 gene in mice ameliorates the age- and diet-induced obesity by causing a reduction in food intake. PLoS One 6(1):e14605. [PubMed: 21298050]  [MGI Ref ID J:169558]

Sun Y; Asnicar M; Saha PK; Chan L; Smith RG. 2006. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3(5):379-86. [PubMed: 16679295]  [MGI Ref ID J:129645]

Sunadome K; Suzuki T; Usui M; Ashida Y; Nishida E. 2014. Antagonism between the master regulators of differentiation ensures the discreteness and robustness of cell fates. Mol Cell 54(3):526-35. [PubMed: 24703953]  [MGI Ref ID J:213621]

Suto J. 2007. The A y allele at the agouti locus enhances sensitivity to endotoxin-induced lethality in mice. J Vet Med Sci 69(9):931-7. [PubMed: 17917378]  [MGI Ref ID J:141486]

Suzuki R; Lee K; Jing E; Biddinger SB; McDonald JG; Montine TJ; Craft S; Kahn CR. 2010. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 12(6):567-79. [PubMed: 21109190]  [MGI Ref ID J:168119]

Swoap SJ. 2001. Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction. Am J Physiol Heart Circ Physiol 281(6):H2473-9. [PubMed: 11709414]  [MGI Ref ID J:108672]

Swoap SJ; Weinshenker D. 2008. Norepinephrine controls both torpor initiation and emergence via distinct mechanisms in the mouse. PLoS ONE 3(12):e4038. [PubMed: 19107190]  [MGI Ref ID J:144352]

Szczypka MS; Rainey MA; Palmiter RD. 2000. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 25(1):102-4. [PubMed: 10802666]  [MGI Ref ID J:61883]

Taguchi K; Kobayashi T; Matsumoto T; Kamata K. 2011. Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/ Akt activation in aortas of ob/ob mice. Am J Physiol Heart Circ Physiol :. [PubMed: 21572010]  [MGI Ref ID J:173236]

Taguchi K; Matsumoto T; Kamata K; Kobayashi T. 2012. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving beta-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction. Endocrinology 153(7):2985-96. [PubMed: 22581458]  [MGI Ref ID J:189042]

Takahashi A; Morita M; Yokoyama K; Suzuki T; Yamamoto T. 2012. Tob2 inhibits peroxisome proliferator-activated receptor gamma2 expression by sequestering Smads and C/EBPalpha during adipocyte differentiation. Mol Cell Biol 32(24):5067-77. [PubMed: 23071089]  [MGI Ref ID J:192861]

Takahashi N; Waelput W; Guisez Y. 1999. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189(1):207-12. [PubMed: 9874578]  [MGI Ref ID J:52060]

Takeda S; Elefteriou F; Levasseur R; Liu X; Zhao L; Parker KL; Armstrong D; Ducy P; Karsenty G. 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3):305-17. [PubMed: 12419242]  [MGI Ref ID J:79873]

Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R. 2010. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 107(15):7036-41. [PubMed: 20231468]  [MGI Ref ID J:159328]

Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clement K; Holvoet P; Tedgui A; Mallat Z. 2007. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 27(12):2691-8. [PubMed: 17690315]  [MGI Ref ID J:147531]

Tam J; Vemuri VK; Liu J; Batkai S; Mukhopadhyay B; Godlewski G; Osei-Hyiaman D; Ohnuma S; Ambudkar SV; Pickel J; Makriyannis A; Kunos G. 2010. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120(8):2953-66. [PubMed: 20664173]  [MGI Ref ID J:163760]

Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100(26):15924-9. [PubMed: 14676330]  [MGI Ref ID J:114135]

Tang Y; Chen A. 2014. Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling. Lab Invest 94(5):503-16. [PubMed: 24614199]  [MGI Ref ID J:208133]

Tanii M; Yonemitsu Y; Fujii T; Shikada Y; Kohno R; Onimaru M; Okano S; Inoue M; Hasegawa M; Onohara T; Maehara Y; Sueishi K. 2006. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res 98(1):55-62. [PubMed: 16306442]  [MGI Ref ID J:118090]

Tarzi RM; Cook HT; Jackson I; Pusey CD; Lord GM. 2004. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol 164(2):385-90. [PubMed: 14742244]  [MGI Ref ID J:88373]

Tattikota SG; Rathjen T; McAnulty SJ; Wessels HH; Akerman I; van de Bunt M; Hausser J; Esguerra JL; Musahl A; Pandey AK; You X; Chen W; Herrera PL; Johnson PR; O'Carroll D; Eliasson L; Zavolan M; Gloyn AL; Ferrer J; Shalom-Feuerstein R; Aberdam D; Poy MN. 2014. Argonaute2 mediates compensatory expansion of the pancreatic beta cell. Cell Metab 19(1):122-34. [PubMed: 24361012]  [MGI Ref ID J:210552]

Taylor IL; Garcia R. 1985. Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice. Am J Physiol 248(3 Pt 1):G277-80. [PubMed: 3976886]  [MGI Ref ID J:7767]

Teng R; Gavrilova O; Suzuki N; Chanturiya T; Schimel D; Hugendubler L; Mammen S; Yver DR; Cushman SW; Mueller E; Yamamoto M; Hsu LL; Noguchi CT. 2011. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun 2:520. [PubMed: 22044999]  [MGI Ref ID J:220935]

Thrybom T; Rooth P; Lindstrom P. 2001. Effect of serotonin reuptake inhibitor on syndrome development in obese hyperglycemic mice (Umea ob/ob). Metabolism 50(2):144-50. [PubMed: 11229420]  [MGI Ref ID J:68407]

Thurlby PL; Trayhurn P. 1979. The role of thermoregulatory thermogenesis in the development of obesity in genetically-obese (ob/ob) mice pair-fed with lean siblings. Br J Nutr 42(3):377-85. [PubMed: 508700]  [MGI Ref ID J:6236]

Togliatto G; Trombetta A; Dentelli P; Baragli A; Rosso A; Granata R; Ghigo D; Pegoraro L; Ghigo E; Brizzi MF. 2010. Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 59(4):1016-25. [PubMed: 20068135]  [MGI Ref ID J:164337]

Toh SY; Gong J; Du G; Li JZ; Yang S; Ye J; Yao H; Zhang Y; Xue B; Li Q; Yang H; Wen Z; Li P. 2008. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS ONE 3(8):e2890. [PubMed: 18682832]  [MGI Ref ID J:140122]

Torre-Villalvazo I; Gonzalez F; Aguilar-Salinas CA; Tovar AR; Torres N. 2009. Dietary soy protein reduces cardiac lipid accumulation and the ceramide concentration in high-fat diet-fed rats and ob/ob mice. J Nutr 139(12):2237-43. [PubMed: 19828684]  [MGI Ref ID J:154693]

Trayhurn P; James WP. 1978. Thermoregulation and non-shivering thermogenesis in the genetically obese (ob/ob) mouse. Pflugers Arch 373(2):189-93. [PubMed: 565045]  [MGI Ref ID J:5958]

Trayhurn P; Thomas ME; Duncan JS; Rayner DV. 1995. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (oblob) mice. FEBS Lett 368(3):488-90. [PubMed: 7635205]  [MGI Ref ID J:27455]

Trayhurn P; Thurlby PL; James WP. 1977. Thermogenic defect in pre-obese ob/ob mice. Nature 266(5597):60-2. [PubMed: 840297]  [MGI Ref ID J:12010]

Trevaskis JL; Butler AA. 2005. Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake. Endocrinology 146(10):4257-65. [PubMed: 15994342]  [MGI Ref ID J:101555]

Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD. 2012. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 302(8):G762-72. [PubMed: 22268099]  [MGI Ref ID J:185386]

Trevaskis JL; Meyer EA; Galgani JE; Butler AA. 2008. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice. Endocrinology 149(1):174-84. [PubMed: 17932216]  [MGI Ref ID J:141477]

Trotter-Mayo RN; Roberts MR. 2008. Leptin acts in the periphery to protect thymocytes from glucocorticoid-mediated apoptosis in the absence of weight loss. Endocrinology 149(10):5209-18. [PubMed: 18583419]  [MGI Ref ID J:145495]

Tsai WW; Niessen S; Goebel N; Yates JR 3rd; Guccione E; Montminy M. 2013. PRMT5 modulates the metabolic response to fasting signals. Proc Natl Acad Sci U S A 110(22):8870-5. [PubMed: 23671120]  [MGI Ref ID J:197425]

Tschop J; Nogueiras R; Haas-Lockie S; Kasten KR; Castaneda TR; Huber N; Guanciale K; Perez-Tilve D; Habegger K; Ottaway N; Woods SC; Oldfield B; Clarke I; Chua S Jr; Farooqi IS; O'Rahilly S; Caldwell CC; Tschop MH. 2010. CNS leptin action modulates immune response and survival in sepsis. J Neurosci 30(17):6036-47. [PubMed: 20427662]  [MGI Ref ID J:159827]

Tsurutani Y; Fujimoto M; Takemoto M; Irisuna H; Koshizaka M; Onishi S; Ishikawa T; Mezawa M; He P; Honjo S; Maezawa Y; Saito Y; Yokote K. 2011. The roles of transforming growth factor-beta and Smad3 signaling in adipocyte differentiation and obesity. Biochem Biophys Res Commun 407(1):68-73. [PubMed: 21356196]  [MGI Ref ID J:171952]

Tsutsumi A; Motoshima H; Kondo T; Kawasaki S; Matsumura T; Hanatani S; Igata M; Ishii N; Kinoshita H; Kawashima J; Taketa K; Furukawa N; Tsuruzoe K; Nishikawa T; Araki E. 2011. Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice. Biochem Biophys Res Commun 404(1):339-44. [PubMed: 21134353]  [MGI Ref ID J:167445]

Tu Z; Keller MP; Zhang C; Rabaglia ME; Greenawalt DM; Yang X; Wang IM; Dai H; Bruss MD; Lum PY; Zhou YP; Kemp DM; Kendziorski C; Yandell BS; Attie AD; Schadt EE; Zhu J. 2012. Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets. PLoS Genet 8(12):e1003107. [PubMed: 23236292]  [MGI Ref ID J:194853]

Turner SM; Roy S; Sul HS; Neese RA; Murphy EJ; Samandi W; Roohk DJ; Hellerstein MK. 2007. Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice. Am J Physiol Endocrinol Metab 292(4):E1101-9. [PubMed: 17164440]  [MGI Ref ID J:120374]

Turpin SM; Hoy AJ; Brown RD; Garcia Rudaz C; Honeyman J; Matzaris M; Watt MJ. 2010. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia :. [PubMed: 20842343]  [MGI Ref ID J:164672]

Turpin SM; Ryall JG; Southgate R; Darby I; Hevener AL; Febbraio MA; Kemp BE; Lynch GS; Watt MJ. 2009. Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J Physiol 587(Pt 7):1593-605. [PubMed: 19204053]  [MGI Ref ID J:176545]

Udagawa J; Hashimoto R; Hioki K; Otani H. 2006. The role of leptin in the development of the cortical neuron in mouse embryos. Brain Res 1120(1):74-82. [PubMed: 17020752]  [MGI Ref ID J:116065]

Udagawa J; Hashimoto R; Suzuki H; Hatta T; Sotomaru Y; Hioki K; Kagohashi Y; Nomura T; Minami Y; Otani H. 2006. The role of leptin in the development of the cerebral cortex in mouse embryos. Endocrinology 147(2):647-58. [PubMed: 16282354]  [MGI Ref ID J:105139]

Udagawa J; Nimura M; Kagohashi Y; Otani H. 2006. Leptin deficiency causes pycnotic change in fetal cingulate cortical cells. Congenit Anom (Kyoto) 46(1):16-20. [PubMed: 16643594]  [MGI Ref ID J:111445]

Ueno N; Oh-ishi S; Segawa M; Nishida M; Fukuwatari Y; Kizaki T; Ookawara T; Ohno H. 1998. Effect of age on brown adipose tissue activity in the obese (ob/ob) mouse. Mech Ageing Dev 100(1):67-76. [PubMed: 9509396]  [MGI Ref ID J:46004]

Ukropec J; Anunciado RV; Ravussin Y; Kozak LP. 2006. Leptin is required for uncoupling protein-1-independent thermogenesis during cold stress. Endocrinology 147(5):2468-80. [PubMed: 16469807]  [MGI Ref ID J:129662]

Um SH; Frigerio F; Watanabe M; Picard F; Joaquin M; Sticker M; Fumagalli S; Allegrini PR; Kozma SC; Auwerx J; Thomas G. 2004. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431(7005):200-5. [PubMed: 15306821]  [MGI Ref ID J:92663]

Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS. 2000. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141(9):3388-96. [PubMed: 10965911]  [MGI Ref ID J:108811]

Uysal KT; Wiesbrock SM; Hotamisligil GS. 1998. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139(12):4832-8. [PubMed: 9832419]  [MGI Ref ID J:110666]

Vachharajani V; Russell JM; Scott KL; Conrad S; Stokes KY; Tallam L; Hall J; Granger DN. 2005. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 12(2):183-94. [PubMed: 15828130]  [MGI Ref ID J:114228]

Valerio A; Cardile A; Cozzi V; Bracale R; Tedesco L; Pisconti A; Palomba L; Cantoni O; Clementi E; Moncada S; Carruba MO; Nisoli E. 2006. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116(10):2791-8. [PubMed: 16981010]  [MGI Ref ID J:115008]

Van den Bergh A; Vanderper A; Vangheluwe P; Desjardins F; Nevelsteen I; Verreth W; Wuytack F; Holvoet P; Flameng W; Balligand JL; Herijgers P. 2008. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res 77(2):371-9. [PubMed: 18006491]  [MGI Ref ID J:161915]

Vegiopoulos A; Muller-Decker K; Strzoda D; Schmitt I; Chichelnitskiy E; Ostertag A; Berriel Diaz M; Rozman J; Hrabe de Angelis M; Nusing RM; Meyer CW; Wahli W; Klingenspor M; Herzig S. 2010. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 328(5982):1158-61. [PubMed: 20448152]  [MGI Ref ID J:160553]

Vergnes L; Beigneux AP; Davis R; Watkins SM; Young SG; Reue K. 2006. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 47(4):745-54. [PubMed: 16436371]  [MGI Ref ID J:108332]

Vernooy JH; Bracke KR; Drummen NE; Pauwels NS; Zabeau L; van Suylen RJ; Tavernier J; Joos GF; Wouters EF; Brusselle GG. 2010. Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. J Immunol 184(12):7169-77. [PubMed: 20488786]  [MGI Ref ID J:161133]

Vicent D; Maratos-Flier E; Kahn CR. 2000. The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob/ob mouse and induced by adipogenesis. Mol Cell Biol 20(6):2158-66. [PubMed: 10688662]  [MGI Ref ID J:60599]

Vicent D; Piper M; Gammeltoft S; Maratos-Flier E; Kahn CR. 1998. Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display [published erratum appears in Diabetes 1998 Dec;47(12):1978] Diabetes 47(9):1451-8. [PubMed: 9726234]  [MGI Ref ID J:49410]

Vidal-Puig A; Jimenez-Linan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE. 1996. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97(11):2553-61. [PubMed: 8647948]  [MGI Ref ID J:33358]

Vieira E; Marroqui L; Batista TM; Caballero-Garrido E; Carneiro EM; Boschero AC; Nadal A; Quesada I. 2012. The clock gene Rev-erbalpha regulates pancreatic beta-cell function: modulation by leptin and high-fat diet. Endocrinology 153(2):592-601. [PubMed: 22166979]  [MGI Ref ID J:181732]

Vienberg SG; Kleinridders A; Suzuki R; Kahn CR. 2015. Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity. Mol Metab 4(2):144-50. [PubMed: 25685701]  [MGI Ref ID J:220980]

Villanueva CJ; Waki H; Godio C; Nielsen R; Chou WL; Vargas L; Wroblewski K; Schmedt C; Chao LC; Boyadjian R; Mandrup S; Hevener A; Saez E; Tontonoz P. 2011. TLE3 is a dual-function transcriptional coregulator of adipogenesis. Cell Metab 13(4):413-27. [PubMed: 21459326]  [MGI Ref ID J:172245]

Villasenor A; Wang ZV; Rivera LB; Ocal O; Asterholm IW; Scherer PE; Brekken RA; Cleaver O; Wilkie TM. 2010. Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes. Dis Model Mech 3(9-10):567-80. [PubMed: 20616094]  [MGI Ref ID J:163324]

Voros G; Maquoi E; Demeulemeester D; Clerx N; Collen D; Lijnen HR. 2005. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146(10):4545-54. [PubMed: 16020476]  [MGI Ref ID J:129817]

Voros G; Sandy JD; Collen D; Lijnen HR. 2006. Expression of aggrecan(ases) during murine preadipocyte differentiation and adipose tissue development. Biochim Biophys Acta 1760(12):1837-44. [PubMed: 17011710]  [MGI Ref ID J:117021]

Wade JM; Juneja P; MacKay AW; Graham J; Havel PJ; Tecott LH; Goulding EH. 2008. Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors. Endocrinology 149(3):955-61. [PubMed: 18039786]  [MGI Ref ID J:135963]

Wan M; Easton RM; Gleason CE; Monks BR; Ueki K; Kahn CR; Birnbaum MJ. 2012. Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity. Mol Cell Biol 32(1):96-106. [PubMed: 22037765]  [MGI Ref ID J:182721]

Wang CY; X738b X798e X9685; Stapleton DS; Schueler KL; Rabaglia ME; Oler AT; Keller MP; Kendziorski CM; Broman KW; Yandell BS; Schadt EE; Attie AD. 2012. Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis. J Lipid Res 53(8):1493-1501. [PubMed: 22628617]  [MGI Ref ID J:186560]

Wang F; Tong Q. 2008. Transcription factor PU.1 is expressed in white adipose and inhibits adipocyte differentiation. Am J Physiol Cell Physiol 295(1):C213-20. [PubMed: 18463231]  [MGI Ref ID J:138523]

Wang J; Liu R; Wang F; Hong J; Li X; Chen M; Ke Y; Zhang X; Ma Q; Wang R; Shi J; Cui B; Gu W; Zhang Y; Zhang Z; Wang W; Xia X; Liu M; Ning G. 2013. Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch. Nat Cell Biol 15(12):1455-63. [PubMed: 24212090]  [MGI Ref ID J:208298]

Wang X; Ota N; Manzanillo P; Kates L; Zavala-Solorio J; Eidenschenk C; Zhang J; Lesch J; Lee WP; Ross J; Diehl L; van Bruggen N; Kolumam G; Ouyang W. 2014. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514(7521):237-41. [PubMed: 25119041]  [MGI Ref ID J:217078]

Wang XQ; Lee S; Wilson H; Seeger M; Iordanov H; Gatla N; Whittington A; Bach D; Lu JY; Paller AS. 2014. Ganglioside GM3 Depletion Reverses Impaired Wound Healing in Diabetic Mice by Activating IGF-1 and Insulin Receptors. J Invest Dermatol 134(5):1446-55. [PubMed: 24326453]  [MGI Ref ID J:208060]

Wang Y; Botolin D; Xu J; Christian B; Mitchell E; Jayaprakasam B; Nair MG; Peters JM; Busik JV; Olson LK; Jump DB. 2006. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 47(9):2028-41. [PubMed: 16790840]  [MGI Ref ID J:114583]

Wang YC; Li Y; Wang XY; Zhang D; Zhang H; Wu Q; He YQ; Wang JY; Zhang L; Xia H; Yan J; Li X; Ying H. 2013. Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity. Diabetologia 56(10):2275-85. [PubMed: 23868745]  [MGI Ref ID J:203291]

Warne JP; Varonin JM; Nielsen SS; Olofsson LE; Kaelin CB; Chua S Jr; Barsh GS; Koliwad SK; Xu AW. 2013. Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein. J Neurosci 33(29):11972-85. [PubMed: 23864684]  [MGI Ref ID J:199803]

Watanabe K; Watson E; Cremona ML; Millings EJ; Lefkowitch JH; Fischer SG; LeDuc CA; Leibel RL. 2013. ILDR2: an endoplasmic reticulum resident molecule mediating hepatic lipid homeostasis. PLoS One 8(6):e67234. [PubMed: 23826244]  [MGI Ref ID J:204339]

Watanabe M; Houten SM; Wang L; Moschetta A; Mangelsdorf DJ; Heyman RA; Moore DD; Auwerx J. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113(10):1408-18. [PubMed: 15146238]  [MGI Ref ID J:120199]

Watanabe T; Kubota N; Ohsugi M; Kubota T; Takamoto I; Iwabu M; Awazawa M; Katsuyama H; Hasegawa C; Tokuyama K; Moroi M; Sugi K; Yamauchi T; Noda T; Nagai R; Terauchi Y; Tobe K; Ueki K; Kadowaki T. 2009. Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways. J Biol Chem 284(3):1803-12. [PubMed: 19008231]  [MGI Ref ID J:145886]

Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR. 2005. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology 146(12):5151-63. [PubMed: 16141392]  [MGI Ref ID J:129798]

Watson SL; Watson CJ; Baghdoyan HA; Lydic R. 2014. Adenosine A(1) receptors in mouse pontine reticular formation modulate nociception only in the presence of systemic leptin. Neuroscience 275:531-9. [PubMed: 24976513]  [MGI Ref ID J:215652]

Wei Z; Peterson JM; Lei X; Cebotaru L; Wolfgang MJ; Baldeviano GC; Wong GW. 2012. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J Biol Chem 287(13):10301-15. [PubMed: 22275362]  [MGI Ref ID J:183116]

Weigle DS; Bukowski TR; Foster DC; Holderman S; Kramer JM; Lasser G; Lofton-Day CE; Prunkard DE; Raymond C; Kuijper JL. 1995. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96(4):2065-70. [PubMed: 7560100]  [MGI Ref ID J:29075]

Weinstock PH; Levak-Frank S; Hudgins LC; Radner H; Friedman JM ; Zechner R ; Breslow JL. 1997. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A 94(19):10261-6. [PubMed: 9294198]  [MGI Ref ID J:42930]

Wellen KE; Fucho R; Gregor MF; Furuhashi M; Morgan C; Lindstad T; Vaillancourt E; Gorgun CZ; Saatcioglu F; Hotamisligil GS. 2007. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129(3):537-48. [PubMed: 17482547]  [MGI Ref ID J:187736]

Wendel AA; Li LO; Li Y; Cline GW; Shulman GI; Coleman RA. 2010. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 59(6):1321-9. [PubMed: 20200319]  [MGI Ref ID J:169655]

Wendel AA; Purushotham A; Liu LF; Belury MA. 2008. Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res 49(1):98-106. [PubMed: 17906221]  [MGI Ref ID J:130036]

Wieland CW; Florquin S; Chan ED; Leemans JC; Weijer S; Verbon A; Fantuzzi G; van der Poll T. 2005. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 17(11):1399-408. [PubMed: 16141243]  [MGI Ref ID J:102314]

Winer S; Chan Y; Paltser G; Truong D; Tsui H; Bahrami J; Dorfman R; Wang Y; Zielenski J; Mastronardi F; Maezawa Y; Drucker DJ; Engleman E; Winer D; Dosch HM. 2009. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15(8):921-9. [PubMed: 19633657]  [MGI Ref ID J:152185]

Wolfrum C; Asilmaz E; Luca E; Friedman JM; Stoffel M. 2004. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432(7020):1027-32. [PubMed: 15616563]  [MGI Ref ID J:95662]

Wolfrum C; Howell JJ; Ndungo E; Stoffel M. 2008. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M. J Biol Chem 283(24):16940-9. [PubMed: 18381283]  [MGI Ref ID J:138581]

Won EY; Yoon MK; Kim SW; Jung Y; Bae HW; Lee D; Park SG; Lee CH; Hwang GS; Chi SW. 2013. Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One 8(10):e75998. [PubMed: 24098417]  [MGI Ref ID J:209039]

Wong GW; Krawczyk SA; Kitidis-Mitrokostas C; Ge G; Spooner E; Hug C; Gimeno R; Lodish HF. 2009. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J 23(1):241-58. [PubMed: 18787108]  [MGI Ref ID J:146036]

Wright WS; Longo KA; Dolinsky VW; Gerin I; Kang S; Bennett CN; Chiang SH; Prestwich TC; Gress C; Burant CF; Susulic VS; MacDougald OA. 2007. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 56(2):295-303. [PubMed: 17259372]  [MGI Ref ID J:121960]

Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J. 2011. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways. PLoS One 6(3):e17868. [PubMed: 21437243]  [MGI Ref ID J:171687]

Wu D; Molofsky AB; Liang HE; Ricardo-Gonzalez RR; Jouihan HA; Bando JK; Chawla A; Locksley RM. 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332(6026):243-7. [PubMed: 21436399]  [MGI Ref ID J:170307]

Wu Q; Whiddon BB; Palmiter RD. 2012. Ablation of neurons expressing agouti-related protein, but not melanin concentrating hormone, in leptin-deficient mice restores metabolic functions and fertility. Proc Natl Acad Sci U S A 109(8):3155-60. [PubMed: 22232663]  [MGI Ref ID J:181947]

Wu X; Ge H; Lemon B; Vonderfecht S; Baribault H; Weiszmann J; Gupte J; Gardner J; Lindberg R; Wang Z; Li Y. 2010. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc Natl Acad Sci U S A 107(32):14158-63. [PubMed: 20660733]  [MGI Ref ID J:163608]

Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y. 2009. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Proc Natl Acad Sci U S A 106(34):14379-84. [PubMed: 19706524]  [MGI Ref ID J:151994]

Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y. 2012. A unique FGF23 with the ability to activate FGFR signaling through both alphaKlotho and betaKlotho. J Mol Biol 418(1-2):82-9. [PubMed: 22370560]  [MGI Ref ID J:197702]

Wu Y; Kim JY; Zhou S; Smas CM. 2008. Differential screening identifies transcripts with depot-dependent expression in white adipose tissues. BMC Genomics 9:397. [PubMed: 18721461]  [MGI Ref ID J:141023]

Wueest S; Rapold RA; Schumann DM; Rytka JM; Schildknecht A; Nov O; Chervonsky AV; Rudich A; Schoenle EJ; Donath MY; Konrad D. 2010. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest 120(1):191-202. [PubMed: 19955656]  [MGI Ref ID J:156776]

Xia Z; Sniderman AD; Cianflone K. 2002. Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice. J Biol Chem 277(48):45874-9. [PubMed: 12244109]  [MGI Ref ID J:80546]

Xiang L; Hester RL. 2009. Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice. Am J Physiol Heart Circ Physiol 297(2):H689-95. [PubMed: 19502550]  [MGI Ref ID J:151096]

Xie H; Lim B; Lodish HF. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58(5):1050-7. [PubMed: 19188425]  [MGI Ref ID J:151131]

Xin XG; Huang XF. 1998. Down-regulated NPY receptor subtype-5 mRNA expression in genetically obese mouse brain. Neuroreport 9(4):737-41. [PubMed: 9559948]  [MGI Ref ID J:46895]

Xu A; Liu J; Liu P; Jia M; Wang H; Tao L. 2014. Mitochondrial translocation of Nur77 induced by ROS contributed to cardiomyocyte apoptosis in metabolic syndrome. Biochem Biophys Res Commun 446(4):1184-9. [PubMed: 24680679]  [MGI Ref ID J:219470]

Xu H; Barnes GT; Yang Q; Tan G; Yang D; Chou CJ; Sole J; Nichols A; Ross JS; Tartaglia LA; Chen H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-30. [PubMed: 14679177]  [MGI Ref ID J:86952]

Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg RA; Veniant MM. 2009. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models----Association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab :. [PubMed: 19706786]  [MGI Ref ID J:159573]

Xu J; Wang P; Li Y; Li G; Kaczmarek LK; Wu Y; Koni PA; Flavell RA; Desir GV. 2004. The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci U S A 101(9):3112-7. [PubMed: 14981264]  [MGI Ref ID J:88651]

Xu N; Nilsson-Ehle P; Hurtig M; Ahren B. 2004. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo. Biochem Biophys Res Commun 321(4):916-21. [PubMed: 15358114]  [MGI Ref ID J:91738]

Xu X; Grijalva A; Skowronski A; van Eijk M; Serlie MJ; Ferrante AW Jr. 2013. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab 18(6):816-30. [PubMed: 24315368]  [MGI Ref ID J:206140]

Xue P; Hou Y; Chen Y; Yang B; Fu J; Zheng H; Yarborough K; Woods CG; Liu D; Yamamoto M; Zhang Q; Andersen ME; Pi J. 2013. Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes 62(3):845-54. [PubMed: 23238296]  [MGI Ref ID J:208590]

Xue Y; Shen L; Cui Y; Zhang H; Chen Q; Cui A; Fang F; Chang Y. 2013. Tff3, as a novel peptide, regulates hepatic glucose metabolism. PLoS One 8(9):e75240. [PubMed: 24086476]  [MGI Ref ID J:207742]

Yadav VK; Oury F; Tanaka KF; Thomas T; Wang Y; Cremers S; Hen R; Krust A; Chambon P; Karsenty G. 2011. Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications. J Exp Med 208(1):41-52. [PubMed: 21187319]  [MGI Ref ID J:176858]

Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N. 2002. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277(22):19353-7. [PubMed: 11923308]  [MGI Ref ID J:76758]

Yahagi N; Shimano H; Matsuzaka T; Najima Y; Sekiya M; Nakagawa Y; Ide T; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Gotoda T; Nagai R; Kimura S; Ishibashi S; Osuga J; Yamada N. 2003. p53 Activation in adipocytes of obese mice. J Biol Chem 278(28):25395-400. [PubMed: 12734185]  [MGI Ref ID J:120652]

Yahagi N; Shimano H; Matsuzaka T; Sekiya M; Najima Y; Okazaki S; Okazaki H; Tamura Y; Iizuka Y; Inoue N; Nakagawa Y; Takeuchi Y; Ohashi K; Harada K; Gotoda T; Nagai R; Kadowaki T; Ishibashi S; Osuga J; Yamada N. 2004. p53 involvement in the pathogenesis of fatty liver disease. J Biol Chem 279(20):20571-5. [PubMed: 14985341]  [MGI Ref ID J:124263]

Yamada N; Katsuura G; Ochi Y; Ebihara K; Kusakabe T; Hosoda K; Nakao K. 2011. Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152(7):2634-43. [PubMed: 21521746]  [MGI Ref ID J:174906]

Yamauchi T; Kamon J; Waki H; Imai Y; Shimozawa N; Hioki K; Uchida S; Ito Y; Takakuwa K; Matsui J; Takata M; Eto K; Terauchi Y; Komeda K; Tsunoda M; Murakami K; Ohnishi Y; Naitoh T; Yamamura K; Ueyama Y; Froguel P; Kimura S; Nagai R; Kadowaki T. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278(4):2461-8. [PubMed: 12431986]  [MGI Ref ID J:81727]

Yang G; Badeanlou L; Bielawski J; Roberts AJ; Hannun YA; Samad F. 2009. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 297(1):E211-24. [PubMed: 19435851]  [MGI Ref ID J:151166]

Yang M; Sun J; Zhang T; Liu J; Zhang J; Shi MA; Darakhshan F; Guerre-Millo M; Clement K; Gelb BD; Dolgnov G; Shi GP. 2008. Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol 28(12):2202-8. [PubMed: 18818416]  [MGI Ref ID J:159791]

Yang M; Zhang Y; Pan J; Sun J; Liu J; Libby P; Sukhova GK; Doria A; Katunuma N; Peroni OD; Guerre-Millo M; Kahn BB; Clement K; Shi GP. 2007. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 9(8):970-7. [PubMed: 17643114]  [MGI Ref ID J:129484]

Yang R; Sikka G; Larson J; Watts VL; Niu X; Ellis C; Miller K; Camara A; Reinke C; Savransky V; Polotsky VY; O'Donnell CP; Berkowitz DE; Barouch LA. 2011. Restoring Leptin Signaling Reduces Hyperlipidemia and Improves Vascular Stiffness Induced by Chronic Intermittent Hypoxia. Am J Physiol Heart Circ Physiol :. [PubMed: 21278136]  [MGI Ref ID J:168540]

Yang RY; Yu L; Graham JL; Hsu DK; Lloyd KC; Havel PJ; Liu FT. 2011. Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice. Proc Natl Acad Sci U S A 108(46):18696-701. [PubMed: 21969596]  [MGI Ref ID J:180097]

Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM. 2001. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61(13):5016-23. [PubMed: 11431335]  [MGI Ref ID J:70169]

Yang SQ; Lin HZ; Mandal AK; Huang J; Diehl AM. 2001. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34(4 Pt 1):694-706. [PubMed: 11584365]  [MGI Ref ID J:106504]

Yang X; Wang X; Liu D; Yu L; Xue B; Shi H. 2014. Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol Endocrinol 28(4):565-74. [PubMed: 24597547]  [MGI Ref ID J:213063]

Ye H; Charpin-El Hamri G; Zwicky K; Christen M; Folcher M; Fussenegger M. 2013. Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc Natl Acad Sci U S A 110(1):141-6. [PubMed: 23248313]  [MGI Ref ID J:192622]

Ye J; Gao Z; Yin J; He Q. 2007. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118-28. [PubMed: 17666485]  [MGI Ref ID J:125547]

Yeh JK; Evans JF; Niu QT; Aloia JF. 2006. A possible role for melanocortin peptides in longitudinal growth. J Endocrinol 191(3):677-86. [PubMed: 17170224]  [MGI Ref ID J:116680]

Yekollu SK; Thomas R; O'Sullivan B. 2011. Targeting curcusomes to inflammatory dendritic cells inhibits NF-kappaB and improves insulin resistance in obese mice. Diabetes 60(11):2928-38. [PubMed: 21885868]  [MGI Ref ID J:189374]

Yi CX; Tschop MH; Woods SC; Hofmann SM. 2012. High-fat-diet exposure induces IgG accumulation in hypothalamic microglia. Dis Model Mech 5(5):686-90. [PubMed: 22381575]  [MGI Ref ID J:187483]

Yi P; Park JS; Melton DA. 2013. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153(4):747-58. [PubMed: 23623304]  [MGI Ref ID J:197679]

Yin J; Gao Z; He Q; Zhou D; Guo Z; Ye J. 2009. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296(2):E333-42. [PubMed: 19066318]  [MGI Ref ID J:146063]

Yin J; Lee JH; Zhang J; Gao Z; Polotsky VY; Ye J. 2014. Regulation of hepatocyte growth factor expression by NF-kappaB and PPARgamma in adipose tissue. Am J Physiol Endocrinol Metab 306(8):E929-36. [PubMed: 24569592]  [MGI Ref ID J:212286]

Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413(6852):131-8. [PubMed: 11557972]  [MGI Ref ID J:120036]

Yoon JW; Leiter EH; Coleman DL; Kim MK; Pak CY; McArthur RG; Roncari DA. 1988. Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes 37(9):1287-93. [PubMed: 3044893]  [MGI Ref ID J:109940]

Yoshihara E; Fujimoto S; Inagaki N; Okawa K; Masaki S; Yodoi J; Masutani H. 2010. Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity. Nat Commun 1:127. [PubMed: 21119640]  [MGI Ref ID J:220940]

Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499(7456):97-101. [PubMed: 23803760]  [MGI Ref ID J:204711]

Yu Y; Liu Y; Shi FD; Zou H; Matarese G; La Cava A. 2013. Cutting Edge: Leptin-Induced RORgammat Expression in CD4+ T Cells Promotes Th17 Responses in Systemic Lupus Erythematosus. J Immunol 190(7):3054-8. [PubMed: 23447682]  [MGI Ref ID J:194839]

Yuan M; Konstantopoulos N; Lee J; Hansen L; Li ZW; Karin M; Shoelson SE. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535):1673-7. [PubMed: 11533494]  [MGI Ref ID J:94827]

Zhang CY; Baffy G; Perret P; Krauss S; Peroni O; Grujic D; Hagen T; Vidal-Puig AJ; Boss O; Kim YB; Zheng XX; Wheeler MB; Shulman GI; Chan CB; Lowell BB. 2001. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105(6):745-55. [PubMed: 11440717]  [MGI Ref ID J:75196]

Zhang F; Dey D; Branstrom R; Forsberg L; Lu M; Zhang Q; Sjoholm A. 2009. BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner. Am J Physiol Cell Physiol 296(2):C346-54. [PubMed: 19052259]  [MGI Ref ID J:146323]

Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S. 2013. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARalpha-dependent and -independent pathways. Am J Physiol Gastrointest Liver Physiol 304(1):G72-86. [PubMed: 23104557]  [MGI Ref ID J:194703]

Zhang J; Nakatsu Y; Shinjo T; Guo Y; Sakoda H; Yamamotoya T; Otani Y; Okubo H; Kushiyama A; Fujishiro M; Fukushima T; Tsuchiya Y; Kamata H; Iwashita M; Nishimura F; Katagiri H; Takahashi S; Kurihara H; Uchida T; Asano T. 2013. Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions. J Biol Chem 288(28):20692-701. [PubMed: 23720771]  [MGI Ref ID J:201792]

Zhang L; Song NN; Chen JY; Huang Y; Li H; Ding YQ. 2012. Satb2 is required for dendritic arborization and soma spacing in mouse cerebral cortex. Cereb Cortex 22(7):1510-9. [PubMed: 21885532]  [MGI Ref ID J:198550]

Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M. 2007. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 100(7):1063-70. [PubMed: 17347480]  [MGI Ref ID J:133914]

Zhang P; O'Loughlin L; Brindley DN; Reue K. 2008. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 49(7):1519-28. [PubMed: 18362392]  [MGI Ref ID J:138464]

Zhang W; Lilja L; Mandic SA; Gromada J; Smidt K; Janson J; Takai Y; Bark C; Berggren PO; Meister B. 2006. Tomosyn is expressed in beta-cells and negatively regulates insulin exocytosis. Diabetes 55(3):574-81. [PubMed: 16505218]  [MGI Ref ID J:106861]

Zhang X; Zhang G; Zhang H; Karin M; Bai H; Cai D. 2008. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135(1):61-73. [PubMed: 18854155]  [MGI Ref ID J:149873]

Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y. 2012. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors. J Biol Chem 287(45):37973-85. [PubMed: 22969086]  [MGI Ref ID J:192963]

Zhang Y; Proenca R; Maffei M; Barone M; Leopold L; Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479] [see comments] Nature 372(6505):425-32. [PubMed: 7984236]  [MGI Ref ID J:20512]

Zhou X; Benson KF; Ashar HR; Chada K. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C [see comments] Nature 376(6543):771-4. [PubMed: 7651535]  [MGI Ref ID J:28571]

Zhu X; Chung S; Bi X; Chuang CC; Brown AL; Liu M; Seo J; Cuffe H; Gebre AK; Boudyguina E; Parks JS. 2013. Myeloid cell-specific ABCA1 deletion does not worsen insulin resistance in HF diet-induced or genetically obese mouse models. J Lipid Res 54(10):2708-17. [PubMed: 23894207]  [MGI Ref ID J:202623]

Ziouzenkova O; Orasanu G; Sharlach M; Akiyama TE; Berger JP; Viereck J; Hamilton JA; Tang G; Dolnikowski GG; Vogel S; Duester G; Plutzky J. 2007. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 13(6):695-702. [PubMed: 17529981]  [MGI Ref ID J:121870]

Zyromski NJ; Mathur A; Pitt HA; Lu D; Gripe JT; Walker JJ; Yancey K; Wade TE; Swartz-Basile DA. 2008. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 295(3):G552-8. [PubMed: 18583460]  [MGI Ref ID J:141913]

van der Velde M; van der Eerden BC; Sun Y; Almering JM; van der Lely AJ; Delhanty PJ; Smith RG; van Leeuwen JP. 2012. An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 153(8):3593-602. [PubMed: 22700774]  [MGI Ref ID J:189083]

von Meyenn F; Porstmann T; Gasser E; Selevsek N; Schmidt A; Aebersold R; Stoffel M. 2013. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. Cell Metab 17(3):436-47. [PubMed: 23416070]  [MGI Ref ID J:198161]

Health & husbandry

The genotypes of the animals provided may not reflect those discussed in the strain description or the mating scheme utilized by The Jackson Laboratory prior to cryopreservation. Please inquire for possible genotypes for this specific strain.

Health & Colony Maintenance Information

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200.

Colony Maintenance

Breeding & HusbandryWhen maintaining a live colony, these mice are bred as heterozygous for the ob mutation and homozygous for the LDLR mutation.

Pricing and Purchasing

Pricing, Supply Level & Notes, Controls

Pricing for USA, Canada and Mexico shipping destinations View International Pricing


Cryopreserved Mice - Ready for Recovery

Price (US dollars $)
Cryorecovery* $2225.00
Animals Provided

At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.

Standard Supply

Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.

Supply Notes

  • Cryorecovery - Standard.
    Progeny testing is not required.

    The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

    Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).

Pricing for International shipping destinations View USA Canada and Mexico Pricing


Cryopreserved Mice - Ready for Recovery

Price (US dollars $)
Cryorecovery* $2892.50
Animals Provided

At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.

Standard Supply

Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.

Supply Notes

  • Cryorecovery - Standard.
    Progeny testing is not required.

    The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

    Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).

View USA Canada and Mexico Pricing View International Pricing

Standard Supply

Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.

Control Information

   Wild-type for Lepob, Homozygous for Ldlrtm1Her
   000664 C57BL/6J
  Considerations for Choosing Controls
  Control Pricing Information for Genetically Engineered Mutant Strains.

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

See Terms of Use tab for General Terms and Conditions

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering Information
JAX® Mice
Surgical and Preconditioning Services
JAX® Services
Customer Services and Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form

Terms of Use

Terms of Use

General Terms and Conditions

Contact information

General inquiries regarding Terms of Use

Contracts Administration


JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

No Warranty


In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.